data_7k7a_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 7k7a _Structure_validation_residue.Date_analyzed 2020-10-02 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 25.5 p . . . . . 0 N--CA 1.467 0.414 0 CA-C-O 122.209 1.004 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 14.0 p -70.46 -27.95 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.887 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.02 -34.66 75.6 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.999 0.428 . . . . 0.0 111.571 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 3.2 tp -48.44 -57.19 11.4 Favored Pre-proline 0 CA--C 1.552 1.038 0 O-C-N 121.949 -0.469 . . . . 0.0 111.529 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -63.68 -37.84 44.08 Favored 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 121.802 1.668 . . . . 0.0 113.194 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 10.0 tp -60.99 -45.4 94.96 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.835 0.35 . . . . 0.0 111.667 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 8.5 p -65.43 -36.39 77.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 O-C-N 122.271 -0.268 . . . . 0.0 110.697 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 68.6 mt -64.43 -43.96 97.02 Favored 'Isoleucine or valine' 0 C--N 1.345 0.374 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 8.3 m-30 -69.36 -37.06 77.44 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.494 0.664 . . . . 0.0 110.592 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -63.72 -36.7 84.73 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.335 0.588 . . . . 0.0 110.652 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.55 -33.71 82.92 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.95 -25.53 63.59 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.157 0.503 . . . . 0.0 111.217 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.62 -38.69 88.55 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.139 0.495 . . . . 0.0 110.616 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.3 mp -59.5 -39.63 84.42 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.287 0.565 . . . . 0.0 110.407 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 14.7 tp -61.58 -40.97 96.67 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.384 0.611 . . . . 0.0 110.322 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 5.9 t -59.02 -46.31 88.52 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 121.333 0.587 . . . . 0.0 110.292 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.4 mt -64.47 -40.57 95.93 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.368 0.604 . . . . 0.0 110.179 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 18.2 mt -64.83 -36.58 84.8 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.062 0.458 . . . . 0.0 110.789 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -65.13 -42.21 94.1 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.249 0.547 . . . . 0.0 110.286 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 43.6 mm -63.91 -41.73 93.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 121.613 0.721 . . . . 0.0 109.967 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -62.26 -32.0 81.13 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 111.611 -0.596 . . . . 0.0 111.611 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.8 tt -58.46 -42.29 87.11 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.601 0.715 . . . . 0.0 110.819 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -66.77 -36.67 82.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.92 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 52.0 t80 . . . . . 0 C--O 1.234 0.273 0 CA-C-O 121.44 0.638 . . . . 0.0 110.422 179.98 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 47.7 t . . . . . 0 CA--C 1.539 0.538 0 CA-C-O 121.467 0.651 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 6.6 tt -67.82 -34.74 77.33 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.664 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.84 -57.52 12.11 Favored Pre-proline 0 CA--C 1.552 1.049 0 O-C-N 121.881 -0.512 . . . . 0.0 111.088 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -63.96 -34.62 58.83 Favored 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 121.797 1.664 . . . . 0.0 112.846 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 8.2 tp -60.36 -45.37 93.75 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.987 0.422 . . . . 0.0 111.705 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.34 -36.56 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 122.214 -0.304 . . . . 0.0 110.286 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 53.5 mt -63.67 -42.24 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -65.14 -36.71 85.1 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.616 0.722 . . . . 0.0 109.942 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.65 -33.39 68.24 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.129 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -70.92 -33.94 65.62 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.47 -32.26 73.12 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.152 0.501 . . . . 0.0 111.119 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -62.13 -38.95 90.91 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.276 0.56 . . . . 0.0 110.838 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 16.7 mt -63.77 -42.31 97.81 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.335 0.588 . . . . 0.0 110.418 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 22.0 tp -58.96 -30.82 68.19 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.189 0.518 . . . . 0.0 110.479 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 6.8 t -56.83 -45.93 82.01 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.984 0.421 . . . . 0.0 110.435 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 10.8 mt -64.52 -42.17 95.94 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.208 0.527 . . . . 0.0 110.249 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 6.7 mp -61.15 -37.42 82.79 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.483 0.659 . . . . 0.0 109.745 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -58.94 -35.48 73.19 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.347 0.594 . . . . 0.0 110.722 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 44.9 mm -62.17 -42.54 95.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.508 0.671 . . . . 0.0 110.205 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -62.77 -33.23 86.29 Favored Glycine 0 CA--C 1.535 1.306 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 9.3 tt . . . . . 0 N--CA 1.467 0.383 0 CA-C-O 121.43 0.633 . . . . 0.0 111.387 -179.343 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 3.2 pp . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 214' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.36 -57.4 17.01 Favored Pre-proline 0 CA--C 1.552 1.028 0 O-C-N 121.931 -0.48 . . . . 0.0 111.062 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.67 -32.1 68.98 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 121.869 1.713 . . . . 0.0 112.992 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.49 -45.31 93.61 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.084 0.469 . . . . 0.0 111.361 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.0 -36.39 77.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 O-C-N 122.132 -0.355 . . . . 0.0 110.244 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 41.8 mm -62.79 -43.71 98.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -63.04 -36.9 85.11 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.381 0.61 . . . . 0.0 109.868 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -57.74 -41.91 82.81 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.518 0.675 . . . . 0.0 110.222 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.04 -33.91 81.3 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 5.2 tp -58.91 -41.61 87.66 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.573 0.701 . . . . 0.0 110.279 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.81 -38.67 89.02 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.501 0.667 . . . . 0.0 110.151 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 1.9 tt -58.62 -38.37 77.87 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.366 0.603 . . . . 0.0 110.047 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 37.9 tp -57.91 -37.63 74.39 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.116 0.484 . . . . 0.0 110.183 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 6.5 t -59.18 -40.24 85.08 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.301 0.572 . . . . 0.0 110.401 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 11.4 mt -67.21 -42.81 83.5 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.465 0.65 . . . . 0.0 110.066 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 17.0 mt -65.69 -36.48 83.76 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.069 0.461 . . . . 0.0 111.11 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -74.98 -42.18 58.06 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.321 0.581 . . . . 0.0 110.893 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 91.1 mt -64.93 -40.56 89.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.29 0.567 . . . . 0.0 110.471 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -63.83 -34.99 91.41 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.49 -39.76 81.2 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.592 0.711 . . . . 0.0 111.248 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.31 -39.27 94.1 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.576 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -65.59 -48.13 73.39 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.503 0.668 . . . . 0.0 110.873 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -66.43 -45.98 78.02 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.589 0.709 . . . . 0.0 110.861 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 49.3 t80 . . . . . 0 CA--C 1.543 0.709 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.772 -179.74 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 39.0 p . . . . . 0 C--O 1.237 0.423 0 CA-C-O 122.498 1.142 . . . . 531.53 110.463 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 40.2 t -70.03 -29.88 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 115.258 -0.883 . . . . 589.41 110.093 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.92 -31.03 69.63 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.906 0.384 . . . . 479.21 111.18 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.3 tp -54.31 -57.67 17.37 Favored Pre-proline 0 CA--C 1.551 1.002 0 O-C-N 121.922 -0.486 . . . . 380.31 110.747 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -63.94 -32.48 65.59 Favored 'Trans proline' 0 N--CA 1.502 2.025 0 C-N-CA 121.887 1.725 . . . . 81.49 112.803 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 8.6 tp -62.06 -45.48 93.36 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.035 0.445 . . . . 454.8 111.471 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.9 p -67.91 -36.41 75.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.762 0.315 . . . . 124.98 110.505 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 43.6 mt -68.5 -43.88 83.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 121.857 -0.527 . . . . 323.67 109.743 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -67.04 -38.1 85.29 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.312 0.577 . . . . 999.99 110.246 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -57.95 -42.35 84.74 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.423 0.63 . . . . 525.2 110.27 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.8 -33.89 88.43 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 110.367 -1.093 . . . . 19.0 110.367 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 6.1 tp -60.75 -42.56 97.63 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.53 0.681 . . . . 179.74 110.653 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.73 89.31 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.402 0.62 . . . . 107.91 110.527 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.02 -37.43 76.93 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.293 0.568 . . . . 307.27 110.318 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 18.3 tp -57.67 -36.31 71.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.205 0.526 . . . . 181.56 110.337 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 5.9 t -59.7 -38.85 82.73 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.371 0.605 . . . . 222.27 110.426 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.8 mt -64.47 -42.68 95.78 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.242 0.544 . . . . 482.77 110.398 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.6 mp -71.33 -34.99 71.03 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.237 0.542 . . . . 320.5 110.718 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -70.77 -42.19 70.72 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 122.163 -0.335 . . . . 566.72 111.821 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 6.0 tp -63.84 -35.91 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.673 0.749 . . . . 433.55 110.813 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -69.14 -31.92 72.37 Favored Glycine 0 CA--C 1.533 1.206 0 N-CA-C 111.314 -0.714 . . . . 70.37 111.314 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 5.2 tt -56.98 -46.09 82.48 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.72 0.771 . . . . 271.16 110.261 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.5 -36.49 73.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.661 -0.7 . . . . 178.76 110.567 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 37.5 t80 . . . . . 0 CA--C 1.533 0.293 0 CA-C-O 121.353 0.597 . . . . 748.35 110.368 179.755 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 29.0 m . . . . . 0 CA--C 1.538 0.482 0 CA-C-O 121.444 0.64 . . . . 521.86 110.669 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 13.4 tp -68.38 -34.73 76.57 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.902 0.382 . . . . 362.12 111.276 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 1.3 tp -53.53 -57.62 16.39 Favored Pre-proline 0 CA--C 1.553 1.062 0 O-C-N 121.993 -0.442 . . . . 469.39 110.942 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.05 -32.77 64.05 Favored 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 121.928 1.752 . . . . 112.15 112.78 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 11.0 tp -62.41 -45.51 92.81 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.086 0.47 . . . . 431.79 111.548 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 8.8 p -67.79 -36.48 76.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.756 0.312 . . . . 122.15 110.412 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 43.6 mt -68.97 -42.98 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 109.423 -0.584 . . . . 232.51 109.423 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -67.75 -38.34 83.34 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.502 0.668 . . . . 419.2 110.532 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -58.73 -43.65 90.23 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.349 0.595 . . . . 604.52 110.623 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.95 -33.93 87.16 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 110.407 -1.077 . . . . 23.71 110.407 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 4.3 tp -61.32 -33.63 73.92 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.528 0.68 . . . . 248.83 111.29 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.59 -38.4 87.41 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.304 0.573 . . . . 128.21 110.956 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 2.0 mp -58.76 -38.19 77.9 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.151 0.5 . . . . 292.85 110.206 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 16.4 tp -61.83 -36.69 81.91 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.989 0.423 . . . . 253.4 110.854 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.3 -46.07 86.82 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 109.831 -0.433 . . . . 291.06 109.831 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 5.9 mp -62.03 -41.38 98.04 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.199 0.523 . . . . 465.18 110.223 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 6.8 mp -60.23 -38.62 83.97 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.234 0.54 . . . . 240.36 109.772 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -62.53 -42.31 99.43 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.343 0.592 . . . . 500.86 110.236 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 50.6 mm -62.94 -45.67 98.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.508 0.671 . . . . 283.89 110.378 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.12 -36.87 86.41 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 111.38 -0.688 . . . . 76.3 111.38 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 5.8 tt . . . . . 0 C--O 1.235 0.311 0 CA-C-O 121.5 0.667 . . . . 300.74 111.299 -179.352 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 12.4 tp . . . . . 0 C--O 1.235 0.31 0 CA-C-O 120.943 0.402 . . . . 655.96 111.316 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 214' ' ' LEU . . . . . . . . . . . . . 1.4 tp -53.19 -57.54 16.18 Favored Pre-proline 0 CA--C 1.551 1.011 0 O-C-N 121.987 -0.445 . . . . 467.81 110.989 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.73 -33.58 65.34 Favored 'Trans proline' 0 N--CA 1.503 2.053 0 C-N-CA 121.853 1.702 . . . . 101.08 113.016 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.09 -45.34 93.93 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.087 0.47 . . . . 517.53 111.362 -178.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 9.0 p -68.48 -36.46 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 O-C-N 122.136 -0.352 . . . . 155.39 110.447 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 50.1 mt -66.05 -44.6 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 O-C-N 121.787 -0.57 . . . . 353.22 109.496 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -66.71 -40.07 88.28 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.472 0.653 . . . . 628.2 110.117 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -59.92 -44.04 94.56 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.356 0.598 . . . . 546.36 110.652 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.32 -33.82 85.92 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 110.409 -1.077 . . . . 17.15 110.409 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 4.4 tp -59.76 -36.85 77.49 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.452 0.644 . . . . 154.45 111.13 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.66 -38.64 88.49 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.271 0.558 . . . . 121.22 110.9 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 1.1 mp -58.93 -39.86 82.89 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.247 0.546 . . . . 298.02 110.044 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 17.0 tp -58.01 -39.52 78.48 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.303 0.573 . . . . 233.21 110.503 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 40.5 t -59.12 -44.23 91.98 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.281 0.562 . . . . 232.53 110.475 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 8.8 mt -61.03 -43.49 98.82 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.231 0.538 . . . . 473.94 110.282 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 7.5 mp -67.96 -36.45 80.09 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.122 0.487 . . . . 313.5 110.66 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -66.11 -42.22 89.5 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.338 0.59 . . . . 476.0 110.782 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 32.2 mm -63.34 -42.23 95.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.642 0.734 . . . . 411.12 109.797 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -67.12 -33.3 82.87 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 111.54 -0.624 . . . . 61.43 111.54 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 5.0 tt -61.0 -46.12 92.04 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.638 0.732 . . . . 271.61 110.779 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -62.35 -35.93 80.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.901 -0.591 . . . . 164.03 110.8 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -61.63 -39.06 89.95 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.294 0.569 . . . . 921.52 110.402 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 5.2 mtt85 -75.26 -34.37 61.36 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.127 0.489 . . . . 999.99 111.349 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 37.7 t80 . . . . . 0 CA--C 1.541 0.616 0 CA-C-O 121.098 0.475 . . . . 812.07 111.225 179.732 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 121.578 0.704 . . . . 0.0 112.208 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 29.5 m -70.47 -33.63 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 121.626 0.727 . . . . 0.0 110.861 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 51.9 mt -69.04 -29.35 67.48 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.2 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.4 tp -54.22 -57.68 17.16 Favored Pre-proline 0 CA--C 1.551 1.004 0 O-C-N 121.862 -0.524 . . . . 0.0 110.408 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.05 -33.38 62.4 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 121.958 1.772 . . . . 0.0 112.503 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.83 -45.27 94.56 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.669 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.1 p -66.09 -36.46 77.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 O-C-N 122.087 -0.383 . . . . 0.0 110.392 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 54.5 mt -63.0 -44.53 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -65.94 -36.78 84.31 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.414 0.626 . . . . 0.0 110.032 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -57.7 -44.44 85.88 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.372 0.606 . . . . 0.0 109.786 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -66.17 -33.87 86.52 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 5.5 tp -59.79 -41.76 91.88 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.662 0.744 . . . . 0.0 110.31 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.7 -38.54 88.22 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.702 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.98 -37.15 76.16 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.378 0.609 . . . . 0.0 109.819 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 15.9 tp -61.73 -41.33 97.49 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.748 -0.595 . . . . 0.0 110.486 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 4.4 m -56.73 -40.83 76.44 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.215 0.531 . . . . 0.0 110.309 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 12.3 mt -66.11 -41.52 90.46 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.087 0.47 . . . . 0.0 110.121 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 6.7 mp -62.48 -38.53 90.21 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.202 0.525 . . . . 0.0 109.991 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -58.84 -41.82 87.82 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.308 0.575 . . . . 0.0 110.098 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 48.6 mm -63.04 -42.09 95.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 121.593 0.711 . . . . 0.0 109.966 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -63.87 -31.99 82.68 Favored Glycine 0 CA--C 1.535 1.286 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 6.8 tt -58.87 -45.76 89.4 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.636 0.731 . . . . 0.0 110.943 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -59.1 -35.91 74.24 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.957 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 37.5 t80 . . . . . 0 CA--C 1.532 0.268 0 CA-C-O 121.46 0.647 . . . . 0.0 110.31 -179.88 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 121.691 0.758 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 5.9 tt -69.42 -36.27 76.53 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.41 -57.5 15.28 Favored Pre-proline 0 CA--C 1.552 1.026 0 O-C-N 121.604 -0.685 . . . . 0.0 111.761 -177.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -63.46 -31.83 71.59 Favored 'Trans proline' 0 N--CA 1.503 2.083 0 C-N-CA 121.599 1.533 . . . . 0.0 112.942 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.86 -45.38 92.82 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.081 0.467 . . . . 0.0 111.458 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 8.0 p -69.29 -36.47 72.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 O-C-N 122.179 -0.326 . . . . 0.0 110.187 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 68.9 mt -63.01 -42.99 98.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -60.55 -36.77 79.25 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.509 0.671 . . . . 0.0 110.183 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -57.78 -43.59 85.68 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.336 0.589 . . . . 0.0 110.774 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.23 -33.92 88.57 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 6.6 tp -62.45 -37.11 84.62 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.515 0.674 . . . . 0.0 111.061 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.63 88.3 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.177 0.513 . . . . 0.0 110.877 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 7.2 mp -60.47 -45.27 94.34 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.127 0.489 . . . . 0.0 110.451 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 21.6 tp -63.42 -38.56 91.62 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.337 0.589 . . . . 0.0 109.993 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.39 -45.42 84.52 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.324 0.583 . . . . 0.0 110.291 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 3.1 tt -60.63 -46.14 91.42 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.411 0.624 . . . . 0.0 110.153 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 7.3 mp -63.0 -37.63 87.93 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.196 0.522 . . . . 0.0 110.4 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -63.44 -42.2 98.67 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.154 0.502 . . . . 0.0 110.274 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 39.5 mm -67.41 -42.76 87.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 121.592 0.71 . . . . 0.0 109.761 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -67.2 -33.1 81.87 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 4.3 tt . . . . . 0 C--O 1.235 0.311 0 CA-C-O 121.599 0.714 . . . . 0.0 111.002 -179.572 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 13.3 tp . . . . . 0 C--O 1.235 0.336 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 214' ' ' LEU . . . . . . . . . . . . . 1.3 tt -50.37 -57.02 14.31 Favored Pre-proline 0 CA--C 1.552 1.055 0 O-C-N 121.938 -0.476 . . . . 0.0 111.623 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.8 -33.68 64.13 Favored 'Trans proline' 0 N--CA 1.503 2.065 0 C-N-CA 121.841 1.694 . . . . 0.0 113.186 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.71 -45.41 94.09 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.065 0.46 . . . . 0.0 111.499 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 7.4 p -67.32 -36.44 76.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 120.848 0.356 . . . . 0.0 110.377 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 47.9 mt -68.22 -42.62 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 121.358 0.599 . . . . 0.0 109.512 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -64.06 -42.1 97.12 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.496 0.665 . . . . 0.0 110.399 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -60.15 -43.53 95.66 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.524 0.678 . . . . 0.0 110.357 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.45 -33.7 87.94 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 10.2 tp -58.96 -40.81 85.86 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.24 0.543 . . . . 0.0 110.657 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.77 -43.58 98.57 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.544 0.688 . . . . 0.0 109.686 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 1.5 tt -64.74 -39.06 92.99 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.832 0.825 . . . . 0.0 109.326 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 4.7 tt -57.94 -44.16 86.78 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.457 0.646 . . . . 0.0 110.155 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 8.2 t -59.37 -43.26 92.88 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.33 0.586 . . . . 0.0 110.824 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 10.1 mt -66.53 -42.69 86.83 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.296 0.57 . . . . 0.0 110.232 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 10.7 tp -66.63 -34.82 78.73 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.092 0.472 . . . . 0.0 110.681 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -66.48 -42.13 87.95 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.413 0.625 . . . . 0.0 110.02 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 88.3 mt -63.25 -36.3 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 121.307 0.575 . . . . 0.0 110.079 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.81 -32.19 61.73 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.46 -40.61 83.16 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.625 0.726 . . . . 0.0 110.273 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.99 -39.2 77.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.052 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -60.29 -48.07 83.31 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.364 0.602 . . . . 0.0 110.679 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 35.6 mmt-85 -72.27 -26.68 62.08 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.097 0.475 . . . . 0.0 111.597 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 23.2 t80 . . . . . 0 CA--C 1.541 0.624 0 CA-C-O 120.973 0.416 . . . . 0.0 111.447 179.946 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 22.1 p . . . . . 0 C--O 1.239 0.511 0 CA-C-O 122.292 1.044 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.13 -31.32 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.875 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 13.5 tp -69.08 -34.4 75.07 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.828 0.347 . . . . 0.0 111.419 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 10.3 tp -51.24 -56.85 16.78 Favored Pre-proline 0 CA--C 1.551 1.012 0 CA-C-O 119.065 -0.493 . . . . 0.0 111.212 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.03 -38.82 35.23 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 121.614 1.543 . . . . 0.0 112.79 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.4 tp -56.88 -45.44 82.53 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.4 p -63.95 -35.97 75.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 122.23 -0.294 . . . . 0.0 110.227 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 58.2 mt -62.66 -45.13 99.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 O-C-N 121.755 -0.591 . . . . 0.0 109.443 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -60.16 -46.93 88.0 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.767 0.794 . . . . 0.0 110.04 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -59.08 -44.16 91.86 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.042 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.3 -33.98 82.85 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 4.6 tp -61.67 -42.5 99.0 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.44 0.638 . . . . 0.0 110.694 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.82 89.47 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.223 0.535 . . . . 0.0 110.447 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.6 tt -59.68 -48.64 80.87 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.312 0.577 . . . . 0.0 109.705 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 23.6 tp -61.12 -41.27 96.39 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.443 0.64 . . . . 0.0 109.743 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 47.8 t -58.81 -47.08 86.05 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.251 0.548 . . . . 0.0 109.732 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 21.0 tp -63.62 -42.2 98.2 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.235 0.54 . . . . 0.0 110.103 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 2.6 tp -61.98 -34.95 77.09 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.26 0.552 . . . . 0.0 109.924 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -58.93 -37.72 77.35 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.245 0.545 . . . . 0.0 110.216 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.6 mp -62.95 -42.32 96.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.536 0.684 . . . . 0.0 109.246 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -63.31 -31.88 82.26 Favored Glycine 0 CA--C 1.535 1.312 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.9 tt -58.32 -44.23 88.56 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.723 0.773 . . . . 0.0 110.511 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.79 -40.55 80.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.792 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 44.8 t80 . . . . . 0 C--O 1.235 0.305 0 CA-C-O 121.524 0.678 . . . . 0.0 110.223 179.914 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 CA--C 1.544 0.714 0 CA-C-O 121.448 0.642 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 13.0 tp -67.22 -38.31 85.06 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.934 0.397 . . . . 0.0 111.544 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.56 -57.3 13.66 Favored Pre-proline 0 CA--C 1.552 1.046 0 O-C-N 121.961 -0.462 . . . . 0.0 111.437 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.75 -33.93 63.75 Favored 'Trans proline' 0 N--CA 1.504 2.108 0 C-N-CA 121.783 1.655 . . . . 0.0 113.018 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 9.4 tp -62.43 -45.48 92.92 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.997 0.427 . . . . 0.0 111.699 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 7.8 p -66.29 -36.47 77.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 120.669 0.271 . . . . 0.0 110.552 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 53.4 mt -65.19 -43.96 95.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -68.87 -36.92 78.68 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.62 0.724 . . . . 0.0 109.93 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -58.46 -42.64 87.9 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.27 0.557 . . . . 0.0 110.828 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.11 -34.13 82.57 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.63 -23.82 65.05 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.307 0.575 . . . . 0.0 110.967 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.46 -38.55 87.64 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.189 0.518 . . . . 0.0 110.569 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.8 mp -59.01 -39.34 81.58 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.137 0.494 . . . . 0.0 110.471 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 47.2 tp -65.98 -33.92 76.92 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.029 0.442 . . . . 0.0 110.548 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 71.4 m -58.52 -43.8 89.28 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.999 0.428 . . . . 0.0 110.115 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -60.75 -43.1 98.41 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.452 0.644 . . . . 0.0 109.771 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 7.4 mp -64.52 -38.18 90.1 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.238 0.542 . . . . 0.0 110.318 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -61.6 -42.22 98.57 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.398 0.618 . . . . 0.0 110.164 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 43.4 mm -66.35 -42.98 91.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 121.605 0.717 . . . . 0.0 109.873 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -66.31 -31.99 80.67 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 9.2 tt . . . . . 0 N--CA 1.464 0.266 0 CA-C-O 121.537 0.684 . . . . 0.0 110.962 -179.544 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 9.1 tt . . . . . 0 C--O 1.235 0.294 0 CA-C-O 120.85 0.357 . . . . 0.0 111.824 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 214' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -46.52 -57.5 8.57 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-O 118.986 -0.531 . . . . 0.0 111.713 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.01 -40.04 29.29 Favored 'Trans proline' 0 N--CA 1.505 2.171 0 C-N-CA 121.883 1.722 . . . . 0.0 113.5 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 7.3 tp -57.14 -45.19 83.76 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.006 0.431 . . . . 0.0 111.919 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 8.3 p -63.72 -36.35 76.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 O-C-N 122.187 -0.32 . . . . 0.0 111.03 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 19.4 mm -62.96 -45.07 99.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -67.4 -36.98 82.37 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.568 0.699 . . . . 0.0 109.721 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -58.16 -44.37 87.89 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.287 0.565 . . . . 0.0 110.407 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.72 -33.89 88.46 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 6.6 tp -60.7 -41.56 95.44 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.443 0.639 . . . . 0.0 110.694 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.89 -38.72 89.39 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.326 0.584 . . . . 0.0 110.571 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 1.2 tp -58.79 -40.75 84.96 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.353 0.597 . . . . 0.0 109.997 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 20.4 tp -58.28 -39.53 79.5 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.233 0.539 . . . . 0.0 110.448 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 49.8 m -57.64 -45.96 84.78 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.269 0.557 . . . . 0.0 110.703 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 26.5 tp -63.63 -42.08 98.21 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.236 0.541 . . . . 0.0 110.359 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 7.4 mp -66.22 -36.99 84.46 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.043 0.449 . . . . 0.0 110.771 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -70.51 -42.45 71.29 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.089 0.471 . . . . 0.0 111.355 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 37.9 mm -67.8 -41.16 84.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 121.575 0.702 . . . . 0.0 109.874 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -64.24 -33.0 86.06 Favored Glycine 0 CA--C 1.533 1.201 0 N-CA-C 111.634 -0.587 . . . . 0.0 111.634 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 4.1 tt -59.44 -46.02 89.94 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.704 0.764 . . . . 0.0 110.632 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -69.49 -35.79 75.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.158 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -59.85 -48.09 83.08 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.303 0.573 . . . . 0.0 110.868 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -72.03 -40.35 68.47 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.524 0.678 . . . . 0.0 111.299 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 20.3 t80 . . . . . 0 CA--C 1.541 0.607 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.132 -179.409 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 C--O 1.237 0.428 0 CA-C-O 122.329 1.061 . . . . 0.0 110.834 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 28.3 m -57.85 -25.23 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.455 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 12.8 tp -69.07 -32.29 71.64 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.883 0.373 . . . . 0.0 110.98 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.77 -57.68 13.84 Favored Pre-proline 0 CA--C 1.55 0.972 0 O-C-N 121.985 -0.447 . . . . 0.0 111.35 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.64 -31.35 70.05 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 121.962 1.775 . . . . 0.0 113.433 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.9 tt -64.03 -45.59 88.23 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.277 0.56 . . . . 0.0 111.151 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.6 p -67.91 -36.65 76.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 120.784 0.326 . . . . 0.0 110.434 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 47.1 mt -69.46 -41.72 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -63.57 -36.86 85.19 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.325 0.583 . . . . 0.0 110.119 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -57.57 -44.61 85.43 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.259 0.552 . . . . 0.0 110.126 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -67.78 -33.95 81.58 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 178.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 7.7 tp -60.29 -35.02 74.61 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.33 0.586 . . . . 0.0 111.039 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.74 89.16 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.213 0.53 . . . . 0.0 110.891 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 48.8 mt -59.04 -39.56 82.36 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.274 0.559 . . . . 0.0 110.638 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 18.1 tp -58.95 -38.65 79.53 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.322 0.582 . . . . 0.0 110.5 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 7.5 t -59.89 -43.41 94.79 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.418 0.627 . . . . 0.0 110.646 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -63.04 -42.44 99.75 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.427 0.632 . . . . 0.0 110.693 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.6 mp -71.08 -35.25 71.79 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.07 0.462 . . . . 0.0 111.225 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -70.13 -42.43 72.61 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.253 0.549 . . . . 0.0 111.618 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 7.3 tp -69.15 -36.37 72.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.617 0.722 . . . . 0.0 111.166 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.82 -31.92 61.8 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 5.1 tt -59.93 -46.04 90.64 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.725 0.774 . . . . 0.0 110.659 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -64.96 -39.5 93.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.74 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 47.8 t80 . . . . . 0 C--O 1.234 0.245 0 CA-C-O 121.524 0.678 . . . . 0.0 110.339 179.906 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 13.2 p . . . . . 0 CA--C 1.542 0.664 0 CA-C-O 121.288 0.565 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 12.7 tp -68.82 -31.6 70.7 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.674 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.29 -57.72 15.57 Favored Pre-proline 0 CA--C 1.552 1.054 0 O-C-N 122.007 -0.433 . . . . 0.0 110.913 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.88 -32.9 65.8 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 121.85 1.7 . . . . 0.0 113.025 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 9.5 tp -62.56 -45.37 93.26 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.099 0.476 . . . . 0.0 111.491 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 8.3 p -67.96 -36.58 76.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 122.248 -0.283 . . . . 0.0 110.285 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 53.5 mt -66.62 -44.14 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -65.13 -37.33 87.09 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.435 0.636 . . . . 0.0 110.299 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.96 -36.6 72.79 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.163 0.506 . . . . 0.0 110.447 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -65.6 -33.85 87.38 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 7.3 tp -58.96 -39.66 82.37 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.387 0.613 . . . . 0.0 110.855 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.84 89.52 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.288 0.566 . . . . 0.0 110.825 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 7.8 mp -62.01 -38.23 87.86 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.24 0.543 . . . . 0.0 110.627 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 16.3 tp -61.28 -40.59 94.68 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.296 0.57 . . . . 0.0 110.391 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 28.3 p -57.98 -45.89 86.04 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.263 0.554 . . . . 0.0 110.213 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 17.6 tp -64.48 -42.21 96.02 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.385 0.612 . . . . 0.0 110.066 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 49.6 mt -63.45 -34.85 78.66 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.246 0.546 . . . . 0.0 110.649 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -65.03 -42.06 94.71 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.476 0.655 . . . . 0.0 110.373 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 43.1 mm -63.33 -43.47 98.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 121.624 0.726 . . . . 0.0 110.033 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -67.0 -33.42 83.79 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 5.8 tt . . . . . 0 C--O 1.236 0.343 0 CA-C-O 121.565 0.698 . . . . 0.0 111.091 -179.442 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.536 0.433 0 CA-C-O 120.99 0.424 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 214' ' ' LEU . . . . . . . . . . . . . 13.6 tp -47.12 -57.01 10.24 Favored Pre-proline 0 CA--C 1.553 1.078 0 CA-C-O 118.892 -0.575 . . . . 0.0 111.975 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.38 -34.77 65.03 Favored 'Trans proline' 0 N--CA 1.505 2.172 0 C-N-CA 121.857 1.705 . . . . 0.0 113.401 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 tt -61.45 -45.6 93.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.072 0.463 . . . . 0.0 111.341 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 7.1 p -66.34 -36.6 77.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 O-C-N 122.111 -0.368 . . . . 0.0 110.498 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 62.1 mt -62.95 -39.65 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -59.41 -43.45 93.01 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.359 0.599 . . . . 0.0 110.509 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -58.38 -44.03 88.73 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.06 0.457 . . . . 0.0 110.599 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.81 -33.85 88.36 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 6.0 tp -59.21 -40.09 84.71 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.47 0.653 . . . . 0.0 110.871 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.7 -38.91 89.59 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.237 0.541 . . . . 0.0 110.833 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 7.5 mp -61.74 -41.32 97.49 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.258 0.552 . . . . 0.0 110.436 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 15.2 tp -60.54 -41.06 93.71 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.363 0.601 . . . . 0.0 110.328 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 38.9 t -60.35 -40.35 90.4 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.282 0.563 . . . . 0.0 110.643 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 12.2 mt -66.54 -41.11 89.2 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.357 0.599 . . . . 0.0 110.706 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 7.1 mp -71.13 -35.06 71.59 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.223 0.535 . . . . 0.0 110.941 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -63.6 -42.89 98.21 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.098 0.475 . . . . 0.0 111.869 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 40.1 pt -69.28 -35.43 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-O 121.514 0.673 . . . . 0.0 110.738 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.83 -31.97 61.56 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 110.559 -1.017 . . . . 0.0 110.559 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 3.8 tt -56.93 -39.34 74.33 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-O 121.692 0.758 . . . . 0.0 110.165 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.89 -44.01 86.45 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.395 0.617 . . . . 0.0 110.594 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -65.39 -43.42 90.72 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.387 0.613 . . . . 0.0 110.49 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 6.5 mmt85 -65.36 -25.04 67.4 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.115 0.483 . . . . 0.0 111.54 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 34.2 t80 . . . . . 0 CA--C 1.542 0.641 0 O-C-N 121.968 -0.458 . . . . 0.0 111.975 -179.344 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 39.6 p . . . . . 0 C--O 1.236 0.381 0 CA-C-O 122.545 1.164 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 13.1 p -70.14 -34.09 57.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.759 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.66 -40.11 96.03 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.978 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 3.1 tp -51.49 -57.36 14.62 Favored Pre-proline 0 CA--C 1.553 1.067 0 O-C-N 121.74 -0.6 . . . . 0.0 111.332 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.09 -32.68 63.76 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 121.816 1.678 . . . . 0.0 112.79 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.1 tt -62.3 -45.46 93.15 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.955 0.407 . . . . 0.0 111.317 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.76 -36.53 76.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 O-C-N 122.243 -0.286 . . . . 0.0 110.385 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 43.7 mt -69.3 -43.41 81.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-O 121.404 0.621 . . . . 0.0 109.333 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -65.41 -37.02 85.7 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.397 0.618 . . . . 0.0 110.688 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.79 -38.44 75.48 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.653 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -65.31 -33.87 87.9 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 3.8 tp -59.28 -45.35 91.49 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.704 0.764 . . . . 0.0 109.677 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.87 -38.34 87.92 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.644 0.735 . . . . 0.0 110.072 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.6 tp -58.67 -40.39 83.39 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.25 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 22.8 tp -59.09 -37.42 77.08 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.955 0.407 . . . . 0.0 110.582 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 17.5 m -56.99 -41.88 79.24 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.413 0.625 . . . . 0.0 110.149 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.0 mp -64.47 -39.9 94.68 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.397 0.618 . . . . 0.0 110.43 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 61.5 mt -71.37 -34.55 70.54 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.215 0.531 . . . . 0.0 111.439 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -59.93 -42.47 94.03 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 7.5 tp -65.08 -35.93 76.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.608 0.718 . . . . 0.0 110.996 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -62.41 -31.9 81.11 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 8.1 tt -57.12 -43.08 82.0 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.74 0.781 . . . . 0.0 110.479 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -69.35 -35.91 76.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.096 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 49.9 t80 . . . . . 0 CA--C 1.534 0.36 0 CA-C-O 121.045 0.45 . . . . 0.0 111.22 -179.185 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 CA--C 1.537 0.479 0 CA-C-O 121.452 0.644 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 13.4 tp -66.12 -32.59 74.14 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.059 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.99 -58.01 16.77 Favored Pre-proline 0 CA--C 1.55 0.945 0 O-C-N 121.817 -0.552 . . . . 0.0 110.401 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.5 -34.0 54.82 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 121.765 1.644 . . . . 0.0 112.178 178.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.16 -45.26 95.35 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.631 -178.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 9.6 p -66.39 -36.43 77.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 122.114 -0.366 . . . . 0.0 110.302 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 36.8 mt -66.48 -45.21 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -64.44 -36.7 85.04 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.506 0.669 . . . . 0.0 110.121 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -57.63 -44.58 85.65 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.259 0.552 . . . . 0.0 110.51 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.65 -35.11 91.61 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 7.2 tp -58.85 -43.99 90.91 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.549 0.69 . . . . 0.0 110.284 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.57 88.37 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.403 0.621 . . . . 0.0 110.605 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 1.4 tp -58.94 -40.61 85.17 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.274 0.559 . . . . 0.0 109.989 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 18.8 tp -58.68 -37.22 75.57 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.173 0.511 . . . . 0.0 110.695 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 11.1 p -56.93 -38.92 73.57 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.294 0.569 . . . . 0.0 110.629 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 1.5 tt -58.02 -48.26 80.6 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.375 0.607 . . . . 0.0 110.453 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 8.4 mp -71.7 -36.74 70.65 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.286 0.565 . . . . 0.0 110.964 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -66.4 -37.43 85.23 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 7.9 tp -62.83 -35.51 71.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.32 0.581 . . . . 0.0 111.629 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.18 -31.9 63.43 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 C--O 1.235 0.318 0 CA-C-O 121.485 0.659 . . . . 0.0 111.122 -179.441 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 16.5 tp . . . . . 0 CA--C 1.535 0.377 0 CA-C-O 120.71 0.291 . . . . 0.0 111.549 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 214' ' ' LEU . . . . . . . . . . . . . 1.9 tt -53.23 -57.49 16.45 Favored Pre-proline 0 CA--C 1.551 0.985 0 CA-C-O 119.083 -0.484 . . . . 0.0 111.039 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.14 -34.72 56.35 Favored 'Trans proline' 0 N--CA 1.501 1.957 0 C-N-CA 121.714 1.609 . . . . 0.0 112.748 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 2.8 tt -62.29 -45.36 93.61 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.55 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 10.3 p -65.7 -36.37 77.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 O-C-N 122.163 -0.336 . . . . 0.0 110.775 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 53.8 mt -65.66 -44.05 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -67.56 -36.48 81.02 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.585 0.707 . . . . 0.0 110.072 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -57.71 -42.43 83.74 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.011 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -59.89 -33.89 80.51 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.79 -29.45 66.83 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.206 0.527 . . . . 0.0 110.942 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.79 -38.79 89.39 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.324 0.583 . . . . 0.0 110.656 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 25.4 mt -61.89 -37.51 84.85 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.409 0.623 . . . . 0.0 110.647 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 11.6 tp -59.65 -36.51 76.54 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.078 0.466 . . . . 0.0 110.838 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 15.7 t -58.39 -39.12 78.79 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.329 0.585 . . . . 0.0 110.498 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 21.3 tp -62.78 -44.49 96.04 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.415 0.626 . . . . 0.0 110.385 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 8.3 mp -71.36 -34.86 70.86 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.477 0.656 . . . . 0.0 111.349 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -62.27 -42.33 99.25 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 5.5 tp -65.32 -38.53 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.494 0.664 . . . . 0.0 111.211 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.87 -32.79 74.08 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 4.4 tt -58.87 -43.06 90.78 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.551 0.691 . . . . 0.0 110.98 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -60.68 -40.96 94.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.368 0.604 . . . . 0.0 110.581 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -65.63 -43.06 90.68 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.619 0.723 . . . . 0.0 110.402 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.77 -18.06 64.73 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.207 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 21.3 t80 . . . . . 0 CA--C 1.541 0.628 0 O-C-N 121.898 -0.501 . . . . 0.0 111.962 -179.603 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 80.0 p . . . . . 0 C--O 1.238 0.481 0 CA-C-O 122.338 1.066 . . . . 0.0 110.335 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 26.9 m -66.2 -30.0 48.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.88 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 1.2 tt -68.98 -35.64 76.96 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.955 0.407 . . . . 0.0 110.931 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.77 -57.32 11.45 Favored Pre-proline 0 CA--C 1.551 1.015 0 O-C-N 121.829 -0.544 . . . . 0.0 111.299 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.86 -34.22 61.41 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 121.82 1.68 . . . . 0.0 112.931 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 5.4 tt -61.69 -45.49 93.78 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.959 0.409 . . . . 0.0 111.529 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.08 -36.65 77.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 O-C-N 122.174 -0.329 . . . . 0.0 110.534 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 48.9 mt -63.11 -45.13 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -67.48 -36.98 82.2 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.615 0.722 . . . . 0.0 109.799 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -58.86 -42.54 89.65 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.34 0.59 . . . . 0.0 110.692 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -62.74 -33.89 88.12 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.89 -29.2 70.58 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.194 0.521 . . . . 0.0 111.012 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -62.15 -38.84 90.53 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.251 0.548 . . . . 0.0 110.674 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.9 mp -63.14 -42.86 99.54 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.289 0.566 . . . . 0.0 110.218 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 31.8 tp -59.48 -41.17 89.18 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.256 0.55 . . . . 0.0 109.995 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 33.1 m -58.18 -47.18 84.2 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.17 0.509 . . . . 0.0 110.471 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -61.54 -42.11 98.35 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.189 0.519 . . . . 0.0 110.528 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 6.7 mp -66.52 -36.59 83.09 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.158 0.504 . . . . 0.0 110.588 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -66.93 -42.15 85.82 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.321 0.582 . . . . 0.0 110.909 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 27.6 mm -62.81 -41.95 94.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 121.494 0.664 . . . . 0.0 110.002 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -61.14 -32.77 81.67 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 111.706 -0.558 . . . . 0.0 111.706 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 9.5 tt -61.41 -38.31 86.64 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 122.037 -0.684 . . . . 0.0 111.369 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.87 -35.92 82.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.136 0.493 . . . . 0.0 111.255 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 36.4 t80 . . . . . 0 C--O 1.235 0.309 0 CA-C-O 121.409 0.623 . . . . 0.0 110.389 -179.613 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 CA--C 1.544 0.739 0 CA-C-O 121.491 0.663 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 3.5 tt -66.96 -40.79 87.56 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.986 0.422 . . . . 0.0 111.161 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 20.2 tp -48.98 -57.54 11.09 Favored Pre-proline 0 CA--C 1.559 1.323 0 O-C-N 121.828 -0.545 . . . . 0.0 111.415 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.23 -29.57 64.32 Favored 'Trans proline' 0 N--CA 1.504 2.09 0 C-N-CA 122.01 1.807 . . . . 0.0 113.05 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 9.5 tp -68.51 -45.08 73.24 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.085 0.469 . . . . 0.0 111.761 -178.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.81 -36.96 78.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 O-C-N 122.272 -0.268 . . . . 0.0 111.344 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 24.8 pt -71.15 -39.24 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 O-C-N 121.518 -0.739 . . . . 0.0 110.589 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -67.21 -37.09 83.04 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.468 0.652 . . . . 0.0 110.3 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -57.69 -40.4 79.35 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.219 0.533 . . . . 0.0 110.74 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -65.28 -34.0 88.29 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 7.6 tp -58.95 -39.67 82.39 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.688 0.756 . . . . 0.0 109.88 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.67 -38.19 86.85 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.586 0.708 . . . . 0.0 109.981 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.2 tp -58.46 -41.88 86.18 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.344 0.592 . . . . 0.0 109.914 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 19.3 tp -57.96 -32.36 67.77 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.15 0.5 . . . . 0.0 110.352 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 6.3 m -56.95 -43.2 81.33 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.15 0.5 . . . . 0.0 110.251 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 6.1 mp -59.08 -44.04 91.84 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.212 0.53 . . . . 0.0 110.28 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 7.3 mp -67.06 -39.37 86.88 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.181 0.515 . . . . 0.0 110.535 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -63.6 -42.16 98.26 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.205 0.526 . . . . 0.0 110.804 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 31.1 mm -62.9 -39.02 83.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.474 0.654 . . . . 0.0 109.862 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -58.23 -32.82 68.3 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.467 0.383 0 CA-C-O 121.458 0.647 . . . . 0.0 111.589 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 9.9 tp . . . . . 0 C--O 1.235 0.293 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 214' ' ' LEU . . . . . . . . . . . . . 3.5 tp -48.98 -57.22 11.96 Favored Pre-proline 0 CA--C 1.551 0.998 0 O-C-N 121.892 -0.505 . . . . 0.0 111.133 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.85 -35.5 55.86 Favored 'Trans proline' 0 N--CA 1.505 2.192 0 C-N-CA 121.736 1.624 . . . . 0.0 113.073 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 3.6 tt -62.02 -45.53 93.18 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.057 0.456 . . . . 0.0 111.487 -178.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 9.2 p -66.53 -36.63 77.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 O-C-N 122.087 -0.383 . . . . 0.0 110.63 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 43.3 mt -69.03 -42.35 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -66.55 -38.35 86.94 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.621 0.725 . . . . 0.0 110.276 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -57.93 -39.19 77.4 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.676 0.75 . . . . 0.0 110.378 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -59.89 -33.41 78.41 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 3.6 tp -58.49 -39.44 80.02 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.541 0.686 . . . . 0.0 110.441 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.94 -38.29 87.92 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.503 0.668 . . . . 0.0 110.032 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 3.2 tp -58.66 -40.32 83.15 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.419 0.628 . . . . 0.0 110.072 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 18.7 tp -59.84 -30.86 69.25 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.231 0.538 . . . . 0.0 110.415 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 2.1 t -58.55 -38.97 78.95 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.136 0.493 . . . . 0.0 110.695 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 8.2 mp -61.29 -47.82 84.23 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.398 0.618 . . . . 0.0 111.007 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 14.6 mt -71.21 -35.08 71.38 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.167 0.508 . . . . 0.0 111.252 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -70.74 -42.22 70.81 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.015 0.436 . . . . 0.0 111.808 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 7.6 tp -67.9 -35.93 73.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 121.561 0.696 . . . . 0.0 111.293 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -69.6 -31.82 70.87 Favored Glycine 0 CA--C 1.535 1.312 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 10.3 tt -60.78 -43.7 97.75 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.442 0.639 . . . . 0.0 110.867 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -67.68 -38.78 84.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.456 0.646 . . . . 0.0 110.763 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -61.58 -47.57 84.91 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.503 0.668 . . . . 0.0 110.378 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 10.1 ttt-85 -66.96 -21.67 65.96 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.313 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 43.7 t80 . . . . . 0 CA--C 1.543 0.686 0 O-C-N 122.097 -0.377 . . . . 0.0 111.731 179.873 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 15.2 p . . . . . 0 N--CA 1.471 0.598 0 CA-C-O 121.328 0.585 . . . . 0.0 112.401 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 47.3 t -70.67 -40.09 76.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.704 0.764 . . . . 0.0 109.905 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 10.6 tp -67.84 -29.9 69.16 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.145 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.15 -57.65 17.19 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 121.901 -0.499 . . . . 0.0 110.816 -178.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.16 -32.31 63.39 Favored 'Trans proline' 0 N--CA 1.504 2.135 0 C-N-CA 121.759 1.639 . . . . 0.0 112.849 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.9 tt -62.89 -45.44 92.52 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.981 0.419 . . . . 0.0 111.582 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.6 p -65.4 -36.77 78.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 O-C-N 122.25 -0.281 . . . . 0.0 110.68 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 38.4 mm -70.71 -43.51 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-O 121.636 0.732 . . . . 0.0 109.127 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -62.12 -36.5 81.94 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.402 0.62 . . . . 0.0 110.475 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -57.53 -43.8 84.6 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.366 0.603 . . . . 0.0 110.171 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -66.62 -34.34 87.24 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 6.5 tp -61.45 -39.99 92.85 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.55 0.691 . . . . 0.0 110.5 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.66 -38.42 87.67 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.409 0.624 . . . . 0.0 110.417 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.6 tt -58.62 -37.43 75.88 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.17 0.509 . . . . 0.0 110.083 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 20.9 tp -59.11 -41.6 88.54 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.31 0.576 . . . . 0.0 110.021 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 43.1 t -60.51 -40.79 92.7 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.469 0.652 . . . . 0.0 110.208 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.83 -42.69 99.34 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.397 0.618 . . . . 0.0 110.162 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 1.6 mp -71.35 -34.79 70.81 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.368 0.604 . . . . 0.0 110.949 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -58.96 -42.28 89.53 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 7.6 tp -64.55 -36.93 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.603 0.716 . . . . 0.0 111.227 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.42 -31.82 62.92 Favored Glycine 0 CA--C 1.534 1.225 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 1.6 tt -57.67 -36.18 71.57 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.549 0.69 . . . . 0.0 110.849 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -61.21 -39.76 91.44 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.32 0.581 . . . . 0.0 111.006 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 34.8 t80 . . . . . 0 C--O 1.234 0.281 0 CA-C-O 121.407 0.622 . . . . 0.0 111.066 -179.37 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 CA--C 1.538 0.495 0 CA-C-O 121.454 0.645 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 11.1 tp -64.62 -36.4 84.12 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.41 -57.73 17.23 Favored Pre-proline 0 CA--C 1.55 0.958 0 O-C-N 121.882 -0.511 . . . . 0.0 110.905 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -64.07 -32.84 63.77 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 121.872 1.715 . . . . 0.0 112.896 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 8.9 tp -60.72 -45.23 95.03 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.049 0.452 . . . . 0.0 111.754 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.67 -36.65 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 O-C-N 122.098 -0.376 . . . . 0.0 110.524 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . 0.409 HD13 HG23 ' B' ' 218' ' ' ILE . 39.3 mm -65.18 -43.84 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -64.95 -36.59 84.9 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.225 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -57.35 -44.94 84.77 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.345 0.593 . . . . 0.0 109.716 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -67.43 -33.77 82.81 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 178.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 6.0 tp -61.95 -35.38 78.27 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.513 0.673 . . . . 0.0 111.055 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.62 88.27 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.152 0.501 . . . . 0.0 110.971 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 7.9 mp -58.87 -39.17 80.57 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.134 0.492 . . . . 0.0 110.49 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 15.1 tp -61.46 -42.85 99.4 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.296 0.57 . . . . 0.0 110.083 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 58.7 m -60.42 -47.08 87.63 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 121.116 0.484 . . . . 0.0 110.426 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.19 -41.63 97.0 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.314 0.578 . . . . 0.0 110.152 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 7.4 tp -61.73 -34.81 76.46 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.286 0.565 . . . . 0.0 109.806 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -62.31 -36.29 81.67 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.412 0.625 . . . . 0.0 110.321 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 46.2 mm -62.88 -44.91 99.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 121.581 0.705 . . . . 0.0 110.34 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -71.74 -33.36 63.36 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 5.1 tt . . . . . 0 C--O 1.235 0.303 0 CA-C-O 121.531 0.681 . . . . 0.0 111.176 -179.534 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 3.2 tt . . . . . 0 CA--C 1.533 0.306 0 CA-C-O 121.114 0.483 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 214' ' ' LEU . . . . . . . . . . . . . 14.0 tp -45.62 -57.25 8.08 Favored Pre-proline 0 CA--C 1.556 1.187 0 CA-C-O 118.962 -0.542 . . . . 0.0 112.038 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.7 -36.85 49.75 Favored 'Trans proline' 0 N--CA 1.506 2.236 0 C-N-CA 121.801 1.667 . . . . 0.0 113.689 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.8 -45.22 94.8 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 122.075 -0.391 . . . . 0.0 111.465 -178.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 7.9 p -64.98 -36.66 78.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 O-C-N 122.084 -0.385 . . . . 0.0 110.566 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 50.8 mt -63.11 -45.16 99.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -65.6 -37.31 86.26 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.492 0.663 . . . . 0.0 109.729 178.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -58.12 -44.33 87.71 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.513 0.673 . . . . 0.0 110.393 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -65.35 -33.99 88.15 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 4.9 tp -59.78 -43.19 94.49 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.421 0.629 . . . . 0.0 109.97 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.62 88.89 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.367 0.603 . . . . 0.0 110.413 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 1.2 tt -58.9 -40.9 85.88 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.124 0.487 . . . . 0.0 110.357 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 22.7 tp -58.99 -40.48 84.99 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.057 0.456 . . . . 0.0 110.764 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 26.9 p -56.64 -41.04 76.49 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.195 0.521 . . . . 0.0 110.409 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.66 -39.79 91.74 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.267 0.556 . . . . 0.0 110.245 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 6.8 mp -67.22 -38.25 84.94 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.154 0.502 . . . . 0.0 110.484 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -64.92 -42.18 94.92 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.316 0.579 . . . . 0.0 110.619 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 35.4 mm -66.46 -42.16 89.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 121.54 0.686 . . . . 0.0 110.095 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -70.6 -35.94 67.69 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 8.1 tt -63.79 -46.37 85.48 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 122.043 -0.681 . . . . 0.0 111.13 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -70.26 -35.85 74.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.151 0.501 . . . . 0.0 111.221 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -59.98 -47.91 83.88 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.391 0.615 . . . . 0.0 110.497 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -69.77 -21.25 63.45 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.086 0.47 . . . . 0.0 111.499 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 64.1 t80 . . . . . 0 CA--C 1.544 0.747 0 O-C-N 122.034 -0.416 . . . . 0.0 111.717 -179.981 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 C--O 1.237 0.402 0 CA-C-O 122.374 1.083 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 23.9 t -69.08 -22.59 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.081 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.26 -36.43 81.58 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.944 0.402 . . . . 0.0 111.09 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.29 -57.35 14.41 Favored Pre-proline 0 CA--C 1.552 1.032 0 O-C-N 121.894 -0.503 . . . . 0.0 111.194 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.76 -31.88 68.31 Favored 'Trans proline' 0 N--CA 1.502 1.993 0 C-N-CA 121.776 1.65 . . . . 0.0 113.039 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 8.9 tp -62.72 -45.38 93.0 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.155 0.502 . . . . 0.0 111.562 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.1 p -66.51 -36.43 77.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 O-C-N 122.226 -0.296 . . . . 0.0 110.371 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 51.6 mt -62.8 -44.06 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -67.9 -36.79 80.82 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.345 0.593 . . . . 0.0 109.908 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -57.75 -44.35 86.05 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.288 0.566 . . . . 0.0 110.128 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -67.9 -34.0 81.17 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 6.2 tp -62.89 -36.07 82.11 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.391 0.615 . . . . 0.0 111.111 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.66 -38.61 88.37 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.226 0.536 . . . . 0.0 111.088 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 19.7 mt -58.95 -44.63 91.47 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.938 0.399 . . . . 0.0 110.74 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 26.0 tp -61.6 -31.76 71.84 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.997 0.427 . . . . 0.0 110.624 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 31.7 t -62.16 -46.41 89.08 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.181 0.515 . . . . 0.0 110.693 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.7 mp -66.42 -39.6 89.06 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.572 0.701 . . . . 0.0 110.577 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 13.1 tp -71.13 -34.38 70.99 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.148 0.499 . . . . 0.0 111.345 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -63.84 -43.22 96.82 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.237 0.541 . . . . 0.0 111.793 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 32.1 pt -69.2 -35.7 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-O 121.417 0.627 . . . . 0.0 110.838 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -59.16 -31.95 70.38 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.8 -32.01 68.96 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.574 0.702 . . . . 0.0 110.581 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.85 -43.5 90.81 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.384 0.612 . . . . 0.0 110.868 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 27.0 t80 . . . . . 0 C--O 1.234 0.262 0 CA-C-O 121.529 0.681 . . . . 0.0 110.577 -179.867 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 CA--C 1.537 0.443 0 CA-C-O 121.442 0.639 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 14.1 tp -68.67 -29.82 68.37 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.636 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.25 -57.78 18.41 Favored Pre-proline 0 CA--C 1.552 1.035 0 O-C-N 121.976 -0.452 . . . . 0.0 110.812 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.04 -32.95 63.93 Favored 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 122.042 1.828 . . . . 0.0 112.889 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.86 -45.22 94.74 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.03 0.443 . . . . 0.0 111.517 -178.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 7.4 p -67.58 -36.4 76.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 122.194 -0.316 . . . . 0.0 110.33 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 46.4 mt -67.44 -43.14 87.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -65.87 -38.97 90.22 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.511 0.672 . . . . 0.0 109.847 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -57.88 -43.78 86.24 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.523 0.677 . . . . 0.0 110.199 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.23 -33.7 87.94 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 9.8 tp -58.76 -39.73 81.82 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.293 0.568 . . . . 0.0 110.337 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.71 88.39 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.652 0.739 . . . . 0.0 109.252 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 3.0 tp -59.76 -38.95 83.22 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.77 0.795 . . . . 0.0 109.335 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 3.7 tt -59.6 -45.1 92.92 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.617 0.722 . . . . 0.0 110.13 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 45.0 m -60.91 -43.8 98.06 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.389 0.614 . . . . 0.0 110.347 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 11.8 mt -64.36 -41.48 96.7 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.282 0.563 . . . . 0.0 110.23 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 21.6 mt -65.87 -37.97 87.58 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.989 0.423 . . . . 0.0 111.079 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -69.55 -42.36 74.67 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.201 0.524 . . . . 0.0 110.892 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 38.8 mm -67.45 -41.21 85.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.716 0.77 . . . . 0.0 109.655 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -58.45 -31.88 67.46 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.529 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 4.6 tt . . . . . 0 N--CA 1.465 0.302 0 CA-C-O 121.512 0.672 . . . . 0.0 110.979 -179.637 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 11.2 tp . . . . . 0 C--O 1.235 0.341 0 CA-C-O 120.791 0.329 . . . . 0.0 111.779 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 214' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.82 -57.35 13.82 Favored Pre-proline 0 CA--C 1.551 0.988 0 CA-C-O 118.919 -0.562 . . . . 0.0 111.367 -178.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.97 -36.68 47.88 Favored 'Trans proline' 0 N--CA 1.505 2.184 0 C-N-CA 121.979 1.786 . . . . 0.0 113.297 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.93 -45.23 93.29 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.893 0.378 . . . . 0.0 111.793 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.84 -36.19 75.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 O-C-N 122.126 -0.359 . . . . 0.0 110.905 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 218' ' ' ILE . . . . . 0.429 HG21 HD12 ' C' ' 218' ' ' ILE . 33.1 mm -62.75 -44.97 99.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 O-C-N 121.615 -0.678 . . . . 0.0 109.198 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -68.9 -37.56 79.07 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.636 0.731 . . . . 0.0 110.205 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -59.37 -44.48 92.72 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.392 0.615 . . . . 0.0 110.529 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.29 -33.8 88.21 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 110.454 -1.059 . . . . 0.0 110.454 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 2.4 tp -62.91 -42.57 99.83 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.561 0.696 . . . . 0.0 110.72 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.86 -38.95 90.18 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.347 0.594 . . . . 0.0 110.798 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.8 -42.04 98.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.319 0.581 . . . . 0.0 109.949 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 22.4 tp -61.37 -38.7 87.94 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.31 0.576 . . . . 0.0 110.246 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 37.4 m -58.43 -46.96 85.46 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.205 0.526 . . . . 0.0 110.3 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -62.88 -41.79 99.54 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.216 0.532 . . . . 0.0 110.478 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 6.6 mp -63.79 -38.31 90.64 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.196 0.522 . . . . 0.0 110.372 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -62.23 -42.22 99.12 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.36 0.6 . . . . 0.0 110.129 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 48.0 mm -68.0 -42.22 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-O 121.621 0.724 . . . . 0.0 109.869 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -65.51 -31.88 81.58 Favored Glycine 0 CA--C 1.533 1.178 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 4.5 tt -57.26 -45.98 83.48 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.711 0.767 . . . . 0.0 110.733 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -61.64 -38.77 88.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.904 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -63.28 -47.18 83.41 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.47 0.652 . . . . 0.0 110.678 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -68.4 -41.2 80.81 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.283 0.563 . . . . 0.0 111.1 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 41.1 t80 . . . . . 0 CA--C 1.541 0.628 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.912 179.976 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.468 0.462 0 CA-C-O 122.346 1.069 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 41.3 t -70.18 -35.69 64.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.439 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 31.7 mt -64.05 -40.58 96.59 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -49.39 -57.26 12.36 Favored Pre-proline 0 CA--C 1.552 1.035 0 O-C-N 121.924 -0.485 . . . . 0.0 111.638 -178.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.56 -36.44 53.7 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 121.805 1.67 . . . . 0.0 113.358 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -45.17 95.55 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.949 0.404 . . . . 0.0 111.74 -178.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 8.7 p -65.36 -36.48 77.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 O-C-N 122.14 -0.35 . . . . 0.0 110.507 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 59.8 mt -63.46 -44.84 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 O-C-N 121.6 -0.688 . . . . 0.0 109.461 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -63.96 -42.97 97.11 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.642 0.734 . . . . 0.0 109.749 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -58.1 -42.72 86.29 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.67 0.748 . . . . 0.0 110.567 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.1 -33.61 84.79 Favored Glycine 0 CA--C 1.531 1.031 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 8.8 tp -58.51 -41.37 85.28 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.235 0.54 . . . . 0.0 110.094 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.93 -39.01 90.59 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.508 0.671 . . . . 0.0 109.467 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.6 tp -62.42 -43.47 98.73 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.938 0.875 . . . . 0.0 109.55 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.69 -38.21 80.91 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.357 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 48.0 m -58.95 -43.53 91.26 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 121.406 0.622 . . . . 0.0 110.428 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.73 -43.98 97.81 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.246 0.546 . . . . 0.0 110.265 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.6 mp -65.95 -38.62 89.07 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.195 0.522 . . . . 0.0 110.48 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -67.38 -42.18 83.78 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.16 0.505 . . . . 0.0 110.595 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 96.0 mt -66.67 -35.48 74.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.444 0.64 . . . . 0.0 109.991 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.5 -31.81 60.43 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 8.7 tt -59.85 -42.78 94.38 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.698 0.761 . . . . 0.0 110.376 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -62.48 -44.08 97.25 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.432 0.634 . . . . 0.0 110.881 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 39.1 t80 . . . . . 0 C--O 1.234 0.278 0 CA-C-O 121.605 0.717 . . . . 0.0 110.737 -179.677 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 CA--C 1.536 0.424 0 CA-C-O 121.433 0.635 . . . . 0.0 111.058 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 11.2 tp -65.97 -37.49 86.11 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.716 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 7.1 tp -51.94 -57.19 15.85 Favored Pre-proline 0 CA--C 1.552 1.021 0 CA-C-O 118.867 -0.587 . . . . 0.0 111.231 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.13 -34.54 57.17 Favored 'Trans proline' 0 N--CA 1.504 2.126 0 C-N-CA 121.823 1.682 . . . . 0.0 113.205 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.75 -45.16 95.38 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.901 0.381 . . . . 0.0 111.724 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.3 -36.33 75.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 O-C-N 122.06 -0.4 . . . . 0.0 110.756 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . 0.404 HD11 HG23 ' B' ' 218' ' ' ILE . 21.5 mm -62.93 -44.75 99.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -64.59 -36.86 85.6 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.451 0.644 . . . . 0.0 110.044 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -57.68 -44.72 86.0 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.201 0.524 . . . . 0.0 110.585 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -67.6 -34.78 84.83 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 5.2 tp -61.85 -40.97 97.19 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.667 0.746 . . . . 0.0 110.235 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.79 -38.44 88.1 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.32 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 2.5 tp -58.69 -38.13 77.57 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.209 0.528 . . . . 0.0 110.2 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 19.3 tp -59.08 -32.34 69.71 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.119 0.485 . . . . 0.0 110.718 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 33.1 t -58.97 -47.03 86.58 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.057 0.456 . . . . 0.0 110.289 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 7.8 mp -62.41 -43.98 97.52 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.197 0.522 . . . . 0.0 110.394 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 7.2 mp -61.56 -36.84 81.76 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.237 0.542 . . . . 0.0 109.974 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -59.46 -42.07 91.14 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.651 0.738 . . . . 0.0 109.956 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 50.4 mm -64.67 -41.04 91.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 121.767 0.794 . . . . 0.0 110.083 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -63.92 -32.01 82.73 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.554 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 6.6 tt . . . . . 0 N--CA 1.465 0.278 0 CA-C-O 121.598 0.713 . . . . 0.0 110.794 -179.639 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 21.9 mt . . . . . 0 C--O 1.236 0.375 0 CA-C-O 120.893 0.378 . . . . 0.0 111.497 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 214' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.38 -57.49 18.31 Favored Pre-proline 0 CA--C 1.549 0.918 0 CA-C-O 118.929 -0.558 . . . . 0.0 111.118 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -63.7 -34.67 61.65 Favored 'Trans proline' 0 N--CA 1.505 2.165 0 C-N-CA 121.777 1.651 . . . . 0.0 113.406 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 tt -59.69 -45.57 91.69 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.103 0.478 . . . . 0.0 111.6 -178.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.54 -36.34 77.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 O-C-N 122.156 -0.34 . . . . 0.0 110.794 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 36.0 mm -63.17 -44.93 99.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -61.73 -36.93 82.38 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.356 0.598 . . . . 0.0 110.186 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -57.79 -44.71 86.44 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.325 0.583 . . . . 0.0 110.101 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -65.6 -33.72 87.0 Favored Glycine 0 CA--C 1.534 1.219 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 4.7 tp -61.9 -38.62 89.03 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.575 0.702 . . . . 0.0 110.842 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.68 -38.49 87.98 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.95 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 7.4 mp -58.91 -42.11 88.88 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.217 0.532 . . . . 0.0 110.164 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 18.6 tp -58.56 -30.88 67.48 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.108 0.48 . . . . 0.0 110.648 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 8.0 t -57.06 -44.45 83.02 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.45 0.643 . . . . 0.0 109.939 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 7.9 mp -66.72 -40.81 88.55 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.36 0.6 . . . . 0.0 110.065 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 30.0 mt -63.61 -35.98 82.32 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.045 0.45 . . . . 0.0 110.547 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -66.79 -42.13 86.48 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.33 0.586 . . . . 0.0 109.971 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.29 -35.73 74.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 121.462 0.648 . . . . 0.0 109.844 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.74 -31.92 61.25 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 5.2 tt -59.49 -42.13 91.42 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.703 0.763 . . . . 0.0 110.172 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -62.45 -44.13 97.15 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.528 0.68 . . . . 0.0 110.554 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -62.44 -45.61 92.29 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.445 0.64 . . . . 0.0 110.586 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -59.64 -19.24 47.87 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.427 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 41.3 t80 . . . . . 0 CA--C 1.542 0.666 0 O-C-N 121.938 -0.476 . . . . 0.0 111.958 -179.785 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 66.6 p . . . . . 0 CA--C 1.536 0.442 0 CA-C-O 122.289 1.042 . . . . 0.0 110.673 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 34.7 m -70.16 -41.32 78.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.428 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 14.0 tp -69.27 -35.54 76.18 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.405 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.3 tt -44.94 -57.1 7.56 Favored Pre-proline 0 CA--C 1.554 1.102 0 CA-C-O 118.887 -0.578 . . . . 0.0 111.744 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -63.79 -38.25 40.65 Favored 'Trans proline' 0 N--CA 1.507 2.27 0 C-N-CA 122.037 1.825 . . . . 0.0 113.925 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.2 tt -59.47 -45.36 91.86 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.205 0.526 . . . . 0.0 111.947 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 9.1 p -61.94 -35.95 71.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.963 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 25.2 mm -62.56 -44.84 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 121.656 -0.653 . . . . 0.0 109.533 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -65.13 -36.66 84.98 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.709 0.766 . . . . 0.0 110.07 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -57.68 -42.38 83.49 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.243 0.544 . . . . 0.0 111.345 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -59.77 -33.63 78.77 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.95 -31.75 71.7 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.124 0.488 . . . . 0.0 111.444 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.64 -38.71 88.69 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.317 0.579 . . . . 0.0 110.619 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.86 -37.54 76.73 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.111 0.481 . . . . 0.0 110.456 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 16.8 tp -57.83 -35.37 70.8 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.079 0.466 . . . . 0.0 110.867 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 35.5 t -58.65 -41.72 86.68 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.228 0.537 . . . . 0.0 110.742 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.8 mp -62.22 -42.78 99.61 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.587 0.708 . . . . 0.0 110.426 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.8 mp -71.25 -36.67 71.85 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.14 0.495 . . . . 0.0 111.029 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -70.36 -42.47 71.76 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.097 0.475 . . . . 0.0 111.568 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 7.9 tp -69.09 -38.37 78.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 121.813 0.816 . . . . 0.0 110.913 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -71.77 -31.8 64.59 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.448 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 10.4 tt -60.87 -37.18 81.25 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 122.084 -0.657 . . . . 0.0 111.174 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.26 -37.48 87.4 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.17 0.509 . . . . 0.0 111.256 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 46.8 t80 . . . . . 0 C--O 1.234 0.282 0 CA-C-O 121.525 0.679 . . . . 0.0 110.217 179.85 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 29.7 m . . . . . 0 N--CA 1.468 0.435 0 CA-C-O 121.388 0.613 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 10.9 tp -63.69 -40.68 97.4 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.795 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 2.9 tp -49.6 -57.55 11.75 Favored Pre-proline 0 CA--C 1.553 1.09 0 O-C-N 121.79 -0.569 . . . . 0.0 111.512 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.42 -39.55 28.42 Favored 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 121.786 1.657 . . . . 0.0 112.754 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.34 -43.66 92.74 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.939 -177.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 10.6 p -66.17 -36.58 77.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 O-C-N 121.971 -0.456 . . . . 0.0 110.714 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 33.6 mt -65.92 -44.45 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -66.58 -36.62 83.08 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.355 0.598 . . . . 0.0 110.139 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -57.55 -43.49 84.5 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.319 0.581 . . . . 0.0 110.116 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.42 -33.64 87.79 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 5.4 tp -58.79 -42.32 88.77 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.543 0.687 . . . . 0.0 110.103 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.8 -38.85 89.65 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.697 0.76 . . . . 0.0 109.567 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 2.9 tp -60.84 -40.1 91.56 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.757 0.789 . . . . 0.0 109.783 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.99 -42.86 89.23 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.061 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 19.4 t -63.24 -44.02 96.4 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 121.51 0.671 . . . . 0.0 109.948 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 11.2 mt -66.85 -39.79 87.71 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.284 0.564 . . . . 0.0 110.23 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 7.6 tp -64.1 -34.76 78.77 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.202 0.525 . . . . 0.0 110.422 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -68.54 -41.17 80.24 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.314 0.578 . . . . 0.0 110.474 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.01 -41.5 89.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 121.585 0.707 . . . . 0.0 109.114 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -60.58 -32.04 76.88 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 6.4 tt . . . . . 0 C--O 1.235 0.312 0 CA-C-O 121.638 0.732 . . . . 0.0 110.762 -179.309 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 11.9 tp . . . . . 0 C--O 1.235 0.294 0 CA-C-O 120.852 0.358 . . . . 0.0 111.873 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 214' ' ' LEU . . . . . . . . . . . . . 20.8 tp -46.87 -57.37 9.19 Favored Pre-proline 0 CA--C 1.556 1.202 0 CA-C-O 118.913 -0.565 . . . . 0.0 111.59 -178.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.5 -42.74 15.6 Favored 'Trans proline' 0 N--CA 1.504 2.117 0 C-N-CA 121.882 1.721 . . . . 0.0 113.316 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.96 -45.16 83.04 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.89 -177.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 11.6 p -60.26 -35.78 64.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 122.055 -0.403 . . . . 0.0 110.757 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 44.7 mm -62.15 -45.16 99.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -60.34 -41.83 94.43 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.511 0.672 . . . . 0.0 109.462 177.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -57.72 -37.7 73.99 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.697 0.76 . . . . 0.0 110.447 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -59.97 -33.52 79.25 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 4.9 tp -58.65 -38.38 78.01 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.534 0.683 . . . . 0.0 110.776 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.71 89.2 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.214 0.53 . . . . 0.0 110.751 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 11.8 mt -61.47 -47.77 84.14 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.2 0.524 . . . . 0.0 110.44 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 18.0 tp -58.19 -38.49 76.81 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.196 0.522 . . . . 0.0 110.381 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 36.1 t -59.85 -40.56 88.99 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.272 0.558 . . . . 0.0 110.746 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 10.5 mt -64.78 -42.72 94.87 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.671 0.748 . . . . 0.0 110.2 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 7.7 mp -70.52 -34.88 72.8 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.204 0.526 . . . . 0.0 111.046 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -70.1 -42.41 72.76 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.022 0.439 . . . . 0.0 111.653 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 6.2 tp -68.84 -35.93 71.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 121.417 0.627 . . . . 0.0 110.931 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -66.72 -32.15 80.5 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 111.559 -0.617 . . . . 0.0 111.559 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 1.9 tt -56.9 -40.8 76.95 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.58 0.705 . . . . 0.0 110.611 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.52 -37.48 73.09 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.837 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -60.32 -44.22 95.65 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.535 0.683 . . . . 0.0 109.954 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 78.8 mtt85 -65.73 -25.99 67.54 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.477 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 36.4 t80 . . . . . 0 CA--C 1.543 0.678 0 O-C-N 122.038 -0.414 . . . . 0.0 111.777 179.975 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.469 0.481 0 CA-C-O 122.006 0.908 . . . . 0.0 111.794 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 26.1 m -70.68 -28.91 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.247 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 21.1 tp -66.1 -41.06 91.14 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 122.11 -0.369 . . . . 0.0 111.891 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 8.0 tp -52.19 -57.29 15.82 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-O 119.03 -0.51 . . . . 0.0 111.396 -178.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.12 -32.06 64.19 Favored 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 121.924 1.75 . . . . 0.0 113.355 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 7.5 tp -69.4 -45.11 70.04 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 122.001 -0.437 . . . . 0.0 111.813 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 13.1 p -65.83 -36.68 78.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 O-C-N 122.245 -0.284 . . . . 0.0 111.456 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 26.4 pt -69.09 -38.39 78.13 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 O-C-N 121.488 -0.757 . . . . 0.0 110.744 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -68.98 -40.56 78.73 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.538 0.685 . . . . 0.0 110.319 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.84 -37.04 75.55 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.568 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -66.65 -33.78 85.46 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 8.2 tp -58.78 -37.44 76.31 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.229 0.538 . . . . 0.0 111.195 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.94 -39.23 91.38 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.105 0.479 . . . . 0.0 110.725 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.2 mp -65.69 -39.32 91.16 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.301 0.572 . . . . 0.0 110.493 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 19.4 tp -59.72 -39.79 85.84 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.191 0.52 . . . . 0.0 110.428 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 50.6 m -58.33 -41.54 84.79 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.308 0.575 . . . . 0.0 110.303 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.3 mt -64.16 -43.47 95.06 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.216 0.531 . . . . 0.0 110.546 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.0 mp -66.49 -38.07 86.45 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.101 0.476 . . . . 0.0 110.607 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -59.77 -42.18 92.7 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.049 0.452 . . . . 0.0 110.572 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.4 mp -64.21 -39.82 86.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.594 0.712 . . . . 0.0 109.367 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -59.67 -32.01 72.79 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 9.1 tt -58.13 -45.27 87.62 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.475 0.655 . . . . 0.0 110.936 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -65.09 -37.51 87.74 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.354 0.597 . . . . 0.0 110.997 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 21.6 t80 . . . . . 0 C--O 1.235 0.304 0 CA-C-O 121.338 0.589 . . . . 0.0 110.738 -179.762 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 CA--C 1.544 0.742 0 CA-C-O 121.392 0.615 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 9.3 tt -69.19 -40.18 78.21 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 2.0 tp -54.42 -56.86 22.1 Favored Pre-proline 0 CA--C 1.548 0.892 0 O-C-N 121.691 -0.631 . . . . 0.0 110.924 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -64.24 -37.45 40.87 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 121.544 1.496 . . . . 0.0 112.476 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 4.4 tt -60.06 -45.38 93.06 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.102 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 11.0 p -65.1 -36.57 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 O-C-N 122.219 -0.301 . . . . 0.0 110.682 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 46.2 mt -65.38 -44.95 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -67.93 -36.72 80.63 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.695 0.759 . . . . 0.0 109.987 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -57.78 -45.18 86.36 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.344 0.592 . . . . 0.0 110.678 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.66 -33.91 86.71 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 6.5 tp -59.86 -41.25 91.04 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.455 0.645 . . . . 0.0 110.959 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.33 91.57 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.266 0.555 . . . . 0.0 110.614 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 1.1 tt -61.78 -41.54 97.85 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.532 0.682 . . . . 0.0 109.811 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 20.7 tp -58.81 -42.97 90.39 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.263 0.554 . . . . 0.0 110.49 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 6.7 m -62.68 -43.51 98.61 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.474 0.654 . . . . 0.0 110.222 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 5.7 mp -65.5 -40.76 93.43 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.326 0.584 . . . . 0.0 110.686 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 16.8 tp -71.13 -34.66 71.26 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.505 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -71.03 -42.64 69.25 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 121.867 -0.521 . . . . 0.0 111.274 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 7.5 tp -69.34 -37.19 75.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 121.838 0.828 . . . . 0.0 111.081 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.69 -31.83 62.23 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.614 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 4.3 tt . . . . . 0 N--CA 1.465 0.323 0 CA-C-O 121.526 0.679 . . . . 0.0 111.007 -179.308 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 4.4 tt . . . . . 0 C--O 1.234 0.285 0 CA-C-O 120.831 0.348 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 214' ' ' LEU . . . . . . . . . . . . . 4.0 tp -46.36 -57.17 9.05 Favored Pre-proline 0 CA--C 1.553 1.093 0 CA-C-O 119.112 -0.471 . . . . 0.0 111.642 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.84 -38.97 35.92 Favored 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 121.841 1.694 . . . . 0.0 113.032 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -45.35 90.91 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.839 0.352 . . . . 0.0 111.723 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.46 -36.57 77.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 122.088 -0.382 . . . . 0.0 110.514 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 50.9 mt -63.0 -45.15 99.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.455 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -64.39 -37.32 87.09 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.618 0.723 . . . . 0.0 110.092 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -57.96 -45.29 86.92 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.419 0.628 . . . . 0.0 110.578 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.13 -33.79 81.22 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 4.8 tp -59.06 -40.33 84.79 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.585 0.707 . . . . 0.0 110.629 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.83 -39.05 90.45 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.864 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 36.2 mt -61.6 -40.01 93.28 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.416 0.627 . . . . 0.0 110.581 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 32.3 tp -60.93 -35.28 76.3 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.062 0.458 . . . . 0.0 110.314 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 42.8 t -57.6 -46.7 83.71 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.371 0.605 . . . . 0.0 109.669 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 8.1 mp -60.89 -42.24 97.63 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.395 0.617 . . . . 0.0 110.244 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.63 -37.25 86.93 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.201 0.524 . . . . 0.0 110.585 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -69.79 -42.08 74.24 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.173 0.511 . . . . 0.0 111.183 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 34.0 mm -63.01 -41.04 91.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.506 0.669 . . . . 0.0 110.072 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -62.78 -33.28 86.44 Favored Glycine 0 CA--C 1.535 1.289 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 7.8 tt -61.89 -34.66 76.44 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 122.178 -0.601 . . . . 0.0 111.764 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -61.43 -35.81 78.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.138 0.494 . . . . 0.0 111.354 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -59.87 -44.49 94.14 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.365 0.602 . . . . 0.0 110.575 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 66.5 mtp85 -63.96 -32.12 73.54 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.429 0.633 . . . . 0.0 110.832 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 57.8 t80 . . . . . 0 CA--C 1.545 0.762 0 CA-C-O 120.959 0.409 . . . . 0.0 111.146 179.416 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 43.7 p . . . . . 0 CA--C 1.539 0.523 0 CA-C-O 122.133 0.968 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 26.2 t -70.31 -34.83 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-O 121.471 0.653 . . . . 0.0 110.207 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 54.2 mt -66.56 -33.26 75.28 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.77 -57.54 17.1 Favored Pre-proline 0 CA--C 1.55 0.955 0 O-C-N 121.96 -0.463 . . . . 0.0 111.085 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.73 -32.94 67.52 Favored 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 121.868 1.712 . . . . 0.0 112.814 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.94 -45.32 95.19 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.041 0.448 . . . . 0.0 111.468 -178.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.3 p -67.92 -36.51 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 O-C-N 122.125 -0.359 . . . . 0.0 110.203 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 52.6 mt -67.84 -42.83 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 121.507 0.67 . . . . 0.0 109.212 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -62.93 -36.72 84.34 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.482 0.658 . . . . 0.0 110.524 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -57.74 -43.44 85.39 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.367 0.603 . . . . 0.0 110.207 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.12 -33.91 88.49 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 6.8 tp -60.58 -38.82 85.87 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.587 0.708 . . . . 0.0 110.643 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.81 -38.77 89.38 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.239 0.542 . . . . 0.0 110.711 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 6.1 mp -59.8 -35.95 75.72 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.207 0.527 . . . . 0.0 110.471 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 13.4 tp -58.44 -36.58 73.86 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.089 0.471 . . . . 0.0 110.913 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 23.5 t -58.46 -44.36 89.21 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.27 0.557 . . . . 0.0 110.533 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.9 mt -61.66 -43.14 99.42 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.461 0.648 . . . . 0.0 110.013 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 6.8 mt -66.51 -37.31 84.77 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.149 0.5 . . . . 0.0 110.414 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -65.85 -41.98 91.01 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.319 0.58 . . . . 0.0 110.117 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 92.6 mt -63.01 -35.96 73.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 121.409 0.623 . . . . 0.0 110.003 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.56 -32.2 61.0 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 10.0 tt -59.21 -37.33 77.19 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.593 0.711 . . . . 0.0 110.568 179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.82 -36.01 73.82 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.254 0.549 . . . . 0.0 111.157 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 29.4 t80 . . . . . 0 C--O 1.235 0.304 0 CA-C-O 121.486 0.66 . . . . 0.0 110.568 -179.67 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 34.7 t . . . . . 0 N--CA 1.469 0.5 0 CA-C-O 121.456 0.646 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 9.1 tp -69.16 -33.39 73.33 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.592 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -49.13 -57.26 12.04 Favored Pre-proline 0 CA--C 1.553 1.058 0 O-C-N 121.908 -0.495 . . . . 0.0 111.319 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.7 -29.31 69.08 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 121.905 1.736 . . . . 0.0 113.484 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.16 -45.14 67.36 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.106 0.479 . . . . 0.0 111.51 -178.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 8.5 p -65.23 -36.78 78.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 122.098 -0.376 . . . . 0.0 111.409 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 28.7 pt -69.07 -38.2 77.92 Favored 'Isoleucine or valine' 0 C--N 1.348 0.526 0 O-C-N 121.355 -0.841 . . . . 0.0 110.661 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -64.42 -44.03 92.49 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.555 0.693 . . . . 0.0 110.083 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -59.22 -44.63 92.3 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.688 0.756 . . . . 0.0 109.956 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -59.97 -33.37 78.63 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 3.7 tp -59.02 -40.79 86.06 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.417 0.627 . . . . 0.0 110.393 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.89 -38.76 89.53 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.141 0.496 . . . . 0.0 110.873 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 15.3 mt -59.35 -39.08 82.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.227 0.537 . . . . 0.0 110.434 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 18.0 tp -60.82 -38.43 85.4 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.316 0.579 . . . . 0.0 110.317 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 5.6 t -58.29 -47.03 84.95 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.286 0.565 . . . . 0.0 110.425 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 7.7 mp -59.09 -43.8 91.86 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.224 0.535 . . . . 0.0 110.54 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 6.9 mp -67.01 -38.74 86.51 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.127 0.489 . . . . 0.0 110.777 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -67.3 -42.27 84.0 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.208 0.528 . . . . 0.0 111.126 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 34.2 mm -64.99 -42.42 94.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-O 121.648 0.737 . . . . 0.0 109.615 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -58.54 -31.84 67.71 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 3.2 tm? . . . . . 0 C--O 1.235 0.311 0 CA-C-O 121.718 0.771 . . . . 0.0 110.608 -179.71 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.536 0.411 0 CA-C-O 120.943 0.402 . . . . 0.0 111.257 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 214' ' ' LEU . . . . . . . . . . . . . 3.1 tp -49.26 -57.41 11.77 Favored Pre-proline 0 CA--C 1.554 1.1 0 O-C-N 121.889 -0.507 . . . . 0.0 111.534 -178.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.09 -34.52 57.65 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 121.852 1.701 . . . . 0.0 112.97 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.61 -45.26 94.85 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.073 0.463 . . . . 0.0 111.615 -178.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 8.4 p -67.3 -36.56 76.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 122.059 -0.4 . . . . 0.0 110.29 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 41.5 mt -68.66 -41.23 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.498 0.666 . . . . 0.0 109.318 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -62.52 -36.97 84.26 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.379 0.609 . . . . 0.0 110.544 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -57.87 -43.55 86.09 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.503 0.668 . . . . 0.0 110.324 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.43 -33.78 82.63 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 7.4 tp -59.39 -36.47 75.86 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.314 0.578 . . . . 0.0 111.293 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.68 -38.72 88.83 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.132 0.491 . . . . 0.0 111.012 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 7.2 mp -59.3 -39.27 82.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.214 0.53 . . . . 0.0 110.416 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 24.2 tp -61.75 -38.51 88.25 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.258 0.551 . . . . 0.0 110.458 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 74.9 m -58.32 -42.65 87.25 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.24 0.543 . . . . 0.0 110.916 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.97 -42.3 97.3 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.386 0.612 . . . . 0.0 110.647 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 6.5 mp -71.16 -34.68 71.19 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.199 0.523 . . . . 0.0 111.103 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -64.94 -42.28 94.77 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.921 0.391 . . . . 0.0 111.816 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 6.6 tp -69.26 -35.77 69.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 121.543 0.687 . . . . 0.0 110.983 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.69 -31.96 62.08 Favored Glycine 0 CA--C 1.535 1.285 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 9.1 tt -57.2 -44.7 83.9 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.513 0.673 . . . . 0.0 111.016 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -62.93 -39.61 95.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.388 0.613 . . . . 0.0 110.797 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -61.0 -45.25 95.59 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.418 0.627 . . . . 0.0 110.539 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -61.52 -38.33 86.97 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.254 0.549 . . . . 0.0 111.029 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 10.5 t80 . . . . . 0 CA--C 1.543 0.677 0 CA-C-O 120.902 0.382 . . . . 0.0 111.677 179.907 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 41.0 p . . . . . 0 N--CA 1.468 0.429 0 CA-C-O 122.099 0.952 . . . . 0.0 111.474 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 57.3 t -70.37 -27.5 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.231 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 4.0 tt -66.84 -39.8 87.72 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.921 0.391 . . . . 0.0 111.315 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 4.5 tp -47.83 -57.34 10.33 Favored Pre-proline 0 CA--C 1.553 1.068 0 CA-C-O 118.895 -0.574 . . . . 0.0 111.581 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -64.0 -34.02 60.58 Favored 'Trans proline' 0 N--CA 1.503 2.083 0 C-N-CA 121.752 1.635 . . . . 0.0 113.113 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.6 tp -61.13 -45.32 95.14 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.011 0.434 . . . . 0.0 111.634 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.39 -36.6 78.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 O-C-N 122.204 -0.31 . . . . 0.0 110.631 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 42.2 mm -65.05 -42.41 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -60.96 -36.75 80.19 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.394 0.616 . . . . 0.0 110.287 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.88 -42.13 83.93 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.399 0.619 . . . . 0.0 109.897 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -65.47 -33.8 87.43 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 7.4 tp -58.75 -34.58 71.56 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.253 0.549 . . . . 0.0 111.077 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.63 -38.76 88.84 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.24 0.543 . . . . 0.0 110.974 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.9 mp -61.5 -38.87 88.9 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.357 0.599 . . . . 0.0 110.443 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 16.8 tp -59.07 -41.91 89.1 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.278 0.561 . . . . 0.0 110.447 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 46.9 t -59.9 -42.26 93.45 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.299 0.571 . . . . 0.0 110.742 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 1.6 tt -62.63 -46.71 86.97 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.365 0.602 . . . . 0.0 110.48 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.4 mp -66.0 -40.18 90.93 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.915 0.388 . . . . 0.0 111.376 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -70.06 -42.27 73.04 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.219 0.533 . . . . 0.0 110.95 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 93.4 mt -68.04 -42.16 85.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.484 0.659 . . . . 0.0 110.164 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -62.97 -34.3 89.56 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 1.4 tt -68.24 -39.18 82.35 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.57 0.7 . . . . 0.0 110.929 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -70.32 -35.61 73.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.294 0.569 . . . . 0.0 112.279 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 34.6 t80 . . . . . 0 CA--C 1.538 0.482 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.276 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 41.5 t . . . . . 0 CA--C 1.543 0.685 0 CA-C-O 121.302 0.572 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 12.1 tp -64.14 -40.94 97.24 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 122.149 -0.344 . . . . 0.0 111.847 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 1.5 tt -54.54 -57.07 20.54 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-O 119.103 -0.475 . . . . 0.0 111.332 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.86 -33.31 64.81 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 121.852 1.701 . . . . 0.0 112.942 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 3.6 tt -61.86 -45.53 93.4 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.091 0.472 . . . . 0.0 111.493 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.66 -36.53 77.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 O-C-N 122.128 -0.357 . . . . 0.0 110.302 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 53.5 mt -67.46 -44.69 86.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -64.43 -36.74 85.13 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.515 0.674 . . . . 0.0 110.029 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -57.65 -43.74 85.17 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.295 0.569 . . . . 0.0 110.408 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -70.15 -35.68 70.91 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.21 -27.56 69.15 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.185 0.517 . . . . 0.0 110.71 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.72 -38.88 89.52 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.263 0.554 . . . . 0.0 110.323 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 51.1 mt -60.31 -38.49 83.85 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.331 0.586 . . . . 0.0 110.367 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 17.4 tp -57.98 -35.41 71.15 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.193 0.52 . . . . 0.0 110.655 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 17.1 m -58.4 -40.43 82.38 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.202 0.525 . . . . 0.0 110.834 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 8.0 mp -63.33 -45.59 90.54 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.49 0.662 . . . . 0.0 110.796 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 8.0 mp -71.23 -34.98 71.28 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.267 0.556 . . . . 0.0 111.224 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -72.52 -42.12 65.12 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.111 0.481 . . . . 0.0 111.82 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 7.7 tp -66.12 -35.92 76.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 121.411 0.624 . . . . 0.0 111.326 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -73.11 -36.73 56.28 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 3.0 tt . . . . . 0 N--CA 1.466 0.336 0 CA-C-O 121.718 0.77 . . . . 0.0 111.126 -179.226 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 15.0 tp . . . . . 0 C--O 1.235 0.317 0 CA-C-O 120.831 0.348 . . . . 0.0 111.775 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 214' ' ' LEU . . . . . . . . . . . . . 11.0 tp -50.6 -57.11 14.34 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-O 119.011 -0.519 . . . . 0.0 111.634 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.87 -35.56 55.26 Favored 'Trans proline' 0 N--CA 1.504 2.116 0 C-N-CA 121.824 1.682 . . . . 0.0 112.961 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 5.3 tt -61.35 -45.43 94.45 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.987 0.423 . . . . 0.0 111.701 -178.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 10.0 p -66.99 -36.45 77.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 122.214 -0.303 . . . . 0.0 110.339 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 57.0 mt -67.59 -45.15 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -66.45 -37.32 84.88 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.41 0.624 . . . . 0.0 110.285 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -60.5 -45.79 92.5 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.462 0.649 . . . . 0.0 110.067 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.23 -33.64 87.77 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 6.0 tp -58.73 -39.64 81.47 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.522 0.677 . . . . 0.0 110.172 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.72 -38.46 87.99 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.577 0.704 . . . . 0.0 110.32 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 2.3 tp -58.71 -45.9 88.52 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.248 0.546 . . . . 0.0 110.257 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 25.4 tp -62.5 -39.56 93.9 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.256 0.55 . . . . 0.0 109.997 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 16.6 t -57.35 -45.56 84.24 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.095 0.474 . . . . 0.0 110.296 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 11.4 mt -63.12 -42.14 99.46 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.206 0.527 . . . . 0.0 110.499 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 5.8 tp -65.88 -34.89 79.18 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.274 0.559 . . . . 0.0 110.442 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -65.34 -38.11 89.13 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.189 0.518 . . . . 0.0 110.936 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 36.3 mm -62.79 -43.39 98.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.526 0.679 . . . . 0.0 110.035 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.98 -37.05 56.76 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 8.3 tt -63.59 -44.08 95.09 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.387 0.613 . . . . 0.0 111.272 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -65.55 -35.55 81.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.347 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -59.73 -44.0 93.95 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.432 0.634 . . . . 0.0 110.296 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -69.64 -18.68 63.61 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.359 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 59.5 t80 . . . . . 0 CA--C 1.542 0.665 0 O-C-N 122.023 -0.423 . . . . 0.0 111.419 179.947 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 56.3 p . . . . . 0 C--O 1.238 0.486 0 CA-C-O 122.159 0.98 . . . . 0.0 111.736 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 12.9 p -69.9 -21.5 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.356 178.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.14 -33.0 72.74 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.073 0.463 . . . . 0.0 110.811 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 3.3 tp -53.95 -57.07 19.43 Favored Pre-proline 0 CA--C 1.554 1.108 0 CA-C-O 119.063 -0.494 . . . . 0.0 111.534 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -63.32 -29.87 72.92 Favored 'Trans proline' 0 N--CA 1.504 2.128 0 C-N-CA 121.969 1.779 . . . . 0.0 113.612 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.5 tt -69.32 -45.31 69.79 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.813 -0.554 . . . . 0.0 111.44 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.9 p -64.93 -36.8 78.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 O-C-N 122.066 -0.396 . . . . 0.0 111.62 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 21.2 pt -70.68 -40.17 76.67 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 O-C-N 121.421 -0.8 . . . . 0.0 110.616 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -67.95 -42.14 81.4 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.668 0.747 . . . . 0.0 110.088 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -60.38 -44.14 95.92 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.535 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.62 -33.84 88.31 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 4.4 tp -59.57 -39.36 83.84 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.561 0.696 . . . . 0.0 110.323 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.52 88.28 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.292 0.568 . . . . 0.0 110.285 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.5 tp -58.89 -38.58 79.2 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.377 0.608 . . . . 0.0 110.007 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 17.5 tp -60.52 -32.35 71.38 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.197 0.522 . . . . 0.0 110.431 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 16.9 m -59.76 -43.67 94.21 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.212 0.529 . . . . 0.0 111.192 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.1 mp -65.04 -41.77 94.92 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.739 0.781 . . . . 0.0 110.58 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 25.8 mt -71.11 -34.8 71.44 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.397 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -69.24 -42.32 75.78 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.24 0.543 . . . . 0.0 111.677 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 6.1 tp -68.1 -36.06 73.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 121.588 0.708 . . . . 0.0 110.866 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -67.51 -31.69 77.18 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -56.89 -43.04 80.9 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.542 0.687 . . . . 0.0 110.485 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -59.66 -38.94 82.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.351 0.596 . . . . 0.0 110.686 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 53.0 t80 . . . . . 0 C--O 1.234 0.286 0 CA-C-O 121.603 0.716 . . . . 0.0 110.011 179.617 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 CA--C 1.539 0.534 0 CA-C-O 121.35 0.595 . . . . 0.0 110.785 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 10.0 tp -67.14 -36.56 82.14 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.487 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.07 -57.64 17.12 Favored Pre-proline 0 CA--C 1.552 1.023 0 O-C-N 122.052 -0.405 . . . . 0.0 110.8 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.95 -34.87 58.02 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 121.9 1.733 . . . . 0.0 112.722 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 7.8 tp -61.33 -45.4 94.59 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.944 0.402 . . . . 0.0 111.694 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 9.2 p -66.46 -36.48 77.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 O-C-N 122.228 -0.295 . . . . 0.0 110.257 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 55.6 mt -68.57 -42.72 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.433 0.635 . . . . 0.0 109.342 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -65.01 -40.55 95.07 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.572 0.701 . . . . 0.0 110.193 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -59.42 -41.65 90.03 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.558 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.66 -33.74 86.1 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 6.4 tp -58.92 -31.69 68.88 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.3 0.572 . . . . 0.0 111.317 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.68 -38.78 89.05 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.091 0.472 . . . . 0.0 110.805 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 6.4 mp -61.69 -39.25 90.78 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.368 0.604 . . . . 0.0 110.149 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 24.7 tp -58.36 -37.96 76.28 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.228 0.537 . . . . 0.0 110.678 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 12.1 t -60.36 -41.65 94.11 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.238 0.542 . . . . 0.0 110.684 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 7.4 mp -62.36 -43.32 99.09 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.189 0.519 . . . . 0.0 110.588 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 1.3 mp -68.38 -42.63 78.83 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.454 0.645 . . . . 0.0 110.22 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -63.96 -42.24 97.33 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.066 0.46 . . . . 0.0 110.748 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.75 -36.13 76.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.336 0.589 . . . . 0.0 110.13 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.82 -32.87 62.48 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 4.1 tt . . . . . 0 C--O 1.234 0.253 0 CA-C-O 121.663 0.744 . . . . 0.0 110.595 179.942 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 1.4 tt . . . . . 0 C--O 1.235 0.319 0 CA-C-O 120.939 0.399 . . . . 0.0 110.962 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 214' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.64 -58.11 11.1 Favored Pre-proline 0 CA--C 1.553 1.084 0 O-C-N 122.03 -0.419 . . . . 0.0 110.895 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -64.27 -34.79 54.58 Favored 'Trans proline' 0 N--CA 1.501 1.926 0 C-N-CA 121.882 1.721 . . . . 0.0 113.044 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.91 -45.11 95.94 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.417 -178.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 10.4 p -64.59 -36.18 76.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 122.084 -0.385 . . . . 0.0 110.873 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 48.9 mt -62.68 -41.7 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -59.39 -42.97 92.94 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.64 0.734 . . . . 0.0 110.05 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.85 -36.96 73.06 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.364 0.602 . . . . 0.0 110.708 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.5 -33.76 88.1 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 4.9 tp -59.18 -39.77 83.59 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.38 0.61 . . . . 0.0 110.994 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.68 -40.03 93.52 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.215 0.531 . . . . 0.0 110.952 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 76.5 mt -62.04 -39.09 91.15 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.389 0.614 . . . . 0.0 110.775 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 44.7 tp -59.32 -39.14 82.17 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.498 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 9.9 p -60.81 -42.09 96.94 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.089 0.471 . . . . 0.0 110.644 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 7.1 mp -63.19 -45.48 91.58 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.342 0.592 . . . . 0.0 109.865 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.69 -37.42 87.54 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.098 0.475 . . . . 0.0 110.439 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -62.75 -42.3 99.61 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.327 0.584 . . . . 0.0 109.72 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.71 -38.93 82.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 121.462 0.648 . . . . 0.0 109.758 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.59 -31.85 60.74 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 5.7 tt -58.67 -40.33 83.21 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.472 0.653 . . . . 0.0 110.388 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -61.17 -44.26 97.59 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.386 0.612 . . . . 0.0 110.761 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -62.08 -46.22 90.05 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.358 0.599 . . . . 0.0 110.645 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -68.47 -36.01 78.37 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.233 0.54 . . . . 0.0 111.49 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 6.9 t80 . . . . . 0 CA--C 1.542 0.658 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.284 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.381 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 41.6 p 46.12 47.21 13.09 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.977 0.894 . . . . 0.0 111.203 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 25.5 p -93.14 33.97 1.16 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 122.209 1.004 . . . . 0.0 110.946 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 14.0 p -70.46 -27.95 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.887 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.02 -34.66 75.6 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.999 0.428 . . . . 0.0 111.571 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 3.2 tp -48.44 -57.19 11.4 Favored Pre-proline 0 CA--C 1.552 1.038 0 O-C-N 121.949 -0.469 . . . . 0.0 111.529 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -63.68 -37.84 44.08 Favored 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 121.802 1.668 . . . . 0.0 113.194 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 10.0 tp -60.99 -45.4 94.96 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.835 0.35 . . . . 0.0 111.667 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 8.5 p -65.43 -36.39 77.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 O-C-N 122.271 -0.268 . . . . 0.0 110.697 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 68.6 mt -64.43 -43.96 97.02 Favored 'Isoleucine or valine' 0 C--N 1.345 0.374 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 8.3 m-30 -69.36 -37.06 77.44 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.494 0.664 . . . . 0.0 110.592 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -63.72 -36.7 84.73 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.335 0.588 . . . . 0.0 110.652 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.55 -33.71 82.92 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.95 -25.53 63.59 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.157 0.503 . . . . 0.0 111.217 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.62 -38.69 88.55 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.139 0.495 . . . . 0.0 110.616 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.3 mp -59.5 -39.63 84.42 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.287 0.565 . . . . 0.0 110.407 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 14.7 tp -61.58 -40.97 96.67 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.384 0.611 . . . . 0.0 110.322 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 5.9 t -59.02 -46.31 88.52 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 121.333 0.587 . . . . 0.0 110.292 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.4 mt -64.47 -40.57 95.93 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.368 0.604 . . . . 0.0 110.179 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 18.2 mt -64.83 -36.58 84.8 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.062 0.458 . . . . 0.0 110.789 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -65.13 -42.21 94.1 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.249 0.547 . . . . 0.0 110.286 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 43.6 mm -63.91 -41.73 93.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 121.613 0.721 . . . . 0.0 109.967 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -62.26 -32.0 81.13 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 111.611 -0.596 . . . . 0.0 111.611 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.8 tt -58.46 -42.29 87.11 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.601 0.715 . . . . 0.0 110.819 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -66.77 -36.67 82.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.92 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -59.95 -44.54 94.34 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.44 0.638 . . . . 0.0 110.422 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 52.9 mmm-85 -61.12 -31.98 71.68 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.26 0.552 . . . . 0.0 111.021 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -85.79 -6.53 59.09 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.873 0.368 . . . . 0.0 111.536 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -130.03 46.57 2.63 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.978 0.894 . . . . 0.0 110.171 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.925 -179.878 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 6.1 m -152.17 -41.85 0.11 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.381 0.61 . . . . 0.0 110.585 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 69.8 p -131.1 50.26 2.25 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 122.42 1.105 . . . . 0.0 110.43 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 47.7 t -70.07 -36.16 67.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.099 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 6.6 tt -67.82 -34.74 77.33 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.664 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.84 -57.52 12.11 Favored Pre-proline 0 CA--C 1.552 1.049 0 O-C-N 121.881 -0.512 . . . . 0.0 111.088 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -63.96 -34.62 58.83 Favored 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 121.797 1.664 . . . . 0.0 112.846 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 8.2 tp -60.36 -45.37 93.75 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.987 0.422 . . . . 0.0 111.705 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.34 -36.56 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 122.214 -0.304 . . . . 0.0 110.286 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 53.5 mt -63.67 -42.24 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -65.14 -36.71 85.1 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.616 0.722 . . . . 0.0 109.942 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.65 -33.39 68.24 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.129 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -70.92 -33.94 65.62 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.47 -32.26 73.12 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.152 0.501 . . . . 0.0 111.119 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -62.13 -38.95 90.91 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.276 0.56 . . . . 0.0 110.838 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 16.7 mt -63.77 -42.31 97.81 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.335 0.588 . . . . 0.0 110.418 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 22.0 tp -58.96 -30.82 68.19 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.189 0.518 . . . . 0.0 110.479 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 6.8 t -56.83 -45.93 82.01 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.984 0.421 . . . . 0.0 110.435 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 10.8 mt -64.52 -42.17 95.94 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.208 0.527 . . . . 0.0 110.249 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 6.7 mp -61.15 -37.42 82.79 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.483 0.659 . . . . 0.0 109.745 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -58.94 -35.48 73.19 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.347 0.594 . . . . 0.0 110.722 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 44.9 mm -62.17 -42.54 95.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.508 0.671 . . . . 0.0 110.205 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -62.77 -33.23 86.29 Favored Glycine 0 CA--C 1.535 1.306 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 9.3 tt -60.92 -44.47 97.14 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.43 0.633 . . . . 0.0 111.387 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -66.0 -39.27 90.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.291 0.567 . . . . 0.0 111.004 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -61.49 -45.9 92.29 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.472 0.653 . . . . 0.0 110.616 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -63.52 -35.63 81.11 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.23 0.538 . . . . 0.0 111.12 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -85.75 -6.66 59.09 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 120.891 0.377 . . . . 0.0 111.548 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -93.1 -31.78 14.69 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.806 -0.559 . . . . 0.0 111.11 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.545 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 7.3 t -154.27 119.67 5.12 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 122.219 -0.577 . . . . 0.0 110.714 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 9.7 t 40.25 44.89 1.67 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 122.359 1.076 . . . . 0.0 111.991 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 35.5 m -70.01 -28.83 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.042 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 3.2 pp -66.37 -35.2 79.72 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 122.646 0.378 . . . . 0.0 111.833 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 214' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.36 -57.4 17.01 Favored Pre-proline 0 CA--C 1.552 1.028 0 O-C-N 121.931 -0.48 . . . . 0.0 111.062 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.67 -32.1 68.98 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 121.869 1.713 . . . . 0.0 112.992 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.49 -45.31 93.61 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.084 0.469 . . . . 0.0 111.361 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.0 -36.39 77.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 O-C-N 122.132 -0.355 . . . . 0.0 110.244 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 41.8 mm -62.79 -43.71 98.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -63.04 -36.9 85.11 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.381 0.61 . . . . 0.0 109.868 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -57.74 -41.91 82.81 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.518 0.675 . . . . 0.0 110.222 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.04 -33.91 81.3 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 5.2 tp -58.91 -41.61 87.66 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.573 0.701 . . . . 0.0 110.279 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.81 -38.67 89.02 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.501 0.667 . . . . 0.0 110.151 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 1.9 tt -58.62 -38.37 77.87 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.366 0.603 . . . . 0.0 110.047 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 37.9 tp -57.91 -37.63 74.39 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.116 0.484 . . . . 0.0 110.183 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 6.5 t -59.18 -40.24 85.08 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.301 0.572 . . . . 0.0 110.401 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 11.4 mt -67.21 -42.81 83.5 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.465 0.65 . . . . 0.0 110.066 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 17.0 mt -65.69 -36.48 83.76 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.069 0.461 . . . . 0.0 111.11 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -74.98 -42.18 58.06 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.321 0.581 . . . . 0.0 110.893 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 91.1 mt -64.93 -40.56 89.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.29 0.567 . . . . 0.0 110.471 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -63.83 -34.99 91.41 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.49 -39.76 81.2 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.592 0.711 . . . . 0.0 111.248 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.31 -39.27 94.1 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.576 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -65.59 -48.13 73.39 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.503 0.668 . . . . 0.0 110.873 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -66.43 -45.98 78.02 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.589 0.709 . . . . 0.0 110.861 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -86.39 5.24 35.88 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.772 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -174.81 97.68 0.08 Allowed 'General case' 0 C--N 1.343 0.307 0 O-C-N 121.675 -0.64 . . . . 0.0 110.131 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 . . . . . 0 N--CA 1.47 0.546 0 CA-C-O 117.929 -1.034 . . . . 0.0 111.763 -179.654 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.366 0 N-CA-C 109.712 -1.355 . . . . 999.99 109.712 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 29.3 p -143.54 146.94 33.75 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 122.195 -0.591 . . . . 999.99 110.608 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 39.0 p -115.03 50.68 0.96 Allowed 'General case' 0 C--O 1.237 0.423 0 CA-C-O 122.498 1.142 . . . . 531.53 110.463 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 40.2 t -70.03 -29.88 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 115.258 -0.883 . . . . 589.41 110.093 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.92 -31.03 69.63 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.906 0.384 . . . . 479.21 111.18 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.3 tp -54.31 -57.67 17.37 Favored Pre-proline 0 CA--C 1.551 1.002 0 O-C-N 121.922 -0.486 . . . . 380.31 110.747 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -63.94 -32.48 65.59 Favored 'Trans proline' 0 N--CA 1.502 2.025 0 C-N-CA 121.887 1.725 . . . . 81.49 112.803 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 8.6 tp -62.06 -45.48 93.36 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.035 0.445 . . . . 454.8 111.471 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.9 p -67.91 -36.41 75.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.762 0.315 . . . . 124.98 110.505 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 43.6 mt -68.5 -43.88 83.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 121.857 -0.527 . . . . 323.67 109.743 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -67.04 -38.1 85.29 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.312 0.577 . . . . 999.99 110.246 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -57.95 -42.35 84.74 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.423 0.63 . . . . 525.2 110.27 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.8 -33.89 88.43 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 110.367 -1.093 . . . . 19.0 110.367 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 6.1 tp -60.75 -42.56 97.63 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.53 0.681 . . . . 179.74 110.653 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.73 89.31 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.402 0.62 . . . . 107.91 110.527 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.02 -37.43 76.93 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.293 0.568 . . . . 307.27 110.318 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 18.3 tp -57.67 -36.31 71.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.205 0.526 . . . . 181.56 110.337 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 5.9 t -59.7 -38.85 82.73 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.371 0.605 . . . . 222.27 110.426 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.8 mt -64.47 -42.68 95.78 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.242 0.544 . . . . 482.77 110.398 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.6 mp -71.33 -34.99 71.03 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.237 0.542 . . . . 320.5 110.718 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -70.77 -42.19 70.72 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 122.163 -0.335 . . . . 566.72 111.821 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 6.0 tp -63.84 -35.91 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.673 0.749 . . . . 433.55 110.813 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -69.14 -31.92 72.37 Favored Glycine 0 CA--C 1.533 1.206 0 N-CA-C 111.314 -0.714 . . . . 70.37 111.314 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 5.2 tt -56.98 -46.09 82.48 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.72 0.771 . . . . 271.16 110.261 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.5 -36.49 73.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.661 -0.7 . . . . 178.76 110.567 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -62.99 -41.01 99.45 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.353 0.597 . . . . 748.35 110.368 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -70.29 -36.52 74.41 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.251 0.548 . . . . 999.99 111.027 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -85.69 -11.99 52.34 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.928 0.394 . . . . 999.99 111.093 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 10.5 tm0? -114.83 -3.95 12.7 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.501 0.556 . . . . 999.99 112.501 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.952 0 C-N-CA 124.123 0.969 . . . . 999.99 113.289 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.562 -1.415 . . . . 999.99 109.562 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 45.5 p -132.41 157.94 43.27 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.424 0.63 . . . . 999.99 110.635 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 17.8 p -103.06 54.5 0.76 Allowed 'General case' 0 C--O 1.237 0.438 0 CA-C-O 122.291 1.044 . . . . 581.51 110.394 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 29.0 m -69.97 -27.8 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 115.465 -0.789 . . . . 521.86 110.669 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 13.4 tp -68.38 -34.73 76.57 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.902 0.382 . . . . 362.12 111.276 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 1.3 tp -53.53 -57.62 16.39 Favored Pre-proline 0 CA--C 1.553 1.062 0 O-C-N 121.993 -0.442 . . . . 469.39 110.942 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.05 -32.77 64.05 Favored 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 121.928 1.752 . . . . 112.15 112.78 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 11.0 tp -62.41 -45.51 92.81 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.086 0.47 . . . . 431.79 111.548 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 8.8 p -67.79 -36.48 76.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.756 0.312 . . . . 122.15 110.412 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 43.6 mt -68.97 -42.98 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 109.423 -0.584 . . . . 232.51 109.423 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -67.75 -38.34 83.34 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.502 0.668 . . . . 419.2 110.532 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -58.73 -43.65 90.23 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.349 0.595 . . . . 604.52 110.623 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.95 -33.93 87.16 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 110.407 -1.077 . . . . 23.71 110.407 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 4.3 tp -61.32 -33.63 73.92 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.528 0.68 . . . . 248.83 111.29 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.59 -38.4 87.41 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.304 0.573 . . . . 128.21 110.956 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 2.0 mp -58.76 -38.19 77.9 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.151 0.5 . . . . 292.85 110.206 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 16.4 tp -61.83 -36.69 81.91 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.989 0.423 . . . . 253.4 110.854 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.3 -46.07 86.82 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 109.831 -0.433 . . . . 291.06 109.831 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 5.9 mp -62.03 -41.38 98.04 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.199 0.523 . . . . 465.18 110.223 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 6.8 mp -60.23 -38.62 83.97 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.234 0.54 . . . . 240.36 109.772 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -62.53 -42.31 99.43 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.343 0.592 . . . . 500.86 110.236 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 50.6 mm -62.94 -45.67 98.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.508 0.671 . . . . 283.89 110.378 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.12 -36.87 86.41 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 111.38 -0.688 . . . . 76.3 111.38 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 5.8 tt -63.13 -46.15 88.62 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.5 0.667 . . . . 300.74 111.299 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.24 -37.29 80.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.19 0.519 . . . . 206.91 110.982 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -59.85 -44.1 94.3 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.521 0.677 . . . . 755.78 109.859 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 51.5 mtt-85 -63.69 -40.73 97.53 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.433 0.635 . . . . 999.99 110.467 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -88.75 4.79 46.19 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.253 -0.431 . . . . 999.99 111.777 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -80.5 -91.42 0.05 Allowed 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.744 -0.598 . . . . 999.99 109.938 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.219 -0.529 0 CA-C-O 118.041 -0.98 . . . . 999.99 110.37 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.619 -1.392 . . . . 999.99 109.619 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 34.8 p -137.91 164.55 28.73 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.357 0.599 . . . . 999.99 110.733 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 20.1 p -103.8 52.33 0.77 Allowed 'General case' 0 C--O 1.238 0.463 0 CA-C-O 122.416 1.103 . . . . 613.08 110.451 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 28.6 m -70.01 -29.79 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 115.415 -0.811 . . . . 510.2 110.761 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 12.4 tp -68.88 -32.68 72.51 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.943 0.402 . . . . 655.96 111.316 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 214' ' ' LEU . . . . . . . . . . . . . 1.4 tp -53.19 -57.54 16.18 Favored Pre-proline 0 CA--C 1.551 1.011 0 O-C-N 121.987 -0.445 . . . . 467.81 110.989 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.73 -33.58 65.34 Favored 'Trans proline' 0 N--CA 1.503 2.053 0 C-N-CA 121.853 1.702 . . . . 101.08 113.016 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.09 -45.34 93.93 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.087 0.47 . . . . 517.53 111.362 -178.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 9.0 p -68.48 -36.46 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 O-C-N 122.136 -0.352 . . . . 155.39 110.447 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 50.1 mt -66.05 -44.6 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 O-C-N 121.787 -0.57 . . . . 353.22 109.496 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -66.71 -40.07 88.28 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.472 0.653 . . . . 628.2 110.117 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -59.92 -44.04 94.56 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.356 0.598 . . . . 546.36 110.652 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.32 -33.82 85.92 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 110.409 -1.077 . . . . 17.15 110.409 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 4.4 tp -59.76 -36.85 77.49 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.452 0.644 . . . . 154.45 111.13 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.66 -38.64 88.49 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.271 0.558 . . . . 121.22 110.9 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 1.1 mp -58.93 -39.86 82.89 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.247 0.546 . . . . 298.02 110.044 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 17.0 tp -58.01 -39.52 78.48 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.303 0.573 . . . . 233.21 110.503 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 40.5 t -59.12 -44.23 91.98 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.281 0.562 . . . . 232.53 110.475 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 8.8 mt -61.03 -43.49 98.82 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.231 0.538 . . . . 473.94 110.282 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 7.5 mp -67.96 -36.45 80.09 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.122 0.487 . . . . 313.5 110.66 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -66.11 -42.22 89.5 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.338 0.59 . . . . 476.0 110.782 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 32.2 mm -63.34 -42.23 95.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.642 0.734 . . . . 411.12 109.797 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -67.12 -33.3 82.87 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 111.54 -0.624 . . . . 61.43 111.54 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 5.0 tt -61.0 -46.12 92.04 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.638 0.732 . . . . 271.61 110.779 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -62.35 -35.93 80.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.901 -0.591 . . . . 164.03 110.8 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -61.63 -39.06 89.95 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.294 0.569 . . . . 921.52 110.402 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 5.2 mtt85 -75.26 -34.37 61.36 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.127 0.489 . . . . 999.99 111.349 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -85.66 -13.3 48.99 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.098 0.475 . . . . 812.07 111.225 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -106.43 -29.98 9.38 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.217 0.532 . . . . 999.99 111.452 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 117.925 -1.036 . . . . 999.99 110.855 -179.84 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.6 m -163.73 153.04 14.38 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 122.306 -0.526 . . . . 0.0 110.056 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 8.9 t -126.91 26.66 6.11 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.578 0.704 . . . . 0.0 112.208 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 29.5 m -70.47 -33.63 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 121.626 0.727 . . . . 0.0 110.861 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 51.9 mt -69.04 -29.35 67.48 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.2 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.4 tp -54.22 -57.68 17.16 Favored Pre-proline 0 CA--C 1.551 1.004 0 O-C-N 121.862 -0.524 . . . . 0.0 110.408 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.05 -33.38 62.4 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 121.958 1.772 . . . . 0.0 112.503 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.83 -45.27 94.56 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.669 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.1 p -66.09 -36.46 77.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 O-C-N 122.087 -0.383 . . . . 0.0 110.392 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 54.5 mt -63.0 -44.53 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -65.94 -36.78 84.31 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.414 0.626 . . . . 0.0 110.032 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -57.7 -44.44 85.88 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.372 0.606 . . . . 0.0 109.786 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -66.17 -33.87 86.52 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 5.5 tp -59.79 -41.76 91.88 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.662 0.744 . . . . 0.0 110.31 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.7 -38.54 88.22 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.702 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.98 -37.15 76.16 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.378 0.609 . . . . 0.0 109.819 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 15.9 tp -61.73 -41.33 97.49 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.748 -0.595 . . . . 0.0 110.486 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 4.4 m -56.73 -40.83 76.44 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.215 0.531 . . . . 0.0 110.309 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 12.3 mt -66.11 -41.52 90.46 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.087 0.47 . . . . 0.0 110.121 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 6.7 mp -62.48 -38.53 90.21 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.202 0.525 . . . . 0.0 109.991 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -58.84 -41.82 87.82 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.308 0.575 . . . . 0.0 110.098 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 48.6 mm -63.04 -42.09 95.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 121.593 0.711 . . . . 0.0 109.966 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -63.87 -31.99 82.68 Favored Glycine 0 CA--C 1.535 1.286 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 6.8 tt -58.87 -45.76 89.4 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.636 0.731 . . . . 0.0 110.943 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -59.1 -35.91 74.24 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.957 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -59.73 -41.25 90.49 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.46 0.647 . . . . 0.0 110.31 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 55.6 mtt85 -64.32 -20.46 66.1 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.089 0.471 . . . . 0.0 111.391 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -85.76 -11.77 52.72 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.962 -0.461 . . . . 0.0 111.553 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -80.47 -48.54 12.66 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.799 0.809 . . . . 0.0 110.479 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.58 179.873 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 3.0 m 53.47 99.49 0.01 OUTLIER 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.287 0.565 . . . . 0.0 110.989 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 7.2 t -127.27 41.23 3.56 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 122.24 1.019 . . . . 0.0 110.819 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 34.7 m -70.33 -37.92 72.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.0 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 5.9 tt -69.42 -36.27 76.53 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.41 -57.5 15.28 Favored Pre-proline 0 CA--C 1.552 1.026 0 O-C-N 121.604 -0.685 . . . . 0.0 111.761 -177.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -63.46 -31.83 71.59 Favored 'Trans proline' 0 N--CA 1.503 2.083 0 C-N-CA 121.599 1.533 . . . . 0.0 112.942 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.86 -45.38 92.82 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.081 0.467 . . . . 0.0 111.458 -178.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 8.0 p -69.29 -36.47 72.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 O-C-N 122.179 -0.326 . . . . 0.0 110.187 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 68.9 mt -63.01 -42.99 98.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -60.55 -36.77 79.25 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.509 0.671 . . . . 0.0 110.183 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -57.78 -43.59 85.68 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.336 0.589 . . . . 0.0 110.774 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.23 -33.92 88.57 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 6.6 tp -62.45 -37.11 84.62 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.515 0.674 . . . . 0.0 111.061 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.63 88.3 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.177 0.513 . . . . 0.0 110.877 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 7.2 mp -60.47 -45.27 94.34 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.127 0.489 . . . . 0.0 110.451 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 21.6 tp -63.42 -38.56 91.62 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.337 0.589 . . . . 0.0 109.993 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.39 -45.42 84.52 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.324 0.583 . . . . 0.0 110.291 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 3.1 tt -60.63 -46.14 91.42 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.411 0.624 . . . . 0.0 110.153 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 7.3 mp -63.0 -37.63 87.93 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.196 0.522 . . . . 0.0 110.4 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -63.44 -42.2 98.67 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.154 0.502 . . . . 0.0 110.274 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 39.5 mm -67.41 -42.76 87.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 121.592 0.71 . . . . 0.0 109.761 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -67.2 -33.1 81.87 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 4.3 tt -58.69 -45.96 88.31 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.599 0.714 . . . . 0.0 111.002 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -61.06 -43.57 98.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.311 0.576 . . . . 0.0 110.942 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -60.0 -44.63 94.4 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.511 0.672 . . . . 0.0 110.142 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -68.09 -37.5 81.28 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.363 0.601 . . . . 0.0 110.941 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -86.69 5.02 38.14 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -119.1 39.53 3.53 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.931 0.872 . . . . 0.0 110.544 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.623 179.619 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 5.8 t -124.22 -36.25 2.7 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.282 0.563 . . . . 0.0 110.904 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 6.5 t -95.75 47.28 1.1 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 122.255 1.026 . . . . 0.0 110.208 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 13.9 p -70.28 -32.63 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.963 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 13.3 tp -67.11 -39.98 86.8 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 214' ' ' LEU . . . . . . . . . . . . . 1.3 tt -50.37 -57.02 14.31 Favored Pre-proline 0 CA--C 1.552 1.055 0 O-C-N 121.938 -0.476 . . . . 0.0 111.623 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.8 -33.68 64.13 Favored 'Trans proline' 0 N--CA 1.503 2.065 0 C-N-CA 121.841 1.694 . . . . 0.0 113.186 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.71 -45.41 94.09 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.065 0.46 . . . . 0.0 111.499 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 7.4 p -67.32 -36.44 76.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 120.848 0.356 . . . . 0.0 110.377 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 47.9 mt -68.22 -42.62 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 121.358 0.599 . . . . 0.0 109.512 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -64.06 -42.1 97.12 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.496 0.665 . . . . 0.0 110.399 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -60.15 -43.53 95.66 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.524 0.678 . . . . 0.0 110.357 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.45 -33.7 87.94 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 10.2 tp -58.96 -40.81 85.86 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.24 0.543 . . . . 0.0 110.657 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.77 -43.58 98.57 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.544 0.688 . . . . 0.0 109.686 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 1.5 tt -64.74 -39.06 92.99 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.832 0.825 . . . . 0.0 109.326 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 4.7 tt -57.94 -44.16 86.78 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.457 0.646 . . . . 0.0 110.155 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 8.2 t -59.37 -43.26 92.88 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.33 0.586 . . . . 0.0 110.824 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 10.1 mt -66.53 -42.69 86.83 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.296 0.57 . . . . 0.0 110.232 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 10.7 tp -66.63 -34.82 78.73 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.092 0.472 . . . . 0.0 110.681 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -66.48 -42.13 87.95 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.413 0.625 . . . . 0.0 110.02 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 88.3 mt -63.25 -36.3 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 121.307 0.575 . . . . 0.0 110.079 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.81 -32.19 61.73 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.46 -40.61 83.16 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.625 0.726 . . . . 0.0 110.273 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.99 -39.2 77.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.052 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -60.29 -48.07 83.31 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.364 0.602 . . . . 0.0 110.679 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 35.6 mmt-85 -72.27 -26.68 62.08 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.097 0.475 . . . . 0.0 111.597 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -85.82 -11.31 53.74 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.973 0.416 . . . . 0.0 111.447 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 57.01 88.13 0.05 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.826 0.822 . . . . 0.0 110.512 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.519 -179.942 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.8 m -133.73 162.98 30.48 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.315 0.578 . . . . 0.0 110.399 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 22.1 p -86.19 54.36 3.12 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 122.292 1.044 . . . . 0.0 110.926 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.13 -31.32 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.875 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 13.5 tp -69.08 -34.4 75.07 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.828 0.347 . . . . 0.0 111.419 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 10.3 tp -51.24 -56.85 16.78 Favored Pre-proline 0 CA--C 1.551 1.012 0 CA-C-O 119.065 -0.493 . . . . 0.0 111.212 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.03 -38.82 35.23 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 121.614 1.543 . . . . 0.0 112.79 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.4 tp -56.88 -45.44 82.53 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.4 p -63.95 -35.97 75.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 122.23 -0.294 . . . . 0.0 110.227 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 58.2 mt -62.66 -45.13 99.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 O-C-N 121.755 -0.591 . . . . 0.0 109.443 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -60.16 -46.93 88.0 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.767 0.794 . . . . 0.0 110.04 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -59.08 -44.16 91.86 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.042 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.3 -33.98 82.85 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 4.6 tp -61.67 -42.5 99.0 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.44 0.638 . . . . 0.0 110.694 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.82 89.47 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.223 0.535 . . . . 0.0 110.447 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.6 tt -59.68 -48.64 80.87 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.312 0.577 . . . . 0.0 109.705 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 23.6 tp -61.12 -41.27 96.39 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.443 0.64 . . . . 0.0 109.743 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 47.8 t -58.81 -47.08 86.05 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.251 0.548 . . . . 0.0 109.732 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 21.0 tp -63.62 -42.2 98.2 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.235 0.54 . . . . 0.0 110.103 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 2.6 tp -61.98 -34.95 77.09 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.26 0.552 . . . . 0.0 109.924 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -58.93 -37.72 77.35 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.245 0.545 . . . . 0.0 110.216 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.6 mp -62.95 -42.32 96.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.536 0.684 . . . . 0.0 109.246 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -63.31 -31.88 82.26 Favored Glycine 0 CA--C 1.535 1.312 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.9 tt -58.32 -44.23 88.56 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.723 0.773 . . . . 0.0 110.511 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.79 -40.55 80.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.792 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -62.77 -45.72 91.34 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.524 0.678 . . . . 0.0 110.223 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -63.28 -32.76 74.26 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.277 0.561 . . . . 0.0 111.165 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -85.86 0.58 52.69 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 122.112 -0.368 . . . . 0.0 111.914 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -64.26 -27.54 69.11 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.763 -0.585 . . . . 0.0 111.116 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.451 179.986 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 7.6 t -71.01 172.65 8.7 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.424 0.631 . . . . 0.0 111.001 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 9.6 p -131.04 50.0 2.27 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 122.212 1.006 . . . . 0.0 110.398 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 12.5 p -70.13 -28.99 38.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.567 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 13.0 tp -67.22 -38.31 85.06 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.934 0.397 . . . . 0.0 111.544 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.56 -57.3 13.66 Favored Pre-proline 0 CA--C 1.552 1.046 0 O-C-N 121.961 -0.462 . . . . 0.0 111.437 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.75 -33.93 63.75 Favored 'Trans proline' 0 N--CA 1.504 2.108 0 C-N-CA 121.783 1.655 . . . . 0.0 113.018 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 9.4 tp -62.43 -45.48 92.92 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.997 0.427 . . . . 0.0 111.699 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 7.8 p -66.29 -36.47 77.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 120.669 0.271 . . . . 0.0 110.552 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 53.4 mt -65.19 -43.96 95.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -68.87 -36.92 78.68 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.62 0.724 . . . . 0.0 109.93 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -58.46 -42.64 87.9 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.27 0.557 . . . . 0.0 110.828 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.11 -34.13 82.57 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.63 -23.82 65.05 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.307 0.575 . . . . 0.0 110.967 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.46 -38.55 87.64 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.189 0.518 . . . . 0.0 110.569 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.8 mp -59.01 -39.34 81.58 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.137 0.494 . . . . 0.0 110.471 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 47.2 tp -65.98 -33.92 76.92 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.029 0.442 . . . . 0.0 110.548 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 71.4 m -58.52 -43.8 89.28 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.999 0.428 . . . . 0.0 110.115 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -60.75 -43.1 98.41 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.452 0.644 . . . . 0.0 109.771 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 7.4 mp -64.52 -38.18 90.1 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.238 0.542 . . . . 0.0 110.318 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -61.6 -42.22 98.57 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.398 0.618 . . . . 0.0 110.164 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 43.4 mm -66.35 -42.98 91.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 121.605 0.717 . . . . 0.0 109.873 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -66.31 -31.99 80.67 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 9.2 tt -58.46 -39.28 79.46 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.537 0.684 . . . . 0.0 110.962 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.4 -36.75 79.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.383 0.611 . . . . 0.0 110.866 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -60.26 -46.98 87.92 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.43 0.633 . . . . 0.0 110.794 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -70.71 -32.22 69.35 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.395 0.617 . . . . 0.0 111.555 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -85.58 -10.37 55.98 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.431 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -99.83 -38.18 8.76 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.7 -0.625 . . . . 0.0 111.195 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.556 -179.867 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 10.6 m -62.64 -58.87 5.99 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 122.291 -0.534 . . . . 0.0 110.565 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 5.6 p -152.88 33.93 0.48 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.983 0.897 . . . . 0.0 111.211 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 11.7 p -70.37 -39.31 76.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 121.762 0.791 . . . . 0.0 110.424 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 9.1 tt -67.27 -38.72 85.54 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.824 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 214' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -46.52 -57.5 8.57 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-O 118.986 -0.531 . . . . 0.0 111.713 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.01 -40.04 29.29 Favored 'Trans proline' 0 N--CA 1.505 2.171 0 C-N-CA 121.883 1.722 . . . . 0.0 113.5 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 7.3 tp -57.14 -45.19 83.76 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.006 0.431 . . . . 0.0 111.919 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 8.3 p -63.72 -36.35 76.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 O-C-N 122.187 -0.32 . . . . 0.0 111.03 -179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 19.4 mm -62.96 -45.07 99.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -67.4 -36.98 82.37 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.568 0.699 . . . . 0.0 109.721 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -58.16 -44.37 87.89 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.287 0.565 . . . . 0.0 110.407 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.72 -33.89 88.46 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 6.6 tp -60.7 -41.56 95.44 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.443 0.639 . . . . 0.0 110.694 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.89 -38.72 89.39 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.326 0.584 . . . . 0.0 110.571 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 1.2 tp -58.79 -40.75 84.96 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.353 0.597 . . . . 0.0 109.997 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 20.4 tp -58.28 -39.53 79.5 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.233 0.539 . . . . 0.0 110.448 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 49.8 m -57.64 -45.96 84.78 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.269 0.557 . . . . 0.0 110.703 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 26.5 tp -63.63 -42.08 98.21 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.236 0.541 . . . . 0.0 110.359 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 7.4 mp -66.22 -36.99 84.46 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.043 0.449 . . . . 0.0 110.771 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -70.51 -42.45 71.29 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.089 0.471 . . . . 0.0 111.355 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 37.9 mm -67.8 -41.16 84.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 121.575 0.702 . . . . 0.0 109.874 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -64.24 -33.0 86.06 Favored Glycine 0 CA--C 1.533 1.201 0 N-CA-C 111.634 -0.587 . . . . 0.0 111.634 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 4.1 tt -59.44 -46.02 89.94 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.704 0.764 . . . . 0.0 110.632 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -69.49 -35.79 75.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.158 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -59.85 -48.09 83.08 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.303 0.573 . . . . 0.0 110.868 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -72.03 -40.35 68.47 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.524 0.678 . . . . 0.0 111.299 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -85.91 5.14 34.34 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.132 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -172.91 93.07 0.11 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.625 0.726 . . . . 0.0 109.939 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 117.958 -1.02 . . . . 0.0 111.092 -179.451 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.5 t -145.93 171.89 14.16 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.356 0.598 . . . . 0.0 110.908 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 9.5 t -78.18 61.32 2.66 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.329 1.061 . . . . 0.0 110.834 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 28.3 m -57.85 -25.23 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.455 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 12.8 tp -69.07 -32.29 71.64 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.883 0.373 . . . . 0.0 110.98 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.77 -57.68 13.84 Favored Pre-proline 0 CA--C 1.55 0.972 0 O-C-N 121.985 -0.447 . . . . 0.0 111.35 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.64 -31.35 70.05 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 121.962 1.775 . . . . 0.0 113.433 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.9 tt -64.03 -45.59 88.23 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.277 0.56 . . . . 0.0 111.151 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.6 p -67.91 -36.65 76.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 120.784 0.326 . . . . 0.0 110.434 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 47.1 mt -69.46 -41.72 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -63.57 -36.86 85.19 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.325 0.583 . . . . 0.0 110.119 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -57.57 -44.61 85.43 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.259 0.552 . . . . 0.0 110.126 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -67.78 -33.95 81.58 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 178.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 7.7 tp -60.29 -35.02 74.61 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.33 0.586 . . . . 0.0 111.039 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.74 89.16 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.213 0.53 . . . . 0.0 110.891 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 48.8 mt -59.04 -39.56 82.36 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.274 0.559 . . . . 0.0 110.638 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 18.1 tp -58.95 -38.65 79.53 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.322 0.582 . . . . 0.0 110.5 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 7.5 t -59.89 -43.41 94.79 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.418 0.627 . . . . 0.0 110.646 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -63.04 -42.44 99.75 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.427 0.632 . . . . 0.0 110.693 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.6 mp -71.08 -35.25 71.79 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.07 0.462 . . . . 0.0 111.225 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -70.13 -42.43 72.61 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.253 0.549 . . . . 0.0 111.618 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 7.3 tp -69.15 -36.37 72.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.617 0.722 . . . . 0.0 111.166 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.82 -31.92 61.8 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 5.1 tt -59.93 -46.04 90.64 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.725 0.774 . . . . 0.0 110.659 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -64.96 -39.5 93.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.74 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -61.91 -47.49 84.72 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.524 0.678 . . . . 0.0 110.339 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.16 -31.89 73.3 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.241 0.543 . . . . 0.0 111.148 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -85.85 -1.1 56.93 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 122.172 -0.33 . . . . 0.0 111.878 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -121.05 65.66 0.86 Allowed 'General case' 0 C--O 1.239 0.511 0 CA-C-O 122.24 1.019 . . . . 0.0 110.055 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.728 -179.892 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.401 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 39.9 p -65.1 -39.7 93.51 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.476 0.655 . . . . 0.0 110.669 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 41.9 p 46.57 54.32 8.89 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 122.384 1.088 . . . . 0.0 111.077 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 13.2 p -70.11 -33.08 53.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.626 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 12.7 tp -68.82 -31.6 70.7 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.674 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.29 -57.72 15.57 Favored Pre-proline 0 CA--C 1.552 1.054 0 O-C-N 122.007 -0.433 . . . . 0.0 110.913 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.88 -32.9 65.8 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 121.85 1.7 . . . . 0.0 113.025 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 9.5 tp -62.56 -45.37 93.26 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.099 0.476 . . . . 0.0 111.491 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 8.3 p -67.96 -36.58 76.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 122.248 -0.283 . . . . 0.0 110.285 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 53.5 mt -66.62 -44.14 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -65.13 -37.33 87.09 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.435 0.636 . . . . 0.0 110.299 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.96 -36.6 72.79 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.163 0.506 . . . . 0.0 110.447 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -65.6 -33.85 87.38 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 7.3 tp -58.96 -39.66 82.37 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.387 0.613 . . . . 0.0 110.855 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.84 89.52 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.288 0.566 . . . . 0.0 110.825 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 7.8 mp -62.01 -38.23 87.86 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.24 0.543 . . . . 0.0 110.627 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 16.3 tp -61.28 -40.59 94.68 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.296 0.57 . . . . 0.0 110.391 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 28.3 p -57.98 -45.89 86.04 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.263 0.554 . . . . 0.0 110.213 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 17.6 tp -64.48 -42.21 96.02 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.385 0.612 . . . . 0.0 110.066 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 49.6 mt -63.45 -34.85 78.66 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.246 0.546 . . . . 0.0 110.649 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -65.03 -42.06 94.71 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.476 0.655 . . . . 0.0 110.373 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 43.1 mm -63.33 -43.47 98.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 121.624 0.726 . . . . 0.0 110.033 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -67.0 -33.42 83.79 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 5.8 tt -60.58 -45.95 92.03 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.565 0.698 . . . . 0.0 111.091 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.95 -38.85 92.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.296 0.569 . . . . 0.0 110.877 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -61.6 -47.31 86.03 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.459 0.647 . . . . 0.0 110.28 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -65.56 -39.19 91.4 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.428 0.632 . . . . 0.0 110.796 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -86.83 5.03 38.7 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.846 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -163.94 87.21 0.5 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.786 0.803 . . . . 0.0 110.348 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 50.8 ptt85 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.787 -179.84 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 43.2 p -94.28 121.99 36.37 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.416 0.627 . . . . 0.0 110.505 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.28 57.2 1.08 Allowed 'General case' 0 C--O 1.238 0.492 0 CA-C-O 122.356 1.074 . . . . 0.0 110.099 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 41.5 t -64.98 -26.47 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.139 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.32 -34.59 74.89 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.99 0.424 . . . . 0.0 110.953 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 214' ' ' LEU . . . . . . . . . . . . . 13.6 tp -47.12 -57.01 10.24 Favored Pre-proline 0 CA--C 1.553 1.078 0 CA-C-O 118.892 -0.575 . . . . 0.0 111.975 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.38 -34.77 65.03 Favored 'Trans proline' 0 N--CA 1.505 2.172 0 C-N-CA 121.857 1.705 . . . . 0.0 113.401 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 3.3 tt -61.45 -45.6 93.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.072 0.463 . . . . 0.0 111.341 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 7.1 p -66.34 -36.6 77.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 O-C-N 122.111 -0.368 . . . . 0.0 110.498 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 62.1 mt -62.95 -39.65 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -59.41 -43.45 93.01 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.359 0.599 . . . . 0.0 110.509 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -58.38 -44.03 88.73 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.06 0.457 . . . . 0.0 110.599 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.81 -33.85 88.36 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 6.0 tp -59.21 -40.09 84.71 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.47 0.653 . . . . 0.0 110.871 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.7 -38.91 89.59 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.237 0.541 . . . . 0.0 110.833 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 7.5 mp -61.74 -41.32 97.49 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.258 0.552 . . . . 0.0 110.436 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 15.2 tp -60.54 -41.06 93.71 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.363 0.601 . . . . 0.0 110.328 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 38.9 t -60.35 -40.35 90.4 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.282 0.563 . . . . 0.0 110.643 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 12.2 mt -66.54 -41.11 89.2 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.357 0.599 . . . . 0.0 110.706 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 7.1 mp -71.13 -35.06 71.59 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.223 0.535 . . . . 0.0 110.941 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -63.6 -42.89 98.21 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.098 0.475 . . . . 0.0 111.869 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 40.1 pt -69.28 -35.43 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-O 121.514 0.673 . . . . 0.0 110.738 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.83 -31.97 61.56 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 110.559 -1.017 . . . . 0.0 110.559 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 3.8 tt -56.93 -39.34 74.33 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-O 121.692 0.758 . . . . 0.0 110.165 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.89 -44.01 86.45 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.395 0.617 . . . . 0.0 110.594 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -65.39 -43.42 90.72 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.387 0.613 . . . . 0.0 110.49 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 6.5 mmt85 -65.36 -25.04 67.4 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.115 0.483 . . . . 0.0 111.54 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -85.94 5.11 34.57 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.968 -0.458 . . . . 0.0 111.975 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -52.29 -35.65 50.9 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.479 0.657 . . . . 0.0 111.152 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 14.7 ttt85 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 117.934 -1.031 . . . . 0.0 110.711 179.734 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 8.6 p -139.9 165.33 27.6 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.325 0.583 . . . . 0.0 110.587 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 39.6 p -109.09 45.52 1.04 Allowed 'General case' 0 C--O 1.236 0.381 0 CA-C-O 122.545 1.164 . . . . 0.0 110.185 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 13.1 p -70.14 -34.09 57.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.759 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.66 -40.11 96.03 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.978 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 3.1 tp -51.49 -57.36 14.62 Favored Pre-proline 0 CA--C 1.553 1.067 0 O-C-N 121.74 -0.6 . . . . 0.0 111.332 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.09 -32.68 63.76 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 121.816 1.678 . . . . 0.0 112.79 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.1 tt -62.3 -45.46 93.15 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.955 0.407 . . . . 0.0 111.317 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.76 -36.53 76.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 O-C-N 122.243 -0.286 . . . . 0.0 110.385 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 43.7 mt -69.3 -43.41 81.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-O 121.404 0.621 . . . . 0.0 109.333 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -65.41 -37.02 85.7 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.397 0.618 . . . . 0.0 110.688 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.79 -38.44 75.48 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.653 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -65.31 -33.87 87.9 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 3.8 tp -59.28 -45.35 91.49 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.704 0.764 . . . . 0.0 109.677 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.87 -38.34 87.92 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.644 0.735 . . . . 0.0 110.072 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.6 tp -58.67 -40.39 83.39 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.25 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 22.8 tp -59.09 -37.42 77.08 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.955 0.407 . . . . 0.0 110.582 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 17.5 m -56.99 -41.88 79.24 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.413 0.625 . . . . 0.0 110.149 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.0 mp -64.47 -39.9 94.68 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.397 0.618 . . . . 0.0 110.43 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 61.5 mt -71.37 -34.55 70.54 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.215 0.531 . . . . 0.0 111.439 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -59.93 -42.47 94.03 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 7.5 tp -65.08 -35.93 76.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.608 0.718 . . . . 0.0 110.996 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -62.41 -31.9 81.11 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 8.1 tt -57.12 -43.08 82.0 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.74 0.781 . . . . 0.0 110.479 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -69.35 -35.91 76.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.096 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -59.87 -48.18 82.72 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.045 0.45 . . . . 0.0 111.22 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.63 -36.87 85.64 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.327 0.584 . . . . 0.0 111.115 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -90.16 5.14 48.2 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 120.886 0.374 . . . . 0.0 111.768 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 56.96 24.0 8.93 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 121.575 -0.703 . . . . 0.0 111.408 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 50.9 ttt-85 . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 117.864 -1.065 . . . . 0.0 110.598 179.65 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 7.3 m 54.57 98.63 0.01 OUTLIER 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.301 0.572 . . . . 0.0 110.647 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 10.1 p -105.14 36.24 2.55 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 122.21 1.005 . . . . 0.0 110.907 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 34.4 m -70.23 -32.68 51.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.918 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 13.4 tp -66.12 -32.59 74.14 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.059 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.99 -58.01 16.77 Favored Pre-proline 0 CA--C 1.55 0.945 0 O-C-N 121.817 -0.552 . . . . 0.0 110.401 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.5 -34.0 54.82 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 121.765 1.644 . . . . 0.0 112.178 178.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.16 -45.26 95.35 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.631 -178.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 9.6 p -66.39 -36.43 77.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 122.114 -0.366 . . . . 0.0 110.302 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 36.8 mt -66.48 -45.21 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -64.44 -36.7 85.04 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.506 0.669 . . . . 0.0 110.121 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -57.63 -44.58 85.65 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.259 0.552 . . . . 0.0 110.51 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.65 -35.11 91.61 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 7.2 tp -58.85 -43.99 90.91 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.549 0.69 . . . . 0.0 110.284 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.57 88.37 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.403 0.621 . . . . 0.0 110.605 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 1.4 tp -58.94 -40.61 85.17 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.274 0.559 . . . . 0.0 109.989 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 18.8 tp -58.68 -37.22 75.57 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.173 0.511 . . . . 0.0 110.695 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 11.1 p -56.93 -38.92 73.57 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.294 0.569 . . . . 0.0 110.629 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 1.5 tt -58.02 -48.26 80.6 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.375 0.607 . . . . 0.0 110.453 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 8.4 mp -71.7 -36.74 70.65 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.286 0.565 . . . . 0.0 110.964 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -66.4 -37.43 85.23 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 7.9 tp -62.83 -35.51 71.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.32 0.581 . . . . 0.0 111.629 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.18 -31.9 63.43 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 9.4 tt -61.24 -42.03 97.9 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.485 0.659 . . . . 0.0 111.122 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -65.35 -35.9 82.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.144 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -59.83 -47.68 84.73 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.265 0.555 . . . . 0.0 110.43 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 62.8 mtp85 -64.05 -28.92 70.12 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.189 0.519 . . . . 0.0 111.078 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -85.81 -7.78 58.52 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 120.975 0.417 . . . . 0.0 111.602 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 56.55 86.55 0.07 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.82 0.819 . . . . 0.0 110.754 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.678 179.942 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.375 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 16.6 m -164.48 105.23 0.85 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.153 0.501 . . . . 0.0 110.698 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 2.7 m -124.54 33.58 5.21 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 122.225 1.012 . . . . 0.0 111.122 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 27.3 m -70.38 -26.91 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.831 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 16.5 tp -64.76 -39.98 94.52 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.549 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 214' ' ' LEU . . . . . . . . . . . . . 1.9 tt -53.23 -57.49 16.45 Favored Pre-proline 0 CA--C 1.551 0.985 0 CA-C-O 119.083 -0.484 . . . . 0.0 111.039 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.14 -34.72 56.35 Favored 'Trans proline' 0 N--CA 1.501 1.957 0 C-N-CA 121.714 1.609 . . . . 0.0 112.748 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 2.8 tt -62.29 -45.36 93.61 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.55 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 10.3 p -65.7 -36.37 77.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 O-C-N 122.163 -0.336 . . . . 0.0 110.775 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 53.8 mt -65.66 -44.05 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -67.56 -36.48 81.02 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.585 0.707 . . . . 0.0 110.072 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -57.71 -42.43 83.74 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.011 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -59.89 -33.89 80.51 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.79 -29.45 66.83 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.206 0.527 . . . . 0.0 110.942 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.79 -38.79 89.39 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.324 0.583 . . . . 0.0 110.656 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 25.4 mt -61.89 -37.51 84.85 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.409 0.623 . . . . 0.0 110.647 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 11.6 tp -59.65 -36.51 76.54 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.078 0.466 . . . . 0.0 110.838 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 15.7 t -58.39 -39.12 78.79 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.329 0.585 . . . . 0.0 110.498 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 21.3 tp -62.78 -44.49 96.04 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.415 0.626 . . . . 0.0 110.385 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 8.3 mp -71.36 -34.86 70.86 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.477 0.656 . . . . 0.0 111.349 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -62.27 -42.33 99.25 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 5.5 tp -65.32 -38.53 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.494 0.664 . . . . 0.0 111.211 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.87 -32.79 74.08 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 4.4 tt -58.87 -43.06 90.78 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.551 0.691 . . . . 0.0 110.98 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -60.68 -40.96 94.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.368 0.604 . . . . 0.0 110.581 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -65.63 -43.06 90.68 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.619 0.723 . . . . 0.0 110.402 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.77 -18.06 64.73 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.207 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -85.88 5.09 34.4 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.898 -0.501 . . . . 0.0 111.962 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -111.38 61.39 0.61 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.28 1.038 . . . . 0.0 110.156 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 20.4 mtp-105 . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.872 -179.898 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 8.1 p -71.97 139.58 48.72 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.345 0.593 . . . . 0.0 110.423 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 80.0 p -114.38 57.74 0.7 Allowed 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.338 1.066 . . . . 0.0 110.335 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 26.9 m -66.2 -30.0 48.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.88 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 1.2 tt -68.98 -35.64 76.96 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.955 0.407 . . . . 0.0 110.931 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.77 -57.32 11.45 Favored Pre-proline 0 CA--C 1.551 1.015 0 O-C-N 121.829 -0.544 . . . . 0.0 111.299 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.86 -34.22 61.41 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 121.82 1.68 . . . . 0.0 112.931 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 5.4 tt -61.69 -45.49 93.78 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.959 0.409 . . . . 0.0 111.529 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.08 -36.65 77.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 O-C-N 122.174 -0.329 . . . . 0.0 110.534 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 48.9 mt -63.11 -45.13 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -67.48 -36.98 82.2 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.615 0.722 . . . . 0.0 109.799 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -58.86 -42.54 89.65 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.34 0.59 . . . . 0.0 110.692 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -62.74 -33.89 88.12 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.89 -29.2 70.58 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.194 0.521 . . . . 0.0 111.012 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -62.15 -38.84 90.53 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.251 0.548 . . . . 0.0 110.674 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.9 mp -63.14 -42.86 99.54 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.289 0.566 . . . . 0.0 110.218 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 31.8 tp -59.48 -41.17 89.18 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.256 0.55 . . . . 0.0 109.995 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 33.1 m -58.18 -47.18 84.2 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.17 0.509 . . . . 0.0 110.471 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -61.54 -42.11 98.35 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.189 0.519 . . . . 0.0 110.528 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 6.7 mp -66.52 -36.59 83.09 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.158 0.504 . . . . 0.0 110.588 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -66.93 -42.15 85.82 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.321 0.582 . . . . 0.0 110.909 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 27.6 mm -62.81 -41.95 94.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 121.494 0.664 . . . . 0.0 110.002 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -61.14 -32.77 81.67 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 111.706 -0.558 . . . . 0.0 111.706 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 9.5 tt -61.41 -38.31 86.64 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 122.037 -0.684 . . . . 0.0 111.369 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.87 -35.92 82.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.136 0.493 . . . . 0.0 111.255 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -59.87 -41.83 92.38 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.409 0.623 . . . . 0.0 110.389 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -59.94 -24.29 64.26 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.148 0.499 . . . . 0.0 111.243 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -85.74 -10.73 55.12 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.977 0.418 . . . . 0.0 111.442 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -70.71 -30.36 66.9 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.431 0.634 . . . . 0.0 111.169 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.733 -179.913 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 4.5 t -118.64 143.6 46.71 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.493 0.663 . . . . 0.0 110.807 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 41.0 p -138.67 49.19 1.89 Allowed 'General case' 0 C--O 1.238 0.462 0 CA-C-O 122.293 1.044 . . . . 0.0 110.299 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.07 -28.44 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.593 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 3.5 tt -66.96 -40.79 87.56 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.986 0.422 . . . . 0.0 111.161 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 20.2 tp -48.98 -57.54 11.09 Favored Pre-proline 0 CA--C 1.559 1.323 0 O-C-N 121.828 -0.545 . . . . 0.0 111.415 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.23 -29.57 64.32 Favored 'Trans proline' 0 N--CA 1.504 2.09 0 C-N-CA 122.01 1.807 . . . . 0.0 113.05 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 9.5 tp -68.51 -45.08 73.24 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.085 0.469 . . . . 0.0 111.761 -178.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.81 -36.96 78.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 O-C-N 122.272 -0.268 . . . . 0.0 111.344 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 24.8 pt -71.15 -39.24 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 O-C-N 121.518 -0.739 . . . . 0.0 110.589 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -67.21 -37.09 83.04 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.468 0.652 . . . . 0.0 110.3 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -57.69 -40.4 79.35 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.219 0.533 . . . . 0.0 110.74 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -65.28 -34.0 88.29 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 7.6 tp -58.95 -39.67 82.39 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.688 0.756 . . . . 0.0 109.88 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.67 -38.19 86.85 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.586 0.708 . . . . 0.0 109.981 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.2 tp -58.46 -41.88 86.18 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.344 0.592 . . . . 0.0 109.914 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 19.3 tp -57.96 -32.36 67.77 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.15 0.5 . . . . 0.0 110.352 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 6.3 m -56.95 -43.2 81.33 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.15 0.5 . . . . 0.0 110.251 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 6.1 mp -59.08 -44.04 91.84 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.212 0.53 . . . . 0.0 110.28 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 7.3 mp -67.06 -39.37 86.88 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.181 0.515 . . . . 0.0 110.535 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -63.6 -42.16 98.26 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.205 0.526 . . . . 0.0 110.804 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 31.1 mm -62.9 -39.02 83.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.474 0.654 . . . . 0.0 109.862 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -58.23 -32.82 68.3 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.91 -33.65 70.8 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.458 0.647 . . . . 0.0 111.589 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.78 -35.97 71.53 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.325 0.584 . . . . 0.0 110.897 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -59.81 -39.67 85.81 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.376 0.608 . . . . 0.0 110.336 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -60.81 -16.08 36.96 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.994 0.425 . . . . 0.0 111.584 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -85.73 -12.5 50.95 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.994 -0.441 . . . . 0.0 111.624 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -107.55 58.76 0.62 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 122.242 1.02 . . . . 0.0 110.278 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.468 179.943 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 15.8 m -101.35 -56.44 2.3 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 122.226 -0.573 . . . . 0.0 111.305 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 14.7 p -108.89 26.36 10.68 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.828 0.823 . . . . 0.0 111.922 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.66 -29.95 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.196 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 9.9 tp -69.08 -33.05 72.92 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.929 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 214' ' ' LEU . . . . . . . . . . . . . 3.5 tp -48.98 -57.22 11.96 Favored Pre-proline 0 CA--C 1.551 0.998 0 O-C-N 121.892 -0.505 . . . . 0.0 111.133 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.85 -35.5 55.86 Favored 'Trans proline' 0 N--CA 1.505 2.192 0 C-N-CA 121.736 1.624 . . . . 0.0 113.073 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 3.6 tt -62.02 -45.53 93.18 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.057 0.456 . . . . 0.0 111.487 -178.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 9.2 p -66.53 -36.63 77.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 O-C-N 122.087 -0.383 . . . . 0.0 110.63 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 43.3 mt -69.03 -42.35 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -66.55 -38.35 86.94 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.621 0.725 . . . . 0.0 110.276 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -57.93 -39.19 77.4 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.676 0.75 . . . . 0.0 110.378 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -59.89 -33.41 78.41 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 3.6 tp -58.49 -39.44 80.02 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.541 0.686 . . . . 0.0 110.441 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.94 -38.29 87.92 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.503 0.668 . . . . 0.0 110.032 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 3.2 tp -58.66 -40.32 83.15 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.419 0.628 . . . . 0.0 110.072 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 18.7 tp -59.84 -30.86 69.25 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.231 0.538 . . . . 0.0 110.415 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 2.1 t -58.55 -38.97 78.95 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.136 0.493 . . . . 0.0 110.695 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 8.2 mp -61.29 -47.82 84.23 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.398 0.618 . . . . 0.0 111.007 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 14.6 mt -71.21 -35.08 71.38 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.167 0.508 . . . . 0.0 111.252 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -70.74 -42.22 70.81 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.015 0.436 . . . . 0.0 111.808 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 7.6 tp -67.9 -35.93 73.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 121.561 0.696 . . . . 0.0 111.293 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -69.6 -31.82 70.87 Favored Glycine 0 CA--C 1.535 1.312 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 10.3 tt -60.78 -43.7 97.75 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.442 0.639 . . . . 0.0 110.867 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -67.68 -38.78 84.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.456 0.646 . . . . 0.0 110.763 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -61.58 -47.57 84.91 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.503 0.668 . . . . 0.0 110.378 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 10.1 ttt-85 -66.96 -21.67 65.96 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.313 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -86.23 -8.32 57.87 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 122.097 -0.377 . . . . 0.0 111.731 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -165.91 88.14 0.39 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.974 0.892 . . . . 0.0 111.002 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 . . . . . 0 N--CA 1.469 0.52 0 CA-C-O 117.896 -1.05 . . . . 0.0 111.07 179.79 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 18.4 p 45.69 32.56 1.23 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.47 0.652 . . . . 0.0 111.67 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 15.2 p -80.35 6.83 11.03 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.328 0.585 . . . . 0.0 112.401 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 47.3 t -70.67 -40.09 76.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.704 0.764 . . . . 0.0 109.905 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 10.6 tp -67.84 -29.9 69.16 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.145 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.15 -57.65 17.19 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 121.901 -0.499 . . . . 0.0 110.816 -178.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.16 -32.31 63.39 Favored 'Trans proline' 0 N--CA 1.504 2.135 0 C-N-CA 121.759 1.639 . . . . 0.0 112.849 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.9 tt -62.89 -45.44 92.52 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.981 0.419 . . . . 0.0 111.582 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.6 p -65.4 -36.77 78.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 O-C-N 122.25 -0.281 . . . . 0.0 110.68 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 38.4 mm -70.71 -43.51 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-O 121.636 0.732 . . . . 0.0 109.127 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -62.12 -36.5 81.94 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.402 0.62 . . . . 0.0 110.475 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -57.53 -43.8 84.6 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.366 0.603 . . . . 0.0 110.171 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -66.62 -34.34 87.24 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 6.5 tp -61.45 -39.99 92.85 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.55 0.691 . . . . 0.0 110.5 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.66 -38.42 87.67 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.409 0.624 . . . . 0.0 110.417 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.6 tt -58.62 -37.43 75.88 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.17 0.509 . . . . 0.0 110.083 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 20.9 tp -59.11 -41.6 88.54 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.31 0.576 . . . . 0.0 110.021 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 43.1 t -60.51 -40.79 92.7 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.469 0.652 . . . . 0.0 110.208 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.83 -42.69 99.34 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.397 0.618 . . . . 0.0 110.162 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 1.6 mp -71.35 -34.79 70.81 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.368 0.604 . . . . 0.0 110.949 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -58.96 -42.28 89.53 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 7.6 tp -64.55 -36.93 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.603 0.716 . . . . 0.0 111.227 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.42 -31.82 62.92 Favored Glycine 0 CA--C 1.534 1.225 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 1.6 tt -57.67 -36.18 71.57 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.549 0.69 . . . . 0.0 110.849 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -61.21 -39.76 91.44 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.32 0.581 . . . . 0.0 111.006 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -61.22 -48.03 83.38 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.407 0.622 . . . . 0.0 111.066 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -72.1 -36.19 69.41 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.399 0.618 . . . . 0.0 111.632 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -85.77 5.44 32.41 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.074 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -151.14 81.76 1.32 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.913 0.863 . . . . 0.0 110.168 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.766 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 3.3 m -130.96 44.81 2.91 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 122.075 0.94 . . . . 0.0 110.319 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 4.0 m 55.86 35.97 26.42 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 122.205 1.002 . . . . 0.0 110.875 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 35.6 m -70.47 -33.97 55.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.221 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 11.1 tp -64.62 -36.4 84.12 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.41 -57.73 17.23 Favored Pre-proline 0 CA--C 1.55 0.958 0 O-C-N 121.882 -0.511 . . . . 0.0 110.905 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -64.07 -32.84 63.77 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 121.872 1.715 . . . . 0.0 112.896 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 8.9 tp -60.72 -45.23 95.03 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.049 0.452 . . . . 0.0 111.754 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.67 -36.65 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 O-C-N 122.098 -0.376 . . . . 0.0 110.524 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . 0.409 HD13 HG23 ' B' ' 218' ' ' ILE . 39.3 mm -65.18 -43.84 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -64.95 -36.59 84.9 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.225 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -57.35 -44.94 84.77 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.345 0.593 . . . . 0.0 109.716 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -67.43 -33.77 82.81 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 178.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 6.0 tp -61.95 -35.38 78.27 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.513 0.673 . . . . 0.0 111.055 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.62 88.27 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.152 0.501 . . . . 0.0 110.971 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 7.9 mp -58.87 -39.17 80.57 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.134 0.492 . . . . 0.0 110.49 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 15.1 tp -61.46 -42.85 99.4 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.296 0.57 . . . . 0.0 110.083 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 58.7 m -60.42 -47.08 87.63 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 121.116 0.484 . . . . 0.0 110.426 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.19 -41.63 97.0 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.314 0.578 . . . . 0.0 110.152 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 7.4 tp -61.73 -34.81 76.46 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.286 0.565 . . . . 0.0 109.806 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -62.31 -36.29 81.67 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.412 0.625 . . . . 0.0 110.321 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 46.2 mm -62.88 -44.91 99.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 121.581 0.705 . . . . 0.0 110.34 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -71.74 -33.36 63.36 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 5.1 tt -60.5 -45.77 92.56 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.531 0.681 . . . . 0.0 111.176 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.41 95.48 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.287 0.565 . . . . 0.0 110.726 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -64.05 -45.95 86.52 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.564 0.697 . . . . 0.0 110.126 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -69.39 -30.58 68.6 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.709 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -85.81 -4.1 59.08 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 122.121 -0.362 . . . . 0.0 111.755 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 55.33 87.35 0.05 OUTLIER 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.752 0.787 . . . . 0.0 110.595 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.118 -0.944 . . . . 0.0 110.463 179.962 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 11.3 m -106.82 126.09 51.85 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.511 0.672 . . . . 0.0 110.853 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 9.8 t 40.32 43.01 1.36 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 122.309 1.052 . . . . 0.0 111.96 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 27.5 m -70.25 -35.68 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.019 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 3.2 tt -66.9 -40.61 87.77 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.114 0.483 . . . . 0.0 111.277 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 214' ' ' LEU . . . . . . . . . . . . . 14.0 tp -45.62 -57.25 8.08 Favored Pre-proline 0 CA--C 1.556 1.187 0 CA-C-O 118.962 -0.542 . . . . 0.0 112.038 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.7 -36.85 49.75 Favored 'Trans proline' 0 N--CA 1.506 2.236 0 C-N-CA 121.801 1.667 . . . . 0.0 113.689 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.8 -45.22 94.8 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 122.075 -0.391 . . . . 0.0 111.465 -178.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 7.9 p -64.98 -36.66 78.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 O-C-N 122.084 -0.385 . . . . 0.0 110.566 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 50.8 mt -63.11 -45.16 99.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -65.6 -37.31 86.26 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.492 0.663 . . . . 0.0 109.729 178.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -58.12 -44.33 87.71 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.513 0.673 . . . . 0.0 110.393 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -65.35 -33.99 88.15 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 4.9 tp -59.78 -43.19 94.49 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.421 0.629 . . . . 0.0 109.97 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.62 88.89 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.367 0.603 . . . . 0.0 110.413 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 1.2 tt -58.9 -40.9 85.88 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.124 0.487 . . . . 0.0 110.357 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 22.7 tp -58.99 -40.48 84.99 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.057 0.456 . . . . 0.0 110.764 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 26.9 p -56.64 -41.04 76.49 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.195 0.521 . . . . 0.0 110.409 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.66 -39.79 91.74 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.267 0.556 . . . . 0.0 110.245 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 6.8 mp -67.22 -38.25 84.94 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.154 0.502 . . . . 0.0 110.484 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -64.92 -42.18 94.92 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.316 0.579 . . . . 0.0 110.619 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 35.4 mm -66.46 -42.16 89.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 121.54 0.686 . . . . 0.0 110.095 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -70.6 -35.94 67.69 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 8.1 tt -63.79 -46.37 85.48 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 122.043 -0.681 . . . . 0.0 111.13 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -70.26 -35.85 74.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.151 0.501 . . . . 0.0 111.221 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -59.98 -47.91 83.88 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.391 0.615 . . . . 0.0 110.497 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -69.77 -21.25 63.45 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.086 0.47 . . . . 0.0 111.499 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -86.17 -6.17 59.05 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 122.034 -0.416 . . . . 0.0 111.717 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 58.86 88.61 0.07 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.623 0.725 . . . . 0.0 110.408 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 118.119 -0.944 . . . . 0.0 111.135 -179.96 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 26.7 p 46.39 92.59 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.593 0.711 . . . . 0.0 111.242 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 9.0 t -84.23 50.81 1.93 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.374 1.083 . . . . 0.0 111.096 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 23.9 t -69.08 -22.59 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.081 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.26 -36.43 81.58 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.944 0.402 . . . . 0.0 111.09 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.29 -57.35 14.41 Favored Pre-proline 0 CA--C 1.552 1.032 0 O-C-N 121.894 -0.503 . . . . 0.0 111.194 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.76 -31.88 68.31 Favored 'Trans proline' 0 N--CA 1.502 1.993 0 C-N-CA 121.776 1.65 . . . . 0.0 113.039 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 8.9 tp -62.72 -45.38 93.0 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.155 0.502 . . . . 0.0 111.562 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.1 p -66.51 -36.43 77.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 O-C-N 122.226 -0.296 . . . . 0.0 110.371 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 51.6 mt -62.8 -44.06 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -67.9 -36.79 80.82 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.345 0.593 . . . . 0.0 109.908 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -57.75 -44.35 86.05 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.288 0.566 . . . . 0.0 110.128 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -67.9 -34.0 81.17 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 6.2 tp -62.89 -36.07 82.11 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.391 0.615 . . . . 0.0 111.111 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.66 -38.61 88.37 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.226 0.536 . . . . 0.0 111.088 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 19.7 mt -58.95 -44.63 91.47 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.938 0.399 . . . . 0.0 110.74 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 26.0 tp -61.6 -31.76 71.84 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.997 0.427 . . . . 0.0 110.624 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 31.7 t -62.16 -46.41 89.08 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.181 0.515 . . . . 0.0 110.693 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.7 mp -66.42 -39.6 89.06 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.572 0.701 . . . . 0.0 110.577 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 13.1 tp -71.13 -34.38 70.99 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.148 0.499 . . . . 0.0 111.345 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -63.84 -43.22 96.82 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.237 0.541 . . . . 0.0 111.793 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 32.1 pt -69.2 -35.7 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-O 121.417 0.627 . . . . 0.0 110.838 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -59.16 -31.95 70.38 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.8 -32.01 68.96 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.574 0.702 . . . . 0.0 110.581 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.85 -43.5 90.81 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.384 0.612 . . . . 0.0 110.868 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -63.24 -43.67 97.39 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.529 0.681 . . . . 0.0 110.577 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -65.68 -20.75 66.41 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.637 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -85.81 -12.45 50.85 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 122.013 -0.43 . . . . 0.0 111.386 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -118.32 46.82 1.72 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.998 0.904 . . . . 0.0 110.516 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 26.6 ttm105 . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.816 179.952 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 46.5 p -106.46 80.69 1.51 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.895 0.855 . . . . 0.0 110.461 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 25.2 p 46.6 48.05 14.37 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 122.362 1.077 . . . . 0.0 111.157 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 35.9 m -70.03 -34.2 58.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.059 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 14.1 tp -68.67 -29.82 68.37 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.636 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.25 -57.78 18.41 Favored Pre-proline 0 CA--C 1.552 1.035 0 O-C-N 121.976 -0.452 . . . . 0.0 110.812 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.04 -32.95 63.93 Favored 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 122.042 1.828 . . . . 0.0 112.889 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.86 -45.22 94.74 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.03 0.443 . . . . 0.0 111.517 -178.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 7.4 p -67.58 -36.4 76.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 122.194 -0.316 . . . . 0.0 110.33 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 46.4 mt -67.44 -43.14 87.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -65.87 -38.97 90.22 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.511 0.672 . . . . 0.0 109.847 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -57.88 -43.78 86.24 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.523 0.677 . . . . 0.0 110.199 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.23 -33.7 87.94 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 9.8 tp -58.76 -39.73 81.82 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.293 0.568 . . . . 0.0 110.337 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.71 88.39 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.652 0.739 . . . . 0.0 109.252 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 3.0 tp -59.76 -38.95 83.22 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.77 0.795 . . . . 0.0 109.335 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 3.7 tt -59.6 -45.1 92.92 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.617 0.722 . . . . 0.0 110.13 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 45.0 m -60.91 -43.8 98.06 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.389 0.614 . . . . 0.0 110.347 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 11.8 mt -64.36 -41.48 96.7 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.282 0.563 . . . . 0.0 110.23 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 21.6 mt -65.87 -37.97 87.58 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.989 0.423 . . . . 0.0 111.079 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -69.55 -42.36 74.67 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.201 0.524 . . . . 0.0 110.892 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 38.8 mm -67.45 -41.21 85.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.716 0.77 . . . . 0.0 109.655 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -58.45 -31.88 67.46 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.529 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 4.6 tt -58.7 -39.87 82.0 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.512 0.672 . . . . 0.0 110.979 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.09 -37.11 80.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.337 0.589 . . . . 0.0 110.789 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -61.44 -47.85 83.85 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.442 0.639 . . . . 0.0 110.658 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -68.61 -37.36 79.72 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.381 0.61 . . . . 0.0 111.192 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -85.83 -2.6 58.4 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.715 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 50.58 50.75 18.25 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 122.191 0.996 . . . . 0.0 110.732 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.141 -0.933 . . . . 0.0 110.926 -179.992 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 24.1 p -57.14 116.8 3.47 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.409 0.623 . . . . 0.0 110.672 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 40.2 p -143.96 52.13 1.31 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.374 1.083 . . . . 0.0 110.48 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 41.3 t -70.06 -36.0 66.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.14 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 11.2 tp -66.73 -35.7 80.73 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.779 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 214' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.82 -57.35 13.82 Favored Pre-proline 0 CA--C 1.551 0.988 0 CA-C-O 118.919 -0.562 . . . . 0.0 111.367 -178.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.97 -36.68 47.88 Favored 'Trans proline' 0 N--CA 1.505 2.184 0 C-N-CA 121.979 1.786 . . . . 0.0 113.297 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.93 -45.23 93.29 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.893 0.378 . . . . 0.0 111.793 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.84 -36.19 75.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 O-C-N 122.126 -0.359 . . . . 0.0 110.905 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 218' ' ' ILE . . . . . 0.429 HG21 HD12 ' C' ' 218' ' ' ILE . 33.1 mm -62.75 -44.97 99.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 O-C-N 121.615 -0.678 . . . . 0.0 109.198 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -68.9 -37.56 79.07 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.636 0.731 . . . . 0.0 110.205 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -59.37 -44.48 92.72 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.392 0.615 . . . . 0.0 110.529 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.29 -33.8 88.21 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 110.454 -1.059 . . . . 0.0 110.454 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 2.4 tp -62.91 -42.57 99.83 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.561 0.696 . . . . 0.0 110.72 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.86 -38.95 90.18 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.347 0.594 . . . . 0.0 110.798 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.8 -42.04 98.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.319 0.581 . . . . 0.0 109.949 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 22.4 tp -61.37 -38.7 87.94 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.31 0.576 . . . . 0.0 110.246 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 37.4 m -58.43 -46.96 85.46 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.205 0.526 . . . . 0.0 110.3 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -62.88 -41.79 99.54 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.216 0.532 . . . . 0.0 110.478 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 6.6 mp -63.79 -38.31 90.64 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.196 0.522 . . . . 0.0 110.372 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -62.23 -42.22 99.12 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.36 0.6 . . . . 0.0 110.129 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 48.0 mm -68.0 -42.22 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-O 121.621 0.724 . . . . 0.0 109.869 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -65.51 -31.88 81.58 Favored Glycine 0 CA--C 1.533 1.178 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 4.5 tt -57.26 -45.98 83.48 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.711 0.767 . . . . 0.0 110.733 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -61.64 -38.77 88.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.904 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -63.28 -47.18 83.41 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.47 0.652 . . . . 0.0 110.678 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -68.4 -41.2 80.81 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.283 0.563 . . . . 0.0 111.1 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -88.42 4.96 44.53 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.912 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -175.68 92.2 0.05 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.587 0.708 . . . . 0.0 110.471 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.46 179.754 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.98 160.13 40.5 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 122.288 -0.536 . . . . 0.0 110.148 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 8.1 t -117.1 45.17 1.93 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 122.346 1.069 . . . . 0.0 110.93 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 41.3 t -70.18 -35.69 64.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.439 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 31.7 mt -64.05 -40.58 96.59 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -49.39 -57.26 12.36 Favored Pre-proline 0 CA--C 1.552 1.035 0 O-C-N 121.924 -0.485 . . . . 0.0 111.638 -178.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.56 -36.44 53.7 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 121.805 1.67 . . . . 0.0 113.358 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -45.17 95.55 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.949 0.404 . . . . 0.0 111.74 -178.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 8.7 p -65.36 -36.48 77.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 O-C-N 122.14 -0.35 . . . . 0.0 110.507 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 59.8 mt -63.46 -44.84 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 O-C-N 121.6 -0.688 . . . . 0.0 109.461 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -63.96 -42.97 97.11 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.642 0.734 . . . . 0.0 109.749 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -58.1 -42.72 86.29 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.67 0.748 . . . . 0.0 110.567 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.1 -33.61 84.79 Favored Glycine 0 CA--C 1.531 1.031 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 8.8 tp -58.51 -41.37 85.28 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.235 0.54 . . . . 0.0 110.094 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.93 -39.01 90.59 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.508 0.671 . . . . 0.0 109.467 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.6 tp -62.42 -43.47 98.73 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.938 0.875 . . . . 0.0 109.55 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.69 -38.21 80.91 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.357 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 48.0 m -58.95 -43.53 91.26 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 121.406 0.622 . . . . 0.0 110.428 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.73 -43.98 97.81 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.246 0.546 . . . . 0.0 110.265 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.6 mp -65.95 -38.62 89.07 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.195 0.522 . . . . 0.0 110.48 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -67.38 -42.18 83.78 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.16 0.505 . . . . 0.0 110.595 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 96.0 mt -66.67 -35.48 74.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.444 0.64 . . . . 0.0 109.991 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.5 -31.81 60.43 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 8.7 tt -59.85 -42.78 94.38 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.698 0.761 . . . . 0.0 110.376 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -62.48 -44.08 97.25 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.432 0.634 . . . . 0.0 110.881 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -65.45 -46.81 78.4 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.605 0.717 . . . . 0.0 110.737 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -61.31 -38.34 86.51 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.418 0.628 . . . . 0.0 111.229 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -85.88 -1.51 57.34 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.807 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -152.19 79.28 1.24 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.839 0.828 . . . . 0.0 110.423 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 90.9 mtm-85 . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 117.872 -1.061 . . . . 0.0 110.561 -179.949 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 34.5 p -62.98 134.39 56.11 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.346 0.593 . . . . 0.0 110.706 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 7.4 t -148.57 47.37 1.03 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 122.305 1.05 . . . . 0.0 110.513 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 33.5 m -69.6 -32.71 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.058 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 11.2 tp -65.97 -37.49 86.11 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.716 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 7.1 tp -51.94 -57.19 15.85 Favored Pre-proline 0 CA--C 1.552 1.021 0 CA-C-O 118.867 -0.587 . . . . 0.0 111.231 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.13 -34.54 57.17 Favored 'Trans proline' 0 N--CA 1.504 2.126 0 C-N-CA 121.823 1.682 . . . . 0.0 113.205 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.75 -45.16 95.38 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.901 0.381 . . . . 0.0 111.724 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.3 -36.33 75.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 O-C-N 122.06 -0.4 . . . . 0.0 110.756 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . 0.404 HD11 HG23 ' B' ' 218' ' ' ILE . 21.5 mm -62.93 -44.75 99.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -64.59 -36.86 85.6 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.451 0.644 . . . . 0.0 110.044 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -57.68 -44.72 86.0 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.201 0.524 . . . . 0.0 110.585 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -67.6 -34.78 84.83 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 5.2 tp -61.85 -40.97 97.19 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.667 0.746 . . . . 0.0 110.235 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.79 -38.44 88.1 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.32 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 2.5 tp -58.69 -38.13 77.57 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.209 0.528 . . . . 0.0 110.2 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 19.3 tp -59.08 -32.34 69.71 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.119 0.485 . . . . 0.0 110.718 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 33.1 t -58.97 -47.03 86.58 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.057 0.456 . . . . 0.0 110.289 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 7.8 mp -62.41 -43.98 97.52 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.197 0.522 . . . . 0.0 110.394 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 7.2 mp -61.56 -36.84 81.76 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.237 0.542 . . . . 0.0 109.974 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -59.46 -42.07 91.14 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.651 0.738 . . . . 0.0 109.956 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 50.4 mm -64.67 -41.04 91.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 121.767 0.794 . . . . 0.0 110.083 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -63.92 -32.01 82.73 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.554 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 6.6 tt -60.5 -46.21 90.96 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.598 0.713 . . . . 0.0 110.794 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -70.07 -39.17 75.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.477 0.656 . . . . 0.0 110.781 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -64.09 -40.65 96.69 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.326 0.584 . . . . 0.0 110.867 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -62.83 -17.42 61.32 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.9 0.381 . . . . 0.0 111.887 -179.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -85.8 -21.16 28.28 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.115 0.483 . . . . 0.0 110.68 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 40.86 31.03 0.11 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.509 0.671 . . . . 0.0 112.178 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.633 -179.796 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 19.7 m -63.79 -47.58 80.31 Favored 'General case' 0 CA--C 1.533 0.327 0 O-C-N 122.31 -0.523 . . . . 0.0 110.561 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 23.0 p -150.54 48.73 0.88 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 122.325 1.06 . . . . 0.0 110.326 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 34.8 m -70.0 -32.48 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.087 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 21.9 mt -69.06 -30.95 69.39 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.893 0.378 . . . . 0.0 111.497 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 214' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.38 -57.49 18.31 Favored Pre-proline 0 CA--C 1.549 0.918 0 CA-C-O 118.929 -0.558 . . . . 0.0 111.118 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -63.7 -34.67 61.65 Favored 'Trans proline' 0 N--CA 1.505 2.165 0 C-N-CA 121.777 1.651 . . . . 0.0 113.406 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 tt -59.69 -45.57 91.69 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.103 0.478 . . . . 0.0 111.6 -178.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.54 -36.34 77.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 O-C-N 122.156 -0.34 . . . . 0.0 110.794 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 36.0 mm -63.17 -44.93 99.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -61.73 -36.93 82.38 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.356 0.598 . . . . 0.0 110.186 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -57.79 -44.71 86.44 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.325 0.583 . . . . 0.0 110.101 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -65.6 -33.72 87.0 Favored Glycine 0 CA--C 1.534 1.219 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 4.7 tp -61.9 -38.62 89.03 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.575 0.702 . . . . 0.0 110.842 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.68 -38.49 87.98 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.95 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 7.4 mp -58.91 -42.11 88.88 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.217 0.532 . . . . 0.0 110.164 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 18.6 tp -58.56 -30.88 67.48 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.108 0.48 . . . . 0.0 110.648 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 8.0 t -57.06 -44.45 83.02 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.45 0.643 . . . . 0.0 109.939 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 7.9 mp -66.72 -40.81 88.55 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.36 0.6 . . . . 0.0 110.065 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 30.0 mt -63.61 -35.98 82.32 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.045 0.45 . . . . 0.0 110.547 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -66.79 -42.13 86.48 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.33 0.586 . . . . 0.0 109.971 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.29 -35.73 74.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 121.462 0.648 . . . . 0.0 109.844 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.74 -31.92 61.25 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 5.2 tt -59.49 -42.13 91.42 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.703 0.763 . . . . 0.0 110.172 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -62.45 -44.13 97.15 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.528 0.68 . . . . 0.0 110.554 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -62.44 -45.61 92.29 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.445 0.64 . . . . 0.0 110.586 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -59.64 -19.24 47.87 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.427 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -85.86 -5.62 59.21 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.938 -0.476 . . . . 0.0 111.958 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -129.15 55.57 1.74 Allowed 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 122.302 1.049 . . . . 0.0 110.299 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 79.8 mtm-85 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.788 -179.909 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.264 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 74.9 p -56.94 115.55 2.67 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 122.316 -0.52 . . . . 0.0 110.056 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 66.6 p -109.45 50.82 0.77 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 122.289 1.042 . . . . 0.0 110.673 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 34.7 m -70.16 -41.32 78.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.428 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 14.0 tp -69.27 -35.54 76.18 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.405 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.3 tt -44.94 -57.1 7.56 Favored Pre-proline 0 CA--C 1.554 1.102 0 CA-C-O 118.887 -0.578 . . . . 0.0 111.744 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -63.79 -38.25 40.65 Favored 'Trans proline' 0 N--CA 1.507 2.27 0 C-N-CA 122.037 1.825 . . . . 0.0 113.925 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.2 tt -59.47 -45.36 91.86 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.205 0.526 . . . . 0.0 111.947 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 9.1 p -61.94 -35.95 71.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.963 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 25.2 mm -62.56 -44.84 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 121.656 -0.653 . . . . 0.0 109.533 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -65.13 -36.66 84.98 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.709 0.766 . . . . 0.0 110.07 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -57.68 -42.38 83.49 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.243 0.544 . . . . 0.0 111.345 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -59.77 -33.63 78.77 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.95 -31.75 71.7 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.124 0.488 . . . . 0.0 111.444 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.64 -38.71 88.69 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.317 0.579 . . . . 0.0 110.619 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.86 -37.54 76.73 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.111 0.481 . . . . 0.0 110.456 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 16.8 tp -57.83 -35.37 70.8 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.079 0.466 . . . . 0.0 110.867 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 35.5 t -58.65 -41.72 86.68 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.228 0.537 . . . . 0.0 110.742 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.8 mp -62.22 -42.78 99.61 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.587 0.708 . . . . 0.0 110.426 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.8 mp -71.25 -36.67 71.85 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.14 0.495 . . . . 0.0 111.029 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -70.36 -42.47 71.76 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.097 0.475 . . . . 0.0 111.568 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 7.9 tp -69.09 -38.37 78.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 121.813 0.816 . . . . 0.0 110.913 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -71.77 -31.8 64.59 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.448 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 10.4 tt -60.87 -37.18 81.25 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 122.084 -0.657 . . . . 0.0 111.174 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.26 -37.48 87.4 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.17 0.509 . . . . 0.0 111.256 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -60.04 -46.33 89.88 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.525 0.679 . . . . 0.0 110.217 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -76.99 -10.87 59.66 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.992 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -85.83 -18.04 33.98 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.882 -0.511 . . . . 0.0 111.178 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -155.73 39.0 0.37 Allowed 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.932 0.873 . . . . 0.0 110.545 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 29.8 ttp180 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.747 -179.734 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 2.0 m -144.04 145.7 32.37 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 122.28 -0.541 . . . . 0.0 110.292 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 40.8 p -98.88 49.26 0.96 Allowed 'General case' 0 C--O 1.238 0.473 0 CA-C-O 122.41 1.1 . . . . 0.0 110.811 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 29.7 m -70.06 -31.94 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.627 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 10.9 tp -63.69 -40.68 97.4 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.795 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 2.9 tp -49.6 -57.55 11.75 Favored Pre-proline 0 CA--C 1.553 1.09 0 O-C-N 121.79 -0.569 . . . . 0.0 111.512 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.42 -39.55 28.42 Favored 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 121.786 1.657 . . . . 0.0 112.754 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.34 -43.66 92.74 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.939 -177.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 10.6 p -66.17 -36.58 77.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 O-C-N 121.971 -0.456 . . . . 0.0 110.714 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 33.6 mt -65.92 -44.45 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -66.58 -36.62 83.08 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.355 0.598 . . . . 0.0 110.139 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -57.55 -43.49 84.5 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.319 0.581 . . . . 0.0 110.116 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.42 -33.64 87.79 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 5.4 tp -58.79 -42.32 88.77 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.543 0.687 . . . . 0.0 110.103 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.8 -38.85 89.65 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.697 0.76 . . . . 0.0 109.567 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 2.9 tp -60.84 -40.1 91.56 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.757 0.789 . . . . 0.0 109.783 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.99 -42.86 89.23 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.061 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 19.4 t -63.24 -44.02 96.4 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 121.51 0.671 . . . . 0.0 109.948 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 11.2 mt -66.85 -39.79 87.71 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.284 0.564 . . . . 0.0 110.23 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 7.6 tp -64.1 -34.76 78.77 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.202 0.525 . . . . 0.0 110.422 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -68.54 -41.17 80.24 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.314 0.578 . . . . 0.0 110.474 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.01 -41.5 89.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 121.585 0.707 . . . . 0.0 109.114 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -60.58 -32.04 76.88 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 6.4 tt -58.98 -46.41 88.2 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.638 0.732 . . . . 0.0 110.762 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -62.8 -38.55 91.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.782 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -60.26 -46.19 90.67 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.562 0.696 . . . . 0.0 109.891 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -70.74 -32.2 69.29 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.102 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -85.24 -8.96 58.29 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 120.991 0.424 . . . . 0.0 111.329 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 47.8 22.09 0.33 Allowed 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.709 -0.619 . . . . 0.0 111.789 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.401 -179.472 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 5.1 t -115.96 24.46 11.45 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 122.151 -0.617 . . . . 0.0 111.6 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 50.2 p -113.85 29.24 8.15 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 122.016 0.912 . . . . 0.0 111.286 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 38.2 t -70.47 -28.09 33.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.637 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 11.9 tp -68.7 -34.05 74.99 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.852 0.358 . . . . 0.0 111.873 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 214' ' ' LEU . . . . . . . . . . . . . 20.8 tp -46.87 -57.37 9.19 Favored Pre-proline 0 CA--C 1.556 1.202 0 CA-C-O 118.913 -0.565 . . . . 0.0 111.59 -178.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.5 -42.74 15.6 Favored 'Trans proline' 0 N--CA 1.504 2.117 0 C-N-CA 121.882 1.721 . . . . 0.0 113.316 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.96 -45.16 83.04 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.89 -177.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 11.6 p -60.26 -35.78 64.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 122.055 -0.403 . . . . 0.0 110.757 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 44.7 mm -62.15 -45.16 99.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -60.34 -41.83 94.43 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.511 0.672 . . . . 0.0 109.462 177.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -57.72 -37.7 73.99 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.697 0.76 . . . . 0.0 110.447 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -59.97 -33.52 79.25 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 4.9 tp -58.65 -38.38 78.01 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.534 0.683 . . . . 0.0 110.776 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.71 89.2 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.214 0.53 . . . . 0.0 110.751 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 11.8 mt -61.47 -47.77 84.14 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.2 0.524 . . . . 0.0 110.44 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 18.0 tp -58.19 -38.49 76.81 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.196 0.522 . . . . 0.0 110.381 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 36.1 t -59.85 -40.56 88.99 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.272 0.558 . . . . 0.0 110.746 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 10.5 mt -64.78 -42.72 94.87 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.671 0.748 . . . . 0.0 110.2 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 7.7 mp -70.52 -34.88 72.8 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.204 0.526 . . . . 0.0 111.046 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -70.1 -42.41 72.76 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.022 0.439 . . . . 0.0 111.653 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 6.2 tp -68.84 -35.93 71.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 121.417 0.627 . . . . 0.0 110.931 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -66.72 -32.15 80.5 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 111.559 -0.617 . . . . 0.0 111.559 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 1.9 tt -56.9 -40.8 76.95 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.58 0.705 . . . . 0.0 110.611 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.52 -37.48 73.09 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.837 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -60.32 -44.22 95.65 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.535 0.683 . . . . 0.0 109.954 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 78.8 mtt85 -65.73 -25.99 67.54 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.477 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -85.24 -1.54 57.05 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 122.038 -0.414 . . . . 0.0 111.777 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -126.58 22.91 6.9 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.827 -0.546 . . . . 0.0 111.315 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.81 -1.091 . . . . 0.0 110.639 179.976 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.4 t -121.1 94.56 4.38 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 122.048 0.927 . . . . 0.0 111.085 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 3.2 m 46.36 31.14 1.18 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 122.006 0.908 . . . . 0.0 111.794 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 26.1 m -70.68 -28.91 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.247 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 21.1 tp -66.1 -41.06 91.14 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 122.11 -0.369 . . . . 0.0 111.891 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 8.0 tp -52.19 -57.29 15.82 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-O 119.03 -0.51 . . . . 0.0 111.396 -178.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.12 -32.06 64.19 Favored 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 121.924 1.75 . . . . 0.0 113.355 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 7.5 tp -69.4 -45.11 70.04 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 122.001 -0.437 . . . . 0.0 111.813 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 13.1 p -65.83 -36.68 78.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 O-C-N 122.245 -0.284 . . . . 0.0 111.456 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 26.4 pt -69.09 -38.39 78.13 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 O-C-N 121.488 -0.757 . . . . 0.0 110.744 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -68.98 -40.56 78.73 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.538 0.685 . . . . 0.0 110.319 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.84 -37.04 75.55 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.568 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -66.65 -33.78 85.46 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 8.2 tp -58.78 -37.44 76.31 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.229 0.538 . . . . 0.0 111.195 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.94 -39.23 91.38 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.105 0.479 . . . . 0.0 110.725 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.2 mp -65.69 -39.32 91.16 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.301 0.572 . . . . 0.0 110.493 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 19.4 tp -59.72 -39.79 85.84 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.191 0.52 . . . . 0.0 110.428 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 50.6 m -58.33 -41.54 84.79 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.308 0.575 . . . . 0.0 110.303 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.3 mt -64.16 -43.47 95.06 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.216 0.531 . . . . 0.0 110.546 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.0 mp -66.49 -38.07 86.45 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.101 0.476 . . . . 0.0 110.607 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -59.77 -42.18 92.7 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.049 0.452 . . . . 0.0 110.572 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.4 mp -64.21 -39.82 86.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.594 0.712 . . . . 0.0 109.367 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -59.67 -32.01 72.79 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 9.1 tt -58.13 -45.27 87.62 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.475 0.655 . . . . 0.0 110.936 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -65.09 -37.51 87.74 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.354 0.597 . . . . 0.0 110.997 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -64.04 -37.52 87.75 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.338 0.589 . . . . 0.0 110.738 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -61.29 -37.79 84.45 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.224 0.535 . . . . 0.0 110.934 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -86.24 5.2 35.44 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.868 0.366 . . . . 0.0 111.956 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -52.18 -32.49 36.36 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.45 0.643 . . . . 0.0 111.056 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 . . . . . 0 N--CA 1.469 0.505 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.794 179.879 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 17.5 p -99.9 115.17 29.01 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.391 0.615 . . . . 0.0 110.565 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 3.2 m 53.0 34.28 16.63 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 122.306 1.051 . . . . 0.0 110.924 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 14.8 p -70.59 -23.23 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.833 179.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 9.3 tt -69.19 -40.18 78.21 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 2.0 tp -54.42 -56.86 22.1 Favored Pre-proline 0 CA--C 1.548 0.892 0 O-C-N 121.691 -0.631 . . . . 0.0 110.924 -178.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -64.24 -37.45 40.87 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 121.544 1.496 . . . . 0.0 112.476 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 4.4 tt -60.06 -45.38 93.06 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.102 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 11.0 p -65.1 -36.57 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 O-C-N 122.219 -0.301 . . . . 0.0 110.682 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 46.2 mt -65.38 -44.95 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -67.93 -36.72 80.63 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.695 0.759 . . . . 0.0 109.987 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -57.78 -45.18 86.36 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.344 0.592 . . . . 0.0 110.678 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.66 -33.91 86.71 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 6.5 tp -59.86 -41.25 91.04 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.455 0.645 . . . . 0.0 110.959 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.33 91.57 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.266 0.555 . . . . 0.0 110.614 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 1.1 tt -61.78 -41.54 97.85 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.532 0.682 . . . . 0.0 109.811 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 20.7 tp -58.81 -42.97 90.39 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.263 0.554 . . . . 0.0 110.49 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 6.7 m -62.68 -43.51 98.61 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.474 0.654 . . . . 0.0 110.222 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 5.7 mp -65.5 -40.76 93.43 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.326 0.584 . . . . 0.0 110.686 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 16.8 tp -71.13 -34.66 71.26 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.505 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -71.03 -42.64 69.25 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 121.867 -0.521 . . . . 0.0 111.274 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 7.5 tp -69.34 -37.19 75.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 121.838 0.828 . . . . 0.0 111.081 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.69 -31.83 62.23 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.614 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 4.3 tt -61.14 -41.02 95.98 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.526 0.679 . . . . 0.0 111.007 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.97 -41.92 97.4 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.365 0.602 . . . . 0.0 110.907 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -63.34 -46.95 84.22 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.614 0.721 . . . . 0.0 110.493 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -59.01 -38.06 78.35 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.418 0.628 . . . . 0.0 110.897 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -86.02 4.52 37.54 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.79 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -141.55 40.41 1.72 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.994 0.902 . . . . 0.0 110.298 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 47.5 ttt85 . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.771 179.989 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 2.5 t 41.26 99.07 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.991 0.9 . . . . 0.0 112.509 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 7.0 p -70.24 73.09 0.47 Allowed 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.321 1.058 . . . . 0.0 110.964 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 27.7 m -64.81 -25.83 38.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.125 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 4.4 tt -68.98 -35.37 76.64 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.886 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 214' ' ' LEU . . . . . . . . . . . . . 4.0 tp -46.36 -57.17 9.05 Favored Pre-proline 0 CA--C 1.553 1.093 0 CA-C-O 119.112 -0.471 . . . . 0.0 111.642 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.84 -38.97 35.92 Favored 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 121.841 1.694 . . . . 0.0 113.032 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -45.35 90.91 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.839 0.352 . . . . 0.0 111.723 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 7.1 p -64.46 -36.57 77.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 122.088 -0.382 . . . . 0.0 110.514 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 50.9 mt -63.0 -45.15 99.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.455 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -64.39 -37.32 87.09 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.618 0.723 . . . . 0.0 110.092 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -57.96 -45.29 86.92 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.419 0.628 . . . . 0.0 110.578 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.13 -33.79 81.22 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 4.8 tp -59.06 -40.33 84.79 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.585 0.707 . . . . 0.0 110.629 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.83 -39.05 90.45 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.864 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 36.2 mt -61.6 -40.01 93.28 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.416 0.627 . . . . 0.0 110.581 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 32.3 tp -60.93 -35.28 76.3 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.062 0.458 . . . . 0.0 110.314 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 42.8 t -57.6 -46.7 83.71 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.371 0.605 . . . . 0.0 109.669 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 8.1 mp -60.89 -42.24 97.63 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.395 0.617 . . . . 0.0 110.244 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.63 -37.25 86.93 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.201 0.524 . . . . 0.0 110.585 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -69.79 -42.08 74.24 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.173 0.511 . . . . 0.0 111.183 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 34.0 mm -63.01 -41.04 91.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.506 0.669 . . . . 0.0 110.072 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -62.78 -33.28 86.44 Favored Glycine 0 CA--C 1.535 1.289 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 7.8 tt -61.89 -34.66 76.44 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 122.178 -0.601 . . . . 0.0 111.764 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -61.43 -35.81 78.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.138 0.494 . . . . 0.0 111.354 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -59.87 -44.49 94.14 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.365 0.602 . . . . 0.0 110.575 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 66.5 mtp85 -63.96 -32.12 73.54 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.429 0.633 . . . . 0.0 110.832 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -85.79 -8.76 57.91 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 120.959 0.409 . . . . 0.0 111.146 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -164.86 88.79 0.48 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.737 0.779 . . . . 0.0 110.231 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.883 -1.056 . . . . 0.0 111.03 -179.693 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 48.4 p -73.14 168.81 18.34 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.385 0.612 . . . . 0.0 110.624 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 43.7 p -97.96 59.51 1.43 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.133 0.968 . . . . 0.0 111.039 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 26.2 t -70.31 -34.83 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-O 121.471 0.653 . . . . 0.0 110.207 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 54.2 mt -66.56 -33.26 75.28 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.77 -57.54 17.1 Favored Pre-proline 0 CA--C 1.55 0.955 0 O-C-N 121.96 -0.463 . . . . 0.0 111.085 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.73 -32.94 67.52 Favored 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 121.868 1.712 . . . . 0.0 112.814 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.94 -45.32 95.19 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.041 0.448 . . . . 0.0 111.468 -178.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.3 p -67.92 -36.51 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 O-C-N 122.125 -0.359 . . . . 0.0 110.203 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 52.6 mt -67.84 -42.83 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 121.507 0.67 . . . . 0.0 109.212 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -62.93 -36.72 84.34 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.482 0.658 . . . . 0.0 110.524 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -57.74 -43.44 85.39 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.367 0.603 . . . . 0.0 110.207 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.12 -33.91 88.49 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 6.8 tp -60.58 -38.82 85.87 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.587 0.708 . . . . 0.0 110.643 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.81 -38.77 89.38 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.239 0.542 . . . . 0.0 110.711 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 6.1 mp -59.8 -35.95 75.72 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.207 0.527 . . . . 0.0 110.471 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 13.4 tp -58.44 -36.58 73.86 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.089 0.471 . . . . 0.0 110.913 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 23.5 t -58.46 -44.36 89.21 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.27 0.557 . . . . 0.0 110.533 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.9 mt -61.66 -43.14 99.42 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.461 0.648 . . . . 0.0 110.013 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 6.8 mt -66.51 -37.31 84.77 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.149 0.5 . . . . 0.0 110.414 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -65.85 -41.98 91.01 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.319 0.58 . . . . 0.0 110.117 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 92.6 mt -63.01 -35.96 73.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 121.409 0.623 . . . . 0.0 110.003 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.56 -32.2 61.0 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 10.0 tt -59.21 -37.33 77.19 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.593 0.711 . . . . 0.0 110.568 179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.82 -36.01 73.82 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.254 0.549 . . . . 0.0 111.157 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -60.49 -46.94 88.29 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.486 0.66 . . . . 0.0 110.568 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -64.46 -37.67 88.33 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.274 0.559 . . . . 0.0 110.955 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -85.91 4.18 38.59 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 120.88 0.371 . . . . 0.0 111.948 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -156.67 82.81 0.96 Allowed 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.772 0.796 . . . . 0.0 109.749 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 34.4 ptt-85 . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 117.914 -1.041 . . . . 0.0 111.166 -179.086 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 20.2 m -101.07 83.24 2.47 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.882 0.848 . . . . 0.0 110.139 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 17.1 p 47.3 50.76 14.15 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 122.405 1.098 . . . . 0.0 111.018 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 34.7 t -70.04 -36.74 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.014 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 9.1 tp -69.16 -33.39 73.33 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.592 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -49.13 -57.26 12.04 Favored Pre-proline 0 CA--C 1.553 1.058 0 O-C-N 121.908 -0.495 . . . . 0.0 111.319 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.7 -29.31 69.08 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 121.905 1.736 . . . . 0.0 113.484 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.16 -45.14 67.36 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.106 0.479 . . . . 0.0 111.51 -178.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 8.5 p -65.23 -36.78 78.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 122.098 -0.376 . . . . 0.0 111.409 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 28.7 pt -69.07 -38.2 77.92 Favored 'Isoleucine or valine' 0 C--N 1.348 0.526 0 O-C-N 121.355 -0.841 . . . . 0.0 110.661 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -64.42 -44.03 92.49 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.555 0.693 . . . . 0.0 110.083 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -59.22 -44.63 92.3 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.688 0.756 . . . . 0.0 109.956 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -59.97 -33.37 78.63 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 3.7 tp -59.02 -40.79 86.06 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.417 0.627 . . . . 0.0 110.393 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.89 -38.76 89.53 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.141 0.496 . . . . 0.0 110.873 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 15.3 mt -59.35 -39.08 82.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.227 0.537 . . . . 0.0 110.434 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 18.0 tp -60.82 -38.43 85.4 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.316 0.579 . . . . 0.0 110.317 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 5.6 t -58.29 -47.03 84.95 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.286 0.565 . . . . 0.0 110.425 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 7.7 mp -59.09 -43.8 91.86 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.224 0.535 . . . . 0.0 110.54 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 6.9 mp -67.01 -38.74 86.51 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.127 0.489 . . . . 0.0 110.777 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -67.3 -42.27 84.0 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.208 0.528 . . . . 0.0 111.126 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 34.2 mm -64.99 -42.42 94.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-O 121.648 0.737 . . . . 0.0 109.615 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -58.54 -31.84 67.71 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -57.78 -43.36 85.48 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.718 0.771 . . . . 0.0 110.608 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -64.53 -37.96 89.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.733 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -60.29 -43.22 96.45 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.516 0.674 . . . . 0.0 110.294 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -59.38 -43.09 92.97 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.428 0.632 . . . . 0.0 110.621 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -86.18 4.96 36.31 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.919 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -102.5 55.89 0.78 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 122.217 1.008 . . . . 0.0 110.397 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 36.9 mtm105 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.772 179.965 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 7.6 t -66.92 123.55 20.51 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.329 0.585 . . . . 0.0 110.882 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 11.7 p -124.93 55.6 1.35 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 122.322 1.058 . . . . 0.0 110.314 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 44.7 t -70.05 -33.01 53.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.076 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.24 -38.49 88.0 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.943 0.402 . . . . 0.0 111.257 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 214' ' ' LEU . . . . . . . . . . . . . 3.1 tp -49.26 -57.41 11.77 Favored Pre-proline 0 CA--C 1.554 1.1 0 O-C-N 121.889 -0.507 . . . . 0.0 111.534 -178.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.09 -34.52 57.65 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 121.852 1.701 . . . . 0.0 112.97 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.61 -45.26 94.85 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.073 0.463 . . . . 0.0 111.615 -178.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 8.4 p -67.3 -36.56 76.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 122.059 -0.4 . . . . 0.0 110.29 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 41.5 mt -68.66 -41.23 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.498 0.666 . . . . 0.0 109.318 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -62.52 -36.97 84.26 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.379 0.609 . . . . 0.0 110.544 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -57.87 -43.55 86.09 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.503 0.668 . . . . 0.0 110.324 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.43 -33.78 82.63 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 7.4 tp -59.39 -36.47 75.86 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.314 0.578 . . . . 0.0 111.293 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.68 -38.72 88.83 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.132 0.491 . . . . 0.0 111.012 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 7.2 mp -59.3 -39.27 82.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.214 0.53 . . . . 0.0 110.416 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 24.2 tp -61.75 -38.51 88.25 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.258 0.551 . . . . 0.0 110.458 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 74.9 m -58.32 -42.65 87.25 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.24 0.543 . . . . 0.0 110.916 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.97 -42.3 97.3 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.386 0.612 . . . . 0.0 110.647 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 6.5 mp -71.16 -34.68 71.19 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.199 0.523 . . . . 0.0 111.103 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -64.94 -42.28 94.77 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.921 0.391 . . . . 0.0 111.816 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 6.6 tp -69.26 -35.77 69.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 121.543 0.687 . . . . 0.0 110.983 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.69 -31.96 62.08 Favored Glycine 0 CA--C 1.535 1.285 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 9.1 tt -57.2 -44.7 83.9 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.513 0.673 . . . . 0.0 111.016 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -62.93 -39.61 95.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.388 0.613 . . . . 0.0 110.797 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -61.0 -45.25 95.59 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.418 0.627 . . . . 0.0 110.539 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -61.52 -38.33 86.97 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.254 0.549 . . . . 0.0 111.029 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -85.83 -1.81 57.62 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.902 0.382 . . . . 0.0 111.677 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -95.79 -31.93 12.94 Favored 'General case' 0 C--N 1.344 0.343 0 O-C-N 121.741 -0.599 . . . . 0.0 111.295 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.541 -179.938 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 5.9 m -140.17 130.76 25.61 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 122.339 -0.507 . . . . 0.0 110.299 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 41.0 p -126.44 36.04 4.55 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 122.099 0.952 . . . . 0.0 111.474 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 57.3 t -70.37 -27.5 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.231 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 4.0 tt -66.84 -39.8 87.72 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.921 0.391 . . . . 0.0 111.315 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 4.5 tp -47.83 -57.34 10.33 Favored Pre-proline 0 CA--C 1.553 1.068 0 CA-C-O 118.895 -0.574 . . . . 0.0 111.581 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -64.0 -34.02 60.58 Favored 'Trans proline' 0 N--CA 1.503 2.083 0 C-N-CA 121.752 1.635 . . . . 0.0 113.113 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.6 tp -61.13 -45.32 95.14 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.011 0.434 . . . . 0.0 111.634 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.39 -36.6 78.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 O-C-N 122.204 -0.31 . . . . 0.0 110.631 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 42.2 mm -65.05 -42.41 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -60.96 -36.75 80.19 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.394 0.616 . . . . 0.0 110.287 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.88 -42.13 83.93 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.399 0.619 . . . . 0.0 109.897 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -65.47 -33.8 87.43 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 7.4 tp -58.75 -34.58 71.56 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.253 0.549 . . . . 0.0 111.077 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.63 -38.76 88.84 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.24 0.543 . . . . 0.0 110.974 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.9 mp -61.5 -38.87 88.9 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.357 0.599 . . . . 0.0 110.443 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 16.8 tp -59.07 -41.91 89.1 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.278 0.561 . . . . 0.0 110.447 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 46.9 t -59.9 -42.26 93.45 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.299 0.571 . . . . 0.0 110.742 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 1.6 tt -62.63 -46.71 86.97 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.365 0.602 . . . . 0.0 110.48 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.4 mp -66.0 -40.18 90.93 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.915 0.388 . . . . 0.0 111.376 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -70.06 -42.27 73.04 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.219 0.533 . . . . 0.0 110.95 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 93.4 mt -68.04 -42.16 85.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.484 0.659 . . . . 0.0 110.164 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -62.97 -34.3 89.56 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 1.4 tt -68.24 -39.18 82.35 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.57 0.7 . . . . 0.0 110.929 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . 0.41 ' HA ' ' CZ ' ' A' ' 236' ' ' TYR . . . -70.32 -35.61 73.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.294 0.569 . . . . 0.0 112.279 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -59.76 -31.9 70.08 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.34 -48.3 70.67 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.59 -0.694 . . . . 0.0 112.516 -178.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.41 ' CZ ' ' HA ' ' A' ' 233' ' ' ALA . 19.1 p90 -96.5 5.54 50.6 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 121.631 -0.668 . . . . 0.0 111.96 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -52.75 -38.95 61.72 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.556 0.693 . . . . 0.0 110.852 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 56.5 ttt-85 . . . . . 0 C--O 1.218 -0.59 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.623 -179.848 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.354 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 3.8 m -111.39 -60.37 1.85 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.369 0.604 . . . . 0.0 110.574 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 1.4 m -139.0 37.78 2.14 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 122.164 0.983 . . . . 0.0 110.675 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 41.5 t -70.34 -26.61 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.422 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 12.1 tp -64.14 -40.94 97.24 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 122.149 -0.344 . . . . 0.0 111.847 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 1.5 tt -54.54 -57.07 20.54 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-O 119.103 -0.475 . . . . 0.0 111.332 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.86 -33.31 64.81 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 121.852 1.701 . . . . 0.0 112.942 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 3.6 tt -61.86 -45.53 93.4 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.091 0.472 . . . . 0.0 111.493 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.66 -36.53 77.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 O-C-N 122.128 -0.357 . . . . 0.0 110.302 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 53.5 mt -67.46 -44.69 86.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -64.43 -36.74 85.13 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.515 0.674 . . . . 0.0 110.029 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -57.65 -43.74 85.17 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.295 0.569 . . . . 0.0 110.408 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -70.15 -35.68 70.91 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.21 -27.56 69.15 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.185 0.517 . . . . 0.0 110.71 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.72 -38.88 89.52 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.263 0.554 . . . . 0.0 110.323 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 51.1 mt -60.31 -38.49 83.85 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.331 0.586 . . . . 0.0 110.367 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 17.4 tp -57.98 -35.41 71.15 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.193 0.52 . . . . 0.0 110.655 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 17.1 m -58.4 -40.43 82.38 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.202 0.525 . . . . 0.0 110.834 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 8.0 mp -63.33 -45.59 90.54 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.49 0.662 . . . . 0.0 110.796 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 8.0 mp -71.23 -34.98 71.28 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.267 0.556 . . . . 0.0 111.224 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -72.52 -42.12 65.12 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.111 0.481 . . . . 0.0 111.82 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 7.7 tp -66.12 -35.92 76.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 121.411 0.624 . . . . 0.0 111.326 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -73.11 -36.73 56.28 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 3.0 tt -62.85 -46.08 89.56 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.718 0.77 . . . . 0.0 111.126 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -70.35 -35.35 73.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.539 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -59.37 -45.45 91.41 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -177.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -60.74 -34.43 74.4 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.452 0.644 . . . . 0.0 110.977 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -85.97 -5.57 59.2 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.824 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -90.14 44.66 1.21 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.987 0.899 . . . . 0.0 110.622 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.717 179.677 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 6.9 p -155.5 150.26 26.38 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.293 0.568 . . . . 0.0 110.53 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.82 42.15 2.86 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 122.437 1.113 . . . . 0.0 110.244 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 13.4 p -70.24 -29.14 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.779 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 15.0 tp -65.6 -40.43 92.66 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.831 0.348 . . . . 0.0 111.775 -179.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 214' ' ' LEU . . . . . . . . . . . . . 11.0 tp -50.6 -57.11 14.34 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-O 119.011 -0.519 . . . . 0.0 111.634 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.87 -35.56 55.26 Favored 'Trans proline' 0 N--CA 1.504 2.116 0 C-N-CA 121.824 1.682 . . . . 0.0 112.961 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 5.3 tt -61.35 -45.43 94.45 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.987 0.423 . . . . 0.0 111.701 -178.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 10.0 p -66.99 -36.45 77.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 122.214 -0.303 . . . . 0.0 110.339 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 57.0 mt -67.59 -45.15 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -66.45 -37.32 84.88 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.41 0.624 . . . . 0.0 110.285 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -60.5 -45.79 92.5 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.462 0.649 . . . . 0.0 110.067 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.23 -33.64 87.77 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 6.0 tp -58.73 -39.64 81.47 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.522 0.677 . . . . 0.0 110.172 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.72 -38.46 87.99 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.577 0.704 . . . . 0.0 110.32 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 2.3 tp -58.71 -45.9 88.52 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.248 0.546 . . . . 0.0 110.257 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 25.4 tp -62.5 -39.56 93.9 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.256 0.55 . . . . 0.0 109.997 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 16.6 t -57.35 -45.56 84.24 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.095 0.474 . . . . 0.0 110.296 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 11.4 mt -63.12 -42.14 99.46 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.206 0.527 . . . . 0.0 110.499 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 5.8 tp -65.88 -34.89 79.18 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.274 0.559 . . . . 0.0 110.442 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -65.34 -38.11 89.13 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.189 0.518 . . . . 0.0 110.936 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 36.3 mm -62.79 -43.39 98.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.526 0.679 . . . . 0.0 110.035 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.98 -37.05 56.76 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 8.3 tt -63.59 -44.08 95.09 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.387 0.613 . . . . 0.0 111.272 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -65.55 -35.55 81.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.347 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -59.73 -44.0 93.95 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.432 0.634 . . . . 0.0 110.296 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -69.64 -18.68 63.61 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.359 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -85.76 -13.68 47.52 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 122.023 -0.423 . . . . 0.0 111.419 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 53.1 49.61 19.65 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 122.123 0.963 . . . . 0.0 110.428 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.737 -179.973 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.369 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 3.6 t -127.77 109.44 11.65 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.747 0.784 . . . . 0.0 111.01 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 56.3 p 45.26 47.32 10.29 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 122.159 0.98 . . . . 0.0 111.736 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 12.9 p -69.9 -21.5 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.356 178.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.14 -33.0 72.74 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.073 0.463 . . . . 0.0 110.811 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 3.3 tp -53.95 -57.07 19.43 Favored Pre-proline 0 CA--C 1.554 1.108 0 CA-C-O 119.063 -0.494 . . . . 0.0 111.534 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -63.32 -29.87 72.92 Favored 'Trans proline' 0 N--CA 1.504 2.128 0 C-N-CA 121.969 1.779 . . . . 0.0 113.612 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.5 tt -69.32 -45.31 69.79 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.813 -0.554 . . . . 0.0 111.44 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 7.9 p -64.93 -36.8 78.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 O-C-N 122.066 -0.396 . . . . 0.0 111.62 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 21.2 pt -70.68 -40.17 76.67 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 O-C-N 121.421 -0.8 . . . . 0.0 110.616 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -67.95 -42.14 81.4 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.668 0.747 . . . . 0.0 110.088 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -60.38 -44.14 95.92 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.535 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.62 -33.84 88.31 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 4.4 tp -59.57 -39.36 83.84 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.561 0.696 . . . . 0.0 110.323 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.52 88.28 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.292 0.568 . . . . 0.0 110.285 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.5 tp -58.89 -38.58 79.2 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.377 0.608 . . . . 0.0 110.007 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 17.5 tp -60.52 -32.35 71.38 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.197 0.522 . . . . 0.0 110.431 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 16.9 m -59.76 -43.67 94.21 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.212 0.529 . . . . 0.0 111.192 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.1 mp -65.04 -41.77 94.92 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.739 0.781 . . . . 0.0 110.58 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 25.8 mt -71.11 -34.8 71.44 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.397 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -69.24 -42.32 75.78 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.24 0.543 . . . . 0.0 111.677 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 6.1 tp -68.1 -36.06 73.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 121.588 0.708 . . . . 0.0 110.866 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -67.51 -31.69 77.18 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -56.89 -43.04 80.9 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.542 0.687 . . . . 0.0 110.485 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -59.66 -38.94 82.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.351 0.596 . . . . 0.0 110.686 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -60.91 -44.16 97.54 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.603 0.716 . . . . 0.0 110.011 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -66.53 -34.62 78.32 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.464 0.65 . . . . 0.0 110.736 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -85.93 0.22 53.75 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.602 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -127.97 36.96 4.25 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.912 0.863 . . . . 0.0 110.625 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.747 179.802 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 25.2 m -149.59 108.3 3.84 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.375 0.607 . . . . 0.0 110.796 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 7.4 t -131.49 40.93 3.36 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.302 1.049 . . . . 0.0 110.592 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 34.2 m -70.26 -25.25 26.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.785 179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 10.0 tp -67.14 -36.56 82.14 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.487 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.07 -57.64 17.12 Favored Pre-proline 0 CA--C 1.552 1.023 0 O-C-N 122.052 -0.405 . . . . 0.0 110.8 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.95 -34.87 58.02 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 121.9 1.733 . . . . 0.0 112.722 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 7.8 tp -61.33 -45.4 94.59 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.944 0.402 . . . . 0.0 111.694 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 9.2 p -66.46 -36.48 77.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 O-C-N 122.228 -0.295 . . . . 0.0 110.257 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 55.6 mt -68.57 -42.72 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.433 0.635 . . . . 0.0 109.342 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -65.01 -40.55 95.07 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.572 0.701 . . . . 0.0 110.193 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -59.42 -41.65 90.03 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.558 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.66 -33.74 86.1 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 6.4 tp -58.92 -31.69 68.88 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.3 0.572 . . . . 0.0 111.317 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.68 -38.78 89.05 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.091 0.472 . . . . 0.0 110.805 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 6.4 mp -61.69 -39.25 90.78 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.368 0.604 . . . . 0.0 110.149 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 24.7 tp -58.36 -37.96 76.28 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.228 0.537 . . . . 0.0 110.678 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 12.1 t -60.36 -41.65 94.11 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.238 0.542 . . . . 0.0 110.684 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 7.4 mp -62.36 -43.32 99.09 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.189 0.519 . . . . 0.0 110.588 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 1.3 mp -68.38 -42.63 78.83 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.454 0.645 . . . . 0.0 110.22 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -63.96 -42.24 97.33 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.066 0.46 . . . . 0.0 110.748 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.75 -36.13 76.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.336 0.589 . . . . 0.0 110.13 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.82 -32.87 62.48 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 4.1 tt -62.85 -44.88 94.96 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.663 0.744 . . . . 0.0 110.595 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -66.88 -36.63 82.73 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.476 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -59.88 -48.02 83.4 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.337 0.589 . . . . 0.0 110.844 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -66.47 -22.54 66.2 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.979 0.418 . . . . 0.0 111.647 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -86.18 -7.16 58.76 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.812 0.339 . . . . 0.0 111.882 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -61.4 -36.23 79.71 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-O 121.415 0.626 . . . . 0.0 111.332 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 33.8 mtp180 . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.603 -179.59 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 4.3 m -97.68 -67.23 0.86 Allowed 'General case' 0 CA--C 1.536 0.433 0 O-C-N 122.308 -0.525 . . . . 0.0 111.403 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 8.1 t -112.55 39.23 2.53 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.056 0.931 . . . . 0.0 111.583 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 27.1 m -70.26 -22.34 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.72 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 1.4 tt -66.81 -35.02 79.09 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.939 0.399 . . . . 0.0 110.962 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 214' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.64 -58.11 11.1 Favored Pre-proline 0 CA--C 1.553 1.084 0 O-C-N 122.03 -0.419 . . . . 0.0 110.895 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -64.27 -34.79 54.58 Favored 'Trans proline' 0 N--CA 1.501 1.926 0 C-N-CA 121.882 1.721 . . . . 0.0 113.044 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.91 -45.11 95.94 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.417 -178.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 217' ' ' VAL . . . . . . . . . . . . . 10.4 p -64.59 -36.18 76.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 122.084 -0.385 . . . . 0.0 110.873 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 48.9 mt -62.68 -41.7 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -59.39 -42.97 92.94 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.64 0.734 . . . . 0.0 110.05 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.85 -36.96 73.06 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.364 0.602 . . . . 0.0 110.708 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.5 -33.76 88.1 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 4.9 tp -59.18 -39.77 83.59 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.38 0.61 . . . . 0.0 110.994 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.68 -40.03 93.52 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.215 0.531 . . . . 0.0 110.952 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 76.5 mt -62.04 -39.09 91.15 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.389 0.614 . . . . 0.0 110.775 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 44.7 tp -59.32 -39.14 82.17 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.498 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 9.9 p -60.81 -42.09 96.94 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.089 0.471 . . . . 0.0 110.644 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 7.1 mp -63.19 -45.48 91.58 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.342 0.592 . . . . 0.0 109.865 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.69 -37.42 87.54 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.098 0.475 . . . . 0.0 110.439 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -62.75 -42.3 99.61 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.327 0.584 . . . . 0.0 109.72 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.71 -38.93 82.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 121.462 0.648 . . . . 0.0 109.758 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.59 -31.85 60.74 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 5.7 tt -58.67 -40.33 83.21 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.472 0.653 . . . . 0.0 110.388 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -61.17 -44.26 97.59 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.386 0.612 . . . . 0.0 110.761 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -62.08 -46.22 90.05 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.358 0.599 . . . . 0.0 110.645 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -68.47 -36.01 78.37 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.233 0.54 . . . . 0.0 111.49 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -89.58 4.98 47.62 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -135.36 55.12 1.89 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 122.081 0.943 . . . . 0.0 110.319 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 63.5 ttt-85 . . . . . 0 C--O 1.221 -0.411 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.548 -179.994 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 25.5 p . . . . . 0 N--CA 1.467 0.414 0 CA-C-O 122.209 1.004 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 14.0 p -70.46 -27.95 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.887 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.5 HD13 ' O ' ' A' ' 213' ' ' LEU . 0.2 OUTLIER -69.02 -34.66 75.6 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.999 0.428 . . . . 0.0 111.571 -179.386 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.486 ' O ' HG12 ' A' ' 217' ' ' VAL . 3.2 tp -48.44 -57.19 11.4 Favored Pre-proline 0 CA--C 1.552 1.038 0 O-C-N 121.949 -0.469 . . . . 0.0 111.529 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -63.68 -37.84 44.08 Favored 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 121.802 1.668 . . . . 0.0 113.194 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 10.0 tp -60.99 -45.4 94.96 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.835 0.35 . . . . 0.0 111.667 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 214' ' ' LEU . 8.5 p -65.43 -36.39 77.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 O-C-N 122.271 -0.268 . . . . 0.0 110.697 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 68.6 mt -64.43 -43.96 97.02 Favored 'Isoleucine or valine' 0 C--N 1.345 0.374 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.475 ' CD1' HG21 ' C' ' 218' ' ' ILE . 8.3 m-30 -69.36 -37.06 77.44 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.494 0.664 . . . . 0.0 110.592 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -63.72 -36.7 84.73 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.335 0.588 . . . . 0.0 110.652 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.55 -33.71 82.92 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.537 HD13 HG23 ' C' ' 218' ' ' ILE . 0.2 OUTLIER -58.95 -25.53 63.59 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.157 0.503 . . . . 0.0 111.217 179.598 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.62 -38.69 88.55 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.139 0.495 . . . . 0.0 110.616 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.3 mp -59.5 -39.63 84.42 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.287 0.565 . . . . 0.0 110.407 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 14.7 tp -61.58 -40.97 96.67 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.384 0.611 . . . . 0.0 110.322 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 5.9 t -59.02 -46.31 88.52 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 121.333 0.587 . . . . 0.0 110.292 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.4 mt -64.47 -40.57 95.93 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.368 0.604 . . . . 0.0 110.179 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 18.2 mt -64.83 -36.58 84.8 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.062 0.458 . . . . 0.0 110.789 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -65.13 -42.21 94.1 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.249 0.547 . . . . 0.0 110.286 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 43.6 mm -63.91 -41.73 93.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 121.613 0.721 . . . . 0.0 109.967 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -62.26 -32.0 81.13 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 111.611 -0.596 . . . . 0.0 111.611 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.8 tt -58.46 -42.29 87.11 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.601 0.715 . . . . 0.0 110.819 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -66.77 -36.67 82.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.92 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 52.0 t80 . . . . . 0 C--O 1.234 0.273 0 CA-C-O 121.44 0.638 . . . . 0.0 110.422 179.98 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 47.7 t . . . . . 0 CA--C 1.539 0.538 0 CA-C-O 121.467 0.651 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 6.6 tt -67.82 -34.74 77.33 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.664 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.512 ' O ' HG12 ' B' ' 217' ' ' VAL . 0.7 OUTLIER -49.84 -57.52 12.11 Favored Pre-proline 0 CA--C 1.552 1.049 0 O-C-N 121.881 -0.512 . . . . 0.0 111.088 -178.973 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 215' ' ' PRO . . . . . 0.431 ' HA ' HD12 ' B' ' 218' ' ' ILE . 33.9 Cg_endo -63.96 -34.62 58.83 Favored 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 121.797 1.664 . . . . 0.0 112.846 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 8.2 tp -60.36 -45.37 93.75 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.987 0.422 . . . . 0.0 111.705 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.512 HG12 ' O ' ' B' ' 214' ' ' LEU . 7.2 p -66.34 -36.56 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 122.214 -0.304 . . . . 0.0 110.286 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 218' ' ' ILE . . . . . 0.474 ' HA ' HD22 ' C' ' 222' ' ' LEU . 53.5 mt -63.67 -42.24 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -65.14 -36.71 85.1 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.616 0.722 . . . . 0.0 109.942 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.65 -33.39 68.24 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.129 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 221' ' ' GLY . . . . . 0.41 ' HA3' HD11 ' C' ' 222' ' ' LEU . . . -70.92 -33.94 65.62 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.47 -32.26 73.12 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.152 0.501 . . . . 0.0 111.119 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -62.13 -38.95 90.91 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.276 0.56 . . . . 0.0 110.838 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 16.7 mt -63.77 -42.31 97.81 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.335 0.588 . . . . 0.0 110.418 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 22.0 tp -58.96 -30.82 68.19 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.189 0.518 . . . . 0.0 110.479 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 6.8 t -56.83 -45.93 82.01 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.984 0.421 . . . . 0.0 110.435 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 10.8 mt -64.52 -42.17 95.94 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.208 0.527 . . . . 0.0 110.249 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 6.7 mp -61.15 -37.42 82.79 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.483 0.659 . . . . 0.0 109.745 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -58.94 -35.48 73.19 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.347 0.594 . . . . 0.0 110.722 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 44.9 mm -62.17 -42.54 95.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.508 0.671 . . . . 0.0 110.205 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -62.77 -33.23 86.29 Favored Glycine 0 CA--C 1.535 1.306 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 232' ' ' LEU . . . . . 0.421 HD23 ' C ' ' B' ' 232' ' ' LEU . 9.3 tt . . . . . 0 N--CA 1.467 0.383 0 CA-C-O 121.43 0.633 . . . . 0.0 111.387 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 213' ' ' LEU . . . . . 0.405 HD12 ' N ' ' C' ' 214' ' ' LEU . 3.2 pp . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 214' ' ' LEU . . . . . 0.493 ' O ' HG12 ' C' ' 217' ' ' VAL . 0.6 OUTLIER -53.36 -57.4 17.01 Favored Pre-proline 0 CA--C 1.552 1.028 0 O-C-N 121.931 -0.48 . . . . 0.0 111.062 -179.113 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.67 -32.1 68.98 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 121.869 1.713 . . . . 0.0 112.992 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.49 -45.31 93.61 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.084 0.469 . . . . 0.0 111.361 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 217' ' ' VAL . . . . . 0.493 HG12 ' O ' ' C' ' 214' ' ' LEU . 7.1 p -67.0 -36.39 77.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 O-C-N 122.132 -0.355 . . . . 0.0 110.244 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 218' ' ' ILE . . . . . 0.537 HG23 HD13 ' A' ' 222' ' ' LEU . 41.8 mm -62.79 -43.71 98.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -63.04 -36.9 85.11 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.381 0.61 . . . . 0.0 109.868 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -57.74 -41.91 82.81 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.518 0.675 . . . . 0.0 110.222 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.04 -33.91 81.3 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 222' ' ' LEU . . . . . 0.474 HD22 ' HA ' ' B' ' 218' ' ' ILE . 5.2 tp -58.91 -41.61 87.66 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.573 0.701 . . . . 0.0 110.279 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.81 -38.67 89.02 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.501 0.667 . . . . 0.0 110.151 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 1.9 tt -58.62 -38.37 77.87 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.366 0.603 . . . . 0.0 110.047 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 37.9 tp -57.91 -37.63 74.39 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.116 0.484 . . . . 0.0 110.183 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 6.5 t -59.18 -40.24 85.08 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.301 0.572 . . . . 0.0 110.401 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 11.4 mt -67.21 -42.81 83.5 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.465 0.65 . . . . 0.0 110.066 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 17.0 mt -65.69 -36.48 83.76 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.069 0.461 . . . . 0.0 111.11 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -74.98 -42.18 58.06 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.321 0.581 . . . . 0.0 110.893 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 91.1 mt -64.93 -40.56 89.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.29 0.567 . . . . 0.0 110.471 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -63.83 -34.99 91.41 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.49 -39.76 81.2 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.592 0.711 . . . . 0.0 111.248 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.31 -39.27 94.1 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.576 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -65.59 -48.13 73.39 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.503 0.668 . . . . 0.0 110.873 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -66.43 -45.98 78.02 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.589 0.709 . . . . 0.0 110.861 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 49.3 t80 . . . . . 0 CA--C 1.543 0.709 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.772 -179.74 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 39.0 p . . . . . 0 C--O 1.237 0.423 0 CA-C-O 122.498 1.142 . . . . 342.29000000000002 110.463 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 40.2 t -70.03 -29.88 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 115.258 -0.883 . . . . 373.69 110.093 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.92 -31.03 69.63 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.906 0.384 . . . . 305.66000000000003 111.18 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.493 ' O ' HG12 ' A' ' 217' ' ' VAL . 1.3 tp -54.31 -57.67 17.37 Favored Pre-proline 0 CA--C 1.551 1.002 0 O-C-N 121.922 -0.486 . . . . 225.87 110.747 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -63.94 -32.48 65.59 Favored 'Trans proline' 0 N--CA 1.502 2.025 0 C-N-CA 121.887 1.725 . . . . 62.090000000000003 112.803 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 8.6 tp -62.06 -45.48 93.36 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.035 0.445 . . . . 248.22 111.471 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.493 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.9 p -67.91 -36.41 75.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.762 0.315 . . . . 35.869999999999997 110.505 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 43.6 mt -68.5 -43.88 83.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 121.857 -0.527 . . . . 147.80000000000001 109.743 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -67.04 -38.1 85.29 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.312 0.577 . . . . 807.13 110.246 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -57.95 -42.35 84.74 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.423 0.63 . . . . 227.36000000000001 110.27 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.8 -33.89 88.43 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 110.367 -1.093 . . . . 19.0 110.367 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.441 HD22 ' HA ' ' C' ' 218' ' ' ILE . 6.1 tp -60.75 -42.56 97.63 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.53 0.681 . . . . 75.469999999999999 110.653 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.73 89.31 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.402 0.62 . . . . 23.100000000000001 110.527 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.02 -37.43 76.93 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.293 0.568 . . . . 167.94999999999999 110.318 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 18.3 tp -57.67 -36.31 71.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.205 0.526 . . . . 68.450000000000003 110.337 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 5.9 t -59.7 -38.85 82.73 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.371 0.605 . . . . 138.30000000000001 110.426 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.8 mt -64.47 -42.68 95.78 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.242 0.544 . . . . 287.99000000000001 110.398 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.6 mp -71.33 -34.99 71.03 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.237 0.542 . . . . 177.81999999999999 110.718 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -70.77 -42.19 70.72 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 122.163 -0.335 . . . . 258.75 111.821 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 6.0 tp -63.84 -35.91 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.673 0.749 . . . . 271.85000000000002 110.813 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -69.14 -31.92 72.37 Favored Glycine 0 CA--C 1.533 1.206 0 N-CA-C 111.314 -0.714 . . . . 63.240000000000002 111.314 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.407 ' O ' HD23 ' A' ' 232' ' ' LEU . 5.2 tt -56.98 -46.09 82.48 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.72 0.771 . . . . 132.75999999999999 110.261 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.5 -36.49 73.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.661 -0.7 . . . . 86.510000000000005 110.567 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 37.5 t80 . . . . . 0 CA--C 1.533 0.293 0 CA-C-O 121.353 0.597 . . . . 462.81 110.368 179.755 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 29.0 m . . . . . 0 CA--C 1.538 0.482 0 CA-C-O 121.444 0.64 . . . . 341.94 110.669 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 13.4 tp -68.38 -34.73 76.57 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.902 0.382 . . . . 191.08000000000001 111.276 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.494 ' O ' HG12 ' B' ' 217' ' ' VAL . 1.3 tp -53.53 -57.62 16.39 Favored Pre-proline 0 CA--C 1.553 1.062 0 O-C-N 121.993 -0.442 . . . . 265.74000000000001 110.942 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.05 -32.77 64.05 Favored 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 121.928 1.752 . . . . 66.310000000000002 112.78 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 11.0 tp -62.41 -45.51 92.81 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.086 0.47 . . . . 240.78999999999999 111.548 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.494 HG12 ' O ' ' B' ' 214' ' ' LEU . 8.8 p -67.79 -36.48 76.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.756 0.312 . . . . 30.699999999999999 110.412 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 43.6 mt -68.97 -42.98 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 109.423 -0.584 . . . . 112.31999999999999 109.423 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -67.75 -38.34 83.34 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.502 0.668 . . . . 176.28 110.532 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -58.73 -43.65 90.23 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.349 0.595 . . . . 284.73000000000002 110.623 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.95 -33.93 87.16 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 110.407 -1.077 . . . . 23.710000000000001 110.407 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 4.3 tp -61.32 -33.63 73.92 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.528 0.68 . . . . 108.06 111.29 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.59 -38.4 87.41 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.304 0.573 . . . . 37.969999999999999 110.956 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 2.0 mp -58.76 -38.19 77.9 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.151 0.5 . . . . 134.24000000000001 110.206 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 16.4 tp -61.83 -36.69 81.91 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.989 0.423 . . . . 103.12 110.854 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.3 -46.07 86.82 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 109.831 -0.433 . . . . 198.08000000000001 109.831 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 5.9 mp -62.03 -41.38 98.04 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.199 0.523 . . . . 283.69999999999999 110.223 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 6.8 mp -60.23 -38.62 83.97 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.234 0.54 . . . . 103.06 109.772 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -62.53 -42.31 99.43 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.343 0.592 . . . . 213.97999999999999 110.236 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 50.6 mm -62.94 -45.67 98.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.508 0.671 . . . . 160.19 110.378 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.12 -36.87 86.41 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 111.38 -0.688 . . . . 76.299999999999997 111.38 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 5.8 tt . . . . . 0 C--O 1.235 0.311 0 CA-C-O 121.5 0.667 . . . . 167.03999999999999 111.299 -179.352 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 12.4 tp . . . . . 0 C--O 1.235 0.31 0 CA-C-O 120.943 0.402 . . . . 417.60000000000002 111.316 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 214' ' ' LEU . . . . . 0.488 ' O ' HG12 ' C' ' 217' ' ' VAL . 1.4 tp -53.19 -57.54 16.18 Favored Pre-proline 0 CA--C 1.551 1.011 0 O-C-N 121.987 -0.445 . . . . 279.05000000000001 110.989 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.73 -33.58 65.34 Favored 'Trans proline' 0 N--CA 1.503 2.053 0 C-N-CA 121.853 1.702 . . . . 82.650000000000006 113.016 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 216' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' C' ' 216' ' ' LEU . 0.2 OUTLIER -62.09 -45.34 93.93 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.087 0.47 . . . . 291.52999999999997 111.362 -178.458 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 217' ' ' VAL . . . . . 0.488 HG12 ' O ' ' C' ' 214' ' ' LEU . 9.0 p -68.48 -36.46 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 O-C-N 122.136 -0.352 . . . . 51.530000000000001 110.447 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 218' ' ' ILE . . . . . 0.441 ' HA ' HD22 ' A' ' 222' ' ' LEU . 50.1 mt -66.05 -44.6 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 O-C-N 121.787 -0.57 . . . . 172.34999999999999 109.496 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -66.71 -40.07 88.28 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.472 0.653 . . . . 320.86000000000001 110.117 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -59.92 -44.04 94.56 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.356 0.598 . . . . 248.21000000000001 110.652 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.32 -33.82 85.92 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 110.409 -1.077 . . . . 14.550000000000001 110.409 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 4.4 tp -59.76 -36.85 77.49 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.452 0.644 . . . . 49.299999999999997 111.13 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.66 -38.64 88.49 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.271 0.558 . . . . 28.030000000000001 110.9 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 1.1 mp -58.93 -39.86 82.89 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.247 0.546 . . . . 136.06 110.044 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 17.0 tp -58.01 -39.52 78.48 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.303 0.573 . . . . 104.95 110.503 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 40.5 t -59.12 -44.23 91.98 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.281 0.562 . . . . 166.55000000000001 110.475 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 8.8 mt -61.03 -43.49 98.82 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.231 0.538 . . . . 300.73000000000002 110.282 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 7.5 mp -67.96 -36.45 80.09 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.122 0.487 . . . . 140.31999999999999 110.66 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -66.11 -42.22 89.5 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.338 0.59 . . . . 213.53 110.782 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 32.2 mm -63.34 -42.23 95.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.642 0.734 . . . . 237.50999999999999 109.797 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -67.12 -33.3 82.87 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 111.54 -0.624 . . . . 55.479999999999997 111.54 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 232' ' ' LEU . . . . . 0.419 ' O ' HD23 ' C' ' 232' ' ' LEU . 5.0 tt -61.0 -46.12 92.04 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.638 0.732 . . . . 135.05000000000001 110.779 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -62.35 -35.93 80.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.901 -0.591 . . . . 79.829999999999998 110.8 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -61.63 -39.06 89.95 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.294 0.569 . . . . 526.85000000000002 110.402 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 5.2 mtt85 -75.26 -34.37 61.36 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.127 0.489 . . . . 940.87 111.349 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 37.7 t80 . . . . . 0 CA--C 1.541 0.616 0 CA-C-O 121.098 0.475 . . . . 507.37 111.225 179.732 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 121.578 0.704 . . . . 0.0 112.208 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 29.5 m -70.47 -33.63 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 121.626 0.727 . . . . 0.0 110.861 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 51.9 mt -69.04 -29.35 67.48 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.2 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.519 ' O ' HG12 ' A' ' 217' ' ' VAL . 1.4 tp -54.22 -57.68 17.16 Favored Pre-proline 0 CA--C 1.551 1.004 0 O-C-N 121.862 -0.524 . . . . 0.0 110.408 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.458 ' HA ' HD12 ' A' ' 218' ' ' ILE . 34.8 Cg_endo -64.05 -33.38 62.4 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 121.958 1.772 . . . . 0.0 112.503 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.83 -45.27 94.56 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.669 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.519 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.1 p -66.09 -36.46 77.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 O-C-N 122.087 -0.383 . . . . 0.0 110.392 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.458 HD12 ' HA ' ' A' ' 215' ' ' PRO . 54.5 mt -63.0 -44.53 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -65.94 -36.78 84.31 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.414 0.626 . . . . 0.0 110.032 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -57.7 -44.44 85.88 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.372 0.606 . . . . 0.0 109.786 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -66.17 -33.87 86.52 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.494 HD22 ' HA ' ' C' ' 218' ' ' ILE . 5.5 tp -59.79 -41.76 91.88 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.662 0.744 . . . . 0.0 110.31 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.7 -38.54 88.22 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.702 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.98 -37.15 76.16 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.378 0.609 . . . . 0.0 109.819 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.417 HD13 HD13 ' B' ' 225' ' ' LEU . 15.9 tp -61.73 -41.33 97.49 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.748 -0.595 . . . . 0.0 110.486 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 4.4 m -56.73 -40.83 76.44 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.215 0.531 . . . . 0.0 110.309 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 12.3 mt -66.11 -41.52 90.46 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.087 0.47 . . . . 0.0 110.121 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 6.7 mp -62.48 -38.53 90.21 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.202 0.525 . . . . 0.0 109.991 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -58.84 -41.82 87.82 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.308 0.575 . . . . 0.0 110.098 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 48.6 mm -63.04 -42.09 95.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 121.593 0.711 . . . . 0.0 109.966 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -63.87 -31.99 82.68 Favored Glycine 0 CA--C 1.535 1.286 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.403 HD23 ' C ' ' A' ' 232' ' ' LEU . 6.8 tt -58.87 -45.76 89.4 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.636 0.731 . . . . 0.0 110.943 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -59.1 -35.91 74.24 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.957 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 37.5 t80 . . . . . 0 CA--C 1.532 0.268 0 CA-C-O 121.46 0.647 . . . . 0.0 110.31 -179.88 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 121.691 0.758 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 5.9 tt -69.42 -36.27 76.53 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.451 ' O ' HG12 ' B' ' 217' ' ' VAL . 0.4 OUTLIER -52.41 -57.5 15.28 Favored Pre-proline 0 CA--C 1.552 1.026 0 O-C-N 121.604 -0.685 . . . . 0.0 111.761 -177.408 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 215' ' ' PRO . . . . . 0.449 ' HA ' HD12 ' B' ' 218' ' ' ILE . 19.8 Cg_exo -63.46 -31.83 71.59 Favored 'Trans proline' 0 N--CA 1.503 2.083 0 C-N-CA 121.599 1.533 . . . . 0.0 112.942 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 216' ' ' LEU . . . . . 0.51 HD13 ' O ' ' B' ' 216' ' ' LEU . 0.3 OUTLIER -62.86 -45.38 92.82 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.081 0.467 . . . . 0.0 111.458 -178.5 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.451 HG12 ' O ' ' B' ' 214' ' ' LEU . 8.0 p -69.29 -36.47 72.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 O-C-N 122.179 -0.326 . . . . 0.0 110.187 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 218' ' ' ILE . . . . . 0.449 HD12 ' HA ' ' B' ' 215' ' ' PRO . 68.9 mt -63.01 -42.99 98.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -60.55 -36.77 79.25 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.509 0.671 . . . . 0.0 110.183 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -57.78 -43.59 85.68 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.336 0.589 . . . . 0.0 110.774 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.23 -33.92 88.57 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 6.6 tp -62.45 -37.11 84.62 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.515 0.674 . . . . 0.0 111.061 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.63 88.3 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.177 0.513 . . . . 0.0 110.877 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 7.2 mp -60.47 -45.27 94.34 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.127 0.489 . . . . 0.0 110.451 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 225' ' ' LEU . . . . . 0.417 HD13 HD13 ' A' ' 225' ' ' LEU . 21.6 tp -63.42 -38.56 91.62 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.337 0.589 . . . . 0.0 109.993 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.39 -45.42 84.52 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.324 0.583 . . . . 0.0 110.291 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 227' ' ' LEU . . . . . 0.427 HD23 ' O ' ' B' ' 227' ' ' LEU . 3.1 tt -60.63 -46.14 91.42 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.411 0.624 . . . . 0.0 110.153 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 7.3 mp -63.0 -37.63 87.93 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.196 0.522 . . . . 0.0 110.4 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -63.44 -42.2 98.67 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.154 0.502 . . . . 0.0 110.274 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 39.5 mm -67.41 -42.76 87.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 121.592 0.71 . . . . 0.0 109.761 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -67.2 -33.1 81.87 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 4.3 tt . . . . . 0 C--O 1.235 0.311 0 CA-C-O 121.599 0.714 . . . . 0.0 111.002 -179.572 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 13.3 tp . . . . . 0 C--O 1.235 0.336 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 214' ' ' LEU . . . . . 0.567 ' CD2' HD11 ' C' ' 218' ' ' ILE . 1.3 tt -50.37 -57.02 14.31 Favored Pre-proline 0 CA--C 1.552 1.055 0 O-C-N 121.938 -0.476 . . . . 0.0 111.623 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.8 -33.68 64.13 Favored 'Trans proline' 0 N--CA 1.503 2.065 0 C-N-CA 121.841 1.694 . . . . 0.0 113.186 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 216' ' ' LEU . . . . . 0.506 HD13 ' O ' ' C' ' 216' ' ' LEU . 0.3 OUTLIER -61.71 -45.41 94.09 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.065 0.46 . . . . 0.0 111.499 -178.442 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 217' ' ' VAL . . . . . 0.482 HG12 ' O ' ' C' ' 214' ' ' LEU . 7.4 p -67.32 -36.44 76.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 120.848 0.356 . . . . 0.0 110.377 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 218' ' ' ILE . . . . . 0.567 HD11 ' CD2' ' C' ' 214' ' ' LEU . 47.9 mt -68.22 -42.62 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 121.358 0.599 . . . . 0.0 109.512 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -64.06 -42.1 97.12 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.496 0.665 . . . . 0.0 110.399 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -60.15 -43.53 95.66 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.524 0.678 . . . . 0.0 110.357 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.45 -33.7 87.94 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 10.2 tp -58.96 -40.81 85.86 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.24 0.543 . . . . 0.0 110.657 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.77 -43.58 98.57 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.544 0.688 . . . . 0.0 109.686 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 1.5 tt -64.74 -39.06 92.99 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.832 0.825 . . . . 0.0 109.326 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 4.7 tt -57.94 -44.16 86.78 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.457 0.646 . . . . 0.0 110.155 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 8.2 t -59.37 -43.26 92.88 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.33 0.586 . . . . 0.0 110.824 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 10.1 mt -66.53 -42.69 86.83 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.296 0.57 . . . . 0.0 110.232 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 10.7 tp -66.63 -34.82 78.73 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.092 0.472 . . . . 0.0 110.681 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -66.48 -42.13 87.95 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.413 0.625 . . . . 0.0 110.02 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 88.3 mt -63.25 -36.3 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 121.307 0.575 . . . . 0.0 110.079 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.81 -32.19 61.73 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 232' ' ' LEU . . . . . 0.527 ' C ' HD13 ' C' ' 232' ' ' LEU . 3.1 tm? -58.46 -40.61 83.16 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.625 0.726 . . . . 0.0 110.273 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.99 -39.2 77.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.052 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -60.29 -48.07 83.31 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.364 0.602 . . . . 0.0 110.679 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 35.6 mmt-85 -72.27 -26.68 62.08 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.097 0.475 . . . . 0.0 111.597 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 23.2 t80 . . . . . 0 CA--C 1.541 0.624 0 CA-C-O 120.973 0.416 . . . . 0.0 111.447 179.946 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 22.1 p . . . . . 0 C--O 1.239 0.511 0 CA-C-O 122.292 1.044 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.13 -31.32 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.875 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 13.5 tp -69.08 -34.4 75.07 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.828 0.347 . . . . 0.0 111.419 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.54 ' O ' HG12 ' A' ' 217' ' ' VAL . 10.3 tp -51.24 -56.85 16.78 Favored Pre-proline 0 CA--C 1.551 1.012 0 CA-C-O 119.065 -0.493 . . . . 0.0 111.212 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.536 ' HA ' HD12 ' A' ' 218' ' ' ILE . 35.7 Cg_endo -64.03 -38.82 35.23 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 121.614 1.543 . . . . 0.0 112.79 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.4 tp -56.88 -45.44 82.53 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.4 p -63.95 -35.97 75.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 122.23 -0.294 . . . . 0.0 110.227 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 215' ' ' PRO . 58.2 mt -62.66 -45.13 99.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 O-C-N 121.755 -0.591 . . . . 0.0 109.443 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -60.16 -46.93 88.0 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.767 0.794 . . . . 0.0 110.04 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -59.08 -44.16 91.86 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.042 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.441 ' HA3' HD11 ' B' ' 222' ' ' LEU . . . -60.3 -33.98 82.85 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 4.6 tp -61.67 -42.5 99.0 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.44 0.638 . . . . 0.0 110.694 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.82 89.47 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.223 0.535 . . . . 0.0 110.447 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.6 tt -59.68 -48.64 80.87 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.312 0.577 . . . . 0.0 109.705 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.457 HD13 HD13 ' C' ' 225' ' ' LEU . 23.6 tp -61.12 -41.27 96.39 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.443 0.64 . . . . 0.0 109.743 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 47.8 t -58.81 -47.08 86.05 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.251 0.548 . . . . 0.0 109.732 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 21.0 tp -63.62 -42.2 98.2 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.235 0.54 . . . . 0.0 110.103 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 2.6 tp -61.98 -34.95 77.09 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.26 0.552 . . . . 0.0 109.924 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -58.93 -37.72 77.35 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.245 0.545 . . . . 0.0 110.216 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.6 mp -62.95 -42.32 96.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.536 0.684 . . . . 0.0 109.246 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -63.31 -31.88 82.26 Favored Glycine 0 CA--C 1.535 1.312 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.407 ' O ' HD23 ' A' ' 232' ' ' LEU . 4.9 tt -58.32 -44.23 88.56 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.723 0.773 . . . . 0.0 110.511 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.79 -40.55 80.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.792 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 44.8 t80 . . . . . 0 C--O 1.235 0.305 0 CA-C-O 121.524 0.678 . . . . 0.0 110.223 179.914 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 CA--C 1.544 0.714 0 CA-C-O 121.448 0.642 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 13.0 tp -67.22 -38.31 85.06 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.934 0.397 . . . . 0.0 111.544 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.499 ' O ' HG12 ' B' ' 217' ' ' VAL . 0.2 OUTLIER -50.56 -57.3 13.66 Favored Pre-proline 0 CA--C 1.552 1.046 0 O-C-N 121.961 -0.462 . . . . 0.0 111.437 -179.1 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.75 -33.93 63.75 Favored 'Trans proline' 0 N--CA 1.504 2.108 0 C-N-CA 121.783 1.655 . . . . 0.0 113.018 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 9.4 tp -62.43 -45.48 92.92 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.997 0.427 . . . . 0.0 111.699 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.499 HG12 ' O ' ' B' ' 214' ' ' LEU . 7.8 p -66.29 -36.47 77.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 120.669 0.271 . . . . 0.0 110.552 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 218' ' ' ILE . . . . . 0.467 ' HA ' HD22 ' C' ' 222' ' ' LEU . 53.4 mt -65.19 -43.96 95.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -68.87 -36.92 78.68 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.62 0.724 . . . . 0.0 109.93 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -58.46 -42.64 87.9 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.27 0.557 . . . . 0.0 110.828 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.11 -34.13 82.57 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 222' ' ' LEU . . . . . 0.441 HD11 ' HA3' ' A' ' 221' ' ' GLY . 0.3 OUTLIER -60.63 -23.82 65.05 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.307 0.575 . . . . 0.0 110.967 179.403 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.46 -38.55 87.64 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.189 0.518 . . . . 0.0 110.569 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 224' ' ' LEU . . . . . 0.475 HD23 ' CG ' ' C' ' 229' ' ' PHE . 4.8 mp -59.01 -39.34 81.58 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.137 0.494 . . . . 0.0 110.471 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 225' ' ' LEU . . . . . 0.443 HD13 HD13 ' A' ' 225' ' ' LEU . 47.2 tp -65.98 -33.92 76.92 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.029 0.442 . . . . 0.0 110.548 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 71.4 m -58.52 -43.8 89.28 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.999 0.428 . . . . 0.0 110.115 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -60.75 -43.1 98.41 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.452 0.644 . . . . 0.0 109.771 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 7.4 mp -64.52 -38.18 90.1 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.238 0.542 . . . . 0.0 110.318 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -61.6 -42.22 98.57 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.398 0.618 . . . . 0.0 110.164 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 43.4 mm -66.35 -42.98 91.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 121.605 0.717 . . . . 0.0 109.873 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -66.31 -31.99 80.67 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 9.2 tt . . . . . 0 N--CA 1.464 0.266 0 CA-C-O 121.537 0.684 . . . . 0.0 110.962 -179.544 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 9.1 tt . . . . . 0 C--O 1.235 0.294 0 CA-C-O 120.85 0.357 . . . . 0.0 111.824 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 214' ' ' LEU . . . . . 0.553 ' O ' HG12 ' C' ' 217' ' ' VAL . 0.8 OUTLIER -46.52 -57.5 8.57 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-O 118.986 -0.531 . . . . 0.0 111.713 -178.75 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.01 -40.04 29.29 Favored 'Trans proline' 0 N--CA 1.505 2.171 0 C-N-CA 121.883 1.722 . . . . 0.0 113.5 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 7.3 tp -57.14 -45.19 83.76 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.006 0.431 . . . . 0.0 111.919 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 217' ' ' VAL . . . . . 0.553 HG12 ' O ' ' C' ' 214' ' ' LEU . 8.3 p -63.72 -36.35 76.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 O-C-N 122.187 -0.32 . . . . 0.0 111.03 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 19.4 mm -62.96 -45.07 99.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -67.4 -36.98 82.37 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.568 0.699 . . . . 0.0 109.721 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -58.16 -44.37 87.89 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.287 0.565 . . . . 0.0 110.407 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.72 -33.89 88.46 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 222' ' ' LEU . . . . . 0.467 HD22 ' HA ' ' B' ' 218' ' ' ILE . 6.6 tp -60.7 -41.56 95.44 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.443 0.639 . . . . 0.0 110.694 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.89 -38.72 89.39 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.326 0.584 . . . . 0.0 110.571 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 1.2 tp -58.79 -40.75 84.96 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.353 0.597 . . . . 0.0 109.997 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 225' ' ' LEU . . . . . 0.457 HD13 HD13 ' A' ' 225' ' ' LEU . 20.4 tp -58.28 -39.53 79.5 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.233 0.539 . . . . 0.0 110.448 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 49.8 m -57.64 -45.96 84.78 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.269 0.557 . . . . 0.0 110.703 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 26.5 tp -63.63 -42.08 98.21 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.236 0.541 . . . . 0.0 110.359 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 7.4 mp -66.22 -36.99 84.46 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.043 0.449 . . . . 0.0 110.771 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 229' ' ' PHE . . . . . 0.475 ' CG ' HD23 ' B' ' 224' ' ' LEU . 30.1 t80 -70.51 -42.45 71.29 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.089 0.471 . . . . 0.0 111.355 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 37.9 mm -67.8 -41.16 84.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 121.575 0.702 . . . . 0.0 109.874 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -64.24 -33.0 86.06 Favored Glycine 0 CA--C 1.533 1.201 0 N-CA-C 111.634 -0.587 . . . . 0.0 111.634 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 232' ' ' LEU . . . . . 0.454 ' O ' HD23 ' C' ' 232' ' ' LEU . 4.1 tt -59.44 -46.02 89.94 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.704 0.764 . . . . 0.0 110.632 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -69.49 -35.79 75.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.158 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -59.85 -48.09 83.08 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.303 0.573 . . . . 0.0 110.868 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -72.03 -40.35 68.47 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.524 0.678 . . . . 0.0 111.299 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 20.3 t80 . . . . . 0 CA--C 1.541 0.607 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.132 -179.409 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.414 ' O ' HG23 ' A' ' 211' ' ' THR . 9.5 t . . . . . 0 C--O 1.237 0.428 0 CA-C-O 122.329 1.061 . . . . 0.0 110.834 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 28.3 m -57.85 -25.23 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.455 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 12.8 tp -69.07 -32.29 71.64 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.883 0.373 . . . . 0.0 110.98 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.471 ' O ' HG12 ' A' ' 217' ' ' VAL . 0.2 OUTLIER -51.77 -57.68 13.84 Favored Pre-proline 0 CA--C 1.55 0.972 0 O-C-N 121.985 -0.447 . . . . 0.0 111.35 -179.272 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.64 -31.35 70.05 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 121.962 1.775 . . . . 0.0 113.433 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.471 HD23 ' O ' ' A' ' 216' ' ' LEU . 3.9 tt -64.03 -45.59 88.23 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.277 0.56 . . . . 0.0 111.151 -178.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.6 p -67.91 -36.65 76.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 120.784 0.326 . . . . 0.0 110.434 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.425 HD11 HD12 ' A' ' 214' ' ' LEU . 47.1 mt -69.46 -41.72 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -63.57 -36.86 85.19 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.325 0.583 . . . . 0.0 110.119 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -57.57 -44.61 85.43 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.259 0.552 . . . . 0.0 110.126 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.445 ' HA3' HD11 ' B' ' 222' ' ' LEU . . . -67.78 -33.95 81.58 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 7.7 tp -60.29 -35.02 74.61 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.33 0.586 . . . . 0.0 111.039 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.74 89.16 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.213 0.53 . . . . 0.0 110.891 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 48.8 mt -59.04 -39.56 82.36 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.274 0.559 . . . . 0.0 110.638 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 18.1 tp -58.95 -38.65 79.53 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.322 0.582 . . . . 0.0 110.5 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 7.5 t -59.89 -43.41 94.79 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.418 0.627 . . . . 0.0 110.646 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -63.04 -42.44 99.75 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.427 0.632 . . . . 0.0 110.693 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.6 mp -71.08 -35.25 71.79 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.07 0.462 . . . . 0.0 111.225 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -70.13 -42.43 72.61 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.253 0.549 . . . . 0.0 111.618 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 7.3 tp -69.15 -36.37 72.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.617 0.722 . . . . 0.0 111.166 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.82 -31.92 61.8 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 5.1 tt -59.93 -46.04 90.64 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.725 0.774 . . . . 0.0 110.659 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -64.96 -39.5 93.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.74 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 47.8 t80 . . . . . 0 C--O 1.234 0.245 0 CA-C-O 121.524 0.678 . . . . 0.0 110.339 179.906 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 13.2 p . . . . . 0 CA--C 1.542 0.664 0 CA-C-O 121.288 0.565 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 12.7 tp -68.82 -31.6 70.7 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.674 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.477 ' O ' HG12 ' B' ' 217' ' ' VAL . 0.1 OUTLIER -53.29 -57.72 15.57 Favored Pre-proline 0 CA--C 1.552 1.054 0 O-C-N 122.007 -0.433 . . . . 0.0 110.913 -179.218 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.88 -32.9 65.8 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 121.85 1.7 . . . . 0.0 113.025 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 9.5 tp -62.56 -45.37 93.26 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.099 0.476 . . . . 0.0 111.491 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.477 HG12 ' O ' ' B' ' 214' ' ' LEU . 8.3 p -67.96 -36.58 76.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 122.248 -0.283 . . . . 0.0 110.285 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 53.5 mt -66.62 -44.14 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -65.13 -37.33 87.09 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.435 0.636 . . . . 0.0 110.299 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.96 -36.6 72.79 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.163 0.506 . . . . 0.0 110.447 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 221' ' ' GLY . . . . . 0.483 ' HA3' HD11 ' C' ' 222' ' ' LEU . . . -65.6 -33.85 87.38 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 222' ' ' LEU . . . . . 0.445 HD11 ' HA3' ' A' ' 221' ' ' GLY . 7.3 tp -58.96 -39.66 82.37 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.387 0.613 . . . . 0.0 110.855 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.84 89.52 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.288 0.566 . . . . 0.0 110.825 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 7.8 mp -62.01 -38.23 87.86 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.24 0.543 . . . . 0.0 110.627 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 16.3 tp -61.28 -40.59 94.68 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.296 0.57 . . . . 0.0 110.391 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 28.3 p -57.98 -45.89 86.04 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.263 0.554 . . . . 0.0 110.213 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 17.6 tp -64.48 -42.21 96.02 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.385 0.612 . . . . 0.0 110.066 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 49.6 mt -63.45 -34.85 78.66 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.246 0.546 . . . . 0.0 110.649 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -65.03 -42.06 94.71 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.476 0.655 . . . . 0.0 110.373 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 43.1 mm -63.33 -43.47 98.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 121.624 0.726 . . . . 0.0 110.033 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -67.0 -33.42 83.79 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 5.8 tt . . . . . 0 C--O 1.236 0.343 0 CA-C-O 121.565 0.698 . . . . 0.0 111.091 -179.442 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.536 0.433 0 CA-C-O 120.99 0.424 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 214' ' ' LEU . . . . . 0.493 ' O ' HG12 ' C' ' 217' ' ' VAL . 13.6 tp -47.12 -57.01 10.24 Favored Pre-proline 0 CA--C 1.553 1.078 0 CA-C-O 118.892 -0.575 . . . . 0.0 111.975 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 215' ' ' PRO . . . . . 0.463 ' HA ' HD12 ' C' ' 218' ' ' ILE . 36.6 Cg_endo -63.38 -34.77 65.03 Favored 'Trans proline' 0 N--CA 1.505 2.172 0 C-N-CA 121.857 1.705 . . . . 0.0 113.401 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 216' ' ' LEU . . . . . 0.416 HD23 ' O ' ' C' ' 216' ' ' LEU . 3.3 tt -61.45 -45.6 93.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.072 0.463 . . . . 0.0 111.341 -178.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 217' ' ' VAL . . . . . 0.493 HG12 ' O ' ' C' ' 214' ' ' LEU . 7.1 p -66.34 -36.6 77.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 O-C-N 122.111 -0.368 . . . . 0.0 110.498 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 218' ' ' ILE . . . . . 0.463 HD12 ' HA ' ' C' ' 215' ' ' PRO . 62.1 mt -62.95 -39.65 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -59.41 -43.45 93.01 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.359 0.599 . . . . 0.0 110.509 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -58.38 -44.03 88.73 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.06 0.457 . . . . 0.0 110.599 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.81 -33.85 88.36 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 222' ' ' LEU . . . . . 0.483 HD11 ' HA3' ' B' ' 221' ' ' GLY . 6.0 tp -59.21 -40.09 84.71 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.47 0.653 . . . . 0.0 110.871 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.7 -38.91 89.59 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.237 0.541 . . . . 0.0 110.833 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 7.5 mp -61.74 -41.32 97.49 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.258 0.552 . . . . 0.0 110.436 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 15.2 tp -60.54 -41.06 93.71 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.363 0.601 . . . . 0.0 110.328 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 38.9 t -60.35 -40.35 90.4 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.282 0.563 . . . . 0.0 110.643 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 12.2 mt -66.54 -41.11 89.2 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.357 0.599 . . . . 0.0 110.706 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 7.1 mp -71.13 -35.06 71.59 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.223 0.535 . . . . 0.0 110.941 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -63.6 -42.89 98.21 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.098 0.475 . . . . 0.0 111.869 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 40.1 pt -69.28 -35.43 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-O 121.514 0.673 . . . . 0.0 110.738 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.83 -31.97 61.56 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 110.559 -1.017 . . . . 0.0 110.559 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 232' ' ' LEU . . . . . 0.454 ' O ' HD23 ' C' ' 232' ' ' LEU . 3.8 tt -56.93 -39.34 74.33 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-O 121.692 0.758 . . . . 0.0 110.165 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.89 -44.01 86.45 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.395 0.617 . . . . 0.0 110.594 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -65.39 -43.42 90.72 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.387 0.613 . . . . 0.0 110.49 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 6.5 mmt85 -65.36 -25.04 67.4 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.115 0.483 . . . . 0.0 111.54 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 34.2 t80 . . . . . 0 CA--C 1.542 0.641 0 O-C-N 121.968 -0.458 . . . . 0.0 111.975 -179.344 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 39.6 p . . . . . 0 C--O 1.236 0.381 0 CA-C-O 122.545 1.164 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 13.1 p -70.14 -34.09 57.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.759 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.579 HD13 ' O ' ' A' ' 213' ' ' LEU . 0.3 OUTLIER -63.66 -40.11 96.03 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.978 -179.24 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.49 ' O ' HG12 ' A' ' 217' ' ' VAL . 3.1 tp -51.49 -57.36 14.62 Favored Pre-proline 0 CA--C 1.553 1.067 0 O-C-N 121.74 -0.6 . . . . 0.0 111.332 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.09 -32.68 63.76 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 121.816 1.678 . . . . 0.0 112.79 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.1 tt -62.3 -45.46 93.15 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.955 0.407 . . . . 0.0 111.317 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 214' ' ' LEU . 8.0 p -67.76 -36.53 76.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 O-C-N 122.243 -0.286 . . . . 0.0 110.385 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 43.7 mt -69.3 -43.41 81.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-O 121.404 0.621 . . . . 0.0 109.333 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -65.41 -37.02 85.7 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.397 0.618 . . . . 0.0 110.688 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.79 -38.44 75.48 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.653 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.484 ' HA3' HD11 ' B' ' 222' ' ' LEU . . . -65.31 -33.87 87.9 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.451 HD11 ' HA3' ' C' ' 221' ' ' GLY . 3.8 tp -59.28 -45.35 91.49 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.704 0.764 . . . . 0.0 109.677 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.87 -38.34 87.92 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.644 0.735 . . . . 0.0 110.072 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.473 HD21 ' CE2' ' B' ' 229' ' ' PHE . 4.6 tp -58.67 -40.39 83.39 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.25 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 22.8 tp -59.09 -37.42 77.08 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.955 0.407 . . . . 0.0 110.582 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 17.5 m -56.99 -41.88 79.24 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.413 0.625 . . . . 0.0 110.149 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.438 ' O ' HG22 ' A' ' 230' ' ' ILE . 7.0 mp -64.47 -39.9 94.68 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.397 0.618 . . . . 0.0 110.43 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 61.5 mt -71.37 -34.55 70.54 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.215 0.531 . . . . 0.0 111.439 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -59.93 -42.47 94.03 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 227' ' ' LEU . 7.5 tp -65.08 -35.93 76.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.608 0.718 . . . . 0.0 110.996 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -62.41 -31.9 81.11 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.413 ' C ' HD23 ' A' ' 232' ' ' LEU . 8.1 tt -57.12 -43.08 82.0 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.74 0.781 . . . . 0.0 110.479 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -69.35 -35.91 76.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.096 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 49.9 t80 . . . . . 0 CA--C 1.534 0.36 0 CA-C-O 121.045 0.45 . . . . 0.0 111.22 -179.185 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 CA--C 1.537 0.479 0 CA-C-O 121.452 0.644 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 13.4 tp -66.12 -32.59 74.14 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.059 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.526 ' O ' HG12 ' B' ' 217' ' ' VAL . 0.2 OUTLIER -54.99 -58.01 16.77 Favored Pre-proline 0 CA--C 1.55 0.945 0 O-C-N 121.817 -0.552 . . . . 0.0 110.401 -179.24 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 215' ' ' PRO . . . . . 0.405 ' HA ' HD12 ' B' ' 218' ' ' ILE . 31.2 Cg_endo -64.5 -34.0 54.82 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 121.765 1.644 . . . . 0.0 112.178 178.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 216' ' ' LEU . . . . . 0.461 HD13 ' O ' ' B' ' 216' ' ' LEU . 0.2 OUTLIER -61.16 -45.26 95.35 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.631 -178.362 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.526 HG12 ' O ' ' B' ' 214' ' ' LEU . 9.6 p -66.39 -36.43 77.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 122.114 -0.366 . . . . 0.0 110.302 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 218' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' B' ' 215' ' ' PRO . 36.8 mt -66.48 -45.21 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -64.44 -36.7 85.04 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.506 0.669 . . . . 0.0 110.121 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -57.63 -44.58 85.65 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.259 0.552 . . . . 0.0 110.51 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.65 -35.11 91.61 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 222' ' ' LEU . . . . . 0.484 HD11 ' HA3' ' A' ' 221' ' ' GLY . 7.2 tp -58.85 -43.99 90.91 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.549 0.69 . . . . 0.0 110.284 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.57 88.37 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.403 0.621 . . . . 0.0 110.605 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 1.4 tp -58.94 -40.61 85.17 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.274 0.559 . . . . 0.0 109.989 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 18.8 tp -58.68 -37.22 75.57 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.173 0.511 . . . . 0.0 110.695 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 11.1 p -56.93 -38.92 73.57 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.294 0.569 . . . . 0.0 110.629 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 227' ' ' LEU . . . . . 0.68 ' O ' HG22 ' B' ' 230' ' ' ILE . 1.5 tt -58.02 -48.26 80.6 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.375 0.607 . . . . 0.0 110.453 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 8.4 mp -71.7 -36.74 70.65 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.286 0.565 . . . . 0.0 110.964 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 229' ' ' PHE . . . . . 0.473 ' CE2' HD21 ' A' ' 224' ' ' LEU . 38.5 t80 -66.4 -37.43 85.23 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.68 HG22 ' O ' ' B' ' 227' ' ' LEU . 7.9 tp -62.83 -35.51 71.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.32 0.581 . . . . 0.0 111.629 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.18 -31.9 63.43 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 232' ' ' LEU . . . . . 0.489 HD23 ' C ' ' B' ' 232' ' ' LEU . 9.4 tt . . . . . 0 C--O 1.235 0.318 0 CA-C-O 121.485 0.659 . . . . 0.0 111.122 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 16.5 tp . . . . . 0 CA--C 1.535 0.377 0 CA-C-O 120.71 0.291 . . . . 0.0 111.549 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 214' ' ' LEU . . . . . 0.515 ' O ' HG12 ' C' ' 217' ' ' VAL . 1.9 tt -53.23 -57.49 16.45 Favored Pre-proline 0 CA--C 1.551 0.985 0 CA-C-O 119.083 -0.484 . . . . 0.0 111.039 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.14 -34.72 56.35 Favored 'Trans proline' 0 N--CA 1.501 1.957 0 C-N-CA 121.714 1.609 . . . . 0.0 112.748 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 216' ' ' LEU . . . . . 0.464 HD23 ' O ' ' C' ' 216' ' ' LEU . 2.8 tt -62.29 -45.36 93.61 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.55 -178.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 217' ' ' VAL . . . . . 0.515 HG12 ' O ' ' C' ' 214' ' ' LEU . 10.3 p -65.7 -36.37 77.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 O-C-N 122.163 -0.336 . . . . 0.0 110.775 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 53.8 mt -65.66 -44.05 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -67.56 -36.48 81.02 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.585 0.707 . . . . 0.0 110.072 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -57.71 -42.43 83.74 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.011 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 221' ' ' GLY . . . . . 0.451 ' HA3' HD11 ' A' ' 222' ' ' LEU . . . -59.89 -33.89 80.51 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.79 -29.45 66.83 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.206 0.527 . . . . 0.0 110.942 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.79 -38.79 89.39 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.324 0.583 . . . . 0.0 110.656 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 25.4 mt -61.89 -37.51 84.85 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.409 0.623 . . . . 0.0 110.647 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 11.6 tp -59.65 -36.51 76.54 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.078 0.466 . . . . 0.0 110.838 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 15.7 t -58.39 -39.12 78.79 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.329 0.585 . . . . 0.0 110.498 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 227' ' ' LEU . . . . . 0.421 ' O ' HG22 ' C' ' 230' ' ' ILE . 21.3 tp -62.78 -44.49 96.04 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.415 0.626 . . . . 0.0 110.385 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 8.3 mp -71.36 -34.86 70.86 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.477 0.656 . . . . 0.0 111.349 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -62.27 -42.33 99.25 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 230' ' ' ILE . . . . . 0.421 HG22 ' O ' ' C' ' 227' ' ' LEU . 5.5 tp -65.32 -38.53 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.494 0.664 . . . . 0.0 111.211 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.87 -32.79 74.08 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 4.4 tt -58.87 -43.06 90.78 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.551 0.691 . . . . 0.0 110.98 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -60.68 -40.96 94.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.368 0.604 . . . . 0.0 110.581 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -65.63 -43.06 90.68 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.619 0.723 . . . . 0.0 110.402 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.77 -18.06 64.73 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.207 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 21.3 t80 . . . . . 0 CA--C 1.541 0.628 0 O-C-N 121.898 -0.501 . . . . 0.0 111.962 -179.603 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 80.0 p . . . . . 0 C--O 1.238 0.481 0 CA-C-O 122.338 1.066 . . . . 0.0 110.335 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 26.9 m -66.2 -30.0 48.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.88 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.488 HD23 ' O ' ' A' ' 213' ' ' LEU . 1.2 tt -68.98 -35.64 76.96 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.955 0.407 . . . . 0.0 110.931 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.502 ' O ' HG12 ' A' ' 217' ' ' VAL . 0.9 OUTLIER -48.77 -57.32 11.45 Favored Pre-proline 0 CA--C 1.551 1.015 0 O-C-N 121.829 -0.544 . . . . 0.0 111.299 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.503 ' HA ' HD12 ' A' ' 218' ' ' ILE . 32.7 Cg_endo -63.86 -34.22 61.41 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 121.82 1.68 . . . . 0.0 112.931 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 5.4 tt -61.69 -45.49 93.78 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.959 0.409 . . . . 0.0 111.529 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.3 p -66.08 -36.65 77.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 O-C-N 122.174 -0.329 . . . . 0.0 110.534 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 215' ' ' PRO . 48.9 mt -63.11 -45.13 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -67.48 -36.98 82.2 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.615 0.722 . . . . 0.0 109.799 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -58.86 -42.54 89.65 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.34 0.59 . . . . 0.0 110.692 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -62.74 -33.89 88.12 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.432 HD11 ' HA3' ' C' ' 221' ' ' GLY . 0.3 OUTLIER -62.89 -29.2 70.58 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.194 0.521 . . . . 0.0 111.012 179.598 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -62.15 -38.84 90.53 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.251 0.548 . . . . 0.0 110.674 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.9 mp -63.14 -42.86 99.54 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.289 0.566 . . . . 0.0 110.218 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.623 HD11 HD12 ' C' ' 228' ' ' LEU . 31.8 tp -59.48 -41.17 89.18 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.256 0.55 . . . . 0.0 109.995 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 33.1 m -58.18 -47.18 84.2 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.17 0.509 . . . . 0.0 110.471 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -61.54 -42.11 98.35 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.189 0.519 . . . . 0.0 110.528 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 6.7 mp -66.52 -36.59 83.09 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.158 0.504 . . . . 0.0 110.588 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -66.93 -42.15 85.82 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.321 0.582 . . . . 0.0 110.909 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 27.6 mm -62.81 -41.95 94.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 121.494 0.664 . . . . 0.0 110.002 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -61.14 -32.77 81.67 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 111.706 -0.558 . . . . 0.0 111.706 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 9.5 tt -61.41 -38.31 86.64 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 122.037 -0.684 . . . . 0.0 111.369 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.87 -35.92 82.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.136 0.493 . . . . 0.0 111.255 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 36.4 t80 . . . . . 0 C--O 1.235 0.309 0 CA-C-O 121.409 0.623 . . . . 0.0 110.389 -179.613 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 CA--C 1.544 0.739 0 CA-C-O 121.491 0.663 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 213' ' ' LEU . . . . . 0.443 HD23 ' O ' ' B' ' 213' ' ' LEU . 3.5 tt -66.96 -40.79 87.56 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.986 0.422 . . . . 0.0 111.161 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.469 ' O ' HG12 ' B' ' 217' ' ' VAL . 20.2 tp -48.98 -57.54 11.09 Favored Pre-proline 0 CA--C 1.559 1.323 0 O-C-N 121.828 -0.545 . . . . 0.0 111.415 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.23 -29.57 64.32 Favored 'Trans proline' 0 N--CA 1.504 2.09 0 C-N-CA 122.01 1.807 . . . . 0.0 113.05 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 9.5 tp -68.51 -45.08 73.24 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.085 0.469 . . . . 0.0 111.761 -178.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.469 HG12 ' O ' ' B' ' 214' ' ' LEU . 9.8 p -65.81 -36.96 78.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 O-C-N 122.272 -0.268 . . . . 0.0 111.344 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 24.8 pt -71.15 -39.24 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 O-C-N 121.518 -0.739 . . . . 0.0 110.589 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -67.21 -37.09 83.04 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.468 0.652 . . . . 0.0 110.3 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -57.69 -40.4 79.35 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.219 0.533 . . . . 0.0 110.74 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 221' ' ' GLY . . . . . 0.501 ' HA3' HD11 ' C' ' 222' ' ' LEU . . . -65.28 -34.0 88.29 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 7.6 tp -58.95 -39.67 82.39 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.688 0.756 . . . . 0.0 109.88 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.67 -38.19 86.85 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.586 0.708 . . . . 0.0 109.981 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.2 tp -58.46 -41.88 86.18 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.344 0.592 . . . . 0.0 109.914 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 19.3 tp -57.96 -32.36 67.77 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.15 0.5 . . . . 0.0 110.352 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 6.3 m -56.95 -43.2 81.33 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.15 0.5 . . . . 0.0 110.251 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 6.1 mp -59.08 -44.04 91.84 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.212 0.53 . . . . 0.0 110.28 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 7.3 mp -67.06 -39.37 86.88 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.181 0.515 . . . . 0.0 110.535 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -63.6 -42.16 98.26 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.205 0.526 . . . . 0.0 110.804 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 31.1 mm -62.9 -39.02 83.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.474 0.654 . . . . 0.0 109.862 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -58.23 -32.82 68.3 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.467 0.383 0 CA-C-O 121.458 0.647 . . . . 0.0 111.589 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 9.9 tp . . . . . 0 C--O 1.235 0.293 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 214' ' ' LEU . . . . . 0.485 ' O ' HG12 ' C' ' 217' ' ' VAL . 3.5 tp -48.98 -57.22 11.96 Favored Pre-proline 0 CA--C 1.551 0.998 0 O-C-N 121.892 -0.505 . . . . 0.0 111.133 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.85 -35.5 55.86 Favored 'Trans proline' 0 N--CA 1.505 2.192 0 C-N-CA 121.736 1.624 . . . . 0.0 113.073 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 216' ' ' LEU . . . . . 0.453 HD23 ' O ' ' C' ' 216' ' ' LEU . 3.6 tt -62.02 -45.53 93.18 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.057 0.456 . . . . 0.0 111.487 -178.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 217' ' ' VAL . . . . . 0.485 HG12 ' O ' ' C' ' 214' ' ' LEU . 9.2 p -66.53 -36.63 77.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 O-C-N 122.087 -0.383 . . . . 0.0 110.63 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 43.3 mt -69.03 -42.35 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -66.55 -38.35 86.94 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.621 0.725 . . . . 0.0 110.276 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -57.93 -39.19 77.4 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.676 0.75 . . . . 0.0 110.378 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 221' ' ' GLY . . . . . 0.432 ' HA3' HD11 ' A' ' 222' ' ' LEU . . . -59.89 -33.41 78.41 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 222' ' ' LEU . . . . . 0.501 HD11 ' HA3' ' B' ' 221' ' ' GLY . 3.6 tp -58.49 -39.44 80.02 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.541 0.686 . . . . 0.0 110.441 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.94 -38.29 87.92 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.503 0.668 . . . . 0.0 110.032 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 3.2 tp -58.66 -40.32 83.15 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.419 0.628 . . . . 0.0 110.072 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 18.7 tp -59.84 -30.86 69.25 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.231 0.538 . . . . 0.0 110.415 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 2.1 t -58.55 -38.97 78.95 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.136 0.493 . . . . 0.0 110.695 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 8.2 mp -61.29 -47.82 84.23 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.398 0.618 . . . . 0.0 111.007 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 228' ' ' LEU . . . . . 0.623 HD12 HD11 ' A' ' 225' ' ' LEU . 14.6 mt -71.21 -35.08 71.38 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.167 0.508 . . . . 0.0 111.252 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -70.74 -42.22 70.81 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.015 0.436 . . . . 0.0 111.808 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 7.6 tp -67.9 -35.93 73.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 121.561 0.696 . . . . 0.0 111.293 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -69.6 -31.82 70.87 Favored Glycine 0 CA--C 1.535 1.312 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 232' ' ' LEU . . . . . 0.483 ' C ' HD23 ' C' ' 232' ' ' LEU . 10.3 tt -60.78 -43.7 97.75 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.442 0.639 . . . . 0.0 110.867 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -67.68 -38.78 84.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.456 0.646 . . . . 0.0 110.763 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -61.58 -47.57 84.91 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.503 0.668 . . . . 0.0 110.378 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 10.1 ttt-85 -66.96 -21.67 65.96 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.313 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 43.7 t80 . . . . . 0 CA--C 1.543 0.686 0 O-C-N 122.097 -0.377 . . . . 0.0 111.731 179.873 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 15.2 p . . . . . 0 N--CA 1.471 0.598 0 CA-C-O 121.328 0.585 . . . . 0.0 112.401 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 47.3 t -70.67 -40.09 76.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.704 0.764 . . . . 0.0 109.905 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 10.6 tp -67.84 -29.9 69.16 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.145 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.535 ' O ' HG12 ' A' ' 217' ' ' VAL . 0.7 OUTLIER -54.15 -57.65 17.19 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 121.901 -0.499 . . . . 0.0 110.816 -178.81 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.16 -32.31 63.39 Favored 'Trans proline' 0 N--CA 1.504 2.135 0 C-N-CA 121.759 1.639 . . . . 0.0 112.849 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.9 tt -62.89 -45.44 92.52 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.981 0.419 . . . . 0.0 111.582 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.6 p -65.4 -36.77 78.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 O-C-N 122.25 -0.281 . . . . 0.0 110.68 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 38.4 mm -70.71 -43.51 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-O 121.636 0.732 . . . . 0.0 109.127 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -62.12 -36.5 81.94 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.402 0.62 . . . . 0.0 110.475 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -57.53 -43.8 84.6 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.366 0.603 . . . . 0.0 110.171 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -66.62 -34.34 87.24 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.401 HD11 ' HA3' ' C' ' 221' ' ' GLY . 6.5 tp -61.45 -39.99 92.85 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.55 0.691 . . . . 0.0 110.5 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.66 -38.42 87.67 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.409 0.624 . . . . 0.0 110.417 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.455 ' O ' HD23 ' A' ' 224' ' ' LEU . 1.6 tt -58.62 -37.43 75.88 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.17 0.509 . . . . 0.0 110.083 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 20.9 tp -59.11 -41.6 88.54 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.31 0.576 . . . . 0.0 110.021 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 43.1 t -60.51 -40.79 92.7 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.469 0.652 . . . . 0.0 110.208 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.471 ' O ' HG22 ' A' ' 230' ' ' ILE . 0.8 OUTLIER -61.83 -42.69 99.34 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.397 0.618 . . . . 0.0 110.162 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.416 HD21 ' CD1' ' B' ' 232' ' ' LEU . 1.6 mp -71.35 -34.79 70.81 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.368 0.604 . . . . 0.0 110.949 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -58.96 -42.28 89.53 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 227' ' ' LEU . 7.6 tp -64.55 -36.93 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.603 0.716 . . . . 0.0 111.227 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.42 -31.82 62.92 Favored Glycine 0 CA--C 1.534 1.225 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.497 ' O ' HD23 ' A' ' 232' ' ' LEU . 1.6 tt -57.67 -36.18 71.57 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.549 0.69 . . . . 0.0 110.849 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -61.21 -39.76 91.44 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.32 0.581 . . . . 0.0 111.006 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 34.8 t80 . . . . . 0 C--O 1.234 0.281 0 CA-C-O 121.407 0.622 . . . . 0.0 111.066 -179.37 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 CA--C 1.538 0.495 0 CA-C-O 121.454 0.645 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 11.1 tp -64.62 -36.4 84.12 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.537 ' O ' HG12 ' B' ' 217' ' ' VAL . 0.1 OUTLIER -54.41 -57.73 17.23 Favored Pre-proline 0 CA--C 1.55 0.958 0 O-C-N 121.882 -0.511 . . . . 0.0 110.905 -179.056 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -64.07 -32.84 63.77 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 121.872 1.715 . . . . 0.0 112.896 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 8.9 tp -60.72 -45.23 95.03 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.049 0.452 . . . . 0.0 111.754 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.537 HG12 ' O ' ' B' ' 214' ' ' LEU . 7.3 p -65.67 -36.65 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 O-C-N 122.098 -0.376 . . . . 0.0 110.524 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 39.3 mm -65.18 -43.84 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -64.95 -36.59 84.9 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.225 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -57.35 -44.94 84.77 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.345 0.593 . . . . 0.0 109.716 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -67.43 -33.77 82.81 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 178.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 6.0 tp -61.95 -35.38 78.27 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.513 0.673 . . . . 0.0 111.055 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.62 88.27 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.152 0.501 . . . . 0.0 110.971 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 7.9 mp -58.87 -39.17 80.57 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.134 0.492 . . . . 0.0 110.49 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 225' ' ' LEU . . . . . 0.461 HD13 HD13 ' C' ' 225' ' ' LEU . 15.1 tp -61.46 -42.85 99.4 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.296 0.57 . . . . 0.0 110.083 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 58.7 m -60.42 -47.08 87.63 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 121.116 0.484 . . . . 0.0 110.426 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.19 -41.63 97.0 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.314 0.578 . . . . 0.0 110.152 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 7.4 tp -61.73 -34.81 76.46 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.286 0.565 . . . . 0.0 109.806 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -62.31 -36.29 81.67 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.412 0.625 . . . . 0.0 110.321 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 46.2 mm -62.88 -44.91 99.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 121.581 0.705 . . . . 0.0 110.34 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -71.74 -33.36 63.36 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 232' ' ' LEU . . . . . 0.416 ' CD1' HD21 ' A' ' 228' ' ' LEU . 5.1 tt . . . . . 0 C--O 1.235 0.303 0 CA-C-O 121.531 0.681 . . . . 0.0 111.176 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 213' ' ' LEU . . . . . 0.506 ' O ' HD23 ' C' ' 213' ' ' LEU . 3.2 tt . . . . . 0 CA--C 1.533 0.306 0 CA-C-O 121.114 0.483 . . . . 0.0 111.277 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 214' ' ' LEU . . . . . 0.488 ' O ' HG12 ' C' ' 217' ' ' VAL . 14.0 tp -45.62 -57.25 8.08 Favored Pre-proline 0 CA--C 1.556 1.187 0 CA-C-O 118.962 -0.542 . . . . 0.0 112.038 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 215' ' ' PRO . . . . . 0.424 ' HA ' HD12 ' C' ' 218' ' ' ILE . 37.6 Cg_endo -63.7 -36.85 49.75 Favored 'Trans proline' 0 N--CA 1.506 2.236 0 C-N-CA 121.801 1.667 . . . . 0.0 113.689 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.8 -45.22 94.8 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 122.075 -0.391 . . . . 0.0 111.465 -178.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 217' ' ' VAL . . . . . 0.488 HG12 ' O ' ' C' ' 214' ' ' LEU . 7.9 p -64.98 -36.66 78.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 O-C-N 122.084 -0.385 . . . . 0.0 110.566 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 218' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' C' ' 215' ' ' PRO . 50.8 mt -63.11 -45.16 99.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -65.6 -37.31 86.26 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.492 0.663 . . . . 0.0 109.729 178.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -58.12 -44.33 87.71 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.513 0.673 . . . . 0.0 110.393 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 221' ' ' GLY . . . . . 0.401 ' HA3' HD11 ' A' ' 222' ' ' LEU . . . -65.35 -33.99 88.15 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 4.9 tp -59.78 -43.19 94.49 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.421 0.629 . . . . 0.0 109.97 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.62 88.89 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.367 0.603 . . . . 0.0 110.413 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 1.2 tt -58.9 -40.9 85.88 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.124 0.487 . . . . 0.0 110.357 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 225' ' ' LEU . . . . . 0.461 HD13 HD13 ' B' ' 225' ' ' LEU . 22.7 tp -58.99 -40.48 84.99 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.057 0.456 . . . . 0.0 110.764 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 26.9 p -56.64 -41.04 76.49 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.195 0.521 . . . . 0.0 110.409 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.66 -39.79 91.74 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.267 0.556 . . . . 0.0 110.245 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 6.8 mp -67.22 -38.25 84.94 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.154 0.502 . . . . 0.0 110.484 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -64.92 -42.18 94.92 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.316 0.579 . . . . 0.0 110.619 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 35.4 mm -66.46 -42.16 89.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 121.54 0.686 . . . . 0.0 110.095 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -70.6 -35.94 67.69 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 232' ' ' LEU . . . . . 0.468 ' C ' HD23 ' C' ' 232' ' ' LEU . 8.1 tt -63.79 -46.37 85.48 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 122.043 -0.681 . . . . 0.0 111.13 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -70.26 -35.85 74.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.151 0.501 . . . . 0.0 111.221 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -59.98 -47.91 83.88 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.391 0.615 . . . . 0.0 110.497 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -69.77 -21.25 63.45 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.086 0.47 . . . . 0.0 111.499 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 64.1 t80 . . . . . 0 CA--C 1.544 0.747 0 O-C-N 122.034 -0.416 . . . . 0.0 111.717 -179.981 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 C--O 1.237 0.402 0 CA-C-O 122.374 1.083 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 23.9 t -69.08 -22.59 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.081 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.564 HD13 ' O ' ' A' ' 213' ' ' LEU . 0.3 OUTLIER -67.26 -36.43 81.58 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.944 0.402 . . . . 0.0 111.09 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.504 ' O ' HG12 ' A' ' 217' ' ' VAL . 0.9 OUTLIER -51.29 -57.35 14.41 Favored Pre-proline 0 CA--C 1.552 1.032 0 O-C-N 121.894 -0.503 . . . . 0.0 111.194 -179.012 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.529 ' HA ' HD12 ' A' ' 218' ' ' ILE . 33.2 Cg_endo -63.76 -31.88 68.31 Favored 'Trans proline' 0 N--CA 1.502 1.993 0 C-N-CA 121.776 1.65 . . . . 0.0 113.039 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 8.9 tp -62.72 -45.38 93.0 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.155 0.502 . . . . 0.0 111.562 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.1 p -66.51 -36.43 77.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 O-C-N 122.226 -0.296 . . . . 0.0 110.371 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 215' ' ' PRO . 51.6 mt -62.8 -44.06 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -67.9 -36.79 80.82 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.345 0.593 . . . . 0.0 109.908 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -57.75 -44.35 86.05 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.288 0.566 . . . . 0.0 110.128 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -67.9 -34.0 81.17 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' C' ' 218' ' ' ILE . 6.2 tp -62.89 -36.07 82.11 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.391 0.615 . . . . 0.0 111.111 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.66 -38.61 88.37 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.226 0.536 . . . . 0.0 111.088 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 19.7 mt -58.95 -44.63 91.47 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.938 0.399 . . . . 0.0 110.74 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.563 ' HB2' HD11 ' B' ' 225' ' ' LEU . 26.0 tp -61.6 -31.76 71.84 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.997 0.427 . . . . 0.0 110.624 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 31.7 t -62.16 -46.41 89.08 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.181 0.515 . . . . 0.0 110.693 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.435 HD12 ' N ' ' A' ' 227' ' ' LEU . 7.7 mp -66.42 -39.6 89.06 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.572 0.701 . . . . 0.0 110.577 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 13.1 tp -71.13 -34.38 70.99 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.148 0.499 . . . . 0.0 111.345 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.434 ' CE1' HD23 ' C' ' 224' ' ' LEU . 27.8 t80 -63.84 -43.22 96.82 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.237 0.541 . . . . 0.0 111.793 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 32.1 pt -69.2 -35.7 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-O 121.417 0.627 . . . . 0.0 110.838 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -59.16 -31.95 70.38 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.8 -32.01 68.96 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.574 0.702 . . . . 0.0 110.581 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.85 -43.5 90.81 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.384 0.612 . . . . 0.0 110.868 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 27.0 t80 . . . . . 0 C--O 1.234 0.262 0 CA-C-O 121.529 0.681 . . . . 0.0 110.577 -179.867 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 CA--C 1.537 0.443 0 CA-C-O 121.442 0.639 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 14.1 tp -68.67 -29.82 68.37 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.636 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.504 ' O ' HG12 ' B' ' 217' ' ' VAL . 1.0 OUTLIER -55.25 -57.78 18.41 Favored Pre-proline 0 CA--C 1.552 1.035 0 O-C-N 121.976 -0.452 . . . . 0.0 110.812 -179.151 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.04 -32.95 63.93 Favored 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 122.042 1.828 . . . . 0.0 112.889 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.86 -45.22 94.74 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.03 0.443 . . . . 0.0 111.517 -178.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.504 HG12 ' O ' ' B' ' 214' ' ' LEU . 7.4 p -67.58 -36.4 76.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 122.194 -0.316 . . . . 0.0 110.33 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 46.4 mt -67.44 -43.14 87.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -65.87 -38.97 90.22 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.511 0.672 . . . . 0.0 109.847 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -57.88 -43.78 86.24 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.523 0.677 . . . . 0.0 110.199 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.23 -33.7 87.94 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 222' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 218' ' ' ILE . 9.8 tp -58.76 -39.73 81.82 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.293 0.568 . . . . 0.0 110.337 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.71 88.39 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.652 0.739 . . . . 0.0 109.252 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 3.0 tp -59.76 -38.95 83.22 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.77 0.795 . . . . 0.0 109.335 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 225' ' ' LEU . . . . . 0.563 HD11 ' HB2' ' A' ' 225' ' ' LEU . 3.7 tt -59.6 -45.1 92.92 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.617 0.722 . . . . 0.0 110.13 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 45.0 m -60.91 -43.8 98.06 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.389 0.614 . . . . 0.0 110.347 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 11.8 mt -64.36 -41.48 96.7 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.282 0.563 . . . . 0.0 110.23 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 21.6 mt -65.87 -37.97 87.58 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.989 0.423 . . . . 0.0 111.079 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -69.55 -42.36 74.67 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.201 0.524 . . . . 0.0 110.892 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 38.8 mm -67.45 -41.21 85.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.716 0.77 . . . . 0.0 109.655 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -58.45 -31.88 67.46 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.529 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 4.6 tt . . . . . 0 N--CA 1.465 0.302 0 CA-C-O 121.512 0.672 . . . . 0.0 110.979 -179.637 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 11.2 tp . . . . . 0 C--O 1.235 0.341 0 CA-C-O 120.791 0.329 . . . . 0.0 111.779 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 214' ' ' LEU . . . . . 0.547 ' O ' HG12 ' C' ' 217' ' ' VAL . 1.0 OUTLIER -50.82 -57.35 13.82 Favored Pre-proline 0 CA--C 1.551 0.988 0 CA-C-O 118.919 -0.562 . . . . 0.0 111.367 -178.692 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.97 -36.68 47.88 Favored 'Trans proline' 0 N--CA 1.505 2.184 0 C-N-CA 121.979 1.786 . . . . 0.0 113.297 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.93 -45.23 93.29 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.893 0.378 . . . . 0.0 111.793 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 217' ' ' VAL . . . . . 0.547 HG12 ' O ' ' C' ' 214' ' ' LEU . 7.6 p -63.84 -36.19 75.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 O-C-N 122.126 -0.359 . . . . 0.0 110.905 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 218' ' ' ILE . . . . . 0.44 ' HA ' HD22 ' A' ' 222' ' ' LEU . 33.1 mm -62.75 -44.97 99.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 O-C-N 121.615 -0.678 . . . . 0.0 109.198 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -68.9 -37.56 79.07 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.636 0.731 . . . . 0.0 110.205 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -59.37 -44.48 92.72 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.392 0.615 . . . . 0.0 110.529 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.29 -33.8 88.21 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 110.454 -1.059 . . . . 0.0 110.454 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 2.4 tp -62.91 -42.57 99.83 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.561 0.696 . . . . 0.0 110.72 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.86 -38.95 90.18 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.347 0.594 . . . . 0.0 110.798 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 224' ' ' LEU . . . . . 0.434 HD23 ' CE1' ' A' ' 229' ' ' PHE . 0.6 OUTLIER -61.8 -42.04 98.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.319 0.581 . . . . 0.0 109.949 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 225' ' ' LEU . . . . . 0.478 HD13 HD13 ' A' ' 225' ' ' LEU . 22.4 tp -61.37 -38.7 87.94 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.31 0.576 . . . . 0.0 110.246 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 37.4 m -58.43 -46.96 85.46 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.205 0.526 . . . . 0.0 110.3 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -62.88 -41.79 99.54 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.216 0.532 . . . . 0.0 110.478 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 228' ' ' LEU . . . . . 0.41 HD13 ' O ' ' C' ' 224' ' ' LEU . 6.6 mp -63.79 -38.31 90.64 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.196 0.522 . . . . 0.0 110.372 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -62.23 -42.22 99.12 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.36 0.6 . . . . 0.0 110.129 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 48.0 mm -68.0 -42.22 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-O 121.621 0.724 . . . . 0.0 109.869 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -65.51 -31.88 81.58 Favored Glycine 0 CA--C 1.533 1.178 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 232' ' ' LEU . . . . . 0.411 ' O ' HD23 ' C' ' 232' ' ' LEU . 4.5 tt -57.26 -45.98 83.48 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.711 0.767 . . . . 0.0 110.733 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -61.64 -38.77 88.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.904 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -63.28 -47.18 83.41 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.47 0.652 . . . . 0.0 110.678 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -68.4 -41.2 80.81 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.283 0.563 . . . . 0.0 111.1 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 41.1 t80 . . . . . 0 CA--C 1.541 0.628 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.912 179.976 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.468 0.462 0 CA-C-O 122.346 1.069 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 41.3 t -70.18 -35.69 64.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.439 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 31.7 mt -64.05 -40.58 96.59 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.521 ' O ' HG12 ' A' ' 217' ' ' VAL . 0.8 OUTLIER -49.39 -57.26 12.36 Favored Pre-proline 0 CA--C 1.552 1.035 0 O-C-N 121.924 -0.485 . . . . 0.0 111.638 -178.594 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.56 -36.44 53.7 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 121.805 1.67 . . . . 0.0 113.358 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.441 HD13 ' O ' ' A' ' 216' ' ' LEU . 0.2 OUTLIER -61.34 -45.17 95.55 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.949 0.404 . . . . 0.0 111.74 -178.602 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 214' ' ' LEU . 8.7 p -65.36 -36.48 77.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 O-C-N 122.14 -0.35 . . . . 0.0 110.507 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 59.8 mt -63.46 -44.84 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 O-C-N 121.6 -0.688 . . . . 0.0 109.461 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -63.96 -42.97 97.11 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.642 0.734 . . . . 0.0 109.749 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -58.1 -42.72 86.29 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.67 0.748 . . . . 0.0 110.567 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.1 -33.61 84.79 Favored Glycine 0 CA--C 1.531 1.031 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.437 HD22 ' HA ' ' C' ' 218' ' ' ILE . 8.8 tp -58.51 -41.37 85.28 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.235 0.54 . . . . 0.0 110.094 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.93 -39.01 90.59 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.508 0.671 . . . . 0.0 109.467 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.6 tp -62.42 -43.47 98.73 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.938 0.875 . . . . 0.0 109.55 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.533 HD11 ' HB2' ' C' ' 225' ' ' LEU . 0.9 OUTLIER -59.69 -38.21 80.91 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.357 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 48.0 m -58.95 -43.53 91.26 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 121.406 0.622 . . . . 0.0 110.428 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.73 -43.98 97.81 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.246 0.546 . . . . 0.0 110.265 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.6 mp -65.95 -38.62 89.07 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.195 0.522 . . . . 0.0 110.48 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -67.38 -42.18 83.78 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.16 0.505 . . . . 0.0 110.595 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 96.0 mt -66.67 -35.48 74.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.444 0.64 . . . . 0.0 109.991 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.5 -31.81 60.43 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.425 HD23 ' C ' ' A' ' 232' ' ' LEU . 8.7 tt -59.85 -42.78 94.38 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.698 0.761 . . . . 0.0 110.376 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -62.48 -44.08 97.25 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.432 0.634 . . . . 0.0 110.881 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 39.1 t80 . . . . . 0 C--O 1.234 0.278 0 CA-C-O 121.605 0.717 . . . . 0.0 110.737 -179.677 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 CA--C 1.536 0.424 0 CA-C-O 121.433 0.635 . . . . 0.0 111.058 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 11.2 tp -65.97 -37.49 86.11 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.716 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.545 ' O ' HG12 ' B' ' 217' ' ' VAL . 7.1 tp -51.94 -57.19 15.85 Favored Pre-proline 0 CA--C 1.552 1.021 0 CA-C-O 118.867 -0.587 . . . . 0.0 111.231 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.13 -34.54 57.17 Favored 'Trans proline' 0 N--CA 1.504 2.126 0 C-N-CA 121.823 1.682 . . . . 0.0 113.205 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.75 -45.16 95.38 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.901 0.381 . . . . 0.0 111.724 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.545 HG12 ' O ' ' B' ' 214' ' ' LEU . 7.1 p -63.3 -36.33 75.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 O-C-N 122.06 -0.4 . . . . 0.0 110.756 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 21.5 mm -62.93 -44.75 99.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -64.59 -36.86 85.6 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.451 0.644 . . . . 0.0 110.044 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -57.68 -44.72 86.0 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.201 0.524 . . . . 0.0 110.585 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -67.6 -34.78 84.83 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 5.2 tp -61.85 -40.97 97.19 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.667 0.746 . . . . 0.0 110.235 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.79 -38.44 88.1 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.32 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 2.5 tp -58.69 -38.13 77.57 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.209 0.528 . . . . 0.0 110.2 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 225' ' ' LEU . . . . . 0.478 HD13 ' HG ' ' A' ' 225' ' ' LEU . 19.3 tp -59.08 -32.34 69.71 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.119 0.485 . . . . 0.0 110.718 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 33.1 t -58.97 -47.03 86.58 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.057 0.456 . . . . 0.0 110.289 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 227' ' ' LEU . . . . . 0.421 HD12 ' N ' ' B' ' 227' ' ' LEU . 7.8 mp -62.41 -43.98 97.52 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.197 0.522 . . . . 0.0 110.394 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 7.2 mp -61.56 -36.84 81.76 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.237 0.542 . . . . 0.0 109.974 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -59.46 -42.07 91.14 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.651 0.738 . . . . 0.0 109.956 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 50.4 mm -64.67 -41.04 91.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 121.767 0.794 . . . . 0.0 110.083 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -63.92 -32.01 82.73 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.554 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 232' ' ' LEU . . . . . 0.413 HD23 ' C ' ' B' ' 232' ' ' LEU . 6.6 tt . . . . . 0 N--CA 1.465 0.278 0 CA-C-O 121.598 0.713 . . . . 0.0 110.794 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 21.9 mt . . . . . 0 C--O 1.236 0.375 0 CA-C-O 120.893 0.378 . . . . 0.0 111.497 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 214' ' ' LEU . . . . . 0.536 ' O ' HG12 ' C' ' 217' ' ' VAL . 0.2 OUTLIER -54.38 -57.49 18.31 Favored Pre-proline 0 CA--C 1.549 0.918 0 CA-C-O 118.929 -0.558 . . . . 0.0 111.118 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -63.7 -34.67 61.65 Favored 'Trans proline' 0 N--CA 1.505 2.165 0 C-N-CA 121.777 1.651 . . . . 0.0 113.406 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 tt -59.69 -45.57 91.69 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.103 0.478 . . . . 0.0 111.6 -178.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 217' ' ' VAL . . . . . 0.536 HG12 ' O ' ' C' ' 214' ' ' LEU . 7.1 p -64.54 -36.34 77.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 O-C-N 122.156 -0.34 . . . . 0.0 110.794 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 218' ' ' ILE . . . . . 0.437 ' HA ' HD22 ' A' ' 222' ' ' LEU . 36.0 mm -63.17 -44.93 99.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -61.73 -36.93 82.38 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.356 0.598 . . . . 0.0 110.186 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -57.79 -44.71 86.44 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.325 0.583 . . . . 0.0 110.101 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -65.6 -33.72 87.0 Favored Glycine 0 CA--C 1.534 1.219 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 4.7 tp -61.9 -38.62 89.03 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.575 0.702 . . . . 0.0 110.842 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.68 -38.49 87.98 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.95 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 7.4 mp -58.91 -42.11 88.88 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.217 0.532 . . . . 0.0 110.164 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 225' ' ' LEU . . . . . 0.533 ' HB2' HD11 ' A' ' 225' ' ' LEU . 18.6 tp -58.56 -30.88 67.48 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.108 0.48 . . . . 0.0 110.648 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 8.0 t -57.06 -44.45 83.02 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.45 0.643 . . . . 0.0 109.939 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 7.9 mp -66.72 -40.81 88.55 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.36 0.6 . . . . 0.0 110.065 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 30.0 mt -63.61 -35.98 82.32 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.045 0.45 . . . . 0.0 110.547 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -66.79 -42.13 86.48 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.33 0.586 . . . . 0.0 109.971 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.29 -35.73 74.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 121.462 0.648 . . . . 0.0 109.844 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.74 -31.92 61.25 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 5.2 tt -59.49 -42.13 91.42 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.703 0.763 . . . . 0.0 110.172 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -62.45 -44.13 97.15 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.528 0.68 . . . . 0.0 110.554 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -62.44 -45.61 92.29 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.445 0.64 . . . . 0.0 110.586 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -59.64 -19.24 47.87 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.427 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 41.3 t80 . . . . . 0 CA--C 1.542 0.666 0 O-C-N 121.938 -0.476 . . . . 0.0 111.958 -179.785 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 66.6 p . . . . . 0 CA--C 1.536 0.442 0 CA-C-O 122.289 1.042 . . . . 0.0 110.673 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 34.7 m -70.16 -41.32 78.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.428 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 14.0 tp -69.27 -35.54 76.18 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.405 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.553 ' O ' HG12 ' A' ' 217' ' ' VAL . 2.3 tt -44.94 -57.1 7.56 Favored Pre-proline 0 CA--C 1.554 1.102 0 CA-C-O 118.887 -0.578 . . . . 0.0 111.744 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -63.79 -38.25 40.65 Favored 'Trans proline' 0 N--CA 1.507 2.27 0 C-N-CA 122.037 1.825 . . . . 0.0 113.925 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.2 tt -59.47 -45.36 91.86 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.205 0.526 . . . . 0.0 111.947 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 214' ' ' LEU . 9.1 p -61.94 -35.95 71.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.963 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 25.2 mm -62.56 -44.84 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 121.656 -0.653 . . . . 0.0 109.533 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -65.13 -36.66 84.98 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.709 0.766 . . . . 0.0 110.07 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -57.68 -42.38 83.49 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.243 0.544 . . . . 0.0 111.345 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.518 ' HA3' HD11 ' B' ' 222' ' ' LEU . . . -59.77 -33.63 78.77 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.95 -31.75 71.7 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.124 0.488 . . . . 0.0 111.444 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.64 -38.71 88.69 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.317 0.579 . . . . 0.0 110.619 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.86 -37.54 76.73 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.111 0.481 . . . . 0.0 110.456 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 16.8 tp -57.83 -35.37 70.8 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.079 0.466 . . . . 0.0 110.867 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 35.5 t -58.65 -41.72 86.68 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.228 0.537 . . . . 0.0 110.742 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 227' ' ' LEU . 7.8 mp -62.22 -42.78 99.61 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.587 0.708 . . . . 0.0 110.426 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.8 mp -71.25 -36.67 71.85 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.14 0.495 . . . . 0.0 111.029 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -70.36 -42.47 71.76 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.097 0.475 . . . . 0.0 111.568 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 7.9 tp -69.09 -38.37 78.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 121.813 0.816 . . . . 0.0 110.913 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -71.77 -31.8 64.59 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.448 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.402 HD23 ' C ' ' A' ' 232' ' ' LEU . 10.4 tt -60.87 -37.18 81.25 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 122.084 -0.657 . . . . 0.0 111.174 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.26 -37.48 87.4 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.17 0.509 . . . . 0.0 111.256 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 46.8 t80 . . . . . 0 C--O 1.234 0.282 0 CA-C-O 121.525 0.679 . . . . 0.0 110.217 179.85 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 29.7 m . . . . . 0 N--CA 1.468 0.435 0 CA-C-O 121.388 0.613 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 10.9 tp -63.69 -40.68 97.4 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.795 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.511 ' O ' HG12 ' B' ' 217' ' ' VAL . 2.9 tp -49.6 -57.55 11.75 Favored Pre-proline 0 CA--C 1.553 1.09 0 O-C-N 121.79 -0.569 . . . . 0.0 111.512 -178.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.42 -39.55 28.42 Favored 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 121.786 1.657 . . . . 0.0 112.754 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.34 -43.66 92.74 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.939 -177.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.511 HG12 ' O ' ' B' ' 214' ' ' LEU . 10.6 p -66.17 -36.58 77.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 O-C-N 121.971 -0.456 . . . . 0.0 110.714 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 33.6 mt -65.92 -44.45 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -66.58 -36.62 83.08 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.355 0.598 . . . . 0.0 110.139 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -57.55 -43.49 84.5 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.319 0.581 . . . . 0.0 110.116 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 221' ' ' GLY . . . . . 0.493 ' HA3' HD11 ' C' ' 222' ' ' LEU . . . -63.42 -33.64 87.79 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 178.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 222' ' ' LEU . . . . . 0.518 HD11 ' HA3' ' A' ' 221' ' ' GLY . 5.4 tp -58.79 -42.32 88.77 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.543 0.687 . . . . 0.0 110.103 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.8 -38.85 89.65 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.697 0.76 . . . . 0.0 109.567 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 2.9 tp -60.84 -40.1 91.56 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.757 0.789 . . . . 0.0 109.783 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.99 -42.86 89.23 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.061 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 226' ' ' SER . . . . . 0.402 ' O ' HD13 ' B' ' 230' ' ' ILE . 19.4 t -63.24 -44.02 96.4 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 121.51 0.671 . . . . 0.0 109.948 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 11.2 mt -66.85 -39.79 87.71 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.284 0.564 . . . . 0.0 110.23 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.42 HD11 HD13 ' C' ' 232' ' ' LEU . 7.6 tp -64.1 -34.76 78.77 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.202 0.525 . . . . 0.0 110.422 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -68.54 -41.17 80.24 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.314 0.578 . . . . 0.0 110.474 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.402 HD13 ' O ' ' B' ' 226' ' ' SER . 1.4 mp -66.01 -41.5 89.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 121.585 0.707 . . . . 0.0 109.114 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -60.58 -32.04 76.88 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 232' ' ' LEU . . . . . 0.458 HD23 ' C ' ' B' ' 232' ' ' LEU . 6.4 tt . . . . . 0 C--O 1.235 0.312 0 CA-C-O 121.638 0.732 . . . . 0.0 110.762 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 11.9 tp . . . . . 0 C--O 1.235 0.294 0 CA-C-O 120.852 0.358 . . . . 0.0 111.873 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 214' ' ' LEU . . . . . 0.579 ' O ' HG12 ' C' ' 217' ' ' VAL . 20.8 tp -46.87 -57.37 9.19 Favored Pre-proline 0 CA--C 1.556 1.202 0 CA-C-O 118.913 -0.565 . . . . 0.0 111.59 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.5 -42.74 15.6 Favored 'Trans proline' 0 N--CA 1.504 2.117 0 C-N-CA 121.882 1.721 . . . . 0.0 113.316 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.96 -45.16 83.04 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.89 -177.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 217' ' ' VAL . . . . . 0.579 HG12 ' O ' ' C' ' 214' ' ' LEU . 11.6 p -60.26 -35.78 64.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 122.055 -0.403 . . . . 0.0 110.757 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 44.7 mm -62.15 -45.16 99.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -60.34 -41.83 94.43 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.511 0.672 . . . . 0.0 109.462 177.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -57.72 -37.7 73.99 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.697 0.76 . . . . 0.0 110.447 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -59.97 -33.52 79.25 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 222' ' ' LEU . . . . . 0.493 HD11 ' HA3' ' B' ' 221' ' ' GLY . 4.9 tp -58.65 -38.38 78.01 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.534 0.683 . . . . 0.0 110.776 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.71 89.2 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.214 0.53 . . . . 0.0 110.751 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 11.8 mt -61.47 -47.77 84.14 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.2 0.524 . . . . 0.0 110.44 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 18.0 tp -58.19 -38.49 76.81 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.196 0.522 . . . . 0.0 110.381 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 36.1 t -59.85 -40.56 88.99 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.272 0.558 . . . . 0.0 110.746 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 10.5 mt -64.78 -42.72 94.87 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.671 0.748 . . . . 0.0 110.2 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 7.7 mp -70.52 -34.88 72.8 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.204 0.526 . . . . 0.0 111.046 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 229' ' ' PHE . . . . . 0.414 ' CD2' HD13 ' B' ' 228' ' ' LEU . 31.7 t80 -70.1 -42.41 72.76 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.022 0.439 . . . . 0.0 111.653 -178.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 6.2 tp -68.84 -35.93 71.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 121.417 0.627 . . . . 0.0 110.931 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -66.72 -32.15 80.5 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 111.559 -0.617 . . . . 0.0 111.559 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 232' ' ' LEU . . . . . 0.461 ' O ' HD23 ' C' ' 232' ' ' LEU . 1.9 tt -56.9 -40.8 76.95 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.58 0.705 . . . . 0.0 110.611 -179.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.52 -37.48 73.09 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.837 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -60.32 -44.22 95.65 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.535 0.683 . . . . 0.0 109.954 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 78.8 mtt85 -65.73 -25.99 67.54 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.477 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 36.4 t80 . . . . . 0 CA--C 1.543 0.678 0 O-C-N 122.038 -0.414 . . . . 0.0 111.777 179.975 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.469 0.481 0 CA-C-O 122.006 0.908 . . . . 0.0 111.794 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 26.1 m -70.68 -28.91 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.247 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 21.1 tp -66.1 -41.06 91.14 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 122.11 -0.369 . . . . 0.0 111.891 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.418 ' O ' HG12 ' A' ' 217' ' ' VAL . 8.0 tp -52.19 -57.29 15.82 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-O 119.03 -0.51 . . . . 0.0 111.396 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.12 -32.06 64.19 Favored 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 121.924 1.75 . . . . 0.0 113.355 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 7.5 tp -69.4 -45.11 70.04 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 122.001 -0.437 . . . . 0.0 111.813 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 214' ' ' LEU . 13.1 p -65.83 -36.68 78.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 O-C-N 122.245 -0.284 . . . . 0.0 111.456 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 26.4 pt -69.09 -38.39 78.13 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 O-C-N 121.488 -0.757 . . . . 0.0 110.744 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -68.98 -40.56 78.73 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.538 0.685 . . . . 0.0 110.319 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.84 -37.04 75.55 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.568 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.473 ' HA3' HD11 ' B' ' 222' ' ' LEU . . . -66.65 -33.78 85.46 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.469 HD11 ' HA3' ' C' ' 221' ' ' GLY . 8.2 tp -58.78 -37.44 76.31 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.229 0.538 . . . . 0.0 111.195 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.94 -39.23 91.38 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.105 0.479 . . . . 0.0 110.725 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.2 mp -65.69 -39.32 91.16 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.301 0.572 . . . . 0.0 110.493 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 19.4 tp -59.72 -39.79 85.84 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.191 0.52 . . . . 0.0 110.428 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 50.6 m -58.33 -41.54 84.79 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.308 0.575 . . . . 0.0 110.303 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.3 mt -64.16 -43.47 95.06 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.216 0.531 . . . . 0.0 110.546 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.0 mp -66.49 -38.07 86.45 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.101 0.476 . . . . 0.0 110.607 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -59.77 -42.18 92.7 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.049 0.452 . . . . 0.0 110.572 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.4 mp -64.21 -39.82 86.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.594 0.712 . . . . 0.0 109.367 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -59.67 -32.01 72.79 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.461 HD23 ' C ' ' A' ' 232' ' ' LEU . 9.1 tt -58.13 -45.27 87.62 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.475 0.655 . . . . 0.0 110.936 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -65.09 -37.51 87.74 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.354 0.597 . . . . 0.0 110.997 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 21.6 t80 . . . . . 0 C--O 1.235 0.304 0 CA-C-O 121.338 0.589 . . . . 0.0 110.738 -179.762 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 CA--C 1.544 0.742 0 CA-C-O 121.392 0.615 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 9.3 tt -69.19 -40.18 78.21 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.497 ' O ' HG12 ' B' ' 217' ' ' VAL . 2.0 tp -54.42 -56.86 22.1 Favored Pre-proline 0 CA--C 1.548 0.892 0 O-C-N 121.691 -0.631 . . . . 0.0 110.924 -178.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 215' ' ' PRO . . . . . 0.406 ' HD3' ' HB3' ' B' ' 214' ' ' LEU . 16.2 Cg_exo -64.24 -37.45 40.87 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 121.544 1.496 . . . . 0.0 112.476 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 4.4 tt -60.06 -45.38 93.06 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.102 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.497 HG12 ' O ' ' B' ' 214' ' ' LEU . 11.0 p -65.1 -36.57 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 O-C-N 122.219 -0.301 . . . . 0.0 110.682 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 46.2 mt -65.38 -44.95 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -67.93 -36.72 80.63 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.695 0.759 . . . . 0.0 109.987 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -57.78 -45.18 86.36 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.344 0.592 . . . . 0.0 110.678 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.66 -33.91 86.71 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 222' ' ' LEU . . . . . 0.473 HD11 ' HA3' ' A' ' 221' ' ' GLY . 6.5 tp -59.86 -41.25 91.04 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.455 0.645 . . . . 0.0 110.959 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.33 91.57 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.266 0.555 . . . . 0.0 110.614 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 1.1 tt -61.78 -41.54 97.85 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.532 0.682 . . . . 0.0 109.811 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 225' ' ' LEU . . . . . 0.401 HD13 HD13 ' C' ' 225' ' ' LEU . 20.7 tp -58.81 -42.97 90.39 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.263 0.554 . . . . 0.0 110.49 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 6.7 m -62.68 -43.51 98.61 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.474 0.654 . . . . 0.0 110.222 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 5.7 mp -65.5 -40.76 93.43 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.326 0.584 . . . . 0.0 110.686 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 16.8 tp -71.13 -34.66 71.26 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.505 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -71.03 -42.64 69.25 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 121.867 -0.521 . . . . 0.0 111.274 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 7.5 tp -69.34 -37.19 75.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 121.838 0.828 . . . . 0.0 111.081 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.69 -31.83 62.23 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.614 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 4.3 tt . . . . . 0 N--CA 1.465 0.323 0 CA-C-O 121.526 0.679 . . . . 0.0 111.007 -179.308 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 4.4 tt . . . . . 0 C--O 1.234 0.285 0 CA-C-O 120.831 0.348 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 214' ' ' LEU . . . . . 0.499 ' O ' HG12 ' C' ' 217' ' ' VAL . 4.0 tp -46.36 -57.17 9.05 Favored Pre-proline 0 CA--C 1.553 1.093 0 CA-C-O 119.112 -0.471 . . . . 0.0 111.642 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 215' ' ' PRO . . . . . 0.429 ' HA ' HD12 ' C' ' 218' ' ' ILE . 37.0 Cg_endo -63.84 -38.97 35.92 Favored 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 121.841 1.694 . . . . 0.0 113.032 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -45.35 90.91 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.839 0.352 . . . . 0.0 111.723 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 217' ' ' VAL . . . . . 0.499 HG12 ' O ' ' C' ' 214' ' ' LEU . 7.1 p -64.46 -36.57 77.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 122.088 -0.382 . . . . 0.0 110.514 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 218' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' C' ' 215' ' ' PRO . 50.9 mt -63.0 -45.15 99.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.455 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -64.39 -37.32 87.09 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.618 0.723 . . . . 0.0 110.092 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -57.96 -45.29 86.92 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.419 0.628 . . . . 0.0 110.578 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 221' ' ' GLY . . . . . 0.469 ' HA3' HD11 ' A' ' 222' ' ' LEU . . . -60.13 -33.79 81.22 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 4.8 tp -59.06 -40.33 84.79 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.585 0.707 . . . . 0.0 110.629 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.83 -39.05 90.45 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.864 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 36.2 mt -61.6 -40.01 93.28 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.416 0.627 . . . . 0.0 110.581 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 225' ' ' LEU . . . . . 0.401 HD13 HD13 ' B' ' 225' ' ' LEU . 32.3 tp -60.93 -35.28 76.3 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.062 0.458 . . . . 0.0 110.314 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 42.8 t -57.6 -46.7 83.71 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.371 0.605 . . . . 0.0 109.669 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 8.1 mp -60.89 -42.24 97.63 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.395 0.617 . . . . 0.0 110.244 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.63 -37.25 86.93 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.201 0.524 . . . . 0.0 110.585 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -69.79 -42.08 74.24 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.173 0.511 . . . . 0.0 111.183 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 34.0 mm -63.01 -41.04 91.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.506 0.669 . . . . 0.0 110.072 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -62.78 -33.28 86.44 Favored Glycine 0 CA--C 1.535 1.289 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 7.8 tt -61.89 -34.66 76.44 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 122.178 -0.601 . . . . 0.0 111.764 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -61.43 -35.81 78.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.138 0.494 . . . . 0.0 111.354 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -59.87 -44.49 94.14 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.365 0.602 . . . . 0.0 110.575 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 66.5 mtp85 -63.96 -32.12 73.54 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.429 0.633 . . . . 0.0 110.832 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 57.8 t80 . . . . . 0 CA--C 1.545 0.762 0 CA-C-O 120.959 0.409 . . . . 0.0 111.146 179.416 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 43.7 p . . . . . 0 CA--C 1.539 0.523 0 CA-C-O 122.133 0.968 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 26.2 t -70.31 -34.83 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-O 121.471 0.653 . . . . 0.0 110.207 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 54.2 mt -66.56 -33.26 75.28 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.499 ' O ' HG12 ' A' ' 217' ' ' VAL . 0.1 OUTLIER -53.77 -57.54 17.1 Favored Pre-proline 0 CA--C 1.55 0.955 0 O-C-N 121.96 -0.463 . . . . 0.0 111.085 -179.213 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.73 -32.94 67.52 Favored 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 121.868 1.712 . . . . 0.0 112.814 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.94 -45.32 95.19 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.041 0.448 . . . . 0.0 111.468 -178.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.499 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.3 p -67.92 -36.51 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 O-C-N 122.125 -0.359 . . . . 0.0 110.203 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 52.6 mt -67.84 -42.83 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 121.507 0.67 . . . . 0.0 109.212 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -62.93 -36.72 84.34 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.482 0.658 . . . . 0.0 110.524 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -57.74 -43.44 85.39 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.367 0.603 . . . . 0.0 110.207 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.415 ' HA3' HD11 ' B' ' 222' ' ' LEU . . . -64.12 -33.91 88.49 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 178.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 6.8 tp -60.58 -38.82 85.87 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.587 0.708 . . . . 0.0 110.643 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.81 -38.77 89.38 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.239 0.542 . . . . 0.0 110.711 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 6.1 mp -59.8 -35.95 75.72 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.207 0.527 . . . . 0.0 110.471 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 13.4 tp -58.44 -36.58 73.86 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.089 0.471 . . . . 0.0 110.913 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 23.5 t -58.46 -44.36 89.21 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.27 0.557 . . . . 0.0 110.533 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.9 mt -61.66 -43.14 99.42 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.461 0.648 . . . . 0.0 110.013 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 6.8 mt -66.51 -37.31 84.77 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.149 0.5 . . . . 0.0 110.414 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -65.85 -41.98 91.01 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.319 0.58 . . . . 0.0 110.117 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 92.6 mt -63.01 -35.96 73.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 121.409 0.623 . . . . 0.0 110.003 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.56 -32.2 61.0 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 10.0 tt -59.21 -37.33 77.19 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.593 0.711 . . . . 0.0 110.568 179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.82 -36.01 73.82 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.254 0.549 . . . . 0.0 111.157 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 29.4 t80 . . . . . 0 C--O 1.235 0.304 0 CA-C-O 121.486 0.66 . . . . 0.0 110.568 -179.67 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 34.7 t . . . . . 0 N--CA 1.469 0.5 0 CA-C-O 121.456 0.646 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 9.1 tp -69.16 -33.39 73.33 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.592 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.445 ' O ' HG12 ' B' ' 217' ' ' VAL . 1.0 OUTLIER -49.13 -57.26 12.04 Favored Pre-proline 0 CA--C 1.553 1.058 0 O-C-N 121.908 -0.495 . . . . 0.0 111.319 -178.906 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 215' ' ' PRO . . . . . 0.419 ' HA ' HG12 ' B' ' 218' ' ' ILE . 37.3 Cg_endo -63.7 -29.31 69.08 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 121.905 1.736 . . . . 0.0 113.484 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.16 -45.14 67.36 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.106 0.479 . . . . 0.0 111.51 -178.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.445 HG12 ' O ' ' B' ' 214' ' ' LEU . 8.5 p -65.23 -36.78 78.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 122.098 -0.376 . . . . 0.0 111.409 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 218' ' ' ILE . . . . . 0.419 HG12 ' HA ' ' B' ' 215' ' ' PRO . 28.7 pt -69.07 -38.2 77.92 Favored 'Isoleucine or valine' 0 C--N 1.348 0.526 0 O-C-N 121.355 -0.841 . . . . 0.0 110.661 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -64.42 -44.03 92.49 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.555 0.693 . . . . 0.0 110.083 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -59.22 -44.63 92.3 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.688 0.756 . . . . 0.0 109.956 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -59.97 -33.37 78.63 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 222' ' ' LEU . . . . . 0.415 HD11 ' HA3' ' A' ' 221' ' ' GLY . 3.7 tp -59.02 -40.79 86.06 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.417 0.627 . . . . 0.0 110.393 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.89 -38.76 89.53 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.141 0.496 . . . . 0.0 110.873 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 15.3 mt -59.35 -39.08 82.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.227 0.537 . . . . 0.0 110.434 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 18.0 tp -60.82 -38.43 85.4 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.316 0.579 . . . . 0.0 110.317 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 5.6 t -58.29 -47.03 84.95 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.286 0.565 . . . . 0.0 110.425 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 7.7 mp -59.09 -43.8 91.86 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.224 0.535 . . . . 0.0 110.54 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 6.9 mp -67.01 -38.74 86.51 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.127 0.489 . . . . 0.0 110.777 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -67.3 -42.27 84.0 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.208 0.528 . . . . 0.0 111.126 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 34.2 mm -64.99 -42.42 94.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-O 121.648 0.737 . . . . 0.0 109.615 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -58.54 -31.84 67.71 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 232' ' ' LEU . . . . . 0.489 HD13 ' C ' ' B' ' 232' ' ' LEU . 3.2 tm? . . . . . 0 C--O 1.235 0.311 0 CA-C-O 121.718 0.771 . . . . 0.0 110.608 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 213' ' ' LEU . . . . . 0.498 HD13 ' O ' ' C' ' 213' ' ' LEU . 0.2 OUTLIER . . . . . 0 CA--C 1.536 0.411 0 CA-C-O 120.943 0.402 . . . . 0.0 111.257 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 214' ' ' LEU . . . . . 0.492 ' O ' HG12 ' C' ' 217' ' ' VAL . 3.1 tp -49.26 -57.41 11.77 Favored Pre-proline 0 CA--C 1.554 1.1 0 O-C-N 121.889 -0.507 . . . . 0.0 111.534 -178.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.09 -34.52 57.65 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 121.852 1.701 . . . . 0.0 112.97 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 216' ' ' LEU . . . . . 0.445 HD13 ' O ' ' C' ' 216' ' ' LEU . 0.2 OUTLIER -61.61 -45.26 94.85 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.073 0.463 . . . . 0.0 111.615 -178.34 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 217' ' ' VAL . . . . . 0.492 HG12 ' O ' ' C' ' 214' ' ' LEU . 8.4 p -67.3 -36.56 76.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 122.059 -0.4 . . . . 0.0 110.29 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 41.5 mt -68.66 -41.23 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.498 0.666 . . . . 0.0 109.318 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -62.52 -36.97 84.26 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.379 0.609 . . . . 0.0 110.544 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -57.87 -43.55 86.09 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.503 0.668 . . . . 0.0 110.324 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.43 -33.78 82.63 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 179.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 7.4 tp -59.39 -36.47 75.86 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.314 0.578 . . . . 0.0 111.293 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.68 -38.72 88.83 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.132 0.491 . . . . 0.0 111.012 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 7.2 mp -59.3 -39.27 82.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.214 0.53 . . . . 0.0 110.416 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 24.2 tp -61.75 -38.51 88.25 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.258 0.551 . . . . 0.0 110.458 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 74.9 m -58.32 -42.65 87.25 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.24 0.543 . . . . 0.0 110.916 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.97 -42.3 97.3 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.386 0.612 . . . . 0.0 110.647 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 6.5 mp -71.16 -34.68 71.19 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.199 0.523 . . . . 0.0 111.103 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -64.94 -42.28 94.77 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.921 0.391 . . . . 0.0 111.816 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 6.6 tp -69.26 -35.77 69.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 121.543 0.687 . . . . 0.0 110.983 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.69 -31.96 62.08 Favored Glycine 0 CA--C 1.535 1.285 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 232' ' ' LEU . . . . . 0.448 ' C ' HD23 ' C' ' 232' ' ' LEU . 9.1 tt -57.2 -44.7 83.9 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.513 0.673 . . . . 0.0 111.016 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -62.93 -39.61 95.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.388 0.613 . . . . 0.0 110.797 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -61.0 -45.25 95.59 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.418 0.627 . . . . 0.0 110.539 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -61.52 -38.33 86.97 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.254 0.549 . . . . 0.0 111.029 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 10.5 t80 . . . . . 0 CA--C 1.543 0.677 0 CA-C-O 120.902 0.382 . . . . 0.0 111.677 179.907 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 41.0 p . . . . . 0 N--CA 1.468 0.429 0 CA-C-O 122.099 0.952 . . . . 0.0 111.474 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 57.3 t -70.37 -27.5 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.231 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.405 ' O ' HD23 ' A' ' 213' ' ' LEU . 4.0 tt -66.84 -39.8 87.72 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.921 0.391 . . . . 0.0 111.315 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.519 ' O ' HG12 ' A' ' 217' ' ' VAL . 4.5 tp -47.83 -57.34 10.33 Favored Pre-proline 0 CA--C 1.553 1.068 0 CA-C-O 118.895 -0.574 . . . . 0.0 111.581 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -64.0 -34.02 60.58 Favored 'Trans proline' 0 N--CA 1.503 2.083 0 C-N-CA 121.752 1.635 . . . . 0.0 113.113 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.6 tp -61.13 -45.32 95.14 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.011 0.434 . . . . 0.0 111.634 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.519 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.2 p -65.39 -36.6 78.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 O-C-N 122.204 -0.31 . . . . 0.0 110.631 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 42.2 mm -65.05 -42.41 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -60.96 -36.75 80.19 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.394 0.616 . . . . 0.0 110.287 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.88 -42.13 83.93 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.399 0.619 . . . . 0.0 109.897 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -65.47 -33.8 87.43 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 7.4 tp -58.75 -34.58 71.56 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.253 0.549 . . . . 0.0 111.077 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.63 -38.76 88.84 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.24 0.543 . . . . 0.0 110.974 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.9 mp -61.5 -38.87 88.9 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.357 0.599 . . . . 0.0 110.443 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.435 HD13 HD13 ' B' ' 225' ' ' LEU . 16.8 tp -59.07 -41.91 89.1 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.278 0.561 . . . . 0.0 110.447 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 46.9 t -59.9 -42.26 93.45 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.299 0.571 . . . . 0.0 110.742 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 1.6 tt -62.63 -46.71 86.97 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.365 0.602 . . . . 0.0 110.48 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.4 mp -66.0 -40.18 90.93 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.915 0.388 . . . . 0.0 111.376 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -70.06 -42.27 73.04 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.219 0.533 . . . . 0.0 110.95 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 93.4 mt -68.04 -42.16 85.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.484 0.659 . . . . 0.0 110.164 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -62.97 -34.3 89.56 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.449 ' O ' HD23 ' A' ' 232' ' ' LEU . 1.4 tt -68.24 -39.18 82.35 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.57 0.7 . . . . 0.0 110.929 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -70.32 -35.61 73.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.294 0.569 . . . . 0.0 112.279 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 34.6 t80 . . . . . 0 CA--C 1.538 0.482 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.276 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 41.5 t . . . . . 0 CA--C 1.543 0.685 0 CA-C-O 121.302 0.572 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 12.1 tp -64.14 -40.94 97.24 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 122.149 -0.344 . . . . 0.0 111.847 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.497 ' O ' HG12 ' B' ' 217' ' ' VAL . 1.5 tt -54.54 -57.07 20.54 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-O 119.103 -0.475 . . . . 0.0 111.332 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.86 -33.31 64.81 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 121.852 1.701 . . . . 0.0 112.942 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 216' ' ' LEU . . . . . 0.445 ' O ' HD23 ' B' ' 216' ' ' LEU . 3.6 tt -61.86 -45.53 93.4 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.091 0.472 . . . . 0.0 111.493 -178.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.497 HG12 ' O ' ' B' ' 214' ' ' LEU . 7.2 p -66.66 -36.53 77.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 O-C-N 122.128 -0.357 . . . . 0.0 110.302 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 218' ' ' ILE . . . . . 0.444 HD11 ' CD2' ' B' ' 214' ' ' LEU . 53.5 mt -67.46 -44.69 86.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -64.43 -36.74 85.13 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.515 0.674 . . . . 0.0 110.029 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -57.65 -43.74 85.17 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.295 0.569 . . . . 0.0 110.408 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -70.15 -35.68 70.91 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.21 -27.56 69.15 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.185 0.517 . . . . 0.0 110.71 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.72 -38.88 89.52 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.263 0.554 . . . . 0.0 110.323 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 51.1 mt -60.31 -38.49 83.85 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.331 0.586 . . . . 0.0 110.367 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 225' ' ' LEU . . . . . 0.435 HD13 HD13 ' A' ' 225' ' ' LEU . 17.4 tp -57.98 -35.41 71.15 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.193 0.52 . . . . 0.0 110.655 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 17.1 m -58.4 -40.43 82.38 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.202 0.525 . . . . 0.0 110.834 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 8.0 mp -63.33 -45.59 90.54 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.49 0.662 . . . . 0.0 110.796 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 8.0 mp -71.23 -34.98 71.28 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.267 0.556 . . . . 0.0 111.224 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -72.52 -42.12 65.12 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.111 0.481 . . . . 0.0 111.82 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 7.7 tp -66.12 -35.92 76.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 121.411 0.624 . . . . 0.0 111.326 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -73.11 -36.73 56.28 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 232' ' ' LEU . . . . . 0.409 HD23 ' O ' ' B' ' 232' ' ' LEU . 3.0 tt . . . . . 0 N--CA 1.466 0.336 0 CA-C-O 121.718 0.77 . . . . 0.0 111.126 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 15.0 tp . . . . . 0 C--O 1.235 0.317 0 CA-C-O 120.831 0.348 . . . . 0.0 111.775 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 214' ' ' LEU . . . . . 0.484 ' O ' HG12 ' C' ' 217' ' ' VAL . 11.0 tp -50.6 -57.11 14.34 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-O 119.011 -0.519 . . . . 0.0 111.634 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.87 -35.56 55.26 Favored 'Trans proline' 0 N--CA 1.504 2.116 0 C-N-CA 121.824 1.682 . . . . 0.0 112.961 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 5.3 tt -61.35 -45.43 94.45 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.987 0.423 . . . . 0.0 111.701 -178.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 217' ' ' VAL . . . . . 0.484 HG12 ' O ' ' C' ' 214' ' ' LEU . 10.0 p -66.99 -36.45 77.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 122.214 -0.303 . . . . 0.0 110.339 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 57.0 mt -67.59 -45.15 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -66.45 -37.32 84.88 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.41 0.624 . . . . 0.0 110.285 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -60.5 -45.79 92.5 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.462 0.649 . . . . 0.0 110.067 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.23 -33.64 87.77 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 222' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' B' ' 218' ' ' ILE . 6.0 tp -58.73 -39.64 81.47 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.522 0.677 . . . . 0.0 110.172 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.72 -38.46 87.99 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.577 0.704 . . . . 0.0 110.32 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 2.3 tp -58.71 -45.9 88.52 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.248 0.546 . . . . 0.0 110.257 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 225' ' ' LEU . . . . . 0.428 HD13 ' CD1' ' A' ' 225' ' ' LEU . 25.4 tp -62.5 -39.56 93.9 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.256 0.55 . . . . 0.0 109.997 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 16.6 t -57.35 -45.56 84.24 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.095 0.474 . . . . 0.0 110.296 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 11.4 mt -63.12 -42.14 99.46 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.206 0.527 . . . . 0.0 110.499 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 5.8 tp -65.88 -34.89 79.18 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.274 0.559 . . . . 0.0 110.442 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -65.34 -38.11 89.13 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.189 0.518 . . . . 0.0 110.936 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 36.3 mm -62.79 -43.39 98.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.526 0.679 . . . . 0.0 110.035 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.98 -37.05 56.76 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 232' ' ' LEU . . . . . 0.416 ' C ' HD23 ' C' ' 232' ' ' LEU . 8.3 tt -63.59 -44.08 95.09 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.387 0.613 . . . . 0.0 111.272 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -65.55 -35.55 81.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.347 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -59.73 -44.0 93.95 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.432 0.634 . . . . 0.0 110.296 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -69.64 -18.68 63.61 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.359 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 59.5 t80 . . . . . 0 CA--C 1.542 0.665 0 O-C-N 122.023 -0.423 . . . . 0.0 111.419 179.947 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 56.3 p . . . . . 0 C--O 1.238 0.486 0 CA-C-O 122.159 0.98 . . . . 0.0 111.736 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 12.9 p -69.9 -21.5 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.356 178.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.14 -33.0 72.74 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.073 0.463 . . . . 0.0 110.811 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.468 ' O ' HG12 ' A' ' 217' ' ' VAL . 3.3 tp -53.95 -57.07 19.43 Favored Pre-proline 0 CA--C 1.554 1.108 0 CA-C-O 119.063 -0.494 . . . . 0.0 111.534 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -63.32 -29.87 72.92 Favored 'Trans proline' 0 N--CA 1.504 2.128 0 C-N-CA 121.969 1.779 . . . . 0.0 113.612 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.5 tt -69.32 -45.31 69.79 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.813 -0.554 . . . . 0.0 111.44 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.9 p -64.93 -36.8 78.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 O-C-N 122.066 -0.396 . . . . 0.0 111.62 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 21.2 pt -70.68 -40.17 76.67 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 O-C-N 121.421 -0.8 . . . . 0.0 110.616 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -67.95 -42.14 81.4 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.668 0.747 . . . . 0.0 110.088 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -60.38 -44.14 95.92 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.535 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.62 -33.84 88.31 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.485 HD13 HG23 ' C' ' 218' ' ' ILE . 4.4 tp -59.57 -39.36 83.84 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.561 0.696 . . . . 0.0 110.323 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.52 88.28 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.292 0.568 . . . . 0.0 110.285 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.5 tp -58.89 -38.58 79.2 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.377 0.608 . . . . 0.0 110.007 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.424 HD13 HD13 ' B' ' 225' ' ' LEU . 17.5 tp -60.52 -32.35 71.38 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.197 0.522 . . . . 0.0 110.431 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 16.9 m -59.76 -43.67 94.21 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.212 0.529 . . . . 0.0 111.192 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.1 mp -65.04 -41.77 94.92 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.739 0.781 . . . . 0.0 110.58 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 25.8 mt -71.11 -34.8 71.44 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.397 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -69.24 -42.32 75.78 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.24 0.543 . . . . 0.0 111.677 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 6.1 tp -68.1 -36.06 73.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 121.588 0.708 . . . . 0.0 110.866 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -67.51 -31.69 77.18 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' LEU . . . . . 0.51 HD13 ' C ' ' A' ' 232' ' ' LEU . 3.2 tm? -56.89 -43.04 80.9 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.542 0.687 . . . . 0.0 110.485 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -59.66 -38.94 82.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.351 0.596 . . . . 0.0 110.686 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 53.0 t80 . . . . . 0 C--O 1.234 0.286 0 CA-C-O 121.603 0.716 . . . . 0.0 110.011 179.617 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 CA--C 1.539 0.534 0 CA-C-O 121.35 0.595 . . . . 0.0 110.785 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 10.0 tp -67.14 -36.56 82.14 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.487 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.503 ' O ' HG12 ' B' ' 217' ' ' VAL . 0.2 OUTLIER -54.07 -57.64 17.12 Favored Pre-proline 0 CA--C 1.552 1.023 0 O-C-N 122.052 -0.405 . . . . 0.0 110.8 -179.149 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.95 -34.87 58.02 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 121.9 1.733 . . . . 0.0 112.722 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 7.8 tp -61.33 -45.4 94.59 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.944 0.402 . . . . 0.0 111.694 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.503 HG12 ' O ' ' B' ' 214' ' ' LEU . 9.2 p -66.46 -36.48 77.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 O-C-N 122.228 -0.295 . . . . 0.0 110.257 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 55.6 mt -68.57 -42.72 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.433 0.635 . . . . 0.0 109.342 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -65.01 -40.55 95.07 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.572 0.701 . . . . 0.0 110.193 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -59.42 -41.65 90.03 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.558 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.66 -33.74 86.1 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 6.4 tp -58.92 -31.69 68.88 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.3 0.572 . . . . 0.0 111.317 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.68 -38.78 89.05 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.091 0.472 . . . . 0.0 110.805 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 6.4 mp -61.69 -39.25 90.78 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.368 0.604 . . . . 0.0 110.149 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 225' ' ' LEU . . . . . 0.424 HD13 HD13 ' A' ' 225' ' ' LEU . 24.7 tp -58.36 -37.96 76.28 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.228 0.537 . . . . 0.0 110.678 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 12.1 t -60.36 -41.65 94.11 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.238 0.542 . . . . 0.0 110.684 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 7.4 mp -62.36 -43.32 99.09 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.189 0.519 . . . . 0.0 110.588 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 1.3 mp -68.38 -42.63 78.83 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.454 0.645 . . . . 0.0 110.22 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -63.96 -42.24 97.33 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.066 0.46 . . . . 0.0 110.748 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.75 -36.13 76.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.336 0.589 . . . . 0.0 110.13 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.82 -32.87 62.48 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 4.1 tt . . . . . 0 C--O 1.234 0.253 0 CA-C-O 121.663 0.744 . . . . 0.0 110.595 179.942 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 213' ' ' LEU . . . . . 0.54 ' O ' HD23 ' C' ' 213' ' ' LEU . 1.4 tt . . . . . 0 C--O 1.235 0.319 0 CA-C-O 120.939 0.399 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 214' ' ' LEU . . . . . 0.581 ' O ' HG12 ' C' ' 217' ' ' VAL . 0.2 OUTLIER -50.64 -58.11 11.1 Favored Pre-proline 0 CA--C 1.553 1.084 0 O-C-N 122.03 -0.419 . . . . 0.0 110.895 -178.901 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -64.27 -34.79 54.58 Favored 'Trans proline' 0 N--CA 1.501 1.926 0 C-N-CA 121.882 1.721 . . . . 0.0 113.044 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.91 -45.11 95.94 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.417 -178.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 217' ' ' VAL . . . . . 0.581 HG12 ' O ' ' C' ' 214' ' ' LEU . 10.4 p -64.59 -36.18 76.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 122.084 -0.385 . . . . 0.0 110.873 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 218' ' ' ILE . . . . . 0.485 HG23 HD13 ' A' ' 222' ' ' LEU . 48.9 mt -62.68 -41.7 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -59.39 -42.97 92.94 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.64 0.734 . . . . 0.0 110.05 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.85 -36.96 73.06 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.364 0.602 . . . . 0.0 110.708 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.5 -33.76 88.1 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 4.9 tp -59.18 -39.77 83.59 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.38 0.61 . . . . 0.0 110.994 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.68 -40.03 93.52 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.215 0.531 . . . . 0.0 110.952 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 76.5 mt -62.04 -39.09 91.15 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.389 0.614 . . . . 0.0 110.775 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 44.7 tp -59.32 -39.14 82.17 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.498 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 9.9 p -60.81 -42.09 96.94 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.089 0.471 . . . . 0.0 110.644 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 7.1 mp -63.19 -45.48 91.58 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.342 0.592 . . . . 0.0 109.865 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.69 -37.42 87.54 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.098 0.475 . . . . 0.0 110.439 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -62.75 -42.3 99.61 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.327 0.584 . . . . 0.0 109.72 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.71 -38.93 82.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 121.462 0.648 . . . . 0.0 109.758 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.59 -31.85 60.74 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 5.7 tt -58.67 -40.33 83.21 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.472 0.653 . . . . 0.0 110.388 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -61.17 -44.26 97.59 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.386 0.612 . . . . 0.0 110.761 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -62.08 -46.22 90.05 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.358 0.599 . . . . 0.0 110.645 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -68.47 -36.01 78.37 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.233 0.54 . . . . 0.0 111.49 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 6.9 t80 . . . . . 0 CA--C 1.542 0.658 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.284 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.381 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 41.6 p 46.12 47.21 13.09 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.977 0.894 . . . . 0.0 111.203 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 25.5 p -93.14 33.97 1.16 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 122.209 1.004 . . . . 0.0 110.946 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 14.0 p -70.46 -27.95 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.887 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.5 HD13 ' O ' ' A' ' 213' ' ' LEU . 0.2 OUTLIER -69.02 -34.66 75.6 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.999 0.428 . . . . 0.0 111.571 -179.386 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.486 ' O ' HG12 ' A' ' 217' ' ' VAL . 3.2 tp -48.44 -57.19 11.4 Favored Pre-proline 0 CA--C 1.552 1.038 0 O-C-N 121.949 -0.469 . . . . 0.0 111.529 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -63.68 -37.84 44.08 Favored 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 121.802 1.668 . . . . 0.0 113.194 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 10.0 tp -60.99 -45.4 94.96 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.835 0.35 . . . . 0.0 111.667 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 214' ' ' LEU . 8.5 p -65.43 -36.39 77.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 O-C-N 122.271 -0.268 . . . . 0.0 110.697 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 68.6 mt -64.43 -43.96 97.02 Favored 'Isoleucine or valine' 0 C--N 1.345 0.374 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.475 ' CD1' HG21 ' C' ' 218' ' ' ILE . 8.3 m-30 -69.36 -37.06 77.44 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.494 0.664 . . . . 0.0 110.592 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -63.72 -36.7 84.73 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.335 0.588 . . . . 0.0 110.652 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.55 -33.71 82.92 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.537 HD13 HG23 ' C' ' 218' ' ' ILE . 0.2 OUTLIER -58.95 -25.53 63.59 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.157 0.503 . . . . 0.0 111.217 179.598 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.62 -38.69 88.55 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.139 0.495 . . . . 0.0 110.616 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.3 mp -59.5 -39.63 84.42 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.287 0.565 . . . . 0.0 110.407 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 14.7 tp -61.58 -40.97 96.67 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.384 0.611 . . . . 0.0 110.322 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 5.9 t -59.02 -46.31 88.52 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 121.333 0.587 . . . . 0.0 110.292 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.4 mt -64.47 -40.57 95.93 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.368 0.604 . . . . 0.0 110.179 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 18.2 mt -64.83 -36.58 84.8 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.062 0.458 . . . . 0.0 110.789 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -65.13 -42.21 94.1 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.249 0.547 . . . . 0.0 110.286 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 43.6 mm -63.91 -41.73 93.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 121.613 0.721 . . . . 0.0 109.967 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -62.26 -32.0 81.13 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 111.611 -0.596 . . . . 0.0 111.611 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.8 tt -58.46 -42.29 87.11 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.601 0.715 . . . . 0.0 110.819 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -66.77 -36.67 82.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.92 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -59.95 -44.54 94.34 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.44 0.638 . . . . 0.0 110.422 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 52.9 mmm-85 -61.12 -31.98 71.68 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.26 0.552 . . . . 0.0 111.021 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -85.79 -6.53 59.09 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.873 0.368 . . . . 0.0 111.536 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -130.03 46.57 2.63 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.978 0.894 . . . . 0.0 110.171 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.925 -179.878 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 6.1 m -152.17 -41.85 0.11 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.381 0.61 . . . . 0.0 110.585 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 69.8 p -131.1 50.26 2.25 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 122.42 1.105 . . . . 0.0 110.43 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 47.7 t -70.07 -36.16 67.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.099 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 6.6 tt -67.82 -34.74 77.33 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.664 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.512 ' O ' HG12 ' B' ' 217' ' ' VAL . 0.7 OUTLIER -49.84 -57.52 12.11 Favored Pre-proline 0 CA--C 1.552 1.049 0 O-C-N 121.881 -0.512 . . . . 0.0 111.088 -178.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 0.431 ' HA ' HD12 ' B' ' 218' ' ' ILE . 33.9 Cg_endo -63.96 -34.62 58.83 Favored 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 121.797 1.664 . . . . 0.0 112.846 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 8.2 tp -60.36 -45.37 93.75 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.987 0.422 . . . . 0.0 111.705 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.512 HG12 ' O ' ' B' ' 214' ' ' LEU . 7.2 p -66.34 -36.56 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 122.214 -0.304 . . . . 0.0 110.286 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 218' ' ' ILE . . . . . 0.474 ' HA ' HD22 ' C' ' 222' ' ' LEU . 53.5 mt -63.67 -42.24 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -65.14 -36.71 85.1 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.616 0.722 . . . . 0.0 109.942 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.65 -33.39 68.24 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.129 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 221' ' ' GLY . . . . . 0.41 ' HA3' HD11 ' C' ' 222' ' ' LEU . . . -70.92 -33.94 65.62 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.47 -32.26 73.12 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.152 0.501 . . . . 0.0 111.119 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -62.13 -38.95 90.91 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.276 0.56 . . . . 0.0 110.838 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 16.7 mt -63.77 -42.31 97.81 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.335 0.588 . . . . 0.0 110.418 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 22.0 tp -58.96 -30.82 68.19 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.189 0.518 . . . . 0.0 110.479 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 6.8 t -56.83 -45.93 82.01 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.984 0.421 . . . . 0.0 110.435 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 10.8 mt -64.52 -42.17 95.94 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.208 0.527 . . . . 0.0 110.249 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 6.7 mp -61.15 -37.42 82.79 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.483 0.659 . . . . 0.0 109.745 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -58.94 -35.48 73.19 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.347 0.594 . . . . 0.0 110.722 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 44.9 mm -62.17 -42.54 95.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.508 0.671 . . . . 0.0 110.205 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -62.77 -33.23 86.29 Favored Glycine 0 CA--C 1.535 1.306 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 232' ' ' LEU . . . . . 0.421 HD23 ' C ' ' B' ' 232' ' ' LEU . 9.3 tt -60.92 -44.47 97.14 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.43 0.633 . . . . 0.0 111.387 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -66.0 -39.27 90.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.291 0.567 . . . . 0.0 111.004 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -61.49 -45.9 92.29 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.472 0.653 . . . . 0.0 110.616 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -63.52 -35.63 81.11 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.23 0.538 . . . . 0.0 111.12 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -85.75 -6.66 59.09 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 120.891 0.377 . . . . 0.0 111.548 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -93.1 -31.78 14.69 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.806 -0.559 . . . . 0.0 111.11 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.545 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 210' ' ' THR . . . . . 0.447 ' O ' HG23 ' C' ' 210' ' ' THR . 7.3 t -154.27 119.67 5.12 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 122.219 -0.577 . . . . 0.0 110.714 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 9.7 t 40.25 44.89 1.67 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 122.359 1.076 . . . . 0.0 111.991 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 35.5 m -70.01 -28.83 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.042 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 213' ' ' LEU . . . . . 0.405 HD12 ' N ' ' C' ' 214' ' ' LEU . 3.2 pp -66.37 -35.2 79.72 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 122.646 0.378 . . . . 0.0 111.833 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 214' ' ' LEU . . . . . 0.493 ' O ' HG12 ' C' ' 217' ' ' VAL . 0.6 OUTLIER -53.36 -57.4 17.01 Favored Pre-proline 0 CA--C 1.552 1.028 0 O-C-N 121.931 -0.48 . . . . 0.0 111.062 -179.113 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.67 -32.1 68.98 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 121.869 1.713 . . . . 0.0 112.992 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.49 -45.31 93.61 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.084 0.469 . . . . 0.0 111.361 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 217' ' ' VAL . . . . . 0.493 HG12 ' O ' ' C' ' 214' ' ' LEU . 7.1 p -67.0 -36.39 77.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 O-C-N 122.132 -0.355 . . . . 0.0 110.244 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 218' ' ' ILE . . . . . 0.537 HG23 HD13 ' A' ' 222' ' ' LEU . 41.8 mm -62.79 -43.71 98.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -63.04 -36.9 85.11 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.381 0.61 . . . . 0.0 109.868 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -57.74 -41.91 82.81 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.518 0.675 . . . . 0.0 110.222 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.04 -33.91 81.3 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 222' ' ' LEU . . . . . 0.474 HD22 ' HA ' ' B' ' 218' ' ' ILE . 5.2 tp -58.91 -41.61 87.66 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.573 0.701 . . . . 0.0 110.279 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.81 -38.67 89.02 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.501 0.667 . . . . 0.0 110.151 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 1.9 tt -58.62 -38.37 77.87 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.366 0.603 . . . . 0.0 110.047 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 37.9 tp -57.91 -37.63 74.39 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.116 0.484 . . . . 0.0 110.183 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 6.5 t -59.18 -40.24 85.08 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.301 0.572 . . . . 0.0 110.401 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 11.4 mt -67.21 -42.81 83.5 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.465 0.65 . . . . 0.0 110.066 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 17.0 mt -65.69 -36.48 83.76 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.069 0.461 . . . . 0.0 111.11 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -74.98 -42.18 58.06 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.321 0.581 . . . . 0.0 110.893 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 91.1 mt -64.93 -40.56 89.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.29 0.567 . . . . 0.0 110.471 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -63.83 -34.99 91.41 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.49 -39.76 81.2 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.592 0.711 . . . . 0.0 111.248 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.31 -39.27 94.1 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.576 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -65.59 -48.13 73.39 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.503 0.668 . . . . 0.0 110.873 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -66.43 -45.98 78.02 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.589 0.709 . . . . 0.0 110.861 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -86.39 5.24 35.88 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.772 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -174.81 97.68 0.08 Allowed 'General case' 0 C--N 1.343 0.307 0 O-C-N 121.675 -0.64 . . . . 0.0 110.131 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 . . . . . 0 N--CA 1.47 0.546 0 CA-C-O 117.929 -1.034 . . . . 0.0 111.763 -179.654 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.366 0 N-CA-C 109.712 -1.355 . . . . 859.95000000000005 109.712 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 29.3 p -143.54 146.94 33.75 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 122.195 -0.591 . . . . 999.99000000000001 110.608 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 39.0 p -115.03 50.68 0.96 Allowed 'General case' 0 C--O 1.237 0.423 0 CA-C-O 122.498 1.142 . . . . 342.29000000000002 110.463 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 40.2 t -70.03 -29.88 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 115.258 -0.883 . . . . 373.69 110.093 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.92 -31.03 69.63 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.906 0.384 . . . . 305.66000000000003 111.18 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.493 ' O ' HG12 ' A' ' 217' ' ' VAL . 1.3 tp -54.31 -57.67 17.37 Favored Pre-proline 0 CA--C 1.551 1.002 0 O-C-N 121.922 -0.486 . . . . 225.87 110.747 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -63.94 -32.48 65.59 Favored 'Trans proline' 0 N--CA 1.502 2.025 0 C-N-CA 121.887 1.725 . . . . 62.090000000000003 112.803 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 8.6 tp -62.06 -45.48 93.36 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.035 0.445 . . . . 248.22 111.471 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.493 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.9 p -67.91 -36.41 75.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.762 0.315 . . . . 35.869999999999997 110.505 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 43.6 mt -68.5 -43.88 83.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 121.857 -0.527 . . . . 147.80000000000001 109.743 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -67.04 -38.1 85.29 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.312 0.577 . . . . 807.13 110.246 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -57.95 -42.35 84.74 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.423 0.63 . . . . 227.36000000000001 110.27 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.8 -33.89 88.43 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 110.367 -1.093 . . . . 19.0 110.367 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.441 HD22 ' HA ' ' C' ' 218' ' ' ILE . 6.1 tp -60.75 -42.56 97.63 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.53 0.681 . . . . 75.469999999999999 110.653 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.73 89.31 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.402 0.62 . . . . 23.100000000000001 110.527 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.02 -37.43 76.93 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.293 0.568 . . . . 167.94999999999999 110.318 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 18.3 tp -57.67 -36.31 71.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.205 0.526 . . . . 68.450000000000003 110.337 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 5.9 t -59.7 -38.85 82.73 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.371 0.605 . . . . 138.30000000000001 110.426 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.8 mt -64.47 -42.68 95.78 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.242 0.544 . . . . 287.99000000000001 110.398 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.6 mp -71.33 -34.99 71.03 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.237 0.542 . . . . 177.81999999999999 110.718 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -70.77 -42.19 70.72 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 122.163 -0.335 . . . . 258.75 111.821 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 6.0 tp -63.84 -35.91 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.673 0.749 . . . . 271.85000000000002 110.813 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -69.14 -31.92 72.37 Favored Glycine 0 CA--C 1.533 1.206 0 N-CA-C 111.314 -0.714 . . . . 63.240000000000002 111.314 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.407 ' O ' HD23 ' A' ' 232' ' ' LEU . 5.2 tt -56.98 -46.09 82.48 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.72 0.771 . . . . 132.75999999999999 110.261 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.5 -36.49 73.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.661 -0.7 . . . . 86.510000000000005 110.567 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -62.99 -41.01 99.45 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.353 0.597 . . . . 462.81 110.368 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -70.29 -36.52 74.41 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.251 0.548 . . . . 999.99000000000001 111.027 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -85.69 -11.99 52.34 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.928 0.394 . . . . 832.95000000000005 111.093 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 10.5 tm0? -114.83 -3.95 12.7 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.501 0.556 . . . . 999.99000000000001 112.501 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.952 0 C-N-CA 124.123 0.969 . . . . 999.99000000000001 113.289 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.562 -1.415 . . . . 999.99000000000001 109.562 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 45.5 p -132.41 157.94 43.27 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.424 0.63 . . . . 999.99000000000001 110.635 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 17.8 p -103.06 54.5 0.76 Allowed 'General case' 0 C--O 1.237 0.438 0 CA-C-O 122.291 1.044 . . . . 355.66000000000003 110.394 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 29.0 m -69.97 -27.8 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 115.465 -0.789 . . . . 341.94 110.669 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 13.4 tp -68.38 -34.73 76.57 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.902 0.382 . . . . 191.08000000000001 111.276 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.494 ' O ' HG12 ' B' ' 217' ' ' VAL . 1.3 tp -53.53 -57.62 16.39 Favored Pre-proline 0 CA--C 1.553 1.062 0 O-C-N 121.993 -0.442 . . . . 265.74000000000001 110.942 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.05 -32.77 64.05 Favored 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 121.928 1.752 . . . . 66.310000000000002 112.78 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 11.0 tp -62.41 -45.51 92.81 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.086 0.47 . . . . 240.78999999999999 111.548 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.494 HG12 ' O ' ' B' ' 214' ' ' LEU . 8.8 p -67.79 -36.48 76.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.756 0.312 . . . . 30.699999999999999 110.412 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 43.6 mt -68.97 -42.98 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 109.423 -0.584 . . . . 112.31999999999999 109.423 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -67.75 -38.34 83.34 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.502 0.668 . . . . 176.28 110.532 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -58.73 -43.65 90.23 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.349 0.595 . . . . 284.73000000000002 110.623 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.95 -33.93 87.16 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 110.407 -1.077 . . . . 23.710000000000001 110.407 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 4.3 tp -61.32 -33.63 73.92 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.528 0.68 . . . . 108.06 111.29 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.59 -38.4 87.41 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.304 0.573 . . . . 37.969999999999999 110.956 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 2.0 mp -58.76 -38.19 77.9 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.151 0.5 . . . . 134.24000000000001 110.206 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 16.4 tp -61.83 -36.69 81.91 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.989 0.423 . . . . 103.12 110.854 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.3 -46.07 86.82 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 109.831 -0.433 . . . . 198.08000000000001 109.831 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 5.9 mp -62.03 -41.38 98.04 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.199 0.523 . . . . 283.69999999999999 110.223 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 6.8 mp -60.23 -38.62 83.97 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.234 0.54 . . . . 103.06 109.772 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -62.53 -42.31 99.43 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.343 0.592 . . . . 213.97999999999999 110.236 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 50.6 mm -62.94 -45.67 98.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.508 0.671 . . . . 160.19 110.378 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.12 -36.87 86.41 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 111.38 -0.688 . . . . 76.299999999999997 111.38 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 5.8 tt -63.13 -46.15 88.62 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.5 0.667 . . . . 167.03999999999999 111.299 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.24 -37.29 80.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.19 0.519 . . . . 155.61000000000001 110.982 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -59.85 -44.1 94.3 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.521 0.677 . . . . 450.22000000000003 109.859 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 51.5 mtt-85 -63.69 -40.73 97.53 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.433 0.635 . . . . 999.99000000000001 110.467 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -88.75 4.79 46.19 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.253 -0.431 . . . . 999.99000000000001 111.777 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -80.5 -91.42 0.05 Allowed 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.744 -0.598 . . . . 999.99000000000001 109.938 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.219 -0.529 0 CA-C-O 118.041 -0.98 . . . . 999.99000000000001 110.37 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.619 -1.392 . . . . 999.99000000000001 109.619 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 34.8 p -137.91 164.55 28.73 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.357 0.599 . . . . 999.99000000000001 110.733 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 20.1 p -103.8 52.33 0.77 Allowed 'General case' 0 C--O 1.238 0.463 0 CA-C-O 122.416 1.103 . . . . 428.22000000000003 110.451 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 28.6 m -70.01 -29.79 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 115.415 -0.811 . . . . 341.68000000000001 110.761 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 12.4 tp -68.88 -32.68 72.51 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.943 0.402 . . . . 417.60000000000002 111.316 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 214' ' ' LEU . . . . . 0.488 ' O ' HG12 ' C' ' 217' ' ' VAL . 1.4 tp -53.19 -57.54 16.18 Favored Pre-proline 0 CA--C 1.551 1.011 0 O-C-N 121.987 -0.445 . . . . 279.05000000000001 110.989 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.73 -33.58 65.34 Favored 'Trans proline' 0 N--CA 1.503 2.053 0 C-N-CA 121.853 1.702 . . . . 82.650000000000006 113.016 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 216' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' C' ' 216' ' ' LEU . 0.2 OUTLIER -62.09 -45.34 93.93 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.087 0.47 . . . . 291.52999999999997 111.362 -178.458 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 217' ' ' VAL . . . . . 0.488 HG12 ' O ' ' C' ' 214' ' ' LEU . 9.0 p -68.48 -36.46 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 O-C-N 122.136 -0.352 . . . . 51.530000000000001 110.447 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 218' ' ' ILE . . . . . 0.441 ' HA ' HD22 ' A' ' 222' ' ' LEU . 50.1 mt -66.05 -44.6 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 O-C-N 121.787 -0.57 . . . . 172.34999999999999 109.496 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -66.71 -40.07 88.28 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.472 0.653 . . . . 320.86000000000001 110.117 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -59.92 -44.04 94.56 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.356 0.598 . . . . 248.21000000000001 110.652 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.32 -33.82 85.92 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 110.409 -1.077 . . . . 14.550000000000001 110.409 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 4.4 tp -59.76 -36.85 77.49 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.452 0.644 . . . . 49.299999999999997 111.13 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.66 -38.64 88.49 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.271 0.558 . . . . 28.030000000000001 110.9 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 1.1 mp -58.93 -39.86 82.89 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.247 0.546 . . . . 136.06 110.044 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 17.0 tp -58.01 -39.52 78.48 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.303 0.573 . . . . 104.95 110.503 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 40.5 t -59.12 -44.23 91.98 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.281 0.562 . . . . 166.55000000000001 110.475 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 8.8 mt -61.03 -43.49 98.82 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.231 0.538 . . . . 300.73000000000002 110.282 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 7.5 mp -67.96 -36.45 80.09 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.122 0.487 . . . . 140.31999999999999 110.66 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -66.11 -42.22 89.5 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.338 0.59 . . . . 213.53 110.782 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 32.2 mm -63.34 -42.23 95.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.642 0.734 . . . . 237.50999999999999 109.797 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -67.12 -33.3 82.87 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 111.54 -0.624 . . . . 55.479999999999997 111.54 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 232' ' ' LEU . . . . . 0.419 ' O ' HD23 ' C' ' 232' ' ' LEU . 5.0 tt -61.0 -46.12 92.04 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.638 0.732 . . . . 135.05000000000001 110.779 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -62.35 -35.93 80.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.901 -0.591 . . . . 79.829999999999998 110.8 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -61.63 -39.06 89.95 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.294 0.569 . . . . 526.85000000000002 110.402 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 5.2 mtt85 -75.26 -34.37 61.36 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.127 0.489 . . . . 940.87 111.349 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -85.66 -13.3 48.99 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.098 0.475 . . . . 507.37 111.225 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -106.43 -29.98 9.38 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.217 0.532 . . . . 999.99000000000001 111.452 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 117.925 -1.036 . . . . 999.99000000000001 110.855 -179.84 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.6 m -163.73 153.04 14.38 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 122.306 -0.526 . . . . 0.0 110.056 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 8.9 t -126.91 26.66 6.11 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.578 0.704 . . . . 0.0 112.208 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 29.5 m -70.47 -33.63 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 121.626 0.727 . . . . 0.0 110.861 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 51.9 mt -69.04 -29.35 67.48 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.2 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.519 ' O ' HG12 ' A' ' 217' ' ' VAL . 1.4 tp -54.22 -57.68 17.16 Favored Pre-proline 0 CA--C 1.551 1.004 0 O-C-N 121.862 -0.524 . . . . 0.0 110.408 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.458 ' HA ' HD12 ' A' ' 218' ' ' ILE . 34.8 Cg_endo -64.05 -33.38 62.4 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 121.958 1.772 . . . . 0.0 112.503 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.83 -45.27 94.56 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.669 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.519 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.1 p -66.09 -36.46 77.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 O-C-N 122.087 -0.383 . . . . 0.0 110.392 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.458 HD12 ' HA ' ' A' ' 215' ' ' PRO . 54.5 mt -63.0 -44.53 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -65.94 -36.78 84.31 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.414 0.626 . . . . 0.0 110.032 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -57.7 -44.44 85.88 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.372 0.606 . . . . 0.0 109.786 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -66.17 -33.87 86.52 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.494 HD22 ' HA ' ' C' ' 218' ' ' ILE . 5.5 tp -59.79 -41.76 91.88 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.662 0.744 . . . . 0.0 110.31 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.7 -38.54 88.22 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.702 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.98 -37.15 76.16 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.378 0.609 . . . . 0.0 109.819 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.417 HD13 HD13 ' B' ' 225' ' ' LEU . 15.9 tp -61.73 -41.33 97.49 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.748 -0.595 . . . . 0.0 110.486 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 4.4 m -56.73 -40.83 76.44 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.215 0.531 . . . . 0.0 110.309 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 12.3 mt -66.11 -41.52 90.46 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.087 0.47 . . . . 0.0 110.121 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 6.7 mp -62.48 -38.53 90.21 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.202 0.525 . . . . 0.0 109.991 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -58.84 -41.82 87.82 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.308 0.575 . . . . 0.0 110.098 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 48.6 mm -63.04 -42.09 95.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 121.593 0.711 . . . . 0.0 109.966 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -63.87 -31.99 82.68 Favored Glycine 0 CA--C 1.535 1.286 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.403 HD23 ' C ' ' A' ' 232' ' ' LEU . 6.8 tt -58.87 -45.76 89.4 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.636 0.731 . . . . 0.0 110.943 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -59.1 -35.91 74.24 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.957 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -59.73 -41.25 90.49 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.46 0.647 . . . . 0.0 110.31 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 55.6 mtt85 -64.32 -20.46 66.1 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.089 0.471 . . . . 0.0 111.391 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -85.76 -11.77 52.72 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.962 -0.461 . . . . 0.0 111.553 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -80.47 -48.54 12.66 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.799 0.809 . . . . 0.0 110.479 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.58 179.873 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 3.0 m 53.47 99.49 0.01 OUTLIER 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.287 0.565 . . . . 0.0 110.989 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 7.2 t -127.27 41.23 3.56 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 122.24 1.019 . . . . 0.0 110.819 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 34.7 m -70.33 -37.92 72.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.0 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 5.9 tt -69.42 -36.27 76.53 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.451 ' O ' HG12 ' B' ' 217' ' ' VAL . 0.4 OUTLIER -52.41 -57.5 15.28 Favored Pre-proline 0 CA--C 1.552 1.026 0 O-C-N 121.604 -0.685 . . . . 0.0 111.761 -177.408 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 0.449 ' HA ' HD12 ' B' ' 218' ' ' ILE . 19.8 Cg_exo -63.46 -31.83 71.59 Favored 'Trans proline' 0 N--CA 1.503 2.083 0 C-N-CA 121.599 1.533 . . . . 0.0 112.942 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 216' ' ' LEU . . . . . 0.51 HD13 ' O ' ' B' ' 216' ' ' LEU . 0.3 OUTLIER -62.86 -45.38 92.82 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.081 0.467 . . . . 0.0 111.458 -178.5 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.451 HG12 ' O ' ' B' ' 214' ' ' LEU . 8.0 p -69.29 -36.47 72.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 O-C-N 122.179 -0.326 . . . . 0.0 110.187 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 218' ' ' ILE . . . . . 0.449 HD12 ' HA ' ' B' ' 215' ' ' PRO . 68.9 mt -63.01 -42.99 98.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -60.55 -36.77 79.25 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.509 0.671 . . . . 0.0 110.183 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -57.78 -43.59 85.68 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.336 0.589 . . . . 0.0 110.774 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.23 -33.92 88.57 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 6.6 tp -62.45 -37.11 84.62 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.515 0.674 . . . . 0.0 111.061 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.63 88.3 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.177 0.513 . . . . 0.0 110.877 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 7.2 mp -60.47 -45.27 94.34 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.127 0.489 . . . . 0.0 110.451 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 225' ' ' LEU . . . . . 0.417 HD13 HD13 ' A' ' 225' ' ' LEU . 21.6 tp -63.42 -38.56 91.62 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.337 0.589 . . . . 0.0 109.993 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.39 -45.42 84.52 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.324 0.583 . . . . 0.0 110.291 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 227' ' ' LEU . . . . . 0.427 HD23 ' O ' ' B' ' 227' ' ' LEU . 3.1 tt -60.63 -46.14 91.42 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.411 0.624 . . . . 0.0 110.153 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 7.3 mp -63.0 -37.63 87.93 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.196 0.522 . . . . 0.0 110.4 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -63.44 -42.2 98.67 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.154 0.502 . . . . 0.0 110.274 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 39.5 mm -67.41 -42.76 87.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 121.592 0.71 . . . . 0.0 109.761 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -67.2 -33.1 81.87 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 4.3 tt -58.69 -45.96 88.31 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.599 0.714 . . . . 0.0 111.002 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -61.06 -43.57 98.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.311 0.576 . . . . 0.0 110.942 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -60.0 -44.63 94.4 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.511 0.672 . . . . 0.0 110.142 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -68.09 -37.5 81.28 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.363 0.601 . . . . 0.0 110.941 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -86.69 5.02 38.14 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -119.1 39.53 3.53 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.931 0.872 . . . . 0.0 110.544 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.623 179.619 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 5.8 t -124.22 -36.25 2.7 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.282 0.563 . . . . 0.0 110.904 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 6.5 t -95.75 47.28 1.1 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 122.255 1.026 . . . . 0.0 110.208 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 13.9 p -70.28 -32.63 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.963 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 13.3 tp -67.11 -39.98 86.8 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 214' ' ' LEU . . . . . 0.567 ' CD2' HD11 ' C' ' 218' ' ' ILE . 1.3 tt -50.37 -57.02 14.31 Favored Pre-proline 0 CA--C 1.552 1.055 0 O-C-N 121.938 -0.476 . . . . 0.0 111.623 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.8 -33.68 64.13 Favored 'Trans proline' 0 N--CA 1.503 2.065 0 C-N-CA 121.841 1.694 . . . . 0.0 113.186 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 216' ' ' LEU . . . . . 0.506 HD13 ' O ' ' C' ' 216' ' ' LEU . 0.3 OUTLIER -61.71 -45.41 94.09 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.065 0.46 . . . . 0.0 111.499 -178.442 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 217' ' ' VAL . . . . . 0.482 HG12 ' O ' ' C' ' 214' ' ' LEU . 7.4 p -67.32 -36.44 76.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 120.848 0.356 . . . . 0.0 110.377 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 218' ' ' ILE . . . . . 0.567 HD11 ' CD2' ' C' ' 214' ' ' LEU . 47.9 mt -68.22 -42.62 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 121.358 0.599 . . . . 0.0 109.512 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -64.06 -42.1 97.12 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.496 0.665 . . . . 0.0 110.399 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -60.15 -43.53 95.66 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.524 0.678 . . . . 0.0 110.357 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.45 -33.7 87.94 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 10.2 tp -58.96 -40.81 85.86 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.24 0.543 . . . . 0.0 110.657 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.77 -43.58 98.57 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.544 0.688 . . . . 0.0 109.686 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 1.5 tt -64.74 -39.06 92.99 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.832 0.825 . . . . 0.0 109.326 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 4.7 tt -57.94 -44.16 86.78 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.457 0.646 . . . . 0.0 110.155 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 8.2 t -59.37 -43.26 92.88 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.33 0.586 . . . . 0.0 110.824 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 10.1 mt -66.53 -42.69 86.83 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.296 0.57 . . . . 0.0 110.232 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 10.7 tp -66.63 -34.82 78.73 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.092 0.472 . . . . 0.0 110.681 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -66.48 -42.13 87.95 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.413 0.625 . . . . 0.0 110.02 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 88.3 mt -63.25 -36.3 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 121.307 0.575 . . . . 0.0 110.079 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.81 -32.19 61.73 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 232' ' ' LEU . . . . . 0.527 ' C ' HD13 ' C' ' 232' ' ' LEU . 3.1 tm? -58.46 -40.61 83.16 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.625 0.726 . . . . 0.0 110.273 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.99 -39.2 77.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.052 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -60.29 -48.07 83.31 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.364 0.602 . . . . 0.0 110.679 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 35.6 mmt-85 -72.27 -26.68 62.08 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.097 0.475 . . . . 0.0 111.597 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -85.82 -11.31 53.74 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.973 0.416 . . . . 0.0 111.447 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 57.01 88.13 0.05 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.826 0.822 . . . . 0.0 110.512 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.519 -179.942 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.466 HG22 ' N ' ' A' ' 211' ' ' THR . 17.8 m -133.73 162.98 30.48 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.315 0.578 . . . . 0.0 110.399 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.466 ' N ' HG22 ' A' ' 210' ' ' THR . 22.1 p -86.19 54.36 3.12 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 122.292 1.044 . . . . 0.0 110.926 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.13 -31.32 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.875 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 13.5 tp -69.08 -34.4 75.07 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.828 0.347 . . . . 0.0 111.419 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.54 ' O ' HG12 ' A' ' 217' ' ' VAL . 10.3 tp -51.24 -56.85 16.78 Favored Pre-proline 0 CA--C 1.551 1.012 0 CA-C-O 119.065 -0.493 . . . . 0.0 111.212 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.536 ' HA ' HD12 ' A' ' 218' ' ' ILE . 35.7 Cg_endo -64.03 -38.82 35.23 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 121.614 1.543 . . . . 0.0 112.79 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.4 tp -56.88 -45.44 82.53 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.4 p -63.95 -35.97 75.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 122.23 -0.294 . . . . 0.0 110.227 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 215' ' ' PRO . 58.2 mt -62.66 -45.13 99.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 O-C-N 121.755 -0.591 . . . . 0.0 109.443 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -60.16 -46.93 88.0 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.767 0.794 . . . . 0.0 110.04 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -59.08 -44.16 91.86 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.042 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.441 ' HA3' HD11 ' B' ' 222' ' ' LEU . . . -60.3 -33.98 82.85 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 4.6 tp -61.67 -42.5 99.0 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.44 0.638 . . . . 0.0 110.694 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.82 89.47 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.223 0.535 . . . . 0.0 110.447 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.6 tt -59.68 -48.64 80.87 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.312 0.577 . . . . 0.0 109.705 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.457 HD13 HD13 ' C' ' 225' ' ' LEU . 23.6 tp -61.12 -41.27 96.39 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.443 0.64 . . . . 0.0 109.743 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 47.8 t -58.81 -47.08 86.05 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.251 0.548 . . . . 0.0 109.732 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 21.0 tp -63.62 -42.2 98.2 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.235 0.54 . . . . 0.0 110.103 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 2.6 tp -61.98 -34.95 77.09 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.26 0.552 . . . . 0.0 109.924 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -58.93 -37.72 77.35 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.245 0.545 . . . . 0.0 110.216 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.6 mp -62.95 -42.32 96.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.536 0.684 . . . . 0.0 109.246 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -63.31 -31.88 82.26 Favored Glycine 0 CA--C 1.535 1.312 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.407 ' O ' HD23 ' A' ' 232' ' ' LEU . 4.9 tt -58.32 -44.23 88.56 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.723 0.773 . . . . 0.0 110.511 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.79 -40.55 80.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.792 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -62.77 -45.72 91.34 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.524 0.678 . . . . 0.0 110.223 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -63.28 -32.76 74.26 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.277 0.561 . . . . 0.0 111.165 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -85.86 0.58 52.69 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 122.112 -0.368 . . . . 0.0 111.914 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -64.26 -27.54 69.11 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.763 -0.585 . . . . 0.0 111.116 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.451 179.986 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 7.6 t -71.01 172.65 8.7 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.424 0.631 . . . . 0.0 111.001 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 9.6 p -131.04 50.0 2.27 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 122.212 1.006 . . . . 0.0 110.398 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 12.5 p -70.13 -28.99 38.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.567 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 13.0 tp -67.22 -38.31 85.06 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.934 0.397 . . . . 0.0 111.544 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.499 ' O ' HG12 ' B' ' 217' ' ' VAL . 0.2 OUTLIER -50.56 -57.3 13.66 Favored Pre-proline 0 CA--C 1.552 1.046 0 O-C-N 121.961 -0.462 . . . . 0.0 111.437 -179.1 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.75 -33.93 63.75 Favored 'Trans proline' 0 N--CA 1.504 2.108 0 C-N-CA 121.783 1.655 . . . . 0.0 113.018 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 9.4 tp -62.43 -45.48 92.92 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.997 0.427 . . . . 0.0 111.699 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.499 HG12 ' O ' ' B' ' 214' ' ' LEU . 7.8 p -66.29 -36.47 77.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 120.669 0.271 . . . . 0.0 110.552 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 218' ' ' ILE . . . . . 0.467 ' HA ' HD22 ' C' ' 222' ' ' LEU . 53.4 mt -65.19 -43.96 95.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -68.87 -36.92 78.68 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.62 0.724 . . . . 0.0 109.93 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -58.46 -42.64 87.9 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.27 0.557 . . . . 0.0 110.828 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.11 -34.13 82.57 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 222' ' ' LEU . . . . . 0.441 HD11 ' HA3' ' A' ' 221' ' ' GLY . 0.3 OUTLIER -60.63 -23.82 65.05 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.307 0.575 . . . . 0.0 110.967 179.403 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.46 -38.55 87.64 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.189 0.518 . . . . 0.0 110.569 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 224' ' ' LEU . . . . . 0.475 HD23 ' CG ' ' C' ' 229' ' ' PHE . 4.8 mp -59.01 -39.34 81.58 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.137 0.494 . . . . 0.0 110.471 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 225' ' ' LEU . . . . . 0.443 HD13 HD13 ' A' ' 225' ' ' LEU . 47.2 tp -65.98 -33.92 76.92 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.029 0.442 . . . . 0.0 110.548 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 71.4 m -58.52 -43.8 89.28 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.999 0.428 . . . . 0.0 110.115 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -60.75 -43.1 98.41 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.452 0.644 . . . . 0.0 109.771 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 7.4 mp -64.52 -38.18 90.1 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.238 0.542 . . . . 0.0 110.318 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -61.6 -42.22 98.57 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.398 0.618 . . . . 0.0 110.164 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 43.4 mm -66.35 -42.98 91.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 121.605 0.717 . . . . 0.0 109.873 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -66.31 -31.99 80.67 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 9.2 tt -58.46 -39.28 79.46 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.537 0.684 . . . . 0.0 110.962 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.4 -36.75 79.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.383 0.611 . . . . 0.0 110.866 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -60.26 -46.98 87.92 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.43 0.633 . . . . 0.0 110.794 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -70.71 -32.22 69.35 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.395 0.617 . . . . 0.0 111.555 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -85.58 -10.37 55.98 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.431 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -99.83 -38.18 8.76 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.7 -0.625 . . . . 0.0 111.195 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.556 -179.867 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 10.6 m -62.64 -58.87 5.99 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 122.291 -0.534 . . . . 0.0 110.565 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 5.6 p -152.88 33.93 0.48 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.983 0.897 . . . . 0.0 111.211 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 11.7 p -70.37 -39.31 76.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 121.762 0.791 . . . . 0.0 110.424 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 9.1 tt -67.27 -38.72 85.54 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.824 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 214' ' ' LEU . . . . . 0.553 ' O ' HG12 ' C' ' 217' ' ' VAL . 0.8 OUTLIER -46.52 -57.5 8.57 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-O 118.986 -0.531 . . . . 0.0 111.713 -178.75 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.01 -40.04 29.29 Favored 'Trans proline' 0 N--CA 1.505 2.171 0 C-N-CA 121.883 1.722 . . . . 0.0 113.5 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 7.3 tp -57.14 -45.19 83.76 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.006 0.431 . . . . 0.0 111.919 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 217' ' ' VAL . . . . . 0.553 HG12 ' O ' ' C' ' 214' ' ' LEU . 8.3 p -63.72 -36.35 76.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 O-C-N 122.187 -0.32 . . . . 0.0 111.03 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 19.4 mm -62.96 -45.07 99.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -67.4 -36.98 82.37 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.568 0.699 . . . . 0.0 109.721 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -58.16 -44.37 87.89 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.287 0.565 . . . . 0.0 110.407 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.72 -33.89 88.46 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 222' ' ' LEU . . . . . 0.467 HD22 ' HA ' ' B' ' 218' ' ' ILE . 6.6 tp -60.7 -41.56 95.44 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.443 0.639 . . . . 0.0 110.694 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.89 -38.72 89.39 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.326 0.584 . . . . 0.0 110.571 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 1.2 tp -58.79 -40.75 84.96 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.353 0.597 . . . . 0.0 109.997 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 225' ' ' LEU . . . . . 0.457 HD13 HD13 ' A' ' 225' ' ' LEU . 20.4 tp -58.28 -39.53 79.5 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.233 0.539 . . . . 0.0 110.448 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 49.8 m -57.64 -45.96 84.78 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.269 0.557 . . . . 0.0 110.703 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 26.5 tp -63.63 -42.08 98.21 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.236 0.541 . . . . 0.0 110.359 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 7.4 mp -66.22 -36.99 84.46 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.043 0.449 . . . . 0.0 110.771 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 229' ' ' PHE . . . . . 0.475 ' CG ' HD23 ' B' ' 224' ' ' LEU . 30.1 t80 -70.51 -42.45 71.29 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.089 0.471 . . . . 0.0 111.355 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 37.9 mm -67.8 -41.16 84.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 121.575 0.702 . . . . 0.0 109.874 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -64.24 -33.0 86.06 Favored Glycine 0 CA--C 1.533 1.201 0 N-CA-C 111.634 -0.587 . . . . 0.0 111.634 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 232' ' ' LEU . . . . . 0.454 ' O ' HD23 ' C' ' 232' ' ' LEU . 4.1 tt -59.44 -46.02 89.94 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.704 0.764 . . . . 0.0 110.632 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -69.49 -35.79 75.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.158 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -59.85 -48.09 83.08 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.303 0.573 . . . . 0.0 110.868 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -72.03 -40.35 68.47 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.524 0.678 . . . . 0.0 111.299 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -85.91 5.14 34.34 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.132 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -172.91 93.07 0.11 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.625 0.726 . . . . 0.0 109.939 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 117.958 -1.02 . . . . 0.0 111.092 -179.451 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.497 HG23 HG13 ' A' ' 212' ' ' VAL . 6.5 t -145.93 171.89 14.16 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.356 0.598 . . . . 0.0 110.908 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.414 ' O ' HG23 ' A' ' 211' ' ' THR . 9.5 t -78.18 61.32 2.66 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.329 1.061 . . . . 0.0 110.834 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.497 HG13 HG23 ' A' ' 210' ' ' THR . 28.3 m -57.85 -25.23 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.455 179.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 12.8 tp -69.07 -32.29 71.64 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.883 0.373 . . . . 0.0 110.98 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.471 ' O ' HG12 ' A' ' 217' ' ' VAL . 0.2 OUTLIER -51.77 -57.68 13.84 Favored Pre-proline 0 CA--C 1.55 0.972 0 O-C-N 121.985 -0.447 . . . . 0.0 111.35 -179.272 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.64 -31.35 70.05 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 121.962 1.775 . . . . 0.0 113.433 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.471 HD23 ' O ' ' A' ' 216' ' ' LEU . 3.9 tt -64.03 -45.59 88.23 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.277 0.56 . . . . 0.0 111.151 -178.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.6 p -67.91 -36.65 76.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 120.784 0.326 . . . . 0.0 110.434 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.425 HD11 HD12 ' A' ' 214' ' ' LEU . 47.1 mt -69.46 -41.72 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -63.57 -36.86 85.19 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.325 0.583 . . . . 0.0 110.119 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -57.57 -44.61 85.43 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.259 0.552 . . . . 0.0 110.126 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.445 ' HA3' HD11 ' B' ' 222' ' ' LEU . . . -67.78 -33.95 81.58 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 7.7 tp -60.29 -35.02 74.61 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.33 0.586 . . . . 0.0 111.039 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.74 89.16 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.213 0.53 . . . . 0.0 110.891 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 48.8 mt -59.04 -39.56 82.36 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.274 0.559 . . . . 0.0 110.638 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 18.1 tp -58.95 -38.65 79.53 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.322 0.582 . . . . 0.0 110.5 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 7.5 t -59.89 -43.41 94.79 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.418 0.627 . . . . 0.0 110.646 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -63.04 -42.44 99.75 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.427 0.632 . . . . 0.0 110.693 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.6 mp -71.08 -35.25 71.79 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.07 0.462 . . . . 0.0 111.225 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -70.13 -42.43 72.61 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.253 0.549 . . . . 0.0 111.618 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 7.3 tp -69.15 -36.37 72.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.617 0.722 . . . . 0.0 111.166 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.82 -31.92 61.8 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 5.1 tt -59.93 -46.04 90.64 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.725 0.774 . . . . 0.0 110.659 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -64.96 -39.5 93.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.74 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -61.91 -47.49 84.72 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.524 0.678 . . . . 0.0 110.339 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.16 -31.89 73.3 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.241 0.543 . . . . 0.0 111.148 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -85.85 -1.1 56.93 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 122.172 -0.33 . . . . 0.0 111.878 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -121.05 65.66 0.86 Allowed 'General case' 0 C--O 1.239 0.511 0 CA-C-O 122.24 1.019 . . . . 0.0 110.055 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.728 -179.892 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.401 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 39.9 p -65.1 -39.7 93.51 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.476 0.655 . . . . 0.0 110.669 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 41.9 p 46.57 54.32 8.89 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 122.384 1.088 . . . . 0.0 111.077 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 13.2 p -70.11 -33.08 53.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.626 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 12.7 tp -68.82 -31.6 70.7 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.674 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.477 ' O ' HG12 ' B' ' 217' ' ' VAL . 0.1 OUTLIER -53.29 -57.72 15.57 Favored Pre-proline 0 CA--C 1.552 1.054 0 O-C-N 122.007 -0.433 . . . . 0.0 110.913 -179.218 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.88 -32.9 65.8 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 121.85 1.7 . . . . 0.0 113.025 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 9.5 tp -62.56 -45.37 93.26 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.099 0.476 . . . . 0.0 111.491 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.477 HG12 ' O ' ' B' ' 214' ' ' LEU . 8.3 p -67.96 -36.58 76.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 122.248 -0.283 . . . . 0.0 110.285 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 53.5 mt -66.62 -44.14 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -65.13 -37.33 87.09 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.435 0.636 . . . . 0.0 110.299 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.96 -36.6 72.79 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.163 0.506 . . . . 0.0 110.447 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 221' ' ' GLY . . . . . 0.483 ' HA3' HD11 ' C' ' 222' ' ' LEU . . . -65.6 -33.85 87.38 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 222' ' ' LEU . . . . . 0.445 HD11 ' HA3' ' A' ' 221' ' ' GLY . 7.3 tp -58.96 -39.66 82.37 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.387 0.613 . . . . 0.0 110.855 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.84 89.52 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.288 0.566 . . . . 0.0 110.825 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 7.8 mp -62.01 -38.23 87.86 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.24 0.543 . . . . 0.0 110.627 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 16.3 tp -61.28 -40.59 94.68 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.296 0.57 . . . . 0.0 110.391 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 28.3 p -57.98 -45.89 86.04 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.263 0.554 . . . . 0.0 110.213 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 17.6 tp -64.48 -42.21 96.02 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.385 0.612 . . . . 0.0 110.066 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 49.6 mt -63.45 -34.85 78.66 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.246 0.546 . . . . 0.0 110.649 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -65.03 -42.06 94.71 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.476 0.655 . . . . 0.0 110.373 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 43.1 mm -63.33 -43.47 98.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 121.624 0.726 . . . . 0.0 110.033 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -67.0 -33.42 83.79 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 5.8 tt -60.58 -45.95 92.03 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.565 0.698 . . . . 0.0 111.091 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.95 -38.85 92.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.296 0.569 . . . . 0.0 110.877 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -61.6 -47.31 86.03 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.459 0.647 . . . . 0.0 110.28 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -65.56 -39.19 91.4 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.428 0.632 . . . . 0.0 110.796 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -86.83 5.03 38.7 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.846 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -163.94 87.21 0.5 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.786 0.803 . . . . 0.0 110.348 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 50.8 ptt85 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.787 -179.84 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 43.2 p -94.28 121.99 36.37 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.416 0.627 . . . . 0.0 110.505 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 211' ' ' THR . . . . . 0.401 HG22 ' HB2' ' C' ' 214' ' ' LEU . 0.2 OUTLIER -122.28 57.2 1.08 Allowed 'General case' 0 C--O 1.238 0.492 0 CA-C-O 122.356 1.074 . . . . 0.0 110.099 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 41.5 t -64.98 -26.47 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.139 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.32 -34.59 74.89 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.99 0.424 . . . . 0.0 110.953 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 214' ' ' LEU . . . . . 0.493 ' O ' HG12 ' C' ' 217' ' ' VAL . 13.6 tp -47.12 -57.01 10.24 Favored Pre-proline 0 CA--C 1.553 1.078 0 CA-C-O 118.892 -0.575 . . . . 0.0 111.975 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 215' ' ' PRO . . . . . 0.463 ' HA ' HD12 ' C' ' 218' ' ' ILE . 36.6 Cg_endo -63.38 -34.77 65.03 Favored 'Trans proline' 0 N--CA 1.505 2.172 0 C-N-CA 121.857 1.705 . . . . 0.0 113.401 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 216' ' ' LEU . . . . . 0.416 HD23 ' O ' ' C' ' 216' ' ' LEU . 3.3 tt -61.45 -45.6 93.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.072 0.463 . . . . 0.0 111.341 -178.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 217' ' ' VAL . . . . . 0.493 HG12 ' O ' ' C' ' 214' ' ' LEU . 7.1 p -66.34 -36.6 77.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 O-C-N 122.111 -0.368 . . . . 0.0 110.498 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 218' ' ' ILE . . . . . 0.463 HD12 ' HA ' ' C' ' 215' ' ' PRO . 62.1 mt -62.95 -39.65 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -59.41 -43.45 93.01 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.359 0.599 . . . . 0.0 110.509 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -58.38 -44.03 88.73 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.06 0.457 . . . . 0.0 110.599 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.81 -33.85 88.36 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 222' ' ' LEU . . . . . 0.483 HD11 ' HA3' ' B' ' 221' ' ' GLY . 6.0 tp -59.21 -40.09 84.71 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.47 0.653 . . . . 0.0 110.871 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.7 -38.91 89.59 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.237 0.541 . . . . 0.0 110.833 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 7.5 mp -61.74 -41.32 97.49 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.258 0.552 . . . . 0.0 110.436 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 15.2 tp -60.54 -41.06 93.71 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.363 0.601 . . . . 0.0 110.328 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 38.9 t -60.35 -40.35 90.4 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.282 0.563 . . . . 0.0 110.643 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 12.2 mt -66.54 -41.11 89.2 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.357 0.599 . . . . 0.0 110.706 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 7.1 mp -71.13 -35.06 71.59 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.223 0.535 . . . . 0.0 110.941 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -63.6 -42.89 98.21 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.098 0.475 . . . . 0.0 111.869 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 40.1 pt -69.28 -35.43 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-O 121.514 0.673 . . . . 0.0 110.738 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.83 -31.97 61.56 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 110.559 -1.017 . . . . 0.0 110.559 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 232' ' ' LEU . . . . . 0.454 ' O ' HD23 ' C' ' 232' ' ' LEU . 3.8 tt -56.93 -39.34 74.33 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-O 121.692 0.758 . . . . 0.0 110.165 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.89 -44.01 86.45 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.395 0.617 . . . . 0.0 110.594 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -65.39 -43.42 90.72 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.387 0.613 . . . . 0.0 110.49 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 6.5 mmt85 -65.36 -25.04 67.4 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.115 0.483 . . . . 0.0 111.54 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -85.94 5.11 34.57 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.968 -0.458 . . . . 0.0 111.975 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -52.29 -35.65 50.9 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.479 0.657 . . . . 0.0 111.152 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 14.7 ttt85 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 117.934 -1.031 . . . . 0.0 110.711 179.734 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 8.6 p -139.9 165.33 27.6 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.325 0.583 . . . . 0.0 110.587 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 39.6 p -109.09 45.52 1.04 Allowed 'General case' 0 C--O 1.236 0.381 0 CA-C-O 122.545 1.164 . . . . 0.0 110.185 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 13.1 p -70.14 -34.09 57.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.759 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.579 HD13 ' O ' ' A' ' 213' ' ' LEU . 0.3 OUTLIER -63.66 -40.11 96.03 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.978 -179.24 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.49 ' O ' HG12 ' A' ' 217' ' ' VAL . 3.1 tp -51.49 -57.36 14.62 Favored Pre-proline 0 CA--C 1.553 1.067 0 O-C-N 121.74 -0.6 . . . . 0.0 111.332 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.09 -32.68 63.76 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 121.816 1.678 . . . . 0.0 112.79 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.1 tt -62.3 -45.46 93.15 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.955 0.407 . . . . 0.0 111.317 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 214' ' ' LEU . 8.0 p -67.76 -36.53 76.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 O-C-N 122.243 -0.286 . . . . 0.0 110.385 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 43.7 mt -69.3 -43.41 81.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-O 121.404 0.621 . . . . 0.0 109.333 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -65.41 -37.02 85.7 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.397 0.618 . . . . 0.0 110.688 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.79 -38.44 75.48 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.653 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.484 ' HA3' HD11 ' B' ' 222' ' ' LEU . . . -65.31 -33.87 87.9 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.451 HD11 ' HA3' ' C' ' 221' ' ' GLY . 3.8 tp -59.28 -45.35 91.49 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.704 0.764 . . . . 0.0 109.677 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.87 -38.34 87.92 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.644 0.735 . . . . 0.0 110.072 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.473 HD21 ' CE2' ' B' ' 229' ' ' PHE . 4.6 tp -58.67 -40.39 83.39 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.25 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 22.8 tp -59.09 -37.42 77.08 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.955 0.407 . . . . 0.0 110.582 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 17.5 m -56.99 -41.88 79.24 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.413 0.625 . . . . 0.0 110.149 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.438 ' O ' HG22 ' A' ' 230' ' ' ILE . 7.0 mp -64.47 -39.9 94.68 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.397 0.618 . . . . 0.0 110.43 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 61.5 mt -71.37 -34.55 70.54 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.215 0.531 . . . . 0.0 111.439 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -59.93 -42.47 94.03 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 227' ' ' LEU . 7.5 tp -65.08 -35.93 76.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.608 0.718 . . . . 0.0 110.996 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -62.41 -31.9 81.11 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.413 ' C ' HD23 ' A' ' 232' ' ' LEU . 8.1 tt -57.12 -43.08 82.0 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.74 0.781 . . . . 0.0 110.479 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -69.35 -35.91 76.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.096 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -59.87 -48.18 82.72 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.045 0.45 . . . . 0.0 111.22 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.63 -36.87 85.64 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.327 0.584 . . . . 0.0 111.115 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -90.16 5.14 48.2 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 120.886 0.374 . . . . 0.0 111.768 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 56.96 24.0 8.93 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 121.575 -0.703 . . . . 0.0 111.408 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 50.9 ttt-85 . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 117.864 -1.065 . . . . 0.0 110.598 179.65 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 210' ' ' THR . . . . . 0.587 HG22 HG22 ' B' ' 212' ' ' VAL . 7.3 m 54.57 98.63 0.01 OUTLIER 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.301 0.572 . . . . 0.0 110.647 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 10.1 p -105.14 36.24 2.55 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 122.21 1.005 . . . . 0.0 110.907 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 212' ' ' VAL . . . . . 0.587 HG22 HG22 ' B' ' 210' ' ' THR . 34.4 m -70.23 -32.68 51.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.918 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 13.4 tp -66.12 -32.59 74.14 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.059 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.526 ' O ' HG12 ' B' ' 217' ' ' VAL . 0.2 OUTLIER -54.99 -58.01 16.77 Favored Pre-proline 0 CA--C 1.55 0.945 0 O-C-N 121.817 -0.552 . . . . 0.0 110.401 -179.24 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 0.405 ' HA ' HD12 ' B' ' 218' ' ' ILE . 31.2 Cg_endo -64.5 -34.0 54.82 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 121.765 1.644 . . . . 0.0 112.178 178.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 216' ' ' LEU . . . . . 0.461 HD13 ' O ' ' B' ' 216' ' ' LEU . 0.2 OUTLIER -61.16 -45.26 95.35 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.631 -178.362 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.526 HG12 ' O ' ' B' ' 214' ' ' LEU . 9.6 p -66.39 -36.43 77.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 122.114 -0.366 . . . . 0.0 110.302 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 218' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' B' ' 215' ' ' PRO . 36.8 mt -66.48 -45.21 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -64.44 -36.7 85.04 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.506 0.669 . . . . 0.0 110.121 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -57.63 -44.58 85.65 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.259 0.552 . . . . 0.0 110.51 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.65 -35.11 91.61 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 222' ' ' LEU . . . . . 0.484 HD11 ' HA3' ' A' ' 221' ' ' GLY . 7.2 tp -58.85 -43.99 90.91 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.549 0.69 . . . . 0.0 110.284 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.57 88.37 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.403 0.621 . . . . 0.0 110.605 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 1.4 tp -58.94 -40.61 85.17 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.274 0.559 . . . . 0.0 109.989 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 18.8 tp -58.68 -37.22 75.57 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.173 0.511 . . . . 0.0 110.695 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 11.1 p -56.93 -38.92 73.57 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.294 0.569 . . . . 0.0 110.629 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 227' ' ' LEU . . . . . 0.68 ' O ' HG22 ' B' ' 230' ' ' ILE . 1.5 tt -58.02 -48.26 80.6 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.375 0.607 . . . . 0.0 110.453 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 8.4 mp -71.7 -36.74 70.65 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.286 0.565 . . . . 0.0 110.964 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 229' ' ' PHE . . . . . 0.473 ' CE2' HD21 ' A' ' 224' ' ' LEU . 38.5 t80 -66.4 -37.43 85.23 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.68 HG22 ' O ' ' B' ' 227' ' ' LEU . 7.9 tp -62.83 -35.51 71.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.32 0.581 . . . . 0.0 111.629 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.18 -31.9 63.43 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 232' ' ' LEU . . . . . 0.489 HD23 ' C ' ' B' ' 232' ' ' LEU . 9.4 tt -61.24 -42.03 97.9 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.485 0.659 . . . . 0.0 111.122 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -65.35 -35.9 82.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.144 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -59.83 -47.68 84.73 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.265 0.555 . . . . 0.0 110.43 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 62.8 mtp85 -64.05 -28.92 70.12 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.189 0.519 . . . . 0.0 111.078 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -85.81 -7.78 58.52 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 120.975 0.417 . . . . 0.0 111.602 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 56.55 86.55 0.07 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.82 0.819 . . . . 0.0 110.754 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.678 179.942 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.375 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 16.6 m -164.48 105.23 0.85 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.153 0.501 . . . . 0.0 110.698 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 2.7 m -124.54 33.58 5.21 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 122.225 1.012 . . . . 0.0 111.122 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 27.3 m -70.38 -26.91 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.831 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 16.5 tp -64.76 -39.98 94.52 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.549 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 214' ' ' LEU . . . . . 0.515 ' O ' HG12 ' C' ' 217' ' ' VAL . 1.9 tt -53.23 -57.49 16.45 Favored Pre-proline 0 CA--C 1.551 0.985 0 CA-C-O 119.083 -0.484 . . . . 0.0 111.039 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.14 -34.72 56.35 Favored 'Trans proline' 0 N--CA 1.501 1.957 0 C-N-CA 121.714 1.609 . . . . 0.0 112.748 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 216' ' ' LEU . . . . . 0.464 HD23 ' O ' ' C' ' 216' ' ' LEU . 2.8 tt -62.29 -45.36 93.61 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.55 -178.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 217' ' ' VAL . . . . . 0.515 HG12 ' O ' ' C' ' 214' ' ' LEU . 10.3 p -65.7 -36.37 77.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 O-C-N 122.163 -0.336 . . . . 0.0 110.775 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 53.8 mt -65.66 -44.05 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -67.56 -36.48 81.02 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.585 0.707 . . . . 0.0 110.072 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -57.71 -42.43 83.74 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.011 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 221' ' ' GLY . . . . . 0.451 ' HA3' HD11 ' A' ' 222' ' ' LEU . . . -59.89 -33.89 80.51 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.79 -29.45 66.83 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.206 0.527 . . . . 0.0 110.942 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.79 -38.79 89.39 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.324 0.583 . . . . 0.0 110.656 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 25.4 mt -61.89 -37.51 84.85 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.409 0.623 . . . . 0.0 110.647 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 11.6 tp -59.65 -36.51 76.54 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.078 0.466 . . . . 0.0 110.838 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 15.7 t -58.39 -39.12 78.79 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.329 0.585 . . . . 0.0 110.498 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 227' ' ' LEU . . . . . 0.421 ' O ' HG22 ' C' ' 230' ' ' ILE . 21.3 tp -62.78 -44.49 96.04 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.415 0.626 . . . . 0.0 110.385 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 8.3 mp -71.36 -34.86 70.86 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.477 0.656 . . . . 0.0 111.349 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -62.27 -42.33 99.25 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 230' ' ' ILE . . . . . 0.421 HG22 ' O ' ' C' ' 227' ' ' LEU . 5.5 tp -65.32 -38.53 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.494 0.664 . . . . 0.0 111.211 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.87 -32.79 74.08 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 4.4 tt -58.87 -43.06 90.78 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.551 0.691 . . . . 0.0 110.98 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -60.68 -40.96 94.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.368 0.604 . . . . 0.0 110.581 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -65.63 -43.06 90.68 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.619 0.723 . . . . 0.0 110.402 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.77 -18.06 64.73 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.207 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -85.88 5.09 34.4 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.898 -0.501 . . . . 0.0 111.962 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -111.38 61.39 0.61 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.28 1.038 . . . . 0.0 110.156 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 20.4 mtp-105 . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.872 -179.898 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 8.1 p -71.97 139.58 48.72 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.345 0.593 . . . . 0.0 110.423 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 80.0 p -114.38 57.74 0.7 Allowed 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.338 1.066 . . . . 0.0 110.335 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 26.9 m -66.2 -30.0 48.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.88 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.488 HD23 ' O ' ' A' ' 213' ' ' LEU . 1.2 tt -68.98 -35.64 76.96 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.955 0.407 . . . . 0.0 110.931 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.502 ' O ' HG12 ' A' ' 217' ' ' VAL . 0.9 OUTLIER -48.77 -57.32 11.45 Favored Pre-proline 0 CA--C 1.551 1.015 0 O-C-N 121.829 -0.544 . . . . 0.0 111.299 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.503 ' HA ' HD12 ' A' ' 218' ' ' ILE . 32.7 Cg_endo -63.86 -34.22 61.41 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 121.82 1.68 . . . . 0.0 112.931 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 5.4 tt -61.69 -45.49 93.78 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.959 0.409 . . . . 0.0 111.529 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.3 p -66.08 -36.65 77.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 O-C-N 122.174 -0.329 . . . . 0.0 110.534 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 215' ' ' PRO . 48.9 mt -63.11 -45.13 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -67.48 -36.98 82.2 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.615 0.722 . . . . 0.0 109.799 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -58.86 -42.54 89.65 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.34 0.59 . . . . 0.0 110.692 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -62.74 -33.89 88.12 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.432 HD11 ' HA3' ' C' ' 221' ' ' GLY . 0.3 OUTLIER -62.89 -29.2 70.58 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.194 0.521 . . . . 0.0 111.012 179.598 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -62.15 -38.84 90.53 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.251 0.548 . . . . 0.0 110.674 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.9 mp -63.14 -42.86 99.54 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.289 0.566 . . . . 0.0 110.218 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.623 HD11 HD12 ' C' ' 228' ' ' LEU . 31.8 tp -59.48 -41.17 89.18 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.256 0.55 . . . . 0.0 109.995 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 33.1 m -58.18 -47.18 84.2 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.17 0.509 . . . . 0.0 110.471 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -61.54 -42.11 98.35 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.189 0.519 . . . . 0.0 110.528 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 6.7 mp -66.52 -36.59 83.09 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.158 0.504 . . . . 0.0 110.588 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -66.93 -42.15 85.82 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.321 0.582 . . . . 0.0 110.909 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 27.6 mm -62.81 -41.95 94.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 121.494 0.664 . . . . 0.0 110.002 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -61.14 -32.77 81.67 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 111.706 -0.558 . . . . 0.0 111.706 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 9.5 tt -61.41 -38.31 86.64 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 122.037 -0.684 . . . . 0.0 111.369 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.87 -35.92 82.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.136 0.493 . . . . 0.0 111.255 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -59.87 -41.83 92.38 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.409 0.623 . . . . 0.0 110.389 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -59.94 -24.29 64.26 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.148 0.499 . . . . 0.0 111.243 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -85.74 -10.73 55.12 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.977 0.418 . . . . 0.0 111.442 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -70.71 -30.36 66.9 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.431 0.634 . . . . 0.0 111.169 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.733 -179.913 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 4.5 t -118.64 143.6 46.71 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.493 0.663 . . . . 0.0 110.807 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 41.0 p -138.67 49.19 1.89 Allowed 'General case' 0 C--O 1.238 0.462 0 CA-C-O 122.293 1.044 . . . . 0.0 110.299 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.07 -28.44 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.593 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 213' ' ' LEU . . . . . 0.443 HD23 ' O ' ' B' ' 213' ' ' LEU . 3.5 tt -66.96 -40.79 87.56 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.986 0.422 . . . . 0.0 111.161 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.469 ' O ' HG12 ' B' ' 217' ' ' VAL . 20.2 tp -48.98 -57.54 11.09 Favored Pre-proline 0 CA--C 1.559 1.323 0 O-C-N 121.828 -0.545 . . . . 0.0 111.415 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.23 -29.57 64.32 Favored 'Trans proline' 0 N--CA 1.504 2.09 0 C-N-CA 122.01 1.807 . . . . 0.0 113.05 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 9.5 tp -68.51 -45.08 73.24 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.085 0.469 . . . . 0.0 111.761 -178.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.469 HG12 ' O ' ' B' ' 214' ' ' LEU . 9.8 p -65.81 -36.96 78.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 O-C-N 122.272 -0.268 . . . . 0.0 111.344 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 24.8 pt -71.15 -39.24 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 O-C-N 121.518 -0.739 . . . . 0.0 110.589 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -67.21 -37.09 83.04 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.468 0.652 . . . . 0.0 110.3 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -57.69 -40.4 79.35 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.219 0.533 . . . . 0.0 110.74 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 221' ' ' GLY . . . . . 0.501 ' HA3' HD11 ' C' ' 222' ' ' LEU . . . -65.28 -34.0 88.29 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 7.6 tp -58.95 -39.67 82.39 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.688 0.756 . . . . 0.0 109.88 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.67 -38.19 86.85 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.586 0.708 . . . . 0.0 109.981 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.2 tp -58.46 -41.88 86.18 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.344 0.592 . . . . 0.0 109.914 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 19.3 tp -57.96 -32.36 67.77 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.15 0.5 . . . . 0.0 110.352 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 6.3 m -56.95 -43.2 81.33 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.15 0.5 . . . . 0.0 110.251 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 6.1 mp -59.08 -44.04 91.84 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.212 0.53 . . . . 0.0 110.28 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 7.3 mp -67.06 -39.37 86.88 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.181 0.515 . . . . 0.0 110.535 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -63.6 -42.16 98.26 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.205 0.526 . . . . 0.0 110.804 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 31.1 mm -62.9 -39.02 83.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.474 0.654 . . . . 0.0 109.862 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -58.23 -32.82 68.3 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.91 -33.65 70.8 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.458 0.647 . . . . 0.0 111.589 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.78 -35.97 71.53 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.325 0.584 . . . . 0.0 110.897 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -59.81 -39.67 85.81 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.376 0.608 . . . . 0.0 110.336 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -60.81 -16.08 36.96 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.994 0.425 . . . . 0.0 111.584 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -85.73 -12.5 50.95 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.994 -0.441 . . . . 0.0 111.624 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -107.55 58.76 0.62 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 122.242 1.02 . . . . 0.0 110.278 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.468 179.943 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 15.8 m -101.35 -56.44 2.3 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 122.226 -0.573 . . . . 0.0 111.305 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 14.7 p -108.89 26.36 10.68 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.828 0.823 . . . . 0.0 111.922 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.66 -29.95 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.196 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 9.9 tp -69.08 -33.05 72.92 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.929 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 214' ' ' LEU . . . . . 0.485 ' O ' HG12 ' C' ' 217' ' ' VAL . 3.5 tp -48.98 -57.22 11.96 Favored Pre-proline 0 CA--C 1.551 0.998 0 O-C-N 121.892 -0.505 . . . . 0.0 111.133 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.85 -35.5 55.86 Favored 'Trans proline' 0 N--CA 1.505 2.192 0 C-N-CA 121.736 1.624 . . . . 0.0 113.073 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 216' ' ' LEU . . . . . 0.453 HD23 ' O ' ' C' ' 216' ' ' LEU . 3.6 tt -62.02 -45.53 93.18 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.057 0.456 . . . . 0.0 111.487 -178.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 217' ' ' VAL . . . . . 0.485 HG12 ' O ' ' C' ' 214' ' ' LEU . 9.2 p -66.53 -36.63 77.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 O-C-N 122.087 -0.383 . . . . 0.0 110.63 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 43.3 mt -69.03 -42.35 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -66.55 -38.35 86.94 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.621 0.725 . . . . 0.0 110.276 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -57.93 -39.19 77.4 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.676 0.75 . . . . 0.0 110.378 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 221' ' ' GLY . . . . . 0.432 ' HA3' HD11 ' A' ' 222' ' ' LEU . . . -59.89 -33.41 78.41 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 222' ' ' LEU . . . . . 0.501 HD11 ' HA3' ' B' ' 221' ' ' GLY . 3.6 tp -58.49 -39.44 80.02 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.541 0.686 . . . . 0.0 110.441 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.94 -38.29 87.92 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.503 0.668 . . . . 0.0 110.032 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 3.2 tp -58.66 -40.32 83.15 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.419 0.628 . . . . 0.0 110.072 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 18.7 tp -59.84 -30.86 69.25 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.231 0.538 . . . . 0.0 110.415 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 2.1 t -58.55 -38.97 78.95 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.136 0.493 . . . . 0.0 110.695 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 8.2 mp -61.29 -47.82 84.23 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.398 0.618 . . . . 0.0 111.007 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 228' ' ' LEU . . . . . 0.623 HD12 HD11 ' A' ' 225' ' ' LEU . 14.6 mt -71.21 -35.08 71.38 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.167 0.508 . . . . 0.0 111.252 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -70.74 -42.22 70.81 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.015 0.436 . . . . 0.0 111.808 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 7.6 tp -67.9 -35.93 73.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 121.561 0.696 . . . . 0.0 111.293 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -69.6 -31.82 70.87 Favored Glycine 0 CA--C 1.535 1.312 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 232' ' ' LEU . . . . . 0.483 ' C ' HD23 ' C' ' 232' ' ' LEU . 10.3 tt -60.78 -43.7 97.75 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.442 0.639 . . . . 0.0 110.867 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -67.68 -38.78 84.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.456 0.646 . . . . 0.0 110.763 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -61.58 -47.57 84.91 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.503 0.668 . . . . 0.0 110.378 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 10.1 ttt-85 -66.96 -21.67 65.96 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.313 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -86.23 -8.32 57.87 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 122.097 -0.377 . . . . 0.0 111.731 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -165.91 88.14 0.39 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.974 0.892 . . . . 0.0 111.002 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 . . . . . 0 N--CA 1.469 0.52 0 CA-C-O 117.896 -1.05 . . . . 0.0 111.07 179.79 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 18.4 p 45.69 32.56 1.23 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.47 0.652 . . . . 0.0 111.67 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 15.2 p -80.35 6.83 11.03 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.328 0.585 . . . . 0.0 112.401 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 47.3 t -70.67 -40.09 76.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.704 0.764 . . . . 0.0 109.905 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 10.6 tp -67.84 -29.9 69.16 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.145 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.535 ' O ' HG12 ' A' ' 217' ' ' VAL . 0.7 OUTLIER -54.15 -57.65 17.19 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 121.901 -0.499 . . . . 0.0 110.816 -178.81 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.16 -32.31 63.39 Favored 'Trans proline' 0 N--CA 1.504 2.135 0 C-N-CA 121.759 1.639 . . . . 0.0 112.849 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.9 tt -62.89 -45.44 92.52 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.981 0.419 . . . . 0.0 111.582 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.6 p -65.4 -36.77 78.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 O-C-N 122.25 -0.281 . . . . 0.0 110.68 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 38.4 mm -70.71 -43.51 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-O 121.636 0.732 . . . . 0.0 109.127 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -62.12 -36.5 81.94 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.402 0.62 . . . . 0.0 110.475 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -57.53 -43.8 84.6 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.366 0.603 . . . . 0.0 110.171 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -66.62 -34.34 87.24 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.401 HD11 ' HA3' ' C' ' 221' ' ' GLY . 6.5 tp -61.45 -39.99 92.85 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.55 0.691 . . . . 0.0 110.5 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.66 -38.42 87.67 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.409 0.624 . . . . 0.0 110.417 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.455 ' O ' HD23 ' A' ' 224' ' ' LEU . 1.6 tt -58.62 -37.43 75.88 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.17 0.509 . . . . 0.0 110.083 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 20.9 tp -59.11 -41.6 88.54 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.31 0.576 . . . . 0.0 110.021 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 43.1 t -60.51 -40.79 92.7 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.469 0.652 . . . . 0.0 110.208 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.471 ' O ' HG22 ' A' ' 230' ' ' ILE . 0.8 OUTLIER -61.83 -42.69 99.34 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.397 0.618 . . . . 0.0 110.162 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.416 HD21 ' CD1' ' B' ' 232' ' ' LEU . 1.6 mp -71.35 -34.79 70.81 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.368 0.604 . . . . 0.0 110.949 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -58.96 -42.28 89.53 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 227' ' ' LEU . 7.6 tp -64.55 -36.93 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.603 0.716 . . . . 0.0 111.227 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.42 -31.82 62.92 Favored Glycine 0 CA--C 1.534 1.225 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.497 ' O ' HD23 ' A' ' 232' ' ' LEU . 1.6 tt -57.67 -36.18 71.57 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.549 0.69 . . . . 0.0 110.849 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -61.21 -39.76 91.44 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.32 0.581 . . . . 0.0 111.006 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -61.22 -48.03 83.38 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.407 0.622 . . . . 0.0 111.066 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -72.1 -36.19 69.41 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.399 0.618 . . . . 0.0 111.632 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -85.77 5.44 32.41 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.074 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -151.14 81.76 1.32 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.913 0.863 . . . . 0.0 110.168 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.766 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 3.3 m -130.96 44.81 2.91 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 122.075 0.94 . . . . 0.0 110.319 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 211' ' ' THR . . . . . 0.532 HG22 ' HB2' ' B' ' 214' ' ' LEU . 4.0 m 55.86 35.97 26.42 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 122.205 1.002 . . . . 0.0 110.875 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 35.6 m -70.47 -33.97 55.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.221 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 11.1 tp -64.62 -36.4 84.12 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.537 ' O ' HG12 ' B' ' 217' ' ' VAL . 0.1 OUTLIER -54.41 -57.73 17.23 Favored Pre-proline 0 CA--C 1.55 0.958 0 O-C-N 121.882 -0.511 . . . . 0.0 110.905 -179.056 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -64.07 -32.84 63.77 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 121.872 1.715 . . . . 0.0 112.896 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 8.9 tp -60.72 -45.23 95.03 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.049 0.452 . . . . 0.0 111.754 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.537 HG12 ' O ' ' B' ' 214' ' ' LEU . 7.3 p -65.67 -36.65 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 O-C-N 122.098 -0.376 . . . . 0.0 110.524 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 39.3 mm -65.18 -43.84 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -64.95 -36.59 84.9 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.225 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -57.35 -44.94 84.77 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.345 0.593 . . . . 0.0 109.716 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -67.43 -33.77 82.81 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 178.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 6.0 tp -61.95 -35.38 78.27 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.513 0.673 . . . . 0.0 111.055 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.62 88.27 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.152 0.501 . . . . 0.0 110.971 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 7.9 mp -58.87 -39.17 80.57 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.134 0.492 . . . . 0.0 110.49 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 225' ' ' LEU . . . . . 0.461 HD13 HD13 ' C' ' 225' ' ' LEU . 15.1 tp -61.46 -42.85 99.4 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.296 0.57 . . . . 0.0 110.083 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 58.7 m -60.42 -47.08 87.63 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 121.116 0.484 . . . . 0.0 110.426 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.19 -41.63 97.0 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.314 0.578 . . . . 0.0 110.152 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 7.4 tp -61.73 -34.81 76.46 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.286 0.565 . . . . 0.0 109.806 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -62.31 -36.29 81.67 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.412 0.625 . . . . 0.0 110.321 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 46.2 mm -62.88 -44.91 99.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 121.581 0.705 . . . . 0.0 110.34 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -71.74 -33.36 63.36 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 232' ' ' LEU . . . . . 0.416 ' CD1' HD21 ' A' ' 228' ' ' LEU . 5.1 tt -60.5 -45.77 92.56 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.531 0.681 . . . . 0.0 111.176 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.41 95.48 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.287 0.565 . . . . 0.0 110.726 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -64.05 -45.95 86.52 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.564 0.697 . . . . 0.0 110.126 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -69.39 -30.58 68.6 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.709 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -85.81 -4.1 59.08 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 122.121 -0.362 . . . . 0.0 111.755 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 55.33 87.35 0.05 OUTLIER 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.752 0.787 . . . . 0.0 110.595 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.118 -0.944 . . . . 0.0 110.463 179.962 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 11.3 m -106.82 126.09 51.85 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.511 0.672 . . . . 0.0 110.853 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 9.8 t 40.32 43.01 1.36 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 122.309 1.052 . . . . 0.0 111.96 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 27.5 m -70.25 -35.68 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.019 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 213' ' ' LEU . . . . . 0.506 ' O ' HD23 ' C' ' 213' ' ' LEU . 3.2 tt -66.9 -40.61 87.77 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.114 0.483 . . . . 0.0 111.277 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 214' ' ' LEU . . . . . 0.488 ' O ' HG12 ' C' ' 217' ' ' VAL . 14.0 tp -45.62 -57.25 8.08 Favored Pre-proline 0 CA--C 1.556 1.187 0 CA-C-O 118.962 -0.542 . . . . 0.0 112.038 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 215' ' ' PRO . . . . . 0.424 ' HA ' HD12 ' C' ' 218' ' ' ILE . 37.6 Cg_endo -63.7 -36.85 49.75 Favored 'Trans proline' 0 N--CA 1.506 2.236 0 C-N-CA 121.801 1.667 . . . . 0.0 113.689 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.8 -45.22 94.8 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 122.075 -0.391 . . . . 0.0 111.465 -178.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 217' ' ' VAL . . . . . 0.488 HG12 ' O ' ' C' ' 214' ' ' LEU . 7.9 p -64.98 -36.66 78.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 O-C-N 122.084 -0.385 . . . . 0.0 110.566 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 218' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' C' ' 215' ' ' PRO . 50.8 mt -63.11 -45.16 99.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -65.6 -37.31 86.26 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.492 0.663 . . . . 0.0 109.729 178.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -58.12 -44.33 87.71 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.513 0.673 . . . . 0.0 110.393 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 221' ' ' GLY . . . . . 0.401 ' HA3' HD11 ' A' ' 222' ' ' LEU . . . -65.35 -33.99 88.15 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 4.9 tp -59.78 -43.19 94.49 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.421 0.629 . . . . 0.0 109.97 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.62 88.89 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.367 0.603 . . . . 0.0 110.413 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 1.2 tt -58.9 -40.9 85.88 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.124 0.487 . . . . 0.0 110.357 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 225' ' ' LEU . . . . . 0.461 HD13 HD13 ' B' ' 225' ' ' LEU . 22.7 tp -58.99 -40.48 84.99 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.057 0.456 . . . . 0.0 110.764 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 26.9 p -56.64 -41.04 76.49 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.195 0.521 . . . . 0.0 110.409 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.66 -39.79 91.74 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.267 0.556 . . . . 0.0 110.245 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 6.8 mp -67.22 -38.25 84.94 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.154 0.502 . . . . 0.0 110.484 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -64.92 -42.18 94.92 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.316 0.579 . . . . 0.0 110.619 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 35.4 mm -66.46 -42.16 89.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 121.54 0.686 . . . . 0.0 110.095 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -70.6 -35.94 67.69 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 232' ' ' LEU . . . . . 0.468 ' C ' HD23 ' C' ' 232' ' ' LEU . 8.1 tt -63.79 -46.37 85.48 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 122.043 -0.681 . . . . 0.0 111.13 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -70.26 -35.85 74.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.151 0.501 . . . . 0.0 111.221 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -59.98 -47.91 83.88 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.391 0.615 . . . . 0.0 110.497 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -69.77 -21.25 63.45 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.086 0.47 . . . . 0.0 111.499 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -86.17 -6.17 59.05 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 122.034 -0.416 . . . . 0.0 111.717 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 58.86 88.61 0.07 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.623 0.725 . . . . 0.0 110.408 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 118.119 -0.944 . . . . 0.0 111.135 -179.96 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 26.7 p 46.39 92.59 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.593 0.711 . . . . 0.0 111.242 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 9.0 t -84.23 50.81 1.93 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.374 1.083 . . . . 0.0 111.096 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 23.9 t -69.08 -22.59 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.081 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.564 HD13 ' O ' ' A' ' 213' ' ' LEU . 0.3 OUTLIER -67.26 -36.43 81.58 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.944 0.402 . . . . 0.0 111.09 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.504 ' O ' HG12 ' A' ' 217' ' ' VAL . 0.9 OUTLIER -51.29 -57.35 14.41 Favored Pre-proline 0 CA--C 1.552 1.032 0 O-C-N 121.894 -0.503 . . . . 0.0 111.194 -179.012 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.529 ' HA ' HD12 ' A' ' 218' ' ' ILE . 33.2 Cg_endo -63.76 -31.88 68.31 Favored 'Trans proline' 0 N--CA 1.502 1.993 0 C-N-CA 121.776 1.65 . . . . 0.0 113.039 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 8.9 tp -62.72 -45.38 93.0 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.155 0.502 . . . . 0.0 111.562 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.1 p -66.51 -36.43 77.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 O-C-N 122.226 -0.296 . . . . 0.0 110.371 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 215' ' ' PRO . 51.6 mt -62.8 -44.06 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -67.9 -36.79 80.82 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.345 0.593 . . . . 0.0 109.908 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -57.75 -44.35 86.05 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.288 0.566 . . . . 0.0 110.128 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -67.9 -34.0 81.17 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' C' ' 218' ' ' ILE . 6.2 tp -62.89 -36.07 82.11 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.391 0.615 . . . . 0.0 111.111 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.66 -38.61 88.37 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.226 0.536 . . . . 0.0 111.088 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 19.7 mt -58.95 -44.63 91.47 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.938 0.399 . . . . 0.0 110.74 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.563 ' HB2' HD11 ' B' ' 225' ' ' LEU . 26.0 tp -61.6 -31.76 71.84 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.997 0.427 . . . . 0.0 110.624 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 31.7 t -62.16 -46.41 89.08 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.181 0.515 . . . . 0.0 110.693 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.435 HD12 ' N ' ' A' ' 227' ' ' LEU . 7.7 mp -66.42 -39.6 89.06 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.572 0.701 . . . . 0.0 110.577 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 13.1 tp -71.13 -34.38 70.99 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.148 0.499 . . . . 0.0 111.345 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.434 ' CE1' HD23 ' C' ' 224' ' ' LEU . 27.8 t80 -63.84 -43.22 96.82 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.237 0.541 . . . . 0.0 111.793 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 32.1 pt -69.2 -35.7 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-O 121.417 0.627 . . . . 0.0 110.838 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -59.16 -31.95 70.38 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.8 -32.01 68.96 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.574 0.702 . . . . 0.0 110.581 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.85 -43.5 90.81 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.384 0.612 . . . . 0.0 110.868 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -63.24 -43.67 97.39 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.529 0.681 . . . . 0.0 110.577 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -65.68 -20.75 66.41 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.637 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -85.81 -12.45 50.85 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 122.013 -0.43 . . . . 0.0 111.386 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -118.32 46.82 1.72 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.998 0.904 . . . . 0.0 110.516 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 26.6 ttm105 . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.816 179.952 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 46.5 p -106.46 80.69 1.51 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.895 0.855 . . . . 0.0 110.461 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 25.2 p 46.6 48.05 14.37 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 122.362 1.077 . . . . 0.0 111.157 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 35.9 m -70.03 -34.2 58.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.059 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 14.1 tp -68.67 -29.82 68.37 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.636 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.504 ' O ' HG12 ' B' ' 217' ' ' VAL . 1.0 OUTLIER -55.25 -57.78 18.41 Favored Pre-proline 0 CA--C 1.552 1.035 0 O-C-N 121.976 -0.452 . . . . 0.0 110.812 -179.151 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.04 -32.95 63.93 Favored 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 122.042 1.828 . . . . 0.0 112.889 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.86 -45.22 94.74 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.03 0.443 . . . . 0.0 111.517 -178.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.504 HG12 ' O ' ' B' ' 214' ' ' LEU . 7.4 p -67.58 -36.4 76.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 122.194 -0.316 . . . . 0.0 110.33 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 46.4 mt -67.44 -43.14 87.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -65.87 -38.97 90.22 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.511 0.672 . . . . 0.0 109.847 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -57.88 -43.78 86.24 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.523 0.677 . . . . 0.0 110.199 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.23 -33.7 87.94 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 222' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 218' ' ' ILE . 9.8 tp -58.76 -39.73 81.82 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.293 0.568 . . . . 0.0 110.337 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.71 88.39 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.652 0.739 . . . . 0.0 109.252 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 3.0 tp -59.76 -38.95 83.22 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.77 0.795 . . . . 0.0 109.335 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 225' ' ' LEU . . . . . 0.563 HD11 ' HB2' ' A' ' 225' ' ' LEU . 3.7 tt -59.6 -45.1 92.92 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.617 0.722 . . . . 0.0 110.13 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 45.0 m -60.91 -43.8 98.06 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.389 0.614 . . . . 0.0 110.347 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 11.8 mt -64.36 -41.48 96.7 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.282 0.563 . . . . 0.0 110.23 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 21.6 mt -65.87 -37.97 87.58 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.989 0.423 . . . . 0.0 111.079 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -69.55 -42.36 74.67 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.201 0.524 . . . . 0.0 110.892 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 38.8 mm -67.45 -41.21 85.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.716 0.77 . . . . 0.0 109.655 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -58.45 -31.88 67.46 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.529 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 4.6 tt -58.7 -39.87 82.0 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.512 0.672 . . . . 0.0 110.979 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.09 -37.11 80.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.337 0.589 . . . . 0.0 110.789 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -61.44 -47.85 83.85 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.442 0.639 . . . . 0.0 110.658 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -68.61 -37.36 79.72 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.381 0.61 . . . . 0.0 111.192 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -85.83 -2.6 58.4 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.715 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 50.58 50.75 18.25 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 122.191 0.996 . . . . 0.0 110.732 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.141 -0.933 . . . . 0.0 110.926 -179.992 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 24.1 p -57.14 116.8 3.47 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.409 0.623 . . . . 0.0 110.672 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 40.2 p -143.96 52.13 1.31 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.374 1.083 . . . . 0.0 110.48 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 41.3 t -70.06 -36.0 66.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.14 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 11.2 tp -66.73 -35.7 80.73 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.779 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 214' ' ' LEU . . . . . 0.547 ' O ' HG12 ' C' ' 217' ' ' VAL . 1.0 OUTLIER -50.82 -57.35 13.82 Favored Pre-proline 0 CA--C 1.551 0.988 0 CA-C-O 118.919 -0.562 . . . . 0.0 111.367 -178.692 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.97 -36.68 47.88 Favored 'Trans proline' 0 N--CA 1.505 2.184 0 C-N-CA 121.979 1.786 . . . . 0.0 113.297 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.93 -45.23 93.29 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.893 0.378 . . . . 0.0 111.793 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 217' ' ' VAL . . . . . 0.547 HG12 ' O ' ' C' ' 214' ' ' LEU . 7.6 p -63.84 -36.19 75.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 O-C-N 122.126 -0.359 . . . . 0.0 110.905 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 218' ' ' ILE . . . . . 0.44 ' HA ' HD22 ' A' ' 222' ' ' LEU . 33.1 mm -62.75 -44.97 99.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 O-C-N 121.615 -0.678 . . . . 0.0 109.198 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -68.9 -37.56 79.07 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.636 0.731 . . . . 0.0 110.205 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -59.37 -44.48 92.72 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.392 0.615 . . . . 0.0 110.529 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.29 -33.8 88.21 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 110.454 -1.059 . . . . 0.0 110.454 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 2.4 tp -62.91 -42.57 99.83 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.561 0.696 . . . . 0.0 110.72 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.86 -38.95 90.18 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.347 0.594 . . . . 0.0 110.798 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 224' ' ' LEU . . . . . 0.434 HD23 ' CE1' ' A' ' 229' ' ' PHE . 0.6 OUTLIER -61.8 -42.04 98.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.319 0.581 . . . . 0.0 109.949 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 225' ' ' LEU . . . . . 0.478 HD13 HD13 ' A' ' 225' ' ' LEU . 22.4 tp -61.37 -38.7 87.94 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.31 0.576 . . . . 0.0 110.246 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 37.4 m -58.43 -46.96 85.46 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.205 0.526 . . . . 0.0 110.3 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -62.88 -41.79 99.54 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.216 0.532 . . . . 0.0 110.478 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 228' ' ' LEU . . . . . 0.41 HD13 ' O ' ' C' ' 224' ' ' LEU . 6.6 mp -63.79 -38.31 90.64 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.196 0.522 . . . . 0.0 110.372 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -62.23 -42.22 99.12 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.36 0.6 . . . . 0.0 110.129 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 48.0 mm -68.0 -42.22 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-O 121.621 0.724 . . . . 0.0 109.869 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -65.51 -31.88 81.58 Favored Glycine 0 CA--C 1.533 1.178 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 232' ' ' LEU . . . . . 0.411 ' O ' HD23 ' C' ' 232' ' ' LEU . 4.5 tt -57.26 -45.98 83.48 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.711 0.767 . . . . 0.0 110.733 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -61.64 -38.77 88.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.904 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -63.28 -47.18 83.41 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.47 0.652 . . . . 0.0 110.678 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -68.4 -41.2 80.81 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.283 0.563 . . . . 0.0 111.1 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -88.42 4.96 44.53 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.912 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -175.68 92.2 0.05 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.587 0.708 . . . . 0.0 110.471 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.46 179.754 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.98 160.13 40.5 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 122.288 -0.536 . . . . 0.0 110.148 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 8.1 t -117.1 45.17 1.93 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 122.346 1.069 . . . . 0.0 110.93 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 41.3 t -70.18 -35.69 64.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.439 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 31.7 mt -64.05 -40.58 96.59 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.521 ' O ' HG12 ' A' ' 217' ' ' VAL . 0.8 OUTLIER -49.39 -57.26 12.36 Favored Pre-proline 0 CA--C 1.552 1.035 0 O-C-N 121.924 -0.485 . . . . 0.0 111.638 -178.594 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.56 -36.44 53.7 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 121.805 1.67 . . . . 0.0 113.358 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.441 HD13 ' O ' ' A' ' 216' ' ' LEU . 0.2 OUTLIER -61.34 -45.17 95.55 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.949 0.404 . . . . 0.0 111.74 -178.602 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 214' ' ' LEU . 8.7 p -65.36 -36.48 77.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 O-C-N 122.14 -0.35 . . . . 0.0 110.507 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 59.8 mt -63.46 -44.84 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 O-C-N 121.6 -0.688 . . . . 0.0 109.461 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -63.96 -42.97 97.11 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.642 0.734 . . . . 0.0 109.749 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -58.1 -42.72 86.29 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.67 0.748 . . . . 0.0 110.567 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.1 -33.61 84.79 Favored Glycine 0 CA--C 1.531 1.031 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.437 HD22 ' HA ' ' C' ' 218' ' ' ILE . 8.8 tp -58.51 -41.37 85.28 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.235 0.54 . . . . 0.0 110.094 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.93 -39.01 90.59 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.508 0.671 . . . . 0.0 109.467 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.6 tp -62.42 -43.47 98.73 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.938 0.875 . . . . 0.0 109.55 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.533 HD11 ' HB2' ' C' ' 225' ' ' LEU . 0.9 OUTLIER -59.69 -38.21 80.91 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.357 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 48.0 m -58.95 -43.53 91.26 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 121.406 0.622 . . . . 0.0 110.428 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.73 -43.98 97.81 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.246 0.546 . . . . 0.0 110.265 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.6 mp -65.95 -38.62 89.07 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.195 0.522 . . . . 0.0 110.48 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -67.38 -42.18 83.78 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.16 0.505 . . . . 0.0 110.595 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 96.0 mt -66.67 -35.48 74.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.444 0.64 . . . . 0.0 109.991 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.5 -31.81 60.43 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.425 HD23 ' C ' ' A' ' 232' ' ' LEU . 8.7 tt -59.85 -42.78 94.38 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.698 0.761 . . . . 0.0 110.376 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -62.48 -44.08 97.25 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.432 0.634 . . . . 0.0 110.881 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -65.45 -46.81 78.4 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.605 0.717 . . . . 0.0 110.737 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -61.31 -38.34 86.51 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.418 0.628 . . . . 0.0 111.229 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -85.88 -1.51 57.34 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.807 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -152.19 79.28 1.24 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.839 0.828 . . . . 0.0 110.423 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 90.9 mtm-85 . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 117.872 -1.061 . . . . 0.0 110.561 -179.949 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 34.5 p -62.98 134.39 56.11 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.346 0.593 . . . . 0.0 110.706 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 7.4 t -148.57 47.37 1.03 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 122.305 1.05 . . . . 0.0 110.513 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 33.5 m -69.6 -32.71 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.058 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 11.2 tp -65.97 -37.49 86.11 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.716 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.545 ' O ' HG12 ' B' ' 217' ' ' VAL . 7.1 tp -51.94 -57.19 15.85 Favored Pre-proline 0 CA--C 1.552 1.021 0 CA-C-O 118.867 -0.587 . . . . 0.0 111.231 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.13 -34.54 57.17 Favored 'Trans proline' 0 N--CA 1.504 2.126 0 C-N-CA 121.823 1.682 . . . . 0.0 113.205 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.75 -45.16 95.38 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.901 0.381 . . . . 0.0 111.724 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.545 HG12 ' O ' ' B' ' 214' ' ' LEU . 7.1 p -63.3 -36.33 75.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 O-C-N 122.06 -0.4 . . . . 0.0 110.756 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 21.5 mm -62.93 -44.75 99.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -64.59 -36.86 85.6 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.451 0.644 . . . . 0.0 110.044 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -57.68 -44.72 86.0 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.201 0.524 . . . . 0.0 110.585 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -67.6 -34.78 84.83 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 5.2 tp -61.85 -40.97 97.19 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.667 0.746 . . . . 0.0 110.235 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.79 -38.44 88.1 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.32 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 2.5 tp -58.69 -38.13 77.57 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.209 0.528 . . . . 0.0 110.2 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 225' ' ' LEU . . . . . 0.478 HD13 ' HG ' ' A' ' 225' ' ' LEU . 19.3 tp -59.08 -32.34 69.71 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.119 0.485 . . . . 0.0 110.718 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 33.1 t -58.97 -47.03 86.58 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.057 0.456 . . . . 0.0 110.289 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 227' ' ' LEU . . . . . 0.421 HD12 ' N ' ' B' ' 227' ' ' LEU . 7.8 mp -62.41 -43.98 97.52 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.197 0.522 . . . . 0.0 110.394 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 7.2 mp -61.56 -36.84 81.76 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.237 0.542 . . . . 0.0 109.974 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -59.46 -42.07 91.14 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.651 0.738 . . . . 0.0 109.956 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 50.4 mm -64.67 -41.04 91.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 121.767 0.794 . . . . 0.0 110.083 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -63.92 -32.01 82.73 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.554 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 232' ' ' LEU . . . . . 0.413 HD23 ' C ' ' B' ' 232' ' ' LEU . 6.6 tt -60.5 -46.21 90.96 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.598 0.713 . . . . 0.0 110.794 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -70.07 -39.17 75.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.477 0.656 . . . . 0.0 110.781 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -64.09 -40.65 96.69 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.326 0.584 . . . . 0.0 110.867 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -62.83 -17.42 61.32 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.9 0.381 . . . . 0.0 111.887 -179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -85.8 -21.16 28.28 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.115 0.483 . . . . 0.0 110.68 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 40.86 31.03 0.11 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.509 0.671 . . . . 0.0 112.178 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.633 -179.796 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 19.7 m -63.79 -47.58 80.31 Favored 'General case' 0 CA--C 1.533 0.327 0 O-C-N 122.31 -0.523 . . . . 0.0 110.561 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 23.0 p -150.54 48.73 0.88 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 122.325 1.06 . . . . 0.0 110.326 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 34.8 m -70.0 -32.48 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.087 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 21.9 mt -69.06 -30.95 69.39 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.893 0.378 . . . . 0.0 111.497 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 214' ' ' LEU . . . . . 0.536 ' O ' HG12 ' C' ' 217' ' ' VAL . 0.2 OUTLIER -54.38 -57.49 18.31 Favored Pre-proline 0 CA--C 1.549 0.918 0 CA-C-O 118.929 -0.558 . . . . 0.0 111.118 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -63.7 -34.67 61.65 Favored 'Trans proline' 0 N--CA 1.505 2.165 0 C-N-CA 121.777 1.651 . . . . 0.0 113.406 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 tt -59.69 -45.57 91.69 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.103 0.478 . . . . 0.0 111.6 -178.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 217' ' ' VAL . . . . . 0.536 HG12 ' O ' ' C' ' 214' ' ' LEU . 7.1 p -64.54 -36.34 77.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 O-C-N 122.156 -0.34 . . . . 0.0 110.794 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 218' ' ' ILE . . . . . 0.437 ' HA ' HD22 ' A' ' 222' ' ' LEU . 36.0 mm -63.17 -44.93 99.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -61.73 -36.93 82.38 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.356 0.598 . . . . 0.0 110.186 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -57.79 -44.71 86.44 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.325 0.583 . . . . 0.0 110.101 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -65.6 -33.72 87.0 Favored Glycine 0 CA--C 1.534 1.219 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 4.7 tp -61.9 -38.62 89.03 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.575 0.702 . . . . 0.0 110.842 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.68 -38.49 87.98 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.95 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 7.4 mp -58.91 -42.11 88.88 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.217 0.532 . . . . 0.0 110.164 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 225' ' ' LEU . . . . . 0.533 ' HB2' HD11 ' A' ' 225' ' ' LEU . 18.6 tp -58.56 -30.88 67.48 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.108 0.48 . . . . 0.0 110.648 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 8.0 t -57.06 -44.45 83.02 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.45 0.643 . . . . 0.0 109.939 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 7.9 mp -66.72 -40.81 88.55 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.36 0.6 . . . . 0.0 110.065 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 30.0 mt -63.61 -35.98 82.32 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.045 0.45 . . . . 0.0 110.547 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -66.79 -42.13 86.48 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.33 0.586 . . . . 0.0 109.971 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.29 -35.73 74.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 121.462 0.648 . . . . 0.0 109.844 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.74 -31.92 61.25 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 5.2 tt -59.49 -42.13 91.42 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.703 0.763 . . . . 0.0 110.172 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -62.45 -44.13 97.15 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.528 0.68 . . . . 0.0 110.554 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -62.44 -45.61 92.29 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.445 0.64 . . . . 0.0 110.586 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -59.64 -19.24 47.87 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.427 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -85.86 -5.62 59.21 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.938 -0.476 . . . . 0.0 111.958 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -129.15 55.57 1.74 Allowed 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 122.302 1.049 . . . . 0.0 110.299 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 79.8 mtm-85 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.788 -179.909 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.481 ' O ' HG23 ' A' ' 211' ' ' THR . . . . . . . . 0 N--CA 1.49 2.264 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 74.9 p -56.94 115.55 2.67 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 122.316 -0.52 . . . . 0.0 110.056 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 209' ' ' GLY . 66.6 p -109.45 50.82 0.77 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 122.289 1.042 . . . . 0.0 110.673 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 34.7 m -70.16 -41.32 78.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.428 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 14.0 tp -69.27 -35.54 76.18 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.405 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.553 ' O ' HG12 ' A' ' 217' ' ' VAL . 2.3 tt -44.94 -57.1 7.56 Favored Pre-proline 0 CA--C 1.554 1.102 0 CA-C-O 118.887 -0.578 . . . . 0.0 111.744 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -63.79 -38.25 40.65 Favored 'Trans proline' 0 N--CA 1.507 2.27 0 C-N-CA 122.037 1.825 . . . . 0.0 113.925 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.2 tt -59.47 -45.36 91.86 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.205 0.526 . . . . 0.0 111.947 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 214' ' ' LEU . 9.1 p -61.94 -35.95 71.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.963 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 25.2 mm -62.56 -44.84 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 121.656 -0.653 . . . . 0.0 109.533 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -65.13 -36.66 84.98 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.709 0.766 . . . . 0.0 110.07 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -57.68 -42.38 83.49 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.243 0.544 . . . . 0.0 111.345 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.518 ' HA3' HD11 ' B' ' 222' ' ' LEU . . . -59.77 -33.63 78.77 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.95 -31.75 71.7 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.124 0.488 . . . . 0.0 111.444 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.64 -38.71 88.69 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.317 0.579 . . . . 0.0 110.619 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.86 -37.54 76.73 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.111 0.481 . . . . 0.0 110.456 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 16.8 tp -57.83 -35.37 70.8 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.079 0.466 . . . . 0.0 110.867 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 35.5 t -58.65 -41.72 86.68 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.228 0.537 . . . . 0.0 110.742 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 227' ' ' LEU . 7.8 mp -62.22 -42.78 99.61 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.587 0.708 . . . . 0.0 110.426 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.8 mp -71.25 -36.67 71.85 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.14 0.495 . . . . 0.0 111.029 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -70.36 -42.47 71.76 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.097 0.475 . . . . 0.0 111.568 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 7.9 tp -69.09 -38.37 78.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 121.813 0.816 . . . . 0.0 110.913 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -71.77 -31.8 64.59 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.448 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.402 HD23 ' C ' ' A' ' 232' ' ' LEU . 10.4 tt -60.87 -37.18 81.25 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 122.084 -0.657 . . . . 0.0 111.174 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.26 -37.48 87.4 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.17 0.509 . . . . 0.0 111.256 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -60.04 -46.33 89.88 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.525 0.679 . . . . 0.0 110.217 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -76.99 -10.87 59.66 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.992 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -85.83 -18.04 33.98 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.882 -0.511 . . . . 0.0 111.178 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -155.73 39.0 0.37 Allowed 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.932 0.873 . . . . 0.0 110.545 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 29.8 ttp180 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.747 -179.734 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 2.0 m -144.04 145.7 32.37 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 122.28 -0.541 . . . . 0.0 110.292 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 40.8 p -98.88 49.26 0.96 Allowed 'General case' 0 C--O 1.238 0.473 0 CA-C-O 122.41 1.1 . . . . 0.0 110.811 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 29.7 m -70.06 -31.94 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.627 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 10.9 tp -63.69 -40.68 97.4 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.795 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.511 ' O ' HG12 ' B' ' 217' ' ' VAL . 2.9 tp -49.6 -57.55 11.75 Favored Pre-proline 0 CA--C 1.553 1.09 0 O-C-N 121.79 -0.569 . . . . 0.0 111.512 -178.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.42 -39.55 28.42 Favored 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 121.786 1.657 . . . . 0.0 112.754 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.34 -43.66 92.74 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.939 -177.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.511 HG12 ' O ' ' B' ' 214' ' ' LEU . 10.6 p -66.17 -36.58 77.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 O-C-N 121.971 -0.456 . . . . 0.0 110.714 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 33.6 mt -65.92 -44.45 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -66.58 -36.62 83.08 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.355 0.598 . . . . 0.0 110.139 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -57.55 -43.49 84.5 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.319 0.581 . . . . 0.0 110.116 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 221' ' ' GLY . . . . . 0.493 ' HA3' HD11 ' C' ' 222' ' ' LEU . . . -63.42 -33.64 87.79 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 178.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 222' ' ' LEU . . . . . 0.518 HD11 ' HA3' ' A' ' 221' ' ' GLY . 5.4 tp -58.79 -42.32 88.77 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.543 0.687 . . . . 0.0 110.103 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.8 -38.85 89.65 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.697 0.76 . . . . 0.0 109.567 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 2.9 tp -60.84 -40.1 91.56 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.757 0.789 . . . . 0.0 109.783 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.99 -42.86 89.23 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.061 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 226' ' ' SER . . . . . 0.402 ' O ' HD13 ' B' ' 230' ' ' ILE . 19.4 t -63.24 -44.02 96.4 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 121.51 0.671 . . . . 0.0 109.948 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 11.2 mt -66.85 -39.79 87.71 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.284 0.564 . . . . 0.0 110.23 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.42 HD11 HD13 ' C' ' 232' ' ' LEU . 7.6 tp -64.1 -34.76 78.77 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.202 0.525 . . . . 0.0 110.422 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -68.54 -41.17 80.24 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.314 0.578 . . . . 0.0 110.474 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.402 HD13 ' O ' ' B' ' 226' ' ' SER . 1.4 mp -66.01 -41.5 89.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 121.585 0.707 . . . . 0.0 109.114 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -60.58 -32.04 76.88 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 232' ' ' LEU . . . . . 0.458 HD23 ' C ' ' B' ' 232' ' ' LEU . 6.4 tt -58.98 -46.41 88.2 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.638 0.732 . . . . 0.0 110.762 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -62.8 -38.55 91.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.782 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -60.26 -46.19 90.67 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.562 0.696 . . . . 0.0 109.891 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -70.74 -32.2 69.29 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.102 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -85.24 -8.96 58.29 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 120.991 0.424 . . . . 0.0 111.329 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 47.8 22.09 0.33 Allowed 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.709 -0.619 . . . . 0.0 111.789 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.401 -179.472 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 5.1 t -115.96 24.46 11.45 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 122.151 -0.617 . . . . 0.0 111.6 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 50.2 p -113.85 29.24 8.15 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 122.016 0.912 . . . . 0.0 111.286 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 38.2 t -70.47 -28.09 33.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.637 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 11.9 tp -68.7 -34.05 74.99 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.852 0.358 . . . . 0.0 111.873 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 214' ' ' LEU . . . . . 0.579 ' O ' HG12 ' C' ' 217' ' ' VAL . 20.8 tp -46.87 -57.37 9.19 Favored Pre-proline 0 CA--C 1.556 1.202 0 CA-C-O 118.913 -0.565 . . . . 0.0 111.59 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.5 -42.74 15.6 Favored 'Trans proline' 0 N--CA 1.504 2.117 0 C-N-CA 121.882 1.721 . . . . 0.0 113.316 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.96 -45.16 83.04 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.89 -177.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 217' ' ' VAL . . . . . 0.579 HG12 ' O ' ' C' ' 214' ' ' LEU . 11.6 p -60.26 -35.78 64.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 122.055 -0.403 . . . . 0.0 110.757 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 44.7 mm -62.15 -45.16 99.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -60.34 -41.83 94.43 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.511 0.672 . . . . 0.0 109.462 177.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -57.72 -37.7 73.99 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.697 0.76 . . . . 0.0 110.447 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -59.97 -33.52 79.25 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 222' ' ' LEU . . . . . 0.493 HD11 ' HA3' ' B' ' 221' ' ' GLY . 4.9 tp -58.65 -38.38 78.01 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.534 0.683 . . . . 0.0 110.776 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.71 89.2 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.214 0.53 . . . . 0.0 110.751 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 11.8 mt -61.47 -47.77 84.14 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.2 0.524 . . . . 0.0 110.44 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 18.0 tp -58.19 -38.49 76.81 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.196 0.522 . . . . 0.0 110.381 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 36.1 t -59.85 -40.56 88.99 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.272 0.558 . . . . 0.0 110.746 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 10.5 mt -64.78 -42.72 94.87 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.671 0.748 . . . . 0.0 110.2 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 7.7 mp -70.52 -34.88 72.8 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.204 0.526 . . . . 0.0 111.046 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 229' ' ' PHE . . . . . 0.414 ' CD2' HD13 ' B' ' 228' ' ' LEU . 31.7 t80 -70.1 -42.41 72.76 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.022 0.439 . . . . 0.0 111.653 -178.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 6.2 tp -68.84 -35.93 71.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 121.417 0.627 . . . . 0.0 110.931 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -66.72 -32.15 80.5 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 111.559 -0.617 . . . . 0.0 111.559 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 232' ' ' LEU . . . . . 0.461 ' O ' HD23 ' C' ' 232' ' ' LEU . 1.9 tt -56.9 -40.8 76.95 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.58 0.705 . . . . 0.0 110.611 -179.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.52 -37.48 73.09 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.837 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -60.32 -44.22 95.65 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.535 0.683 . . . . 0.0 109.954 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 78.8 mtt85 -65.73 -25.99 67.54 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.477 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -85.24 -1.54 57.05 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 122.038 -0.414 . . . . 0.0 111.777 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -126.58 22.91 6.9 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.827 -0.546 . . . . 0.0 111.315 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.81 -1.091 . . . . 0.0 110.639 179.976 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.524 ' O ' HG23 ' A' ' 210' ' ' THR . 6.4 t -121.1 94.56 4.38 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 122.048 0.927 . . . . 0.0 111.085 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 3.2 m 46.36 31.14 1.18 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 122.006 0.908 . . . . 0.0 111.794 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 26.1 m -70.68 -28.91 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.247 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 21.1 tp -66.1 -41.06 91.14 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 122.11 -0.369 . . . . 0.0 111.891 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.418 ' O ' HG12 ' A' ' 217' ' ' VAL . 8.0 tp -52.19 -57.29 15.82 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-O 119.03 -0.51 . . . . 0.0 111.396 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.12 -32.06 64.19 Favored 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 121.924 1.75 . . . . 0.0 113.355 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 7.5 tp -69.4 -45.11 70.04 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 122.001 -0.437 . . . . 0.0 111.813 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 214' ' ' LEU . 13.1 p -65.83 -36.68 78.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 O-C-N 122.245 -0.284 . . . . 0.0 111.456 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 26.4 pt -69.09 -38.39 78.13 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 O-C-N 121.488 -0.757 . . . . 0.0 110.744 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -68.98 -40.56 78.73 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.538 0.685 . . . . 0.0 110.319 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.84 -37.04 75.55 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.568 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.473 ' HA3' HD11 ' B' ' 222' ' ' LEU . . . -66.65 -33.78 85.46 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.469 HD11 ' HA3' ' C' ' 221' ' ' GLY . 8.2 tp -58.78 -37.44 76.31 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.229 0.538 . . . . 0.0 111.195 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.94 -39.23 91.38 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.105 0.479 . . . . 0.0 110.725 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.2 mp -65.69 -39.32 91.16 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.301 0.572 . . . . 0.0 110.493 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 19.4 tp -59.72 -39.79 85.84 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.191 0.52 . . . . 0.0 110.428 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 50.6 m -58.33 -41.54 84.79 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.308 0.575 . . . . 0.0 110.303 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.3 mt -64.16 -43.47 95.06 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.216 0.531 . . . . 0.0 110.546 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.0 mp -66.49 -38.07 86.45 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.101 0.476 . . . . 0.0 110.607 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -59.77 -42.18 92.7 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.049 0.452 . . . . 0.0 110.572 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.4 mp -64.21 -39.82 86.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.594 0.712 . . . . 0.0 109.367 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -59.67 -32.01 72.79 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.461 HD23 ' C ' ' A' ' 232' ' ' LEU . 9.1 tt -58.13 -45.27 87.62 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.475 0.655 . . . . 0.0 110.936 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -65.09 -37.51 87.74 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.354 0.597 . . . . 0.0 110.997 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -64.04 -37.52 87.75 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.338 0.589 . . . . 0.0 110.738 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -61.29 -37.79 84.45 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.224 0.535 . . . . 0.0 110.934 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -86.24 5.2 35.44 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.868 0.366 . . . . 0.0 111.956 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -52.18 -32.49 36.36 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.45 0.643 . . . . 0.0 111.056 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 . . . . . 0 N--CA 1.469 0.505 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.794 179.879 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 17.5 p -99.9 115.17 29.01 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.391 0.615 . . . . 0.0 110.565 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 3.2 m 53.0 34.28 16.63 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 122.306 1.051 . . . . 0.0 110.924 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 14.8 p -70.59 -23.23 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.833 179.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 9.3 tt -69.19 -40.18 78.21 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.497 ' O ' HG12 ' B' ' 217' ' ' VAL . 2.0 tp -54.42 -56.86 22.1 Favored Pre-proline 0 CA--C 1.548 0.892 0 O-C-N 121.691 -0.631 . . . . 0.0 110.924 -178.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 0.406 ' HD3' ' HB3' ' B' ' 214' ' ' LEU . 16.2 Cg_exo -64.24 -37.45 40.87 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 121.544 1.496 . . . . 0.0 112.476 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 4.4 tt -60.06 -45.38 93.06 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.102 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.497 HG12 ' O ' ' B' ' 214' ' ' LEU . 11.0 p -65.1 -36.57 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 O-C-N 122.219 -0.301 . . . . 0.0 110.682 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 46.2 mt -65.38 -44.95 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -67.93 -36.72 80.63 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.695 0.759 . . . . 0.0 109.987 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -57.78 -45.18 86.36 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.344 0.592 . . . . 0.0 110.678 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.66 -33.91 86.71 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 222' ' ' LEU . . . . . 0.473 HD11 ' HA3' ' A' ' 221' ' ' GLY . 6.5 tp -59.86 -41.25 91.04 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.455 0.645 . . . . 0.0 110.959 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.33 91.57 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.266 0.555 . . . . 0.0 110.614 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 1.1 tt -61.78 -41.54 97.85 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.532 0.682 . . . . 0.0 109.811 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 225' ' ' LEU . . . . . 0.401 HD13 HD13 ' C' ' 225' ' ' LEU . 20.7 tp -58.81 -42.97 90.39 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.263 0.554 . . . . 0.0 110.49 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 6.7 m -62.68 -43.51 98.61 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.474 0.654 . . . . 0.0 110.222 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 5.7 mp -65.5 -40.76 93.43 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.326 0.584 . . . . 0.0 110.686 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 16.8 tp -71.13 -34.66 71.26 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.505 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -71.03 -42.64 69.25 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 121.867 -0.521 . . . . 0.0 111.274 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 7.5 tp -69.34 -37.19 75.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 121.838 0.828 . . . . 0.0 111.081 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.69 -31.83 62.23 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.614 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 4.3 tt -61.14 -41.02 95.98 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.526 0.679 . . . . 0.0 111.007 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.97 -41.92 97.4 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.365 0.602 . . . . 0.0 110.907 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -63.34 -46.95 84.22 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.614 0.721 . . . . 0.0 110.493 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -59.01 -38.06 78.35 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.418 0.628 . . . . 0.0 110.897 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -86.02 4.52 37.54 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.79 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -141.55 40.41 1.72 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.994 0.902 . . . . 0.0 110.298 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 47.5 ttt85 . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.771 179.989 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 2.5 t 41.26 99.07 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.991 0.9 . . . . 0.0 112.509 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 7.0 p -70.24 73.09 0.47 Allowed 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.321 1.058 . . . . 0.0 110.964 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 27.7 m -64.81 -25.83 38.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.125 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 4.4 tt -68.98 -35.37 76.64 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.886 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 214' ' ' LEU . . . . . 0.499 ' O ' HG12 ' C' ' 217' ' ' VAL . 4.0 tp -46.36 -57.17 9.05 Favored Pre-proline 0 CA--C 1.553 1.093 0 CA-C-O 119.112 -0.471 . . . . 0.0 111.642 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 215' ' ' PRO . . . . . 0.429 ' HA ' HD12 ' C' ' 218' ' ' ILE . 37.0 Cg_endo -63.84 -38.97 35.92 Favored 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 121.841 1.694 . . . . 0.0 113.032 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -45.35 90.91 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.839 0.352 . . . . 0.0 111.723 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 217' ' ' VAL . . . . . 0.499 HG12 ' O ' ' C' ' 214' ' ' LEU . 7.1 p -64.46 -36.57 77.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 122.088 -0.382 . . . . 0.0 110.514 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 218' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' C' ' 215' ' ' PRO . 50.9 mt -63.0 -45.15 99.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.455 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -64.39 -37.32 87.09 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.618 0.723 . . . . 0.0 110.092 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -57.96 -45.29 86.92 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.419 0.628 . . . . 0.0 110.578 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 221' ' ' GLY . . . . . 0.469 ' HA3' HD11 ' A' ' 222' ' ' LEU . . . -60.13 -33.79 81.22 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 4.8 tp -59.06 -40.33 84.79 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.585 0.707 . . . . 0.0 110.629 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.83 -39.05 90.45 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.864 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 36.2 mt -61.6 -40.01 93.28 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.416 0.627 . . . . 0.0 110.581 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 225' ' ' LEU . . . . . 0.401 HD13 HD13 ' B' ' 225' ' ' LEU . 32.3 tp -60.93 -35.28 76.3 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.062 0.458 . . . . 0.0 110.314 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 42.8 t -57.6 -46.7 83.71 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.371 0.605 . . . . 0.0 109.669 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 8.1 mp -60.89 -42.24 97.63 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.395 0.617 . . . . 0.0 110.244 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.63 -37.25 86.93 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.201 0.524 . . . . 0.0 110.585 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -69.79 -42.08 74.24 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.173 0.511 . . . . 0.0 111.183 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 34.0 mm -63.01 -41.04 91.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.506 0.669 . . . . 0.0 110.072 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -62.78 -33.28 86.44 Favored Glycine 0 CA--C 1.535 1.289 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 7.8 tt -61.89 -34.66 76.44 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 122.178 -0.601 . . . . 0.0 111.764 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -61.43 -35.81 78.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.138 0.494 . . . . 0.0 111.354 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -59.87 -44.49 94.14 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.365 0.602 . . . . 0.0 110.575 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 66.5 mtp85 -63.96 -32.12 73.54 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.429 0.633 . . . . 0.0 110.832 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -85.79 -8.76 57.91 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 120.959 0.409 . . . . 0.0 111.146 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -164.86 88.79 0.48 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.737 0.779 . . . . 0.0 110.231 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.883 -1.056 . . . . 0.0 111.03 -179.693 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 48.4 p -73.14 168.81 18.34 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.385 0.612 . . . . 0.0 110.624 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 43.7 p -97.96 59.51 1.43 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.133 0.968 . . . . 0.0 111.039 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 26.2 t -70.31 -34.83 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-O 121.471 0.653 . . . . 0.0 110.207 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 54.2 mt -66.56 -33.26 75.28 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.499 ' O ' HG12 ' A' ' 217' ' ' VAL . 0.1 OUTLIER -53.77 -57.54 17.1 Favored Pre-proline 0 CA--C 1.55 0.955 0 O-C-N 121.96 -0.463 . . . . 0.0 111.085 -179.213 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.73 -32.94 67.52 Favored 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 121.868 1.712 . . . . 0.0 112.814 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.94 -45.32 95.19 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.041 0.448 . . . . 0.0 111.468 -178.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.499 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.3 p -67.92 -36.51 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 O-C-N 122.125 -0.359 . . . . 0.0 110.203 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 52.6 mt -67.84 -42.83 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 121.507 0.67 . . . . 0.0 109.212 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -62.93 -36.72 84.34 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.482 0.658 . . . . 0.0 110.524 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -57.74 -43.44 85.39 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.367 0.603 . . . . 0.0 110.207 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.415 ' HA3' HD11 ' B' ' 222' ' ' LEU . . . -64.12 -33.91 88.49 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 178.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 6.8 tp -60.58 -38.82 85.87 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.587 0.708 . . . . 0.0 110.643 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.81 -38.77 89.38 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.239 0.542 . . . . 0.0 110.711 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 6.1 mp -59.8 -35.95 75.72 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.207 0.527 . . . . 0.0 110.471 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 13.4 tp -58.44 -36.58 73.86 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.089 0.471 . . . . 0.0 110.913 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 23.5 t -58.46 -44.36 89.21 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.27 0.557 . . . . 0.0 110.533 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.9 mt -61.66 -43.14 99.42 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.461 0.648 . . . . 0.0 110.013 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 6.8 mt -66.51 -37.31 84.77 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.149 0.5 . . . . 0.0 110.414 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -65.85 -41.98 91.01 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.319 0.58 . . . . 0.0 110.117 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 92.6 mt -63.01 -35.96 73.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 121.409 0.623 . . . . 0.0 110.003 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.56 -32.2 61.0 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 10.0 tt -59.21 -37.33 77.19 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.593 0.711 . . . . 0.0 110.568 179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.82 -36.01 73.82 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.254 0.549 . . . . 0.0 111.157 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -60.49 -46.94 88.29 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.486 0.66 . . . . 0.0 110.568 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -64.46 -37.67 88.33 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.274 0.559 . . . . 0.0 110.955 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -85.91 4.18 38.59 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 120.88 0.371 . . . . 0.0 111.948 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -156.67 82.81 0.96 Allowed 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.772 0.796 . . . . 0.0 109.749 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 34.4 ptt-85 . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 117.914 -1.041 . . . . 0.0 111.166 -179.086 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 20.2 m -101.07 83.24 2.47 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.882 0.848 . . . . 0.0 110.139 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 17.1 p 47.3 50.76 14.15 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 122.405 1.098 . . . . 0.0 111.018 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 34.7 t -70.04 -36.74 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.014 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 9.1 tp -69.16 -33.39 73.33 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.592 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.445 ' O ' HG12 ' B' ' 217' ' ' VAL . 1.0 OUTLIER -49.13 -57.26 12.04 Favored Pre-proline 0 CA--C 1.553 1.058 0 O-C-N 121.908 -0.495 . . . . 0.0 111.319 -178.906 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 0.419 ' HA ' HG12 ' B' ' 218' ' ' ILE . 37.3 Cg_endo -63.7 -29.31 69.08 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 121.905 1.736 . . . . 0.0 113.484 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.16 -45.14 67.36 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.106 0.479 . . . . 0.0 111.51 -178.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.445 HG12 ' O ' ' B' ' 214' ' ' LEU . 8.5 p -65.23 -36.78 78.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 122.098 -0.376 . . . . 0.0 111.409 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 218' ' ' ILE . . . . . 0.419 HG12 ' HA ' ' B' ' 215' ' ' PRO . 28.7 pt -69.07 -38.2 77.92 Favored 'Isoleucine or valine' 0 C--N 1.348 0.526 0 O-C-N 121.355 -0.841 . . . . 0.0 110.661 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -64.42 -44.03 92.49 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.555 0.693 . . . . 0.0 110.083 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -59.22 -44.63 92.3 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.688 0.756 . . . . 0.0 109.956 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -59.97 -33.37 78.63 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 222' ' ' LEU . . . . . 0.415 HD11 ' HA3' ' A' ' 221' ' ' GLY . 3.7 tp -59.02 -40.79 86.06 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.417 0.627 . . . . 0.0 110.393 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.89 -38.76 89.53 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.141 0.496 . . . . 0.0 110.873 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 15.3 mt -59.35 -39.08 82.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.227 0.537 . . . . 0.0 110.434 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 18.0 tp -60.82 -38.43 85.4 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.316 0.579 . . . . 0.0 110.317 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 5.6 t -58.29 -47.03 84.95 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.286 0.565 . . . . 0.0 110.425 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 7.7 mp -59.09 -43.8 91.86 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.224 0.535 . . . . 0.0 110.54 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 6.9 mp -67.01 -38.74 86.51 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.127 0.489 . . . . 0.0 110.777 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -67.3 -42.27 84.0 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.208 0.528 . . . . 0.0 111.126 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 34.2 mm -64.99 -42.42 94.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-O 121.648 0.737 . . . . 0.0 109.615 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -58.54 -31.84 67.71 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 232' ' ' LEU . . . . . 0.489 HD13 ' C ' ' B' ' 232' ' ' LEU . 3.2 tm? -57.78 -43.36 85.48 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.718 0.771 . . . . 0.0 110.608 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -64.53 -37.96 89.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.733 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -60.29 -43.22 96.45 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.516 0.674 . . . . 0.0 110.294 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -59.38 -43.09 92.97 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.428 0.632 . . . . 0.0 110.621 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -86.18 4.96 36.31 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.919 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -102.5 55.89 0.78 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 122.217 1.008 . . . . 0.0 110.397 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 36.9 mtm105 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.772 179.965 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 210' ' ' THR . . . . . 0.412 ' O ' HG23 ' C' ' 210' ' ' THR . 7.6 t -66.92 123.55 20.51 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.329 0.585 . . . . 0.0 110.882 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 11.7 p -124.93 55.6 1.35 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 122.322 1.058 . . . . 0.0 110.314 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 44.7 t -70.05 -33.01 53.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.076 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 213' ' ' LEU . . . . . 0.498 HD13 ' O ' ' C' ' 213' ' ' LEU . 0.2 OUTLIER -66.24 -38.49 88.0 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.943 0.402 . . . . 0.0 111.257 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 214' ' ' LEU . . . . . 0.492 ' O ' HG12 ' C' ' 217' ' ' VAL . 3.1 tp -49.26 -57.41 11.77 Favored Pre-proline 0 CA--C 1.554 1.1 0 O-C-N 121.889 -0.507 . . . . 0.0 111.534 -178.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.09 -34.52 57.65 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 121.852 1.701 . . . . 0.0 112.97 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 216' ' ' LEU . . . . . 0.445 HD13 ' O ' ' C' ' 216' ' ' LEU . 0.2 OUTLIER -61.61 -45.26 94.85 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.073 0.463 . . . . 0.0 111.615 -178.34 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 217' ' ' VAL . . . . . 0.492 HG12 ' O ' ' C' ' 214' ' ' LEU . 8.4 p -67.3 -36.56 76.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 122.059 -0.4 . . . . 0.0 110.29 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 41.5 mt -68.66 -41.23 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.498 0.666 . . . . 0.0 109.318 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -62.52 -36.97 84.26 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.379 0.609 . . . . 0.0 110.544 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -57.87 -43.55 86.09 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.503 0.668 . . . . 0.0 110.324 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.43 -33.78 82.63 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 179.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 7.4 tp -59.39 -36.47 75.86 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.314 0.578 . . . . 0.0 111.293 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.68 -38.72 88.83 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.132 0.491 . . . . 0.0 111.012 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 7.2 mp -59.3 -39.27 82.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.214 0.53 . . . . 0.0 110.416 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 24.2 tp -61.75 -38.51 88.25 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.258 0.551 . . . . 0.0 110.458 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 74.9 m -58.32 -42.65 87.25 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.24 0.543 . . . . 0.0 110.916 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.97 -42.3 97.3 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.386 0.612 . . . . 0.0 110.647 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 6.5 mp -71.16 -34.68 71.19 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.199 0.523 . . . . 0.0 111.103 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -64.94 -42.28 94.77 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.921 0.391 . . . . 0.0 111.816 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 6.6 tp -69.26 -35.77 69.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 121.543 0.687 . . . . 0.0 110.983 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.69 -31.96 62.08 Favored Glycine 0 CA--C 1.535 1.285 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 232' ' ' LEU . . . . . 0.448 ' C ' HD23 ' C' ' 232' ' ' LEU . 9.1 tt -57.2 -44.7 83.9 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.513 0.673 . . . . 0.0 111.016 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -62.93 -39.61 95.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.388 0.613 . . . . 0.0 110.797 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -61.0 -45.25 95.59 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.418 0.627 . . . . 0.0 110.539 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -61.52 -38.33 86.97 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.254 0.549 . . . . 0.0 111.029 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -85.83 -1.81 57.62 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.902 0.382 . . . . 0.0 111.677 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -95.79 -31.93 12.94 Favored 'General case' 0 C--N 1.344 0.343 0 O-C-N 121.741 -0.599 . . . . 0.0 111.295 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.541 -179.938 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 5.9 m -140.17 130.76 25.61 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 122.339 -0.507 . . . . 0.0 110.299 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 41.0 p -126.44 36.04 4.55 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 122.099 0.952 . . . . 0.0 111.474 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 57.3 t -70.37 -27.5 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.231 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.405 ' O ' HD23 ' A' ' 213' ' ' LEU . 4.0 tt -66.84 -39.8 87.72 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.921 0.391 . . . . 0.0 111.315 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.519 ' O ' HG12 ' A' ' 217' ' ' VAL . 4.5 tp -47.83 -57.34 10.33 Favored Pre-proline 0 CA--C 1.553 1.068 0 CA-C-O 118.895 -0.574 . . . . 0.0 111.581 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -64.0 -34.02 60.58 Favored 'Trans proline' 0 N--CA 1.503 2.083 0 C-N-CA 121.752 1.635 . . . . 0.0 113.113 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.6 tp -61.13 -45.32 95.14 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.011 0.434 . . . . 0.0 111.634 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.519 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.2 p -65.39 -36.6 78.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 O-C-N 122.204 -0.31 . . . . 0.0 110.631 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 42.2 mm -65.05 -42.41 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -60.96 -36.75 80.19 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.394 0.616 . . . . 0.0 110.287 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.88 -42.13 83.93 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.399 0.619 . . . . 0.0 109.897 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -65.47 -33.8 87.43 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 7.4 tp -58.75 -34.58 71.56 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.253 0.549 . . . . 0.0 111.077 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.63 -38.76 88.84 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.24 0.543 . . . . 0.0 110.974 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.9 mp -61.5 -38.87 88.9 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.357 0.599 . . . . 0.0 110.443 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.435 HD13 HD13 ' B' ' 225' ' ' LEU . 16.8 tp -59.07 -41.91 89.1 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.278 0.561 . . . . 0.0 110.447 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 46.9 t -59.9 -42.26 93.45 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.299 0.571 . . . . 0.0 110.742 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 1.6 tt -62.63 -46.71 86.97 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.365 0.602 . . . . 0.0 110.48 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.4 mp -66.0 -40.18 90.93 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.915 0.388 . . . . 0.0 111.376 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -70.06 -42.27 73.04 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.219 0.533 . . . . 0.0 110.95 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 93.4 mt -68.04 -42.16 85.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.484 0.659 . . . . 0.0 110.164 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -62.97 -34.3 89.56 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.449 ' O ' HD23 ' A' ' 232' ' ' LEU . 1.4 tt -68.24 -39.18 82.35 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.57 0.7 . . . . 0.0 110.929 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' ALA . . . . . 0.42 ' HA ' ' CZ ' ' A' ' 236' ' ' TYR . . . -70.32 -35.61 73.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.294 0.569 . . . . 0.0 112.279 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -59.76 -31.9 70.08 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.34 -48.3 70.67 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.59 -0.694 . . . . 0.0 112.516 -178.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.42 ' CZ ' ' HA ' ' A' ' 233' ' ' ALA . 19.1 p90 -96.5 5.54 50.6 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 121.631 -0.668 . . . . 0.0 111.96 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -52.75 -38.95 61.72 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.556 0.693 . . . . 0.0 110.852 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 56.5 ttt-85 . . . . . 0 C--O 1.218 -0.59 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.623 -179.848 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.354 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 3.8 m -111.39 -60.37 1.85 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.369 0.604 . . . . 0.0 110.574 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 1.4 m -139.0 37.78 2.14 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 122.164 0.983 . . . . 0.0 110.675 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 41.5 t -70.34 -26.61 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.422 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 12.1 tp -64.14 -40.94 97.24 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 122.149 -0.344 . . . . 0.0 111.847 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.497 ' O ' HG12 ' B' ' 217' ' ' VAL . 1.5 tt -54.54 -57.07 20.54 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-O 119.103 -0.475 . . . . 0.0 111.332 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.86 -33.31 64.81 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 121.852 1.701 . . . . 0.0 112.942 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 216' ' ' LEU . . . . . 0.445 ' O ' HD23 ' B' ' 216' ' ' LEU . 3.6 tt -61.86 -45.53 93.4 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.091 0.472 . . . . 0.0 111.493 -178.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.497 HG12 ' O ' ' B' ' 214' ' ' LEU . 7.2 p -66.66 -36.53 77.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 O-C-N 122.128 -0.357 . . . . 0.0 110.302 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 218' ' ' ILE . . . . . 0.444 HD11 ' CD2' ' B' ' 214' ' ' LEU . 53.5 mt -67.46 -44.69 86.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -64.43 -36.74 85.13 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.515 0.674 . . . . 0.0 110.029 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -57.65 -43.74 85.17 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.295 0.569 . . . . 0.0 110.408 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -70.15 -35.68 70.91 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.21 -27.56 69.15 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.185 0.517 . . . . 0.0 110.71 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.72 -38.88 89.52 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.263 0.554 . . . . 0.0 110.323 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 51.1 mt -60.31 -38.49 83.85 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.331 0.586 . . . . 0.0 110.367 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 225' ' ' LEU . . . . . 0.435 HD13 HD13 ' A' ' 225' ' ' LEU . 17.4 tp -57.98 -35.41 71.15 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.193 0.52 . . . . 0.0 110.655 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 17.1 m -58.4 -40.43 82.38 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.202 0.525 . . . . 0.0 110.834 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 8.0 mp -63.33 -45.59 90.54 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.49 0.662 . . . . 0.0 110.796 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 8.0 mp -71.23 -34.98 71.28 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.267 0.556 . . . . 0.0 111.224 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -72.52 -42.12 65.12 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.111 0.481 . . . . 0.0 111.82 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 7.7 tp -66.12 -35.92 76.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 121.411 0.624 . . . . 0.0 111.326 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -73.11 -36.73 56.28 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 232' ' ' LEU . . . . . 0.409 HD23 ' O ' ' B' ' 232' ' ' LEU . 3.0 tt -62.85 -46.08 89.56 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.718 0.77 . . . . 0.0 111.126 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -70.35 -35.35 73.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.539 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -59.37 -45.45 91.41 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -177.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -60.74 -34.43 74.4 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.452 0.644 . . . . 0.0 110.977 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -85.97 -5.57 59.2 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.824 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -90.14 44.66 1.21 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.987 0.899 . . . . 0.0 110.622 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.717 179.677 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 209' ' ' GLY . . . . . 0.436 ' O ' HG23 ' C' ' 210' ' ' THR . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 210' ' ' THR . . . . . 0.436 HG23 ' O ' ' C' ' 209' ' ' GLY . 6.9 p -155.5 150.26 26.38 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.293 0.568 . . . . 0.0 110.53 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 211' ' ' THR . . . . . 0.447 HG22 ' HB2' ' C' ' 214' ' ' LEU . 0.2 OUTLIER -118.82 42.15 2.86 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 122.437 1.113 . . . . 0.0 110.244 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 13.4 p -70.24 -29.14 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.779 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 15.0 tp -65.6 -40.43 92.66 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.831 0.348 . . . . 0.0 111.775 -179.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 214' ' ' LEU . . . . . 0.484 ' O ' HG12 ' C' ' 217' ' ' VAL . 11.0 tp -50.6 -57.11 14.34 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-O 119.011 -0.519 . . . . 0.0 111.634 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.87 -35.56 55.26 Favored 'Trans proline' 0 N--CA 1.504 2.116 0 C-N-CA 121.824 1.682 . . . . 0.0 112.961 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 5.3 tt -61.35 -45.43 94.45 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.987 0.423 . . . . 0.0 111.701 -178.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 217' ' ' VAL . . . . . 0.484 HG12 ' O ' ' C' ' 214' ' ' LEU . 10.0 p -66.99 -36.45 77.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 122.214 -0.303 . . . . 0.0 110.339 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 57.0 mt -67.59 -45.15 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -66.45 -37.32 84.88 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.41 0.624 . . . . 0.0 110.285 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -60.5 -45.79 92.5 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.462 0.649 . . . . 0.0 110.067 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.23 -33.64 87.77 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 222' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' B' ' 218' ' ' ILE . 6.0 tp -58.73 -39.64 81.47 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.522 0.677 . . . . 0.0 110.172 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.72 -38.46 87.99 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.577 0.704 . . . . 0.0 110.32 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 2.3 tp -58.71 -45.9 88.52 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.248 0.546 . . . . 0.0 110.257 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 225' ' ' LEU . . . . . 0.428 HD13 ' CD1' ' A' ' 225' ' ' LEU . 25.4 tp -62.5 -39.56 93.9 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.256 0.55 . . . . 0.0 109.997 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 16.6 t -57.35 -45.56 84.24 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.095 0.474 . . . . 0.0 110.296 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 11.4 mt -63.12 -42.14 99.46 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.206 0.527 . . . . 0.0 110.499 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 5.8 tp -65.88 -34.89 79.18 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.274 0.559 . . . . 0.0 110.442 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -65.34 -38.11 89.13 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.189 0.518 . . . . 0.0 110.936 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 36.3 mm -62.79 -43.39 98.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.526 0.679 . . . . 0.0 110.035 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.98 -37.05 56.76 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 232' ' ' LEU . . . . . 0.416 ' C ' HD23 ' C' ' 232' ' ' LEU . 8.3 tt -63.59 -44.08 95.09 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.387 0.613 . . . . 0.0 111.272 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -65.55 -35.55 81.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.347 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -59.73 -44.0 93.95 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.432 0.634 . . . . 0.0 110.296 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -69.64 -18.68 63.61 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.359 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -85.76 -13.68 47.52 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 122.023 -0.423 . . . . 0.0 111.419 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 53.1 49.61 19.65 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 122.123 0.963 . . . . 0.0 110.428 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.737 -179.973 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.369 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.426 ' O ' HG23 ' A' ' 210' ' ' THR . 3.6 t -127.77 109.44 11.65 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.747 0.784 . . . . 0.0 111.01 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 56.3 p 45.26 47.32 10.29 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 122.159 0.98 . . . . 0.0 111.736 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 12.9 p -69.9 -21.5 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.356 178.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.14 -33.0 72.74 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.073 0.463 . . . . 0.0 110.811 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.468 ' O ' HG12 ' A' ' 217' ' ' VAL . 3.3 tp -53.95 -57.07 19.43 Favored Pre-proline 0 CA--C 1.554 1.108 0 CA-C-O 119.063 -0.494 . . . . 0.0 111.534 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -63.32 -29.87 72.92 Favored 'Trans proline' 0 N--CA 1.504 2.128 0 C-N-CA 121.969 1.779 . . . . 0.0 113.612 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.5 tt -69.32 -45.31 69.79 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.813 -0.554 . . . . 0.0 111.44 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.9 p -64.93 -36.8 78.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 O-C-N 122.066 -0.396 . . . . 0.0 111.62 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 21.2 pt -70.68 -40.17 76.67 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 O-C-N 121.421 -0.8 . . . . 0.0 110.616 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -67.95 -42.14 81.4 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.668 0.747 . . . . 0.0 110.088 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -60.38 -44.14 95.92 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.535 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.62 -33.84 88.31 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.485 HD13 HG23 ' C' ' 218' ' ' ILE . 4.4 tp -59.57 -39.36 83.84 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.561 0.696 . . . . 0.0 110.323 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.52 88.28 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.292 0.568 . . . . 0.0 110.285 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.5 tp -58.89 -38.58 79.2 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.377 0.608 . . . . 0.0 110.007 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.424 HD13 HD13 ' B' ' 225' ' ' LEU . 17.5 tp -60.52 -32.35 71.38 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.197 0.522 . . . . 0.0 110.431 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 16.9 m -59.76 -43.67 94.21 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.212 0.529 . . . . 0.0 111.192 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.1 mp -65.04 -41.77 94.92 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.739 0.781 . . . . 0.0 110.58 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 25.8 mt -71.11 -34.8 71.44 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.397 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -69.24 -42.32 75.78 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.24 0.543 . . . . 0.0 111.677 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 6.1 tp -68.1 -36.06 73.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 121.588 0.708 . . . . 0.0 110.866 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -67.51 -31.69 77.18 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.51 HD13 ' C ' ' A' ' 232' ' ' LEU . 3.2 tm? -56.89 -43.04 80.9 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.542 0.687 . . . . 0.0 110.485 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -59.66 -38.94 82.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.351 0.596 . . . . 0.0 110.686 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -60.91 -44.16 97.54 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.603 0.716 . . . . 0.0 110.011 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -66.53 -34.62 78.32 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.464 0.65 . . . . 0.0 110.736 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -85.93 0.22 53.75 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.602 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -127.97 36.96 4.25 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.912 0.863 . . . . 0.0 110.625 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.747 179.802 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 25.2 m -149.59 108.3 3.84 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.375 0.607 . . . . 0.0 110.796 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 7.4 t -131.49 40.93 3.36 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.302 1.049 . . . . 0.0 110.592 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 34.2 m -70.26 -25.25 26.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.785 179.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 10.0 tp -67.14 -36.56 82.14 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.487 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.503 ' O ' HG12 ' B' ' 217' ' ' VAL . 0.2 OUTLIER -54.07 -57.64 17.12 Favored Pre-proline 0 CA--C 1.552 1.023 0 O-C-N 122.052 -0.405 . . . . 0.0 110.8 -179.149 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.95 -34.87 58.02 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 121.9 1.733 . . . . 0.0 112.722 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 7.8 tp -61.33 -45.4 94.59 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.944 0.402 . . . . 0.0 111.694 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.503 HG12 ' O ' ' B' ' 214' ' ' LEU . 9.2 p -66.46 -36.48 77.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 O-C-N 122.228 -0.295 . . . . 0.0 110.257 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 55.6 mt -68.57 -42.72 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.433 0.635 . . . . 0.0 109.342 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -65.01 -40.55 95.07 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.572 0.701 . . . . 0.0 110.193 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -59.42 -41.65 90.03 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.558 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.66 -33.74 86.1 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 6.4 tp -58.92 -31.69 68.88 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.3 0.572 . . . . 0.0 111.317 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.68 -38.78 89.05 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.091 0.472 . . . . 0.0 110.805 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 6.4 mp -61.69 -39.25 90.78 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.368 0.604 . . . . 0.0 110.149 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 225' ' ' LEU . . . . . 0.424 HD13 HD13 ' A' ' 225' ' ' LEU . 24.7 tp -58.36 -37.96 76.28 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.228 0.537 . . . . 0.0 110.678 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 12.1 t -60.36 -41.65 94.11 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.238 0.542 . . . . 0.0 110.684 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 7.4 mp -62.36 -43.32 99.09 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.189 0.519 . . . . 0.0 110.588 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 1.3 mp -68.38 -42.63 78.83 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.454 0.645 . . . . 0.0 110.22 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -63.96 -42.24 97.33 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.066 0.46 . . . . 0.0 110.748 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.75 -36.13 76.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.336 0.589 . . . . 0.0 110.13 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.82 -32.87 62.48 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 4.1 tt -62.85 -44.88 94.96 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.663 0.744 . . . . 0.0 110.595 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -66.88 -36.63 82.73 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.476 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -59.88 -48.02 83.4 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.337 0.589 . . . . 0.0 110.844 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -66.47 -22.54 66.2 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.979 0.418 . . . . 0.0 111.647 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -86.18 -7.16 58.76 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.812 0.339 . . . . 0.0 111.882 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -61.4 -36.23 79.71 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-O 121.415 0.626 . . . . 0.0 111.332 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 33.8 mtp180 . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.603 -179.59 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 4.3 m -97.68 -67.23 0.86 Allowed 'General case' 0 CA--C 1.536 0.433 0 O-C-N 122.308 -0.525 . . . . 0.0 111.403 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 8.1 t -112.55 39.23 2.53 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.056 0.931 . . . . 0.0 111.583 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 27.1 m -70.26 -22.34 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.72 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 213' ' ' LEU . . . . . 0.54 ' O ' HD23 ' C' ' 213' ' ' LEU . 1.4 tt -66.81 -35.02 79.09 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.939 0.399 . . . . 0.0 110.962 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 214' ' ' LEU . . . . . 0.581 ' O ' HG12 ' C' ' 217' ' ' VAL . 0.2 OUTLIER -50.64 -58.11 11.1 Favored Pre-proline 0 CA--C 1.553 1.084 0 O-C-N 122.03 -0.419 . . . . 0.0 110.895 -178.901 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -64.27 -34.79 54.58 Favored 'Trans proline' 0 N--CA 1.501 1.926 0 C-N-CA 121.882 1.721 . . . . 0.0 113.044 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.91 -45.11 95.94 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.417 -178.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 217' ' ' VAL . . . . . 0.581 HG12 ' O ' ' C' ' 214' ' ' LEU . 10.4 p -64.59 -36.18 76.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 122.084 -0.385 . . . . 0.0 110.873 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 218' ' ' ILE . . . . . 0.485 HG23 HD13 ' A' ' 222' ' ' LEU . 48.9 mt -62.68 -41.7 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -59.39 -42.97 92.94 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.64 0.734 . . . . 0.0 110.05 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.85 -36.96 73.06 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.364 0.602 . . . . 0.0 110.708 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.5 -33.76 88.1 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 4.9 tp -59.18 -39.77 83.59 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.38 0.61 . . . . 0.0 110.994 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.68 -40.03 93.52 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.215 0.531 . . . . 0.0 110.952 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 76.5 mt -62.04 -39.09 91.15 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.389 0.614 . . . . 0.0 110.775 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 44.7 tp -59.32 -39.14 82.17 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.498 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 9.9 p -60.81 -42.09 96.94 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.089 0.471 . . . . 0.0 110.644 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 7.1 mp -63.19 -45.48 91.58 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.342 0.592 . . . . 0.0 109.865 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.69 -37.42 87.54 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.098 0.475 . . . . 0.0 110.439 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -62.75 -42.3 99.61 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.327 0.584 . . . . 0.0 109.72 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.71 -38.93 82.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 121.462 0.648 . . . . 0.0 109.758 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.59 -31.85 60.74 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 5.7 tt -58.67 -40.33 83.21 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.472 0.653 . . . . 0.0 110.388 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -61.17 -44.26 97.59 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.386 0.612 . . . . 0.0 110.761 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -62.08 -46.22 90.05 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.358 0.599 . . . . 0.0 110.645 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -68.47 -36.01 78.37 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.233 0.54 . . . . 0.0 111.49 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -89.58 4.98 47.62 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -135.36 55.12 1.89 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 122.081 0.943 . . . . 0.0 110.319 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 63.5 ttt-85 . . . . . 0 C--O 1.221 -0.411 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.548 -179.994 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 25.5 p . . . . . 0 N--CA 1.467 0.414 0 CA-C-O 122.209 1.004 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 14.0 p -70.46 -27.95 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.887 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.5 HD13 ' O ' ' A' ' 213' ' ' LEU . 0.2 OUTLIER -69.02 -34.66 75.6 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.999 0.428 . . . . 0.0 111.571 -179.386 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.486 ' O ' HG12 ' A' ' 217' ' ' VAL . 3.2 tp -48.44 -57.19 11.4 Favored Pre-proline 0 CA--C 1.552 1.038 0 O-C-N 121.949 -0.469 . . . . 0.0 111.529 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -63.68 -37.84 44.08 Favored 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 121.802 1.668 . . . . 0.0 113.194 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 10.0 tp -60.99 -45.4 94.96 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.835 0.35 . . . . 0.0 111.667 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 214' ' ' LEU . 8.5 p -65.43 -36.39 77.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 O-C-N 122.271 -0.268 . . . . 0.0 110.697 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 68.6 mt -64.43 -43.96 97.02 Favored 'Isoleucine or valine' 0 C--N 1.345 0.374 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.475 ' CD1' HG21 ' C' ' 218' ' ' ILE . 8.3 m-30 -69.36 -37.06 77.44 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.494 0.664 . . . . 0.0 110.592 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -63.72 -36.7 84.73 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.335 0.588 . . . . 0.0 110.652 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.55 -33.71 82.92 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.537 HD13 HG23 ' C' ' 218' ' ' ILE . 0.2 OUTLIER -58.95 -25.53 63.59 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.157 0.503 . . . . 0.0 111.217 179.598 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.62 -38.69 88.55 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.139 0.495 . . . . 0.0 110.616 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.3 mp -59.5 -39.63 84.42 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.287 0.565 . . . . 0.0 110.407 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 14.7 tp -61.58 -40.97 96.67 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.384 0.611 . . . . 0.0 110.322 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 5.9 t -59.02 -46.31 88.52 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 121.333 0.587 . . . . 0.0 110.292 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.4 mt -64.47 -40.57 95.93 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.368 0.604 . . . . 0.0 110.179 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 18.2 mt -64.83 -36.58 84.8 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.062 0.458 . . . . 0.0 110.789 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -65.13 -42.21 94.1 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.249 0.547 . . . . 0.0 110.286 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 43.6 mm -63.91 -41.73 93.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 121.613 0.721 . . . . 0.0 109.967 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -62.26 -32.0 81.13 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 111.611 -0.596 . . . . 0.0 111.611 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.8 tt -58.46 -42.29 87.11 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.601 0.715 . . . . 0.0 110.819 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -66.77 -36.67 82.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.92 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 52.0 t80 . . . . . 0 C--O 1.234 0.273 0 CA-C-O 121.44 0.638 . . . . 0.0 110.422 179.98 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 47.7 t . . . . . 0 CA--C 1.539 0.538 0 CA-C-O 121.467 0.651 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 6.6 tt -67.82 -34.74 77.33 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.664 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.512 ' O ' HG12 ' B' ' 217' ' ' VAL . 0.7 OUTLIER -49.84 -57.52 12.11 Favored Pre-proline 0 CA--C 1.552 1.049 0 O-C-N 121.881 -0.512 . . . . 0.0 111.088 -178.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . 0.431 ' HA ' HD12 ' B' ' 218' ' ' ILE . 33.9 Cg_endo -63.96 -34.62 58.83 Favored 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 121.797 1.664 . . . . 0.0 112.846 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 8.2 tp -60.36 -45.37 93.75 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.987 0.422 . . . . 0.0 111.705 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.512 HG12 ' O ' ' B' ' 214' ' ' LEU . 7.2 p -66.34 -36.56 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 122.214 -0.304 . . . . 0.0 110.286 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . 0.474 ' HA ' HD22 ' C' ' 222' ' ' LEU . 53.5 mt -63.67 -42.24 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -65.14 -36.71 85.1 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.616 0.722 . . . . 0.0 109.942 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.65 -33.39 68.24 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.129 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . 0.41 ' HA3' HD11 ' C' ' 222' ' ' LEU . . . -70.92 -33.94 65.62 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.47 -32.26 73.12 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.152 0.501 . . . . 0.0 111.119 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -62.13 -38.95 90.91 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.276 0.56 . . . . 0.0 110.838 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 16.7 mt -63.77 -42.31 97.81 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.335 0.588 . . . . 0.0 110.418 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 22.0 tp -58.96 -30.82 68.19 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.189 0.518 . . . . 0.0 110.479 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 6.8 t -56.83 -45.93 82.01 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.984 0.421 . . . . 0.0 110.435 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 10.8 mt -64.52 -42.17 95.94 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.208 0.527 . . . . 0.0 110.249 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 6.7 mp -61.15 -37.42 82.79 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.483 0.659 . . . . 0.0 109.745 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -58.94 -35.48 73.19 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.347 0.594 . . . . 0.0 110.722 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 44.9 mm -62.17 -42.54 95.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.508 0.671 . . . . 0.0 110.205 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -62.77 -33.23 86.29 Favored Glycine 0 CA--C 1.535 1.306 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 232' ' ' LEU . . . . . 0.421 ' C ' HD23 ' B' ' 232' ' ' LEU . 9.3 tt . . . . . 0 N--CA 1.467 0.383 0 CA-C-O 121.43 0.633 . . . . 0.0 111.387 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 213' ' ' LEU . . . . . 0.405 HD12 ' N ' ' C' ' 214' ' ' LEU . 3.2 pp . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 214' ' ' LEU . . . . . 0.493 ' O ' HG12 ' C' ' 217' ' ' VAL . 0.6 OUTLIER -53.36 -57.4 17.01 Favored Pre-proline 0 CA--C 1.552 1.028 0 O-C-N 121.931 -0.48 . . . . 0.0 111.062 -179.113 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.67 -32.1 68.98 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 121.869 1.713 . . . . 0.0 112.992 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.49 -45.31 93.61 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.084 0.469 . . . . 0.0 111.361 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 217' ' ' VAL . . . . . 0.493 HG12 ' O ' ' C' ' 214' ' ' LEU . 7.1 p -67.0 -36.39 77.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 O-C-N 122.132 -0.355 . . . . 0.0 110.244 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 218' ' ' ILE . . . . . 0.537 HG23 HD13 ' A' ' 222' ' ' LEU . 41.8 mm -62.79 -43.71 98.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -63.04 -36.9 85.11 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.381 0.61 . . . . 0.0 109.868 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -57.74 -41.91 82.81 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.518 0.675 . . . . 0.0 110.222 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.04 -33.91 81.3 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 222' ' ' LEU . . . . . 0.474 HD22 ' HA ' ' B' ' 218' ' ' ILE . 5.2 tp -58.91 -41.61 87.66 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.573 0.701 . . . . 0.0 110.279 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.81 -38.67 89.02 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.501 0.667 . . . . 0.0 110.151 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 1.9 tt -58.62 -38.37 77.87 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.366 0.603 . . . . 0.0 110.047 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 37.9 tp -57.91 -37.63 74.39 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.116 0.484 . . . . 0.0 110.183 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 6.5 t -59.18 -40.24 85.08 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.301 0.572 . . . . 0.0 110.401 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 11.4 mt -67.21 -42.81 83.5 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.465 0.65 . . . . 0.0 110.066 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 17.0 mt -65.69 -36.48 83.76 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.069 0.461 . . . . 0.0 111.11 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -74.98 -42.18 58.06 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.321 0.581 . . . . 0.0 110.893 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 91.1 mt -64.93 -40.56 89.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.29 0.567 . . . . 0.0 110.471 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -63.83 -34.99 91.41 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.49 -39.76 81.2 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.592 0.711 . . . . 0.0 111.248 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.31 -39.27 94.1 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.576 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -65.59 -48.13 73.39 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.503 0.668 . . . . 0.0 110.873 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -66.43 -45.98 78.02 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.589 0.709 . . . . 0.0 110.861 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 49.3 t80 . . . . . 0 CA--C 1.543 0.709 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.772 -179.74 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 39.0 p . . . . . 0 C--O 1.237 0.423 0 CA-C-O 122.498 1.142 . . . . 342.29 110.463 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 40.2 t -70.03 -29.88 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 115.258 -0.883 . . . . 373.69 110.093 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.92 -31.03 69.63 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.906 0.384 . . . . 305.66 111.18 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.493 ' O ' HG12 ' A' ' 217' ' ' VAL . 1.3 tp -54.31 -57.67 17.37 Favored Pre-proline 0 CA--C 1.551 1.002 0 O-C-N 121.922 -0.486 . . . . 225.87 110.747 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -63.94 -32.48 65.59 Favored 'Trans proline' 0 N--CA 1.502 2.025 0 C-N-CA 121.887 1.725 . . . . 62.09 112.803 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 8.6 tp -62.06 -45.48 93.36 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.035 0.445 . . . . 248.22 111.471 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.493 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.9 p -67.91 -36.41 75.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.762 0.315 . . . . 35.87 110.505 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 43.6 mt -68.5 -43.88 83.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 121.857 -0.527 . . . . 147.8 109.743 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -67.04 -38.1 85.29 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.312 0.577 . . . . 807.13 110.246 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -57.95 -42.35 84.74 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.423 0.63 . . . . 227.36 110.27 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.8 -33.89 88.43 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 110.367 -1.093 . . . . 19.0 110.367 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.441 HD22 ' HA ' ' C' ' 218' ' ' ILE . 6.1 tp -60.75 -42.56 97.63 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.53 0.681 . . . . 75.47 110.653 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.73 89.31 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.402 0.62 . . . . 23.1 110.527 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.02 -37.43 76.93 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.293 0.568 . . . . 167.95 110.318 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 18.3 tp -57.67 -36.31 71.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.205 0.526 . . . . 68.45 110.337 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 5.9 t -59.7 -38.85 82.73 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.371 0.605 . . . . 138.3 110.426 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.8 mt -64.47 -42.68 95.78 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.242 0.544 . . . . 287.99 110.398 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.6 mp -71.33 -34.99 71.03 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.237 0.542 . . . . 177.82 110.718 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -70.77 -42.19 70.72 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 122.163 -0.335 . . . . 258.75 111.821 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 6.0 tp -63.84 -35.91 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.673 0.749 . . . . 271.85 110.813 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -69.14 -31.92 72.37 Favored Glycine 0 CA--C 1.533 1.206 0 N-CA-C 111.314 -0.714 . . . . 63.24 111.314 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.407 ' O ' HD23 ' A' ' 232' ' ' LEU . 5.2 tt -56.98 -46.09 82.48 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.72 0.771 . . . . 132.76 110.261 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.5 -36.49 73.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.661 -0.7 . . . . 86.51 110.567 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 37.5 t80 . . . . . 0 CA--C 1.533 0.293 0 CA-C-O 121.353 0.597 . . . . 462.81 110.368 179.755 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 29.0 m . . . . . 0 CA--C 1.538 0.482 0 CA-C-O 121.444 0.64 . . . . 341.94 110.669 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 13.4 tp -68.38 -34.73 76.57 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.902 0.382 . . . . 191.08 111.276 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.494 ' O ' HG12 ' B' ' 217' ' ' VAL . 1.3 tp -53.53 -57.62 16.39 Favored Pre-proline 0 CA--C 1.553 1.062 0 O-C-N 121.993 -0.442 . . . . 265.74 110.942 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.05 -32.77 64.05 Favored 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 121.928 1.752 . . . . 66.31 112.78 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 11.0 tp -62.41 -45.51 92.81 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.086 0.47 . . . . 240.79 111.548 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.494 HG12 ' O ' ' B' ' 214' ' ' LEU . 8.8 p -67.79 -36.48 76.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.756 0.312 . . . . 30.7 110.412 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 43.6 mt -68.97 -42.98 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 109.423 -0.584 . . . . 112.32 109.423 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -67.75 -38.34 83.34 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.502 0.668 . . . . 176.28 110.532 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -58.73 -43.65 90.23 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.349 0.595 . . . . 284.73 110.623 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.95 -33.93 87.16 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 110.407 -1.077 . . . . 23.71 110.407 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 4.3 tp -61.32 -33.63 73.92 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.528 0.68 . . . . 108.06 111.29 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.59 -38.4 87.41 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.304 0.573 . . . . 37.97 110.956 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 2.0 mp -58.76 -38.19 77.9 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.151 0.5 . . . . 134.24 110.206 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 16.4 tp -61.83 -36.69 81.91 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.989 0.423 . . . . 103.12 110.854 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.3 -46.07 86.82 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 109.831 -0.433 . . . . 198.08 109.831 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 5.9 mp -62.03 -41.38 98.04 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.199 0.523 . . . . 283.7 110.223 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 6.8 mp -60.23 -38.62 83.97 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.234 0.54 . . . . 103.06 109.772 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -62.53 -42.31 99.43 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.343 0.592 . . . . 213.98 110.236 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 50.6 mm -62.94 -45.67 98.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.508 0.671 . . . . 160.19 110.378 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.12 -36.87 86.41 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 111.38 -0.688 . . . . 76.3 111.38 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 5.8 tt . . . . . 0 C--O 1.235 0.311 0 CA-C-O 121.5 0.667 . . . . 167.04 111.299 -179.352 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 12.4 tp . . . . . 0 C--O 1.235 0.31 0 CA-C-O 120.943 0.402 . . . . 417.6 111.316 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 214' ' ' LEU . . . . . 0.488 ' O ' HG12 ' C' ' 217' ' ' VAL . 1.4 tp -53.19 -57.54 16.18 Favored Pre-proline 0 CA--C 1.551 1.011 0 O-C-N 121.987 -0.445 . . . . 279.05 110.989 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.73 -33.58 65.34 Favored 'Trans proline' 0 N--CA 1.503 2.053 0 C-N-CA 121.853 1.702 . . . . 82.65 113.016 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 216' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' C' ' 216' ' ' LEU . 0.2 OUTLIER -62.09 -45.34 93.93 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.087 0.47 . . . . 291.53 111.362 -178.458 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 217' ' ' VAL . . . . . 0.488 HG12 ' O ' ' C' ' 214' ' ' LEU . 9.0 p -68.48 -36.46 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 O-C-N 122.136 -0.352 . . . . 51.53 110.447 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 218' ' ' ILE . . . . . 0.441 ' HA ' HD22 ' A' ' 222' ' ' LEU . 50.1 mt -66.05 -44.6 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 O-C-N 121.787 -0.57 . . . . 172.35 109.496 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -66.71 -40.07 88.28 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.472 0.653 . . . . 320.86 110.117 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -59.92 -44.04 94.56 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.356 0.598 . . . . 248.21 110.652 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.32 -33.82 85.92 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 110.409 -1.077 . . . . 14.55 110.409 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 4.4 tp -59.76 -36.85 77.49 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.452 0.644 . . . . 49.3 111.13 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.66 -38.64 88.49 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.271 0.558 . . . . 28.03 110.9 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 1.1 mp -58.93 -39.86 82.89 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.247 0.546 . . . . 136.06 110.044 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 17.0 tp -58.01 -39.52 78.48 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.303 0.573 . . . . 104.95 110.503 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 40.5 t -59.12 -44.23 91.98 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.281 0.562 . . . . 166.55 110.475 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 8.8 mt -61.03 -43.49 98.82 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.231 0.538 . . . . 300.73 110.282 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 7.5 mp -67.96 -36.45 80.09 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.122 0.487 . . . . 140.32 110.66 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -66.11 -42.22 89.5 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.338 0.59 . . . . 213.53 110.782 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 32.2 mm -63.34 -42.23 95.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.642 0.734 . . . . 237.51 109.797 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -67.12 -33.3 82.87 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 111.54 -0.624 . . . . 55.48 111.54 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 232' ' ' LEU . . . . . 0.419 HD23 ' O ' ' C' ' 232' ' ' LEU . 5.0 tt -61.0 -46.12 92.04 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.638 0.732 . . . . 135.05 110.779 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -62.35 -35.93 80.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.901 -0.591 . . . . 79.83 110.8 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -61.63 -39.06 89.95 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.294 0.569 . . . . 526.85 110.402 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 5.2 mtt85 -75.26 -34.37 61.36 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.127 0.489 . . . . 940.87 111.349 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 37.7 t80 . . . . . 0 CA--C 1.541 0.616 0 CA-C-O 121.098 0.475 . . . . 507.37 111.225 179.732 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 121.578 0.704 . . . . 0.0 112.208 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 29.5 m -70.47 -33.63 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 121.626 0.727 . . . . 0.0 110.861 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 51.9 mt -69.04 -29.35 67.48 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.2 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.519 ' O ' HG12 ' A' ' 217' ' ' VAL . 1.4 tp -54.22 -57.68 17.16 Favored Pre-proline 0 CA--C 1.551 1.004 0 O-C-N 121.862 -0.524 . . . . 0.0 110.408 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.458 ' HA ' HD12 ' A' ' 218' ' ' ILE . 34.8 Cg_endo -64.05 -33.38 62.4 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 121.958 1.772 . . . . 0.0 112.503 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.83 -45.27 94.56 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.669 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.519 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.1 p -66.09 -36.46 77.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 O-C-N 122.087 -0.383 . . . . 0.0 110.392 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.458 HD12 ' HA ' ' A' ' 215' ' ' PRO . 54.5 mt -63.0 -44.53 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -65.94 -36.78 84.31 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.414 0.626 . . . . 0.0 110.032 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -57.7 -44.44 85.88 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.372 0.606 . . . . 0.0 109.786 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -66.17 -33.87 86.52 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.494 HD22 ' HA ' ' C' ' 218' ' ' ILE . 5.5 tp -59.79 -41.76 91.88 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.662 0.744 . . . . 0.0 110.31 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.7 -38.54 88.22 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.702 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.98 -37.15 76.16 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.378 0.609 . . . . 0.0 109.819 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.417 HD13 HD13 ' B' ' 225' ' ' LEU . 15.9 tp -61.73 -41.33 97.49 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.748 -0.595 . . . . 0.0 110.486 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 4.4 m -56.73 -40.83 76.44 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.215 0.531 . . . . 0.0 110.309 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 12.3 mt -66.11 -41.52 90.46 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.087 0.47 . . . . 0.0 110.121 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 6.7 mp -62.48 -38.53 90.21 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.202 0.525 . . . . 0.0 109.991 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -58.84 -41.82 87.82 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.308 0.575 . . . . 0.0 110.098 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 48.6 mm -63.04 -42.09 95.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 121.593 0.711 . . . . 0.0 109.966 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -63.87 -31.99 82.68 Favored Glycine 0 CA--C 1.535 1.286 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.403 ' C ' HD23 ' A' ' 232' ' ' LEU . 6.8 tt -58.87 -45.76 89.4 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.636 0.731 . . . . 0.0 110.943 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -59.1 -35.91 74.24 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.957 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 37.5 t80 . . . . . 0 CA--C 1.532 0.268 0 CA-C-O 121.46 0.647 . . . . 0.0 110.31 -179.88 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 121.691 0.758 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 5.9 tt -69.42 -36.27 76.53 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.451 ' O ' HG12 ' B' ' 217' ' ' VAL . 0.4 OUTLIER -52.41 -57.5 15.28 Favored Pre-proline 0 CA--C 1.552 1.026 0 O-C-N 121.604 -0.685 . . . . 0.0 111.761 -177.408 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . 0.449 ' HA ' HD12 ' B' ' 218' ' ' ILE . 19.8 Cg_exo -63.46 -31.83 71.59 Favored 'Trans proline' 0 N--CA 1.503 2.083 0 C-N-CA 121.599 1.533 . . . . 0.0 112.942 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 216' ' ' LEU . . . . . 0.51 ' O ' HD13 ' B' ' 216' ' ' LEU . 0.3 OUTLIER -62.86 -45.38 92.82 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.081 0.467 . . . . 0.0 111.458 -178.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.451 HG12 ' O ' ' B' ' 214' ' ' LEU . 8.0 p -69.29 -36.47 72.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 O-C-N 122.179 -0.326 . . . . 0.0 110.187 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . 0.449 HD12 ' HA ' ' B' ' 215' ' ' PRO . 68.9 mt -63.01 -42.99 98.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -60.55 -36.77 79.25 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.509 0.671 . . . . 0.0 110.183 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -57.78 -43.59 85.68 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.336 0.589 . . . . 0.0 110.774 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.23 -33.92 88.57 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 6.6 tp -62.45 -37.11 84.62 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.515 0.674 . . . . 0.0 111.061 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.63 88.3 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.177 0.513 . . . . 0.0 110.877 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 7.2 mp -60.47 -45.27 94.34 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.127 0.489 . . . . 0.0 110.451 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . 0.417 HD13 HD13 ' A' ' 225' ' ' LEU . 21.6 tp -63.42 -38.56 91.62 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.337 0.589 . . . . 0.0 109.993 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.39 -45.42 84.52 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.324 0.583 . . . . 0.0 110.291 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . 0.427 ' O ' HD23 ' B' ' 227' ' ' LEU . 3.1 tt -60.63 -46.14 91.42 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.411 0.624 . . . . 0.0 110.153 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 7.3 mp -63.0 -37.63 87.93 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.196 0.522 . . . . 0.0 110.4 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -63.44 -42.2 98.67 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.154 0.502 . . . . 0.0 110.274 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 39.5 mm -67.41 -42.76 87.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 121.592 0.71 . . . . 0.0 109.761 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -67.2 -33.1 81.87 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 4.3 tt . . . . . 0 C--O 1.235 0.311 0 CA-C-O 121.599 0.714 . . . . 0.0 111.002 -179.572 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 13.3 tp . . . . . 0 C--O 1.235 0.336 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 214' ' ' LEU . . . . . 0.567 ' CD2' HD11 ' C' ' 218' ' ' ILE . 1.3 tt -50.37 -57.02 14.31 Favored Pre-proline 0 CA--C 1.552 1.055 0 O-C-N 121.938 -0.476 . . . . 0.0 111.623 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.8 -33.68 64.13 Favored 'Trans proline' 0 N--CA 1.503 2.065 0 C-N-CA 121.841 1.694 . . . . 0.0 113.186 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 216' ' ' LEU . . . . . 0.506 HD13 ' O ' ' C' ' 216' ' ' LEU . 0.3 OUTLIER -61.71 -45.41 94.09 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.065 0.46 . . . . 0.0 111.499 -178.442 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 217' ' ' VAL . . . . . 0.482 HG12 ' O ' ' C' ' 214' ' ' LEU . 7.4 p -67.32 -36.44 76.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 120.848 0.356 . . . . 0.0 110.377 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 218' ' ' ILE . . . . . 0.567 HD11 ' CD2' ' C' ' 214' ' ' LEU . 47.9 mt -68.22 -42.62 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 121.358 0.599 . . . . 0.0 109.512 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -64.06 -42.1 97.12 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.496 0.665 . . . . 0.0 110.399 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -60.15 -43.53 95.66 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.524 0.678 . . . . 0.0 110.357 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.45 -33.7 87.94 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 10.2 tp -58.96 -40.81 85.86 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.24 0.543 . . . . 0.0 110.657 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.77 -43.58 98.57 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.544 0.688 . . . . 0.0 109.686 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 1.5 tt -64.74 -39.06 92.99 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.832 0.825 . . . . 0.0 109.326 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 4.7 tt -57.94 -44.16 86.78 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.457 0.646 . . . . 0.0 110.155 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 8.2 t -59.37 -43.26 92.88 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.33 0.586 . . . . 0.0 110.824 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 10.1 mt -66.53 -42.69 86.83 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.296 0.57 . . . . 0.0 110.232 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 10.7 tp -66.63 -34.82 78.73 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.092 0.472 . . . . 0.0 110.681 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -66.48 -42.13 87.95 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.413 0.625 . . . . 0.0 110.02 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 88.3 mt -63.25 -36.3 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 121.307 0.575 . . . . 0.0 110.079 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.81 -32.19 61.73 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 232' ' ' LEU . . . . . 0.527 HD13 ' C ' ' C' ' 232' ' ' LEU . 3.1 tm? -58.46 -40.61 83.16 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.625 0.726 . . . . 0.0 110.273 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.99 -39.2 77.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.052 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -60.29 -48.07 83.31 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.364 0.602 . . . . 0.0 110.679 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 35.6 mmt-85 -72.27 -26.68 62.08 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.097 0.475 . . . . 0.0 111.597 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 23.2 t80 . . . . . 0 CA--C 1.541 0.624 0 CA-C-O 120.973 0.416 . . . . 0.0 111.447 179.946 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 22.1 p . . . . . 0 C--O 1.239 0.511 0 CA-C-O 122.292 1.044 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.13 -31.32 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.875 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 13.5 tp -69.08 -34.4 75.07 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.828 0.347 . . . . 0.0 111.419 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.54 ' O ' HG12 ' A' ' 217' ' ' VAL . 10.3 tp -51.24 -56.85 16.78 Favored Pre-proline 0 CA--C 1.551 1.012 0 CA-C-O 119.065 -0.493 . . . . 0.0 111.212 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.536 ' HA ' HD12 ' A' ' 218' ' ' ILE . 35.7 Cg_endo -64.03 -38.82 35.23 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 121.614 1.543 . . . . 0.0 112.79 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.4 tp -56.88 -45.44 82.53 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.4 p -63.95 -35.97 75.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 122.23 -0.294 . . . . 0.0 110.227 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 215' ' ' PRO . 58.2 mt -62.66 -45.13 99.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 O-C-N 121.755 -0.591 . . . . 0.0 109.443 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -60.16 -46.93 88.0 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.767 0.794 . . . . 0.0 110.04 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -59.08 -44.16 91.86 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.042 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.441 ' HA3' HD11 ' B' ' 222' ' ' LEU . . . -60.3 -33.98 82.85 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 4.6 tp -61.67 -42.5 99.0 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.44 0.638 . . . . 0.0 110.694 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.82 89.47 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.223 0.535 . . . . 0.0 110.447 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.6 tt -59.68 -48.64 80.87 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.312 0.577 . . . . 0.0 109.705 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.457 HD13 HD13 ' C' ' 225' ' ' LEU . 23.6 tp -61.12 -41.27 96.39 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.443 0.64 . . . . 0.0 109.743 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 47.8 t -58.81 -47.08 86.05 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.251 0.548 . . . . 0.0 109.732 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 21.0 tp -63.62 -42.2 98.2 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.235 0.54 . . . . 0.0 110.103 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 2.6 tp -61.98 -34.95 77.09 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.26 0.552 . . . . 0.0 109.924 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -58.93 -37.72 77.35 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.245 0.545 . . . . 0.0 110.216 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.6 mp -62.95 -42.32 96.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.536 0.684 . . . . 0.0 109.246 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -63.31 -31.88 82.26 Favored Glycine 0 CA--C 1.535 1.312 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.407 ' O ' HD23 ' A' ' 232' ' ' LEU . 4.9 tt -58.32 -44.23 88.56 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.723 0.773 . . . . 0.0 110.511 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.79 -40.55 80.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.792 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 44.8 t80 . . . . . 0 C--O 1.235 0.305 0 CA-C-O 121.524 0.678 . . . . 0.0 110.223 179.914 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 CA--C 1.544 0.714 0 CA-C-O 121.448 0.642 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 13.0 tp -67.22 -38.31 85.06 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.934 0.397 . . . . 0.0 111.544 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.499 ' O ' HG12 ' B' ' 217' ' ' VAL . 0.2 OUTLIER -50.56 -57.3 13.66 Favored Pre-proline 0 CA--C 1.552 1.046 0 O-C-N 121.961 -0.462 . . . . 0.0 111.437 -179.1 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.75 -33.93 63.75 Favored 'Trans proline' 0 N--CA 1.504 2.108 0 C-N-CA 121.783 1.655 . . . . 0.0 113.018 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 9.4 tp -62.43 -45.48 92.92 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.997 0.427 . . . . 0.0 111.699 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.499 HG12 ' O ' ' B' ' 214' ' ' LEU . 7.8 p -66.29 -36.47 77.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 120.669 0.271 . . . . 0.0 110.552 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . 0.467 ' HA ' HD22 ' C' ' 222' ' ' LEU . 53.4 mt -65.19 -43.96 95.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -68.87 -36.92 78.68 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.62 0.724 . . . . 0.0 109.93 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -58.46 -42.64 87.9 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.27 0.557 . . . . 0.0 110.828 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.11 -34.13 82.57 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . 0.441 HD11 ' HA3' ' A' ' 221' ' ' GLY . 0.3 OUTLIER -60.63 -23.82 65.05 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.307 0.575 . . . . 0.0 110.967 179.403 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.46 -38.55 87.64 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.189 0.518 . . . . 0.0 110.569 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 224' ' ' LEU . . . . . 0.475 HD23 ' CG ' ' C' ' 229' ' ' PHE . 4.8 mp -59.01 -39.34 81.58 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.137 0.494 . . . . 0.0 110.471 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . 0.443 HD13 HD13 ' A' ' 225' ' ' LEU . 47.2 tp -65.98 -33.92 76.92 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.029 0.442 . . . . 0.0 110.548 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 71.4 m -58.52 -43.8 89.28 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.999 0.428 . . . . 0.0 110.115 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -60.75 -43.1 98.41 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.452 0.644 . . . . 0.0 109.771 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 7.4 mp -64.52 -38.18 90.1 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.238 0.542 . . . . 0.0 110.318 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -61.6 -42.22 98.57 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.398 0.618 . . . . 0.0 110.164 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 43.4 mm -66.35 -42.98 91.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 121.605 0.717 . . . . 0.0 109.873 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -66.31 -31.99 80.67 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 9.2 tt . . . . . 0 N--CA 1.464 0.266 0 CA-C-O 121.537 0.684 . . . . 0.0 110.962 -179.544 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 9.1 tt . . . . . 0 C--O 1.235 0.294 0 CA-C-O 120.85 0.357 . . . . 0.0 111.824 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 214' ' ' LEU . . . . . 0.553 ' O ' HG12 ' C' ' 217' ' ' VAL . 0.8 OUTLIER -46.52 -57.5 8.57 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-O 118.986 -0.531 . . . . 0.0 111.713 -178.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.01 -40.04 29.29 Favored 'Trans proline' 0 N--CA 1.505 2.171 0 C-N-CA 121.883 1.722 . . . . 0.0 113.5 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 7.3 tp -57.14 -45.19 83.76 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.006 0.431 . . . . 0.0 111.919 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 217' ' ' VAL . . . . . 0.553 HG12 ' O ' ' C' ' 214' ' ' LEU . 8.3 p -63.72 -36.35 76.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 O-C-N 122.187 -0.32 . . . . 0.0 111.03 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 19.4 mm -62.96 -45.07 99.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -67.4 -36.98 82.37 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.568 0.699 . . . . 0.0 109.721 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -58.16 -44.37 87.89 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.287 0.565 . . . . 0.0 110.407 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.72 -33.89 88.46 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 222' ' ' LEU . . . . . 0.467 HD22 ' HA ' ' B' ' 218' ' ' ILE . 6.6 tp -60.7 -41.56 95.44 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.443 0.639 . . . . 0.0 110.694 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.89 -38.72 89.39 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.326 0.584 . . . . 0.0 110.571 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 1.2 tp -58.79 -40.75 84.96 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.353 0.597 . . . . 0.0 109.997 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . 0.457 HD13 HD13 ' A' ' 225' ' ' LEU . 20.4 tp -58.28 -39.53 79.5 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.233 0.539 . . . . 0.0 110.448 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 49.8 m -57.64 -45.96 84.78 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.269 0.557 . . . . 0.0 110.703 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 26.5 tp -63.63 -42.08 98.21 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.236 0.541 . . . . 0.0 110.359 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 7.4 mp -66.22 -36.99 84.46 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.043 0.449 . . . . 0.0 110.771 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 229' ' ' PHE . . . . . 0.475 ' CG ' HD23 ' B' ' 224' ' ' LEU . 30.1 t80 -70.51 -42.45 71.29 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.089 0.471 . . . . 0.0 111.355 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 37.9 mm -67.8 -41.16 84.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 121.575 0.702 . . . . 0.0 109.874 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -64.24 -33.0 86.06 Favored Glycine 0 CA--C 1.533 1.201 0 N-CA-C 111.634 -0.587 . . . . 0.0 111.634 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 232' ' ' LEU . . . . . 0.454 HD23 ' O ' ' C' ' 232' ' ' LEU . 4.1 tt -59.44 -46.02 89.94 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.704 0.764 . . . . 0.0 110.632 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -69.49 -35.79 75.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.158 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -59.85 -48.09 83.08 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.303 0.573 . . . . 0.0 110.868 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -72.03 -40.35 68.47 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.524 0.678 . . . . 0.0 111.299 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 20.3 t80 . . . . . 0 CA--C 1.541 0.607 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.132 -179.409 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 211' ' ' THR . 9.5 t . . . . . 0 C--O 1.237 0.428 0 CA-C-O 122.329 1.061 . . . . 0.0 110.834 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 28.3 m -57.85 -25.23 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.455 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 12.8 tp -69.07 -32.29 71.64 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.883 0.373 . . . . 0.0 110.98 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.471 ' O ' HG12 ' A' ' 217' ' ' VAL . 0.2 OUTLIER -51.77 -57.68 13.84 Favored Pre-proline 0 CA--C 1.55 0.972 0 O-C-N 121.985 -0.447 . . . . 0.0 111.35 -179.272 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.64 -31.35 70.05 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 121.962 1.775 . . . . 0.0 113.433 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.471 ' O ' HD23 ' A' ' 216' ' ' LEU . 3.9 tt -64.03 -45.59 88.23 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.277 0.56 . . . . 0.0 111.151 -178.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.6 p -67.91 -36.65 76.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 120.784 0.326 . . . . 0.0 110.434 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.425 HD11 HD12 ' A' ' 214' ' ' LEU . 47.1 mt -69.46 -41.72 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -63.57 -36.86 85.19 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.325 0.583 . . . . 0.0 110.119 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -57.57 -44.61 85.43 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.259 0.552 . . . . 0.0 110.126 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.445 ' HA3' HD11 ' B' ' 222' ' ' LEU . . . -67.78 -33.95 81.58 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 7.7 tp -60.29 -35.02 74.61 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.33 0.586 . . . . 0.0 111.039 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.74 89.16 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.213 0.53 . . . . 0.0 110.891 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 48.8 mt -59.04 -39.56 82.36 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.274 0.559 . . . . 0.0 110.638 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 18.1 tp -58.95 -38.65 79.53 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.322 0.582 . . . . 0.0 110.5 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 7.5 t -59.89 -43.41 94.79 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.418 0.627 . . . . 0.0 110.646 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -63.04 -42.44 99.75 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.427 0.632 . . . . 0.0 110.693 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.6 mp -71.08 -35.25 71.79 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.07 0.462 . . . . 0.0 111.225 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -70.13 -42.43 72.61 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.253 0.549 . . . . 0.0 111.618 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 7.3 tp -69.15 -36.37 72.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.617 0.722 . . . . 0.0 111.166 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.82 -31.92 61.8 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 5.1 tt -59.93 -46.04 90.64 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.725 0.774 . . . . 0.0 110.659 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -64.96 -39.5 93.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.74 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 47.8 t80 . . . . . 0 C--O 1.234 0.245 0 CA-C-O 121.524 0.678 . . . . 0.0 110.339 179.906 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 13.2 p . . . . . 0 CA--C 1.542 0.664 0 CA-C-O 121.288 0.565 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 12.7 tp -68.82 -31.6 70.7 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.674 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.477 ' O ' HG12 ' B' ' 217' ' ' VAL . 0.1 OUTLIER -53.29 -57.72 15.57 Favored Pre-proline 0 CA--C 1.552 1.054 0 O-C-N 122.007 -0.433 . . . . 0.0 110.913 -179.218 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.88 -32.9 65.8 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 121.85 1.7 . . . . 0.0 113.025 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 9.5 tp -62.56 -45.37 93.26 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.099 0.476 . . . . 0.0 111.491 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.477 HG12 ' O ' ' B' ' 214' ' ' LEU . 8.3 p -67.96 -36.58 76.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 122.248 -0.283 . . . . 0.0 110.285 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 53.5 mt -66.62 -44.14 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -65.13 -37.33 87.09 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.435 0.636 . . . . 0.0 110.299 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.96 -36.6 72.79 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.163 0.506 . . . . 0.0 110.447 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . 0.483 ' HA3' HD11 ' C' ' 222' ' ' LEU . . . -65.6 -33.85 87.38 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . 0.445 HD11 ' HA3' ' A' ' 221' ' ' GLY . 7.3 tp -58.96 -39.66 82.37 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.387 0.613 . . . . 0.0 110.855 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.84 89.52 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.288 0.566 . . . . 0.0 110.825 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 7.8 mp -62.01 -38.23 87.86 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.24 0.543 . . . . 0.0 110.627 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 16.3 tp -61.28 -40.59 94.68 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.296 0.57 . . . . 0.0 110.391 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 28.3 p -57.98 -45.89 86.04 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.263 0.554 . . . . 0.0 110.213 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 17.6 tp -64.48 -42.21 96.02 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.385 0.612 . . . . 0.0 110.066 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 49.6 mt -63.45 -34.85 78.66 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.246 0.546 . . . . 0.0 110.649 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -65.03 -42.06 94.71 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.476 0.655 . . . . 0.0 110.373 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 43.1 mm -63.33 -43.47 98.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 121.624 0.726 . . . . 0.0 110.033 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -67.0 -33.42 83.79 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 5.8 tt . . . . . 0 C--O 1.236 0.343 0 CA-C-O 121.565 0.698 . . . . 0.0 111.091 -179.442 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.536 0.433 0 CA-C-O 120.99 0.424 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 214' ' ' LEU . . . . . 0.493 ' O ' HG12 ' C' ' 217' ' ' VAL . 13.6 tp -47.12 -57.01 10.24 Favored Pre-proline 0 CA--C 1.553 1.078 0 CA-C-O 118.892 -0.575 . . . . 0.0 111.975 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 215' ' ' PRO . . . . . 0.463 ' HA ' HD12 ' C' ' 218' ' ' ILE . 36.6 Cg_endo -63.38 -34.77 65.03 Favored 'Trans proline' 0 N--CA 1.505 2.172 0 C-N-CA 121.857 1.705 . . . . 0.0 113.401 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 216' ' ' LEU . . . . . 0.416 ' O ' HD23 ' C' ' 216' ' ' LEU . 3.3 tt -61.45 -45.6 93.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.072 0.463 . . . . 0.0 111.341 -178.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 217' ' ' VAL . . . . . 0.493 HG12 ' O ' ' C' ' 214' ' ' LEU . 7.1 p -66.34 -36.6 77.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 O-C-N 122.111 -0.368 . . . . 0.0 110.498 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 218' ' ' ILE . . . . . 0.463 HD12 ' HA ' ' C' ' 215' ' ' PRO . 62.1 mt -62.95 -39.65 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -59.41 -43.45 93.01 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.359 0.599 . . . . 0.0 110.509 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -58.38 -44.03 88.73 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.06 0.457 . . . . 0.0 110.599 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.81 -33.85 88.36 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 222' ' ' LEU . . . . . 0.483 HD11 ' HA3' ' B' ' 221' ' ' GLY . 6.0 tp -59.21 -40.09 84.71 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.47 0.653 . . . . 0.0 110.871 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.7 -38.91 89.59 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.237 0.541 . . . . 0.0 110.833 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 7.5 mp -61.74 -41.32 97.49 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.258 0.552 . . . . 0.0 110.436 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 15.2 tp -60.54 -41.06 93.71 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.363 0.601 . . . . 0.0 110.328 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 38.9 t -60.35 -40.35 90.4 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.282 0.563 . . . . 0.0 110.643 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 12.2 mt -66.54 -41.11 89.2 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.357 0.599 . . . . 0.0 110.706 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 7.1 mp -71.13 -35.06 71.59 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.223 0.535 . . . . 0.0 110.941 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -63.6 -42.89 98.21 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.098 0.475 . . . . 0.0 111.869 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 40.1 pt -69.28 -35.43 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-O 121.514 0.673 . . . . 0.0 110.738 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.83 -31.97 61.56 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 110.559 -1.017 . . . . 0.0 110.559 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 232' ' ' LEU . . . . . 0.454 HD23 ' O ' ' C' ' 232' ' ' LEU . 3.8 tt -56.93 -39.34 74.33 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-O 121.692 0.758 . . . . 0.0 110.165 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.89 -44.01 86.45 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.395 0.617 . . . . 0.0 110.594 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -65.39 -43.42 90.72 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.387 0.613 . . . . 0.0 110.49 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 6.5 mmt85 -65.36 -25.04 67.4 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.115 0.483 . . . . 0.0 111.54 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 34.2 t80 . . . . . 0 CA--C 1.542 0.641 0 O-C-N 121.968 -0.458 . . . . 0.0 111.975 -179.344 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 39.6 p . . . . . 0 C--O 1.236 0.381 0 CA-C-O 122.545 1.164 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 13.1 p -70.14 -34.09 57.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.759 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.579 HD13 ' O ' ' A' ' 213' ' ' LEU . 0.3 OUTLIER -63.66 -40.11 96.03 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.978 -179.24 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.49 ' O ' HG12 ' A' ' 217' ' ' VAL . 3.1 tp -51.49 -57.36 14.62 Favored Pre-proline 0 CA--C 1.553 1.067 0 O-C-N 121.74 -0.6 . . . . 0.0 111.332 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.09 -32.68 63.76 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 121.816 1.678 . . . . 0.0 112.79 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.1 tt -62.3 -45.46 93.15 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.955 0.407 . . . . 0.0 111.317 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 214' ' ' LEU . 8.0 p -67.76 -36.53 76.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 O-C-N 122.243 -0.286 . . . . 0.0 110.385 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 43.7 mt -69.3 -43.41 81.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-O 121.404 0.621 . . . . 0.0 109.333 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -65.41 -37.02 85.7 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.397 0.618 . . . . 0.0 110.688 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.79 -38.44 75.48 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.653 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.484 ' HA3' HD11 ' B' ' 222' ' ' LEU . . . -65.31 -33.87 87.9 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.451 HD11 ' HA3' ' C' ' 221' ' ' GLY . 3.8 tp -59.28 -45.35 91.49 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.704 0.764 . . . . 0.0 109.677 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.87 -38.34 87.92 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.644 0.735 . . . . 0.0 110.072 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.473 HD21 ' CE2' ' B' ' 229' ' ' PHE . 4.6 tp -58.67 -40.39 83.39 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.25 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 22.8 tp -59.09 -37.42 77.08 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.955 0.407 . . . . 0.0 110.582 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 17.5 m -56.99 -41.88 79.24 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.413 0.625 . . . . 0.0 110.149 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.438 ' O ' HG22 ' A' ' 230' ' ' ILE . 7.0 mp -64.47 -39.9 94.68 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.397 0.618 . . . . 0.0 110.43 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 61.5 mt -71.37 -34.55 70.54 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.215 0.531 . . . . 0.0 111.439 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -59.93 -42.47 94.03 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 227' ' ' LEU . 7.5 tp -65.08 -35.93 76.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.608 0.718 . . . . 0.0 110.996 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -62.41 -31.9 81.11 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.413 ' C ' HD23 ' A' ' 232' ' ' LEU . 8.1 tt -57.12 -43.08 82.0 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.74 0.781 . . . . 0.0 110.479 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -69.35 -35.91 76.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.096 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 49.9 t80 . . . . . 0 CA--C 1.534 0.36 0 CA-C-O 121.045 0.45 . . . . 0.0 111.22 -179.185 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 CA--C 1.537 0.479 0 CA-C-O 121.452 0.644 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 13.4 tp -66.12 -32.59 74.14 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.059 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.526 ' O ' HG12 ' B' ' 217' ' ' VAL . 0.2 OUTLIER -54.99 -58.01 16.77 Favored Pre-proline 0 CA--C 1.55 0.945 0 O-C-N 121.817 -0.552 . . . . 0.0 110.401 -179.24 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . 0.405 ' HA ' HD12 ' B' ' 218' ' ' ILE . 31.2 Cg_endo -64.5 -34.0 54.82 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 121.765 1.644 . . . . 0.0 112.178 178.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 216' ' ' LEU . . . . . 0.461 ' O ' HD13 ' B' ' 216' ' ' LEU . 0.2 OUTLIER -61.16 -45.26 95.35 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.631 -178.362 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.526 HG12 ' O ' ' B' ' 214' ' ' LEU . 9.6 p -66.39 -36.43 77.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 122.114 -0.366 . . . . 0.0 110.302 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' B' ' 215' ' ' PRO . 36.8 mt -66.48 -45.21 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -64.44 -36.7 85.04 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.506 0.669 . . . . 0.0 110.121 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -57.63 -44.58 85.65 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.259 0.552 . . . . 0.0 110.51 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.65 -35.11 91.61 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . 0.484 HD11 ' HA3' ' A' ' 221' ' ' GLY . 7.2 tp -58.85 -43.99 90.91 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.549 0.69 . . . . 0.0 110.284 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.57 88.37 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.403 0.621 . . . . 0.0 110.605 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 1.4 tp -58.94 -40.61 85.17 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.274 0.559 . . . . 0.0 109.989 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 18.8 tp -58.68 -37.22 75.57 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.173 0.511 . . . . 0.0 110.695 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 11.1 p -56.93 -38.92 73.57 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.294 0.569 . . . . 0.0 110.629 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . 0.68 ' O ' HG22 ' B' ' 230' ' ' ILE . 1.5 tt -58.02 -48.26 80.6 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.375 0.607 . . . . 0.0 110.453 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 8.4 mp -71.7 -36.74 70.65 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.286 0.565 . . . . 0.0 110.964 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 229' ' ' PHE . . . . . 0.473 ' CE2' HD21 ' A' ' 224' ' ' LEU . 38.5 t80 -66.4 -37.43 85.23 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.68 HG22 ' O ' ' B' ' 227' ' ' LEU . 7.9 tp -62.83 -35.51 71.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.32 0.581 . . . . 0.0 111.629 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.18 -31.9 63.43 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 232' ' ' LEU . . . . . 0.489 ' C ' HD23 ' B' ' 232' ' ' LEU . 9.4 tt . . . . . 0 C--O 1.235 0.318 0 CA-C-O 121.485 0.659 . . . . 0.0 111.122 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 16.5 tp . . . . . 0 CA--C 1.535 0.377 0 CA-C-O 120.71 0.291 . . . . 0.0 111.549 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 214' ' ' LEU . . . . . 0.515 ' O ' HG12 ' C' ' 217' ' ' VAL . 1.9 tt -53.23 -57.49 16.45 Favored Pre-proline 0 CA--C 1.551 0.985 0 CA-C-O 119.083 -0.484 . . . . 0.0 111.039 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.14 -34.72 56.35 Favored 'Trans proline' 0 N--CA 1.501 1.957 0 C-N-CA 121.714 1.609 . . . . 0.0 112.748 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 216' ' ' LEU . . . . . 0.464 ' O ' HD23 ' C' ' 216' ' ' LEU . 2.8 tt -62.29 -45.36 93.61 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.55 -178.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 217' ' ' VAL . . . . . 0.515 HG12 ' O ' ' C' ' 214' ' ' LEU . 10.3 p -65.7 -36.37 77.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 O-C-N 122.163 -0.336 . . . . 0.0 110.775 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 53.8 mt -65.66 -44.05 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -67.56 -36.48 81.02 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.585 0.707 . . . . 0.0 110.072 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -57.71 -42.43 83.74 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.011 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 221' ' ' GLY . . . . . 0.451 ' HA3' HD11 ' A' ' 222' ' ' LEU . . . -59.89 -33.89 80.51 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.79 -29.45 66.83 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.206 0.527 . . . . 0.0 110.942 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.79 -38.79 89.39 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.324 0.583 . . . . 0.0 110.656 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 25.4 mt -61.89 -37.51 84.85 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.409 0.623 . . . . 0.0 110.647 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 11.6 tp -59.65 -36.51 76.54 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.078 0.466 . . . . 0.0 110.838 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 15.7 t -58.39 -39.12 78.79 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.329 0.585 . . . . 0.0 110.498 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 227' ' ' LEU . . . . . 0.421 ' O ' HG22 ' C' ' 230' ' ' ILE . 21.3 tp -62.78 -44.49 96.04 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.415 0.626 . . . . 0.0 110.385 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 8.3 mp -71.36 -34.86 70.86 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.477 0.656 . . . . 0.0 111.349 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -62.27 -42.33 99.25 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 230' ' ' ILE . . . . . 0.421 HG22 ' O ' ' C' ' 227' ' ' LEU . 5.5 tp -65.32 -38.53 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.494 0.664 . . . . 0.0 111.211 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.87 -32.79 74.08 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 4.4 tt -58.87 -43.06 90.78 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.551 0.691 . . . . 0.0 110.98 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -60.68 -40.96 94.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.368 0.604 . . . . 0.0 110.581 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -65.63 -43.06 90.68 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.619 0.723 . . . . 0.0 110.402 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.77 -18.06 64.73 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.207 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 21.3 t80 . . . . . 0 CA--C 1.541 0.628 0 O-C-N 121.898 -0.501 . . . . 0.0 111.962 -179.603 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 80.0 p . . . . . 0 C--O 1.238 0.481 0 CA-C-O 122.338 1.066 . . . . 0.0 110.335 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 26.9 m -66.2 -30.0 48.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.88 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.488 HD23 ' O ' ' A' ' 213' ' ' LEU . 1.2 tt -68.98 -35.64 76.96 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.955 0.407 . . . . 0.0 110.931 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.502 ' O ' HG12 ' A' ' 217' ' ' VAL . 0.9 OUTLIER -48.77 -57.32 11.45 Favored Pre-proline 0 CA--C 1.551 1.015 0 O-C-N 121.829 -0.544 . . . . 0.0 111.299 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.503 ' HA ' HD12 ' A' ' 218' ' ' ILE . 32.7 Cg_endo -63.86 -34.22 61.41 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 121.82 1.68 . . . . 0.0 112.931 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 5.4 tt -61.69 -45.49 93.78 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.959 0.409 . . . . 0.0 111.529 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.3 p -66.08 -36.65 77.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 O-C-N 122.174 -0.329 . . . . 0.0 110.534 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 215' ' ' PRO . 48.9 mt -63.11 -45.13 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -67.48 -36.98 82.2 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.615 0.722 . . . . 0.0 109.799 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -58.86 -42.54 89.65 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.34 0.59 . . . . 0.0 110.692 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -62.74 -33.89 88.12 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.432 HD11 ' HA3' ' C' ' 221' ' ' GLY . 0.3 OUTLIER -62.89 -29.2 70.58 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.194 0.521 . . . . 0.0 111.012 179.598 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -62.15 -38.84 90.53 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.251 0.548 . . . . 0.0 110.674 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.9 mp -63.14 -42.86 99.54 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.289 0.566 . . . . 0.0 110.218 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.623 HD11 HD12 ' C' ' 228' ' ' LEU . 31.8 tp -59.48 -41.17 89.18 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.256 0.55 . . . . 0.0 109.995 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 33.1 m -58.18 -47.18 84.2 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.17 0.509 . . . . 0.0 110.471 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -61.54 -42.11 98.35 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.189 0.519 . . . . 0.0 110.528 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 6.7 mp -66.52 -36.59 83.09 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.158 0.504 . . . . 0.0 110.588 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -66.93 -42.15 85.82 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.321 0.582 . . . . 0.0 110.909 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 27.6 mm -62.81 -41.95 94.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 121.494 0.664 . . . . 0.0 110.002 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -61.14 -32.77 81.67 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 111.706 -0.558 . . . . 0.0 111.706 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 9.5 tt -61.41 -38.31 86.64 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 122.037 -0.684 . . . . 0.0 111.369 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.87 -35.92 82.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.136 0.493 . . . . 0.0 111.255 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 36.4 t80 . . . . . 0 C--O 1.235 0.309 0 CA-C-O 121.409 0.623 . . . . 0.0 110.389 -179.613 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 CA--C 1.544 0.739 0 CA-C-O 121.491 0.663 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 213' ' ' LEU . . . . . 0.443 HD23 ' O ' ' B' ' 213' ' ' LEU . 3.5 tt -66.96 -40.79 87.56 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.986 0.422 . . . . 0.0 111.161 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.469 ' O ' HG12 ' B' ' 217' ' ' VAL . 20.2 tp -48.98 -57.54 11.09 Favored Pre-proline 0 CA--C 1.559 1.323 0 O-C-N 121.828 -0.545 . . . . 0.0 111.415 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.23 -29.57 64.32 Favored 'Trans proline' 0 N--CA 1.504 2.09 0 C-N-CA 122.01 1.807 . . . . 0.0 113.05 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 9.5 tp -68.51 -45.08 73.24 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.085 0.469 . . . . 0.0 111.761 -178.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.469 HG12 ' O ' ' B' ' 214' ' ' LEU . 9.8 p -65.81 -36.96 78.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 O-C-N 122.272 -0.268 . . . . 0.0 111.344 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 24.8 pt -71.15 -39.24 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 O-C-N 121.518 -0.739 . . . . 0.0 110.589 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -67.21 -37.09 83.04 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.468 0.652 . . . . 0.0 110.3 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -57.69 -40.4 79.35 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.219 0.533 . . . . 0.0 110.74 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . 0.501 ' HA3' HD11 ' C' ' 222' ' ' LEU . . . -65.28 -34.0 88.29 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 7.6 tp -58.95 -39.67 82.39 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.688 0.756 . . . . 0.0 109.88 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.67 -38.19 86.85 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.586 0.708 . . . . 0.0 109.981 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.2 tp -58.46 -41.88 86.18 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.344 0.592 . . . . 0.0 109.914 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 19.3 tp -57.96 -32.36 67.77 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.15 0.5 . . . . 0.0 110.352 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 6.3 m -56.95 -43.2 81.33 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.15 0.5 . . . . 0.0 110.251 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 6.1 mp -59.08 -44.04 91.84 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.212 0.53 . . . . 0.0 110.28 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 7.3 mp -67.06 -39.37 86.88 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.181 0.515 . . . . 0.0 110.535 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -63.6 -42.16 98.26 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.205 0.526 . . . . 0.0 110.804 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 31.1 mm -62.9 -39.02 83.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.474 0.654 . . . . 0.0 109.862 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -58.23 -32.82 68.3 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.467 0.383 0 CA-C-O 121.458 0.647 . . . . 0.0 111.589 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 9.9 tp . . . . . 0 C--O 1.235 0.293 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 214' ' ' LEU . . . . . 0.485 ' O ' HG12 ' C' ' 217' ' ' VAL . 3.5 tp -48.98 -57.22 11.96 Favored Pre-proline 0 CA--C 1.551 0.998 0 O-C-N 121.892 -0.505 . . . . 0.0 111.133 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.85 -35.5 55.86 Favored 'Trans proline' 0 N--CA 1.505 2.192 0 C-N-CA 121.736 1.624 . . . . 0.0 113.073 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 216' ' ' LEU . . . . . 0.453 ' O ' HD23 ' C' ' 216' ' ' LEU . 3.6 tt -62.02 -45.53 93.18 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.057 0.456 . . . . 0.0 111.487 -178.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 217' ' ' VAL . . . . . 0.485 HG12 ' O ' ' C' ' 214' ' ' LEU . 9.2 p -66.53 -36.63 77.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 O-C-N 122.087 -0.383 . . . . 0.0 110.63 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 43.3 mt -69.03 -42.35 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -66.55 -38.35 86.94 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.621 0.725 . . . . 0.0 110.276 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -57.93 -39.19 77.4 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.676 0.75 . . . . 0.0 110.378 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 221' ' ' GLY . . . . . 0.432 ' HA3' HD11 ' A' ' 222' ' ' LEU . . . -59.89 -33.41 78.41 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 222' ' ' LEU . . . . . 0.501 HD11 ' HA3' ' B' ' 221' ' ' GLY . 3.6 tp -58.49 -39.44 80.02 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.541 0.686 . . . . 0.0 110.441 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.94 -38.29 87.92 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.503 0.668 . . . . 0.0 110.032 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 3.2 tp -58.66 -40.32 83.15 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.419 0.628 . . . . 0.0 110.072 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 18.7 tp -59.84 -30.86 69.25 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.231 0.538 . . . . 0.0 110.415 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 2.1 t -58.55 -38.97 78.95 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.136 0.493 . . . . 0.0 110.695 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 8.2 mp -61.29 -47.82 84.23 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.398 0.618 . . . . 0.0 111.007 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 228' ' ' LEU . . . . . 0.623 HD12 HD11 ' A' ' 225' ' ' LEU . 14.6 mt -71.21 -35.08 71.38 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.167 0.508 . . . . 0.0 111.252 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -70.74 -42.22 70.81 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.015 0.436 . . . . 0.0 111.808 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 7.6 tp -67.9 -35.93 73.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 121.561 0.696 . . . . 0.0 111.293 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -69.6 -31.82 70.87 Favored Glycine 0 CA--C 1.535 1.312 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 232' ' ' LEU . . . . . 0.483 HD23 ' C ' ' C' ' 232' ' ' LEU . 10.3 tt -60.78 -43.7 97.75 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.442 0.639 . . . . 0.0 110.867 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -67.68 -38.78 84.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.456 0.646 . . . . 0.0 110.763 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -61.58 -47.57 84.91 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.503 0.668 . . . . 0.0 110.378 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 10.1 ttt-85 -66.96 -21.67 65.96 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.313 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 43.7 t80 . . . . . 0 CA--C 1.543 0.686 0 O-C-N 122.097 -0.377 . . . . 0.0 111.731 179.873 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 15.2 p . . . . . 0 N--CA 1.471 0.598 0 CA-C-O 121.328 0.585 . . . . 0.0 112.401 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 47.3 t -70.67 -40.09 76.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.704 0.764 . . . . 0.0 109.905 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 10.6 tp -67.84 -29.9 69.16 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.145 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.535 ' O ' HG12 ' A' ' 217' ' ' VAL . 0.7 OUTLIER -54.15 -57.65 17.19 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 121.901 -0.499 . . . . 0.0 110.816 -178.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.16 -32.31 63.39 Favored 'Trans proline' 0 N--CA 1.504 2.135 0 C-N-CA 121.759 1.639 . . . . 0.0 112.849 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.9 tt -62.89 -45.44 92.52 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.981 0.419 . . . . 0.0 111.582 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.6 p -65.4 -36.77 78.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 O-C-N 122.25 -0.281 . . . . 0.0 110.68 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 38.4 mm -70.71 -43.51 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-O 121.636 0.732 . . . . 0.0 109.127 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -62.12 -36.5 81.94 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.402 0.62 . . . . 0.0 110.475 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -57.53 -43.8 84.6 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.366 0.603 . . . . 0.0 110.171 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -66.62 -34.34 87.24 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.401 HD11 ' HA3' ' C' ' 221' ' ' GLY . 6.5 tp -61.45 -39.99 92.85 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.55 0.691 . . . . 0.0 110.5 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.66 -38.42 87.67 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.409 0.624 . . . . 0.0 110.417 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.455 ' O ' HD23 ' A' ' 224' ' ' LEU . 1.6 tt -58.62 -37.43 75.88 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.17 0.509 . . . . 0.0 110.083 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 20.9 tp -59.11 -41.6 88.54 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.31 0.576 . . . . 0.0 110.021 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 43.1 t -60.51 -40.79 92.7 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.469 0.652 . . . . 0.0 110.208 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.471 ' O ' HG22 ' A' ' 230' ' ' ILE . 0.8 OUTLIER -61.83 -42.69 99.34 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.397 0.618 . . . . 0.0 110.162 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.416 HD21 ' CD1' ' B' ' 232' ' ' LEU . 1.6 mp -71.35 -34.79 70.81 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.368 0.604 . . . . 0.0 110.949 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -58.96 -42.28 89.53 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 227' ' ' LEU . 7.6 tp -64.55 -36.93 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.603 0.716 . . . . 0.0 111.227 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.42 -31.82 62.92 Favored Glycine 0 CA--C 1.534 1.225 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.497 ' O ' HD23 ' A' ' 232' ' ' LEU . 1.6 tt -57.67 -36.18 71.57 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.549 0.69 . . . . 0.0 110.849 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -61.21 -39.76 91.44 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.32 0.581 . . . . 0.0 111.006 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 34.8 t80 . . . . . 0 C--O 1.234 0.281 0 CA-C-O 121.407 0.622 . . . . 0.0 111.066 -179.37 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 CA--C 1.538 0.495 0 CA-C-O 121.454 0.645 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 11.1 tp -64.62 -36.4 84.12 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.537 ' O ' HG12 ' B' ' 217' ' ' VAL . 0.1 OUTLIER -54.41 -57.73 17.23 Favored Pre-proline 0 CA--C 1.55 0.958 0 O-C-N 121.882 -0.511 . . . . 0.0 110.905 -179.056 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -64.07 -32.84 63.77 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 121.872 1.715 . . . . 0.0 112.896 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 8.9 tp -60.72 -45.23 95.03 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.049 0.452 . . . . 0.0 111.754 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.537 HG12 ' O ' ' B' ' 214' ' ' LEU . 7.3 p -65.67 -36.65 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 O-C-N 122.098 -0.376 . . . . 0.0 110.524 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 39.3 mm -65.18 -43.84 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -64.95 -36.59 84.9 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.225 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -57.35 -44.94 84.77 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.345 0.593 . . . . 0.0 109.716 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -67.43 -33.77 82.81 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 178.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 6.0 tp -61.95 -35.38 78.27 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.513 0.673 . . . . 0.0 111.055 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.62 88.27 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.152 0.501 . . . . 0.0 110.971 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 7.9 mp -58.87 -39.17 80.57 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.134 0.492 . . . . 0.0 110.49 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . 0.461 HD13 HD13 ' C' ' 225' ' ' LEU . 15.1 tp -61.46 -42.85 99.4 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.296 0.57 . . . . 0.0 110.083 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 58.7 m -60.42 -47.08 87.63 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 121.116 0.484 . . . . 0.0 110.426 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.19 -41.63 97.0 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.314 0.578 . . . . 0.0 110.152 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 7.4 tp -61.73 -34.81 76.46 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.286 0.565 . . . . 0.0 109.806 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -62.31 -36.29 81.67 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.412 0.625 . . . . 0.0 110.321 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 46.2 mm -62.88 -44.91 99.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 121.581 0.705 . . . . 0.0 110.34 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -71.74 -33.36 63.36 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 232' ' ' LEU . . . . . 0.416 ' CD1' HD21 ' A' ' 228' ' ' LEU . 5.1 tt . . . . . 0 C--O 1.235 0.303 0 CA-C-O 121.531 0.681 . . . . 0.0 111.176 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 213' ' ' LEU . . . . . 0.506 ' O ' HD23 ' C' ' 213' ' ' LEU . 3.2 tt . . . . . 0 CA--C 1.533 0.306 0 CA-C-O 121.114 0.483 . . . . 0.0 111.277 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 214' ' ' LEU . . . . . 0.488 ' O ' HG12 ' C' ' 217' ' ' VAL . 14.0 tp -45.62 -57.25 8.08 Favored Pre-proline 0 CA--C 1.556 1.187 0 CA-C-O 118.962 -0.542 . . . . 0.0 112.038 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 215' ' ' PRO . . . . . 0.424 ' HA ' HD12 ' C' ' 218' ' ' ILE . 37.6 Cg_endo -63.7 -36.85 49.75 Favored 'Trans proline' 0 N--CA 1.506 2.236 0 C-N-CA 121.801 1.667 . . . . 0.0 113.689 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.8 -45.22 94.8 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 122.075 -0.391 . . . . 0.0 111.465 -178.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 217' ' ' VAL . . . . . 0.488 HG12 ' O ' ' C' ' 214' ' ' LEU . 7.9 p -64.98 -36.66 78.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 O-C-N 122.084 -0.385 . . . . 0.0 110.566 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 218' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' C' ' 215' ' ' PRO . 50.8 mt -63.11 -45.16 99.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -65.6 -37.31 86.26 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.492 0.663 . . . . 0.0 109.729 178.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -58.12 -44.33 87.71 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.513 0.673 . . . . 0.0 110.393 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 221' ' ' GLY . . . . . 0.401 ' HA3' HD11 ' A' ' 222' ' ' LEU . . . -65.35 -33.99 88.15 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 4.9 tp -59.78 -43.19 94.49 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.421 0.629 . . . . 0.0 109.97 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.62 88.89 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.367 0.603 . . . . 0.0 110.413 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 1.2 tt -58.9 -40.9 85.88 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.124 0.487 . . . . 0.0 110.357 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . 0.461 HD13 HD13 ' B' ' 225' ' ' LEU . 22.7 tp -58.99 -40.48 84.99 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.057 0.456 . . . . 0.0 110.764 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 26.9 p -56.64 -41.04 76.49 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.195 0.521 . . . . 0.0 110.409 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.66 -39.79 91.74 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.267 0.556 . . . . 0.0 110.245 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 6.8 mp -67.22 -38.25 84.94 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.154 0.502 . . . . 0.0 110.484 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -64.92 -42.18 94.92 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.316 0.579 . . . . 0.0 110.619 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 35.4 mm -66.46 -42.16 89.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 121.54 0.686 . . . . 0.0 110.095 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -70.6 -35.94 67.69 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 232' ' ' LEU . . . . . 0.468 HD23 ' C ' ' C' ' 232' ' ' LEU . 8.1 tt -63.79 -46.37 85.48 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 122.043 -0.681 . . . . 0.0 111.13 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -70.26 -35.85 74.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.151 0.501 . . . . 0.0 111.221 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -59.98 -47.91 83.88 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.391 0.615 . . . . 0.0 110.497 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -69.77 -21.25 63.45 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.086 0.47 . . . . 0.0 111.499 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 64.1 t80 . . . . . 0 CA--C 1.544 0.747 0 O-C-N 122.034 -0.416 . . . . 0.0 111.717 -179.981 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 C--O 1.237 0.402 0 CA-C-O 122.374 1.083 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 23.9 t -69.08 -22.59 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.081 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.564 HD13 ' O ' ' A' ' 213' ' ' LEU . 0.3 OUTLIER -67.26 -36.43 81.58 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.944 0.402 . . . . 0.0 111.09 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.504 ' O ' HG12 ' A' ' 217' ' ' VAL . 0.9 OUTLIER -51.29 -57.35 14.41 Favored Pre-proline 0 CA--C 1.552 1.032 0 O-C-N 121.894 -0.503 . . . . 0.0 111.194 -179.012 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.529 ' HA ' HD12 ' A' ' 218' ' ' ILE . 33.2 Cg_endo -63.76 -31.88 68.31 Favored 'Trans proline' 0 N--CA 1.502 1.993 0 C-N-CA 121.776 1.65 . . . . 0.0 113.039 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 8.9 tp -62.72 -45.38 93.0 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.155 0.502 . . . . 0.0 111.562 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.1 p -66.51 -36.43 77.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 O-C-N 122.226 -0.296 . . . . 0.0 110.371 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 215' ' ' PRO . 51.6 mt -62.8 -44.06 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -67.9 -36.79 80.82 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.345 0.593 . . . . 0.0 109.908 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -57.75 -44.35 86.05 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.288 0.566 . . . . 0.0 110.128 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -67.9 -34.0 81.17 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' C' ' 218' ' ' ILE . 6.2 tp -62.89 -36.07 82.11 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.391 0.615 . . . . 0.0 111.111 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.66 -38.61 88.37 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.226 0.536 . . . . 0.0 111.088 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 19.7 mt -58.95 -44.63 91.47 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.938 0.399 . . . . 0.0 110.74 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.563 ' HB2' HD11 ' B' ' 225' ' ' LEU . 26.0 tp -61.6 -31.76 71.84 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.997 0.427 . . . . 0.0 110.624 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 31.7 t -62.16 -46.41 89.08 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.181 0.515 . . . . 0.0 110.693 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.435 ' N ' HD12 ' A' ' 227' ' ' LEU . 7.7 mp -66.42 -39.6 89.06 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.572 0.701 . . . . 0.0 110.577 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 13.1 tp -71.13 -34.38 70.99 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.148 0.499 . . . . 0.0 111.345 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.434 ' CE1' HD23 ' C' ' 224' ' ' LEU . 27.8 t80 -63.84 -43.22 96.82 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.237 0.541 . . . . 0.0 111.793 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 32.1 pt -69.2 -35.7 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-O 121.417 0.627 . . . . 0.0 110.838 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -59.16 -31.95 70.38 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.8 -32.01 68.96 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.574 0.702 . . . . 0.0 110.581 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.85 -43.5 90.81 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.384 0.612 . . . . 0.0 110.868 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 27.0 t80 . . . . . 0 C--O 1.234 0.262 0 CA-C-O 121.529 0.681 . . . . 0.0 110.577 -179.867 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 CA--C 1.537 0.443 0 CA-C-O 121.442 0.639 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 14.1 tp -68.67 -29.82 68.37 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.636 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.504 ' O ' HG12 ' B' ' 217' ' ' VAL . 1.0 OUTLIER -55.25 -57.78 18.41 Favored Pre-proline 0 CA--C 1.552 1.035 0 O-C-N 121.976 -0.452 . . . . 0.0 110.812 -179.151 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.04 -32.95 63.93 Favored 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 122.042 1.828 . . . . 0.0 112.889 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.86 -45.22 94.74 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.03 0.443 . . . . 0.0 111.517 -178.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.504 HG12 ' O ' ' B' ' 214' ' ' LEU . 7.4 p -67.58 -36.4 76.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 122.194 -0.316 . . . . 0.0 110.33 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 46.4 mt -67.44 -43.14 87.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -65.87 -38.97 90.22 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.511 0.672 . . . . 0.0 109.847 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -57.88 -43.78 86.24 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.523 0.677 . . . . 0.0 110.199 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.23 -33.7 87.94 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 218' ' ' ILE . 9.8 tp -58.76 -39.73 81.82 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.293 0.568 . . . . 0.0 110.337 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.71 88.39 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.652 0.739 . . . . 0.0 109.252 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 3.0 tp -59.76 -38.95 83.22 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.77 0.795 . . . . 0.0 109.335 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . 0.563 HD11 ' HB2' ' A' ' 225' ' ' LEU . 3.7 tt -59.6 -45.1 92.92 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.617 0.722 . . . . 0.0 110.13 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 45.0 m -60.91 -43.8 98.06 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.389 0.614 . . . . 0.0 110.347 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 11.8 mt -64.36 -41.48 96.7 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.282 0.563 . . . . 0.0 110.23 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 21.6 mt -65.87 -37.97 87.58 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.989 0.423 . . . . 0.0 111.079 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -69.55 -42.36 74.67 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.201 0.524 . . . . 0.0 110.892 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 38.8 mm -67.45 -41.21 85.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.716 0.77 . . . . 0.0 109.655 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -58.45 -31.88 67.46 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.529 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 4.6 tt . . . . . 0 N--CA 1.465 0.302 0 CA-C-O 121.512 0.672 . . . . 0.0 110.979 -179.637 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 11.2 tp . . . . . 0 C--O 1.235 0.341 0 CA-C-O 120.791 0.329 . . . . 0.0 111.779 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 214' ' ' LEU . . . . . 0.547 ' O ' HG12 ' C' ' 217' ' ' VAL . 1.0 OUTLIER -50.82 -57.35 13.82 Favored Pre-proline 0 CA--C 1.551 0.988 0 CA-C-O 118.919 -0.562 . . . . 0.0 111.367 -178.692 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.97 -36.68 47.88 Favored 'Trans proline' 0 N--CA 1.505 2.184 0 C-N-CA 121.979 1.786 . . . . 0.0 113.297 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.93 -45.23 93.29 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.893 0.378 . . . . 0.0 111.793 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 217' ' ' VAL . . . . . 0.547 HG12 ' O ' ' C' ' 214' ' ' LEU . 7.6 p -63.84 -36.19 75.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 O-C-N 122.126 -0.359 . . . . 0.0 110.905 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 218' ' ' ILE . . . . . 0.44 ' HA ' HD22 ' A' ' 222' ' ' LEU . 33.1 mm -62.75 -44.97 99.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 O-C-N 121.615 -0.678 . . . . 0.0 109.198 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -68.9 -37.56 79.07 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.636 0.731 . . . . 0.0 110.205 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -59.37 -44.48 92.72 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.392 0.615 . . . . 0.0 110.529 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.29 -33.8 88.21 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 110.454 -1.059 . . . . 0.0 110.454 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 2.4 tp -62.91 -42.57 99.83 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.561 0.696 . . . . 0.0 110.72 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.86 -38.95 90.18 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.347 0.594 . . . . 0.0 110.798 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 224' ' ' LEU . . . . . 0.434 HD23 ' CE1' ' A' ' 229' ' ' PHE . 0.6 OUTLIER -61.8 -42.04 98.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.319 0.581 . . . . 0.0 109.949 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . 0.478 HD13 HD13 ' A' ' 225' ' ' LEU . 22.4 tp -61.37 -38.7 87.94 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.31 0.576 . . . . 0.0 110.246 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 37.4 m -58.43 -46.96 85.46 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.205 0.526 . . . . 0.0 110.3 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -62.88 -41.79 99.54 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.216 0.532 . . . . 0.0 110.478 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 228' ' ' LEU . . . . . 0.41 HD13 ' O ' ' C' ' 224' ' ' LEU . 6.6 mp -63.79 -38.31 90.64 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.196 0.522 . . . . 0.0 110.372 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -62.23 -42.22 99.12 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.36 0.6 . . . . 0.0 110.129 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 48.0 mm -68.0 -42.22 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-O 121.621 0.724 . . . . 0.0 109.869 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -65.51 -31.88 81.58 Favored Glycine 0 CA--C 1.533 1.178 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 232' ' ' LEU . . . . . 0.411 HD23 ' O ' ' C' ' 232' ' ' LEU . 4.5 tt -57.26 -45.98 83.48 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.711 0.767 . . . . 0.0 110.733 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -61.64 -38.77 88.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.904 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -63.28 -47.18 83.41 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.47 0.652 . . . . 0.0 110.678 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -68.4 -41.2 80.81 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.283 0.563 . . . . 0.0 111.1 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 41.1 t80 . . . . . 0 CA--C 1.541 0.628 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.912 179.976 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.468 0.462 0 CA-C-O 122.346 1.069 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 41.3 t -70.18 -35.69 64.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.439 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 31.7 mt -64.05 -40.58 96.59 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.521 ' O ' HG12 ' A' ' 217' ' ' VAL . 0.8 OUTLIER -49.39 -57.26 12.36 Favored Pre-proline 0 CA--C 1.552 1.035 0 O-C-N 121.924 -0.485 . . . . 0.0 111.638 -178.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.56 -36.44 53.7 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 121.805 1.67 . . . . 0.0 113.358 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.441 ' O ' HD13 ' A' ' 216' ' ' LEU . 0.2 OUTLIER -61.34 -45.17 95.55 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.949 0.404 . . . . 0.0 111.74 -178.602 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 214' ' ' LEU . 8.7 p -65.36 -36.48 77.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 O-C-N 122.14 -0.35 . . . . 0.0 110.507 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 59.8 mt -63.46 -44.84 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 O-C-N 121.6 -0.688 . . . . 0.0 109.461 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -63.96 -42.97 97.11 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.642 0.734 . . . . 0.0 109.749 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -58.1 -42.72 86.29 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.67 0.748 . . . . 0.0 110.567 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.1 -33.61 84.79 Favored Glycine 0 CA--C 1.531 1.031 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.437 HD22 ' HA ' ' C' ' 218' ' ' ILE . 8.8 tp -58.51 -41.37 85.28 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.235 0.54 . . . . 0.0 110.094 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.93 -39.01 90.59 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.508 0.671 . . . . 0.0 109.467 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.6 tp -62.42 -43.47 98.73 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.938 0.875 . . . . 0.0 109.55 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.533 HD11 ' HB2' ' C' ' 225' ' ' LEU . 0.9 OUTLIER -59.69 -38.21 80.91 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.357 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 48.0 m -58.95 -43.53 91.26 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 121.406 0.622 . . . . 0.0 110.428 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.73 -43.98 97.81 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.246 0.546 . . . . 0.0 110.265 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.6 mp -65.95 -38.62 89.07 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.195 0.522 . . . . 0.0 110.48 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -67.38 -42.18 83.78 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.16 0.505 . . . . 0.0 110.595 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 96.0 mt -66.67 -35.48 74.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.444 0.64 . . . . 0.0 109.991 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.5 -31.81 60.43 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.425 ' C ' HD23 ' A' ' 232' ' ' LEU . 8.7 tt -59.85 -42.78 94.38 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.698 0.761 . . . . 0.0 110.376 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -62.48 -44.08 97.25 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.432 0.634 . . . . 0.0 110.881 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 39.1 t80 . . . . . 0 C--O 1.234 0.278 0 CA-C-O 121.605 0.717 . . . . 0.0 110.737 -179.677 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 CA--C 1.536 0.424 0 CA-C-O 121.433 0.635 . . . . 0.0 111.058 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 11.2 tp -65.97 -37.49 86.11 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.716 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.545 ' O ' HG12 ' B' ' 217' ' ' VAL . 7.1 tp -51.94 -57.19 15.85 Favored Pre-proline 0 CA--C 1.552 1.021 0 CA-C-O 118.867 -0.587 . . . . 0.0 111.231 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.13 -34.54 57.17 Favored 'Trans proline' 0 N--CA 1.504 2.126 0 C-N-CA 121.823 1.682 . . . . 0.0 113.205 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.75 -45.16 95.38 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.901 0.381 . . . . 0.0 111.724 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.545 HG12 ' O ' ' B' ' 214' ' ' LEU . 7.1 p -63.3 -36.33 75.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 O-C-N 122.06 -0.4 . . . . 0.0 110.756 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 21.5 mm -62.93 -44.75 99.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -64.59 -36.86 85.6 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.451 0.644 . . . . 0.0 110.044 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -57.68 -44.72 86.0 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.201 0.524 . . . . 0.0 110.585 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -67.6 -34.78 84.83 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 5.2 tp -61.85 -40.97 97.19 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.667 0.746 . . . . 0.0 110.235 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.79 -38.44 88.1 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.32 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 2.5 tp -58.69 -38.13 77.57 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.209 0.528 . . . . 0.0 110.2 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . 0.478 HD13 ' HG ' ' A' ' 225' ' ' LEU . 19.3 tp -59.08 -32.34 69.71 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.119 0.485 . . . . 0.0 110.718 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 33.1 t -58.97 -47.03 86.58 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.057 0.456 . . . . 0.0 110.289 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . 0.421 ' N ' HD12 ' B' ' 227' ' ' LEU . 7.8 mp -62.41 -43.98 97.52 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.197 0.522 . . . . 0.0 110.394 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 7.2 mp -61.56 -36.84 81.76 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.237 0.542 . . . . 0.0 109.974 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -59.46 -42.07 91.14 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.651 0.738 . . . . 0.0 109.956 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 50.4 mm -64.67 -41.04 91.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 121.767 0.794 . . . . 0.0 110.083 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -63.92 -32.01 82.73 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.554 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 232' ' ' LEU . . . . . 0.413 ' C ' HD23 ' B' ' 232' ' ' LEU . 6.6 tt . . . . . 0 N--CA 1.465 0.278 0 CA-C-O 121.598 0.713 . . . . 0.0 110.794 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 21.9 mt . . . . . 0 C--O 1.236 0.375 0 CA-C-O 120.893 0.378 . . . . 0.0 111.497 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 214' ' ' LEU . . . . . 0.536 ' O ' HG12 ' C' ' 217' ' ' VAL . 0.2 OUTLIER -54.38 -57.49 18.31 Favored Pre-proline 0 CA--C 1.549 0.918 0 CA-C-O 118.929 -0.558 . . . . 0.0 111.118 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -63.7 -34.67 61.65 Favored 'Trans proline' 0 N--CA 1.505 2.165 0 C-N-CA 121.777 1.651 . . . . 0.0 113.406 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 tt -59.69 -45.57 91.69 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.103 0.478 . . . . 0.0 111.6 -178.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 217' ' ' VAL . . . . . 0.536 HG12 ' O ' ' C' ' 214' ' ' LEU . 7.1 p -64.54 -36.34 77.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 O-C-N 122.156 -0.34 . . . . 0.0 110.794 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 218' ' ' ILE . . . . . 0.437 ' HA ' HD22 ' A' ' 222' ' ' LEU . 36.0 mm -63.17 -44.93 99.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -61.73 -36.93 82.38 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.356 0.598 . . . . 0.0 110.186 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -57.79 -44.71 86.44 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.325 0.583 . . . . 0.0 110.101 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -65.6 -33.72 87.0 Favored Glycine 0 CA--C 1.534 1.219 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 4.7 tp -61.9 -38.62 89.03 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.575 0.702 . . . . 0.0 110.842 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.68 -38.49 87.98 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.95 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 7.4 mp -58.91 -42.11 88.88 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.217 0.532 . . . . 0.0 110.164 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . 0.533 ' HB2' HD11 ' A' ' 225' ' ' LEU . 18.6 tp -58.56 -30.88 67.48 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.108 0.48 . . . . 0.0 110.648 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 8.0 t -57.06 -44.45 83.02 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.45 0.643 . . . . 0.0 109.939 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 7.9 mp -66.72 -40.81 88.55 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.36 0.6 . . . . 0.0 110.065 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 30.0 mt -63.61 -35.98 82.32 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.045 0.45 . . . . 0.0 110.547 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -66.79 -42.13 86.48 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.33 0.586 . . . . 0.0 109.971 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.29 -35.73 74.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 121.462 0.648 . . . . 0.0 109.844 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.74 -31.92 61.25 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 5.2 tt -59.49 -42.13 91.42 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.703 0.763 . . . . 0.0 110.172 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -62.45 -44.13 97.15 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.528 0.68 . . . . 0.0 110.554 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -62.44 -45.61 92.29 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.445 0.64 . . . . 0.0 110.586 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -59.64 -19.24 47.87 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.427 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 41.3 t80 . . . . . 0 CA--C 1.542 0.666 0 O-C-N 121.938 -0.476 . . . . 0.0 111.958 -179.785 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 66.6 p . . . . . 0 CA--C 1.536 0.442 0 CA-C-O 122.289 1.042 . . . . 0.0 110.673 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 34.7 m -70.16 -41.32 78.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.428 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 14.0 tp -69.27 -35.54 76.18 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.405 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.553 ' O ' HG12 ' A' ' 217' ' ' VAL . 2.3 tt -44.94 -57.1 7.56 Favored Pre-proline 0 CA--C 1.554 1.102 0 CA-C-O 118.887 -0.578 . . . . 0.0 111.744 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -63.79 -38.25 40.65 Favored 'Trans proline' 0 N--CA 1.507 2.27 0 C-N-CA 122.037 1.825 . . . . 0.0 113.925 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.2 tt -59.47 -45.36 91.86 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.205 0.526 . . . . 0.0 111.947 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 214' ' ' LEU . 9.1 p -61.94 -35.95 71.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.963 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 25.2 mm -62.56 -44.84 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 121.656 -0.653 . . . . 0.0 109.533 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -65.13 -36.66 84.98 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.709 0.766 . . . . 0.0 110.07 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -57.68 -42.38 83.49 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.243 0.544 . . . . 0.0 111.345 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.518 ' HA3' HD11 ' B' ' 222' ' ' LEU . . . -59.77 -33.63 78.77 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.95 -31.75 71.7 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.124 0.488 . . . . 0.0 111.444 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.64 -38.71 88.69 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.317 0.579 . . . . 0.0 110.619 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.86 -37.54 76.73 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.111 0.481 . . . . 0.0 110.456 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 16.8 tp -57.83 -35.37 70.8 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.079 0.466 . . . . 0.0 110.867 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 35.5 t -58.65 -41.72 86.68 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.228 0.537 . . . . 0.0 110.742 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.443 ' N ' HD12 ' A' ' 227' ' ' LEU . 7.8 mp -62.22 -42.78 99.61 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.587 0.708 . . . . 0.0 110.426 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.8 mp -71.25 -36.67 71.85 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.14 0.495 . . . . 0.0 111.029 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -70.36 -42.47 71.76 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.097 0.475 . . . . 0.0 111.568 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 7.9 tp -69.09 -38.37 78.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 121.813 0.816 . . . . 0.0 110.913 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -71.77 -31.8 64.59 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.448 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.402 ' C ' HD23 ' A' ' 232' ' ' LEU . 10.4 tt -60.87 -37.18 81.25 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 122.084 -0.657 . . . . 0.0 111.174 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.26 -37.48 87.4 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.17 0.509 . . . . 0.0 111.256 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 46.8 t80 . . . . . 0 C--O 1.234 0.282 0 CA-C-O 121.525 0.679 . . . . 0.0 110.217 179.85 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 29.7 m . . . . . 0 N--CA 1.468 0.435 0 CA-C-O 121.388 0.613 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 10.9 tp -63.69 -40.68 97.4 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.795 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.511 ' O ' HG12 ' B' ' 217' ' ' VAL . 2.9 tp -49.6 -57.55 11.75 Favored Pre-proline 0 CA--C 1.553 1.09 0 O-C-N 121.79 -0.569 . . . . 0.0 111.512 -178.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.42 -39.55 28.42 Favored 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 121.786 1.657 . . . . 0.0 112.754 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.34 -43.66 92.74 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.939 -177.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.511 HG12 ' O ' ' B' ' 214' ' ' LEU . 10.6 p -66.17 -36.58 77.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 O-C-N 121.971 -0.456 . . . . 0.0 110.714 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 33.6 mt -65.92 -44.45 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -66.58 -36.62 83.08 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.355 0.598 . . . . 0.0 110.139 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -57.55 -43.49 84.5 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.319 0.581 . . . . 0.0 110.116 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . 0.493 ' HA3' HD11 ' C' ' 222' ' ' LEU . . . -63.42 -33.64 87.79 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 178.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . 0.518 HD11 ' HA3' ' A' ' 221' ' ' GLY . 5.4 tp -58.79 -42.32 88.77 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.543 0.687 . . . . 0.0 110.103 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.8 -38.85 89.65 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.697 0.76 . . . . 0.0 109.567 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 2.9 tp -60.84 -40.1 91.56 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.757 0.789 . . . . 0.0 109.783 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.99 -42.86 89.23 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.061 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . 0.402 ' O ' HD13 ' B' ' 230' ' ' ILE . 19.4 t -63.24 -44.02 96.4 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 121.51 0.671 . . . . 0.0 109.948 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 11.2 mt -66.85 -39.79 87.71 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.284 0.564 . . . . 0.0 110.23 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.42 HD11 HD13 ' C' ' 232' ' ' LEU . 7.6 tp -64.1 -34.76 78.77 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.202 0.525 . . . . 0.0 110.422 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -68.54 -41.17 80.24 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.314 0.578 . . . . 0.0 110.474 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.402 HD13 ' O ' ' B' ' 226' ' ' SER . 1.4 mp -66.01 -41.5 89.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 121.585 0.707 . . . . 0.0 109.114 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -60.58 -32.04 76.88 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 232' ' ' LEU . . . . . 0.458 ' C ' HD23 ' B' ' 232' ' ' LEU . 6.4 tt . . . . . 0 C--O 1.235 0.312 0 CA-C-O 121.638 0.732 . . . . 0.0 110.762 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 11.9 tp . . . . . 0 C--O 1.235 0.294 0 CA-C-O 120.852 0.358 . . . . 0.0 111.873 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 214' ' ' LEU . . . . . 0.579 ' O ' HG12 ' C' ' 217' ' ' VAL . 20.8 tp -46.87 -57.37 9.19 Favored Pre-proline 0 CA--C 1.556 1.202 0 CA-C-O 118.913 -0.565 . . . . 0.0 111.59 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.5 -42.74 15.6 Favored 'Trans proline' 0 N--CA 1.504 2.117 0 C-N-CA 121.882 1.721 . . . . 0.0 113.316 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.96 -45.16 83.04 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.89 -177.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 217' ' ' VAL . . . . . 0.579 HG12 ' O ' ' C' ' 214' ' ' LEU . 11.6 p -60.26 -35.78 64.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 122.055 -0.403 . . . . 0.0 110.757 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 44.7 mm -62.15 -45.16 99.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -60.34 -41.83 94.43 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.511 0.672 . . . . 0.0 109.462 177.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -57.72 -37.7 73.99 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.697 0.76 . . . . 0.0 110.447 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -59.97 -33.52 79.25 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 222' ' ' LEU . . . . . 0.493 HD11 ' HA3' ' B' ' 221' ' ' GLY . 4.9 tp -58.65 -38.38 78.01 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.534 0.683 . . . . 0.0 110.776 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.71 89.2 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.214 0.53 . . . . 0.0 110.751 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 11.8 mt -61.47 -47.77 84.14 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.2 0.524 . . . . 0.0 110.44 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 18.0 tp -58.19 -38.49 76.81 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.196 0.522 . . . . 0.0 110.381 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 36.1 t -59.85 -40.56 88.99 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.272 0.558 . . . . 0.0 110.746 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 10.5 mt -64.78 -42.72 94.87 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.671 0.748 . . . . 0.0 110.2 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 7.7 mp -70.52 -34.88 72.8 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.204 0.526 . . . . 0.0 111.046 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 229' ' ' PHE . . . . . 0.414 ' CD2' HD13 ' B' ' 228' ' ' LEU . 31.7 t80 -70.1 -42.41 72.76 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.022 0.439 . . . . 0.0 111.653 -178.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 6.2 tp -68.84 -35.93 71.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 121.417 0.627 . . . . 0.0 110.931 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -66.72 -32.15 80.5 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 111.559 -0.617 . . . . 0.0 111.559 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 232' ' ' LEU . . . . . 0.461 HD23 ' O ' ' C' ' 232' ' ' LEU . 1.9 tt -56.9 -40.8 76.95 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.58 0.705 . . . . 0.0 110.611 -179.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.52 -37.48 73.09 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.837 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -60.32 -44.22 95.65 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.535 0.683 . . . . 0.0 109.954 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 78.8 mtt85 -65.73 -25.99 67.54 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.477 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 36.4 t80 . . . . . 0 CA--C 1.543 0.678 0 O-C-N 122.038 -0.414 . . . . 0.0 111.777 179.975 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.469 0.481 0 CA-C-O 122.006 0.908 . . . . 0.0 111.794 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 26.1 m -70.68 -28.91 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.247 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 21.1 tp -66.1 -41.06 91.14 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 122.11 -0.369 . . . . 0.0 111.891 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.418 ' O ' HG12 ' A' ' 217' ' ' VAL . 8.0 tp -52.19 -57.29 15.82 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-O 119.03 -0.51 . . . . 0.0 111.396 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.12 -32.06 64.19 Favored 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 121.924 1.75 . . . . 0.0 113.355 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 7.5 tp -69.4 -45.11 70.04 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 122.001 -0.437 . . . . 0.0 111.813 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 214' ' ' LEU . 13.1 p -65.83 -36.68 78.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 O-C-N 122.245 -0.284 . . . . 0.0 111.456 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 26.4 pt -69.09 -38.39 78.13 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 O-C-N 121.488 -0.757 . . . . 0.0 110.744 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -68.98 -40.56 78.73 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.538 0.685 . . . . 0.0 110.319 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.84 -37.04 75.55 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.568 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.473 ' HA3' HD11 ' B' ' 222' ' ' LEU . . . -66.65 -33.78 85.46 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.469 HD11 ' HA3' ' C' ' 221' ' ' GLY . 8.2 tp -58.78 -37.44 76.31 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.229 0.538 . . . . 0.0 111.195 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.94 -39.23 91.38 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.105 0.479 . . . . 0.0 110.725 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.2 mp -65.69 -39.32 91.16 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.301 0.572 . . . . 0.0 110.493 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 19.4 tp -59.72 -39.79 85.84 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.191 0.52 . . . . 0.0 110.428 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 50.6 m -58.33 -41.54 84.79 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.308 0.575 . . . . 0.0 110.303 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.3 mt -64.16 -43.47 95.06 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.216 0.531 . . . . 0.0 110.546 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.0 mp -66.49 -38.07 86.45 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.101 0.476 . . . . 0.0 110.607 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -59.77 -42.18 92.7 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.049 0.452 . . . . 0.0 110.572 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.4 mp -64.21 -39.82 86.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.594 0.712 . . . . 0.0 109.367 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -59.67 -32.01 72.79 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.461 ' C ' HD23 ' A' ' 232' ' ' LEU . 9.1 tt -58.13 -45.27 87.62 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.475 0.655 . . . . 0.0 110.936 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -65.09 -37.51 87.74 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.354 0.597 . . . . 0.0 110.997 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 21.6 t80 . . . . . 0 C--O 1.235 0.304 0 CA-C-O 121.338 0.589 . . . . 0.0 110.738 -179.762 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 CA--C 1.544 0.742 0 CA-C-O 121.392 0.615 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 9.3 tt -69.19 -40.18 78.21 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.497 ' O ' HG12 ' B' ' 217' ' ' VAL . 2.0 tp -54.42 -56.86 22.1 Favored Pre-proline 0 CA--C 1.548 0.892 0 O-C-N 121.691 -0.631 . . . . 0.0 110.924 -178.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . 0.406 ' HD3' ' HB3' ' B' ' 214' ' ' LEU . 16.2 Cg_exo -64.24 -37.45 40.87 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 121.544 1.496 . . . . 0.0 112.476 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 4.4 tt -60.06 -45.38 93.06 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.102 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.497 HG12 ' O ' ' B' ' 214' ' ' LEU . 11.0 p -65.1 -36.57 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 O-C-N 122.219 -0.301 . . . . 0.0 110.682 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 46.2 mt -65.38 -44.95 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -67.93 -36.72 80.63 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.695 0.759 . . . . 0.0 109.987 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -57.78 -45.18 86.36 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.344 0.592 . . . . 0.0 110.678 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.66 -33.91 86.71 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . 0.473 HD11 ' HA3' ' A' ' 221' ' ' GLY . 6.5 tp -59.86 -41.25 91.04 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.455 0.645 . . . . 0.0 110.959 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.33 91.57 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.266 0.555 . . . . 0.0 110.614 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 1.1 tt -61.78 -41.54 97.85 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.532 0.682 . . . . 0.0 109.811 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . 0.401 HD13 HD13 ' C' ' 225' ' ' LEU . 20.7 tp -58.81 -42.97 90.39 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.263 0.554 . . . . 0.0 110.49 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 6.7 m -62.68 -43.51 98.61 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.474 0.654 . . . . 0.0 110.222 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 5.7 mp -65.5 -40.76 93.43 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.326 0.584 . . . . 0.0 110.686 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 16.8 tp -71.13 -34.66 71.26 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.505 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -71.03 -42.64 69.25 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 121.867 -0.521 . . . . 0.0 111.274 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 7.5 tp -69.34 -37.19 75.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 121.838 0.828 . . . . 0.0 111.081 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.69 -31.83 62.23 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.614 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 4.3 tt . . . . . 0 N--CA 1.465 0.323 0 CA-C-O 121.526 0.679 . . . . 0.0 111.007 -179.308 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 4.4 tt . . . . . 0 C--O 1.234 0.285 0 CA-C-O 120.831 0.348 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 214' ' ' LEU . . . . . 0.499 ' O ' HG12 ' C' ' 217' ' ' VAL . 4.0 tp -46.36 -57.17 9.05 Favored Pre-proline 0 CA--C 1.553 1.093 0 CA-C-O 119.112 -0.471 . . . . 0.0 111.642 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 215' ' ' PRO . . . . . 0.429 ' HA ' HD12 ' C' ' 218' ' ' ILE . 37.0 Cg_endo -63.84 -38.97 35.92 Favored 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 121.841 1.694 . . . . 0.0 113.032 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -45.35 90.91 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.839 0.352 . . . . 0.0 111.723 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 217' ' ' VAL . . . . . 0.499 HG12 ' O ' ' C' ' 214' ' ' LEU . 7.1 p -64.46 -36.57 77.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 122.088 -0.382 . . . . 0.0 110.514 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 218' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' C' ' 215' ' ' PRO . 50.9 mt -63.0 -45.15 99.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.455 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -64.39 -37.32 87.09 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.618 0.723 . . . . 0.0 110.092 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -57.96 -45.29 86.92 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.419 0.628 . . . . 0.0 110.578 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 221' ' ' GLY . . . . . 0.469 ' HA3' HD11 ' A' ' 222' ' ' LEU . . . -60.13 -33.79 81.22 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 4.8 tp -59.06 -40.33 84.79 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.585 0.707 . . . . 0.0 110.629 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.83 -39.05 90.45 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.864 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 36.2 mt -61.6 -40.01 93.28 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.416 0.627 . . . . 0.0 110.581 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . 0.401 HD13 HD13 ' B' ' 225' ' ' LEU . 32.3 tp -60.93 -35.28 76.3 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.062 0.458 . . . . 0.0 110.314 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 42.8 t -57.6 -46.7 83.71 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.371 0.605 . . . . 0.0 109.669 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 8.1 mp -60.89 -42.24 97.63 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.395 0.617 . . . . 0.0 110.244 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.63 -37.25 86.93 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.201 0.524 . . . . 0.0 110.585 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -69.79 -42.08 74.24 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.173 0.511 . . . . 0.0 111.183 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 34.0 mm -63.01 -41.04 91.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.506 0.669 . . . . 0.0 110.072 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -62.78 -33.28 86.44 Favored Glycine 0 CA--C 1.535 1.289 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 7.8 tt -61.89 -34.66 76.44 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 122.178 -0.601 . . . . 0.0 111.764 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -61.43 -35.81 78.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.138 0.494 . . . . 0.0 111.354 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -59.87 -44.49 94.14 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.365 0.602 . . . . 0.0 110.575 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 66.5 mtp85 -63.96 -32.12 73.54 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.429 0.633 . . . . 0.0 110.832 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 57.8 t80 . . . . . 0 CA--C 1.545 0.762 0 CA-C-O 120.959 0.409 . . . . 0.0 111.146 179.416 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 43.7 p . . . . . 0 CA--C 1.539 0.523 0 CA-C-O 122.133 0.968 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 26.2 t -70.31 -34.83 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-O 121.471 0.653 . . . . 0.0 110.207 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 54.2 mt -66.56 -33.26 75.28 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.499 ' O ' HG12 ' A' ' 217' ' ' VAL . 0.1 OUTLIER -53.77 -57.54 17.1 Favored Pre-proline 0 CA--C 1.55 0.955 0 O-C-N 121.96 -0.463 . . . . 0.0 111.085 -179.213 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.73 -32.94 67.52 Favored 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 121.868 1.712 . . . . 0.0 112.814 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.94 -45.32 95.19 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.041 0.448 . . . . 0.0 111.468 -178.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.499 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.3 p -67.92 -36.51 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 O-C-N 122.125 -0.359 . . . . 0.0 110.203 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 52.6 mt -67.84 -42.83 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 121.507 0.67 . . . . 0.0 109.212 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -62.93 -36.72 84.34 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.482 0.658 . . . . 0.0 110.524 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -57.74 -43.44 85.39 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.367 0.603 . . . . 0.0 110.207 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.415 ' HA3' HD11 ' B' ' 222' ' ' LEU . . . -64.12 -33.91 88.49 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 178.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 6.8 tp -60.58 -38.82 85.87 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.587 0.708 . . . . 0.0 110.643 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.81 -38.77 89.38 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.239 0.542 . . . . 0.0 110.711 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 6.1 mp -59.8 -35.95 75.72 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.207 0.527 . . . . 0.0 110.471 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 13.4 tp -58.44 -36.58 73.86 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.089 0.471 . . . . 0.0 110.913 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 23.5 t -58.46 -44.36 89.21 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.27 0.557 . . . . 0.0 110.533 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.9 mt -61.66 -43.14 99.42 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.461 0.648 . . . . 0.0 110.013 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 6.8 mt -66.51 -37.31 84.77 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.149 0.5 . . . . 0.0 110.414 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -65.85 -41.98 91.01 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.319 0.58 . . . . 0.0 110.117 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 92.6 mt -63.01 -35.96 73.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 121.409 0.623 . . . . 0.0 110.003 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.56 -32.2 61.0 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 10.0 tt -59.21 -37.33 77.19 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.593 0.711 . . . . 0.0 110.568 179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.82 -36.01 73.82 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.254 0.549 . . . . 0.0 111.157 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 29.4 t80 . . . . . 0 C--O 1.235 0.304 0 CA-C-O 121.486 0.66 . . . . 0.0 110.568 -179.67 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 34.7 t . . . . . 0 N--CA 1.469 0.5 0 CA-C-O 121.456 0.646 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 9.1 tp -69.16 -33.39 73.33 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.592 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.445 ' O ' HG12 ' B' ' 217' ' ' VAL . 1.0 OUTLIER -49.13 -57.26 12.04 Favored Pre-proline 0 CA--C 1.553 1.058 0 O-C-N 121.908 -0.495 . . . . 0.0 111.319 -178.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . 0.419 ' HA ' HG12 ' B' ' 218' ' ' ILE . 37.3 Cg_endo -63.7 -29.31 69.08 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 121.905 1.736 . . . . 0.0 113.484 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.16 -45.14 67.36 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.106 0.479 . . . . 0.0 111.51 -178.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.445 HG12 ' O ' ' B' ' 214' ' ' LEU . 8.5 p -65.23 -36.78 78.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 122.098 -0.376 . . . . 0.0 111.409 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . 0.419 HG12 ' HA ' ' B' ' 215' ' ' PRO . 28.7 pt -69.07 -38.2 77.92 Favored 'Isoleucine or valine' 0 C--N 1.348 0.526 0 O-C-N 121.355 -0.841 . . . . 0.0 110.661 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -64.42 -44.03 92.49 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.555 0.693 . . . . 0.0 110.083 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -59.22 -44.63 92.3 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.688 0.756 . . . . 0.0 109.956 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -59.97 -33.37 78.63 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . 0.415 HD11 ' HA3' ' A' ' 221' ' ' GLY . 3.7 tp -59.02 -40.79 86.06 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.417 0.627 . . . . 0.0 110.393 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.89 -38.76 89.53 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.141 0.496 . . . . 0.0 110.873 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 15.3 mt -59.35 -39.08 82.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.227 0.537 . . . . 0.0 110.434 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 18.0 tp -60.82 -38.43 85.4 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.316 0.579 . . . . 0.0 110.317 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 5.6 t -58.29 -47.03 84.95 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.286 0.565 . . . . 0.0 110.425 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 7.7 mp -59.09 -43.8 91.86 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.224 0.535 . . . . 0.0 110.54 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 6.9 mp -67.01 -38.74 86.51 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.127 0.489 . . . . 0.0 110.777 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -67.3 -42.27 84.0 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.208 0.528 . . . . 0.0 111.126 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 34.2 mm -64.99 -42.42 94.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-O 121.648 0.737 . . . . 0.0 109.615 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -58.54 -31.84 67.71 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 232' ' ' LEU . . . . . 0.489 HD13 ' C ' ' B' ' 232' ' ' LEU . 3.2 tm? . . . . . 0 C--O 1.235 0.311 0 CA-C-O 121.718 0.771 . . . . 0.0 110.608 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 213' ' ' LEU . . . . . 0.498 ' O ' HD13 ' C' ' 213' ' ' LEU . 0.2 OUTLIER . . . . . 0 CA--C 1.536 0.411 0 CA-C-O 120.943 0.402 . . . . 0.0 111.257 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 214' ' ' LEU . . . . . 0.492 ' O ' HG12 ' C' ' 217' ' ' VAL . 3.1 tp -49.26 -57.41 11.77 Favored Pre-proline 0 CA--C 1.554 1.1 0 O-C-N 121.889 -0.507 . . . . 0.0 111.534 -178.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.09 -34.52 57.65 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 121.852 1.701 . . . . 0.0 112.97 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 216' ' ' LEU . . . . . 0.445 HD13 ' O ' ' C' ' 216' ' ' LEU . 0.2 OUTLIER -61.61 -45.26 94.85 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.073 0.463 . . . . 0.0 111.615 -178.34 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 217' ' ' VAL . . . . . 0.492 HG12 ' O ' ' C' ' 214' ' ' LEU . 8.4 p -67.3 -36.56 76.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 122.059 -0.4 . . . . 0.0 110.29 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 41.5 mt -68.66 -41.23 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.498 0.666 . . . . 0.0 109.318 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -62.52 -36.97 84.26 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.379 0.609 . . . . 0.0 110.544 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -57.87 -43.55 86.09 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.503 0.668 . . . . 0.0 110.324 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.43 -33.78 82.63 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 179.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 7.4 tp -59.39 -36.47 75.86 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.314 0.578 . . . . 0.0 111.293 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.68 -38.72 88.83 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.132 0.491 . . . . 0.0 111.012 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 7.2 mp -59.3 -39.27 82.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.214 0.53 . . . . 0.0 110.416 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 24.2 tp -61.75 -38.51 88.25 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.258 0.551 . . . . 0.0 110.458 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 74.9 m -58.32 -42.65 87.25 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.24 0.543 . . . . 0.0 110.916 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.97 -42.3 97.3 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.386 0.612 . . . . 0.0 110.647 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 6.5 mp -71.16 -34.68 71.19 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.199 0.523 . . . . 0.0 111.103 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -64.94 -42.28 94.77 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.921 0.391 . . . . 0.0 111.816 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 6.6 tp -69.26 -35.77 69.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 121.543 0.687 . . . . 0.0 110.983 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.69 -31.96 62.08 Favored Glycine 0 CA--C 1.535 1.285 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 232' ' ' LEU . . . . . 0.448 HD23 ' C ' ' C' ' 232' ' ' LEU . 9.1 tt -57.2 -44.7 83.9 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.513 0.673 . . . . 0.0 111.016 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -62.93 -39.61 95.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.388 0.613 . . . . 0.0 110.797 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -61.0 -45.25 95.59 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.418 0.627 . . . . 0.0 110.539 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -61.52 -38.33 86.97 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.254 0.549 . . . . 0.0 111.029 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 10.5 t80 . . . . . 0 CA--C 1.543 0.677 0 CA-C-O 120.902 0.382 . . . . 0.0 111.677 179.907 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 41.0 p . . . . . 0 N--CA 1.468 0.429 0 CA-C-O 122.099 0.952 . . . . 0.0 111.474 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 57.3 t -70.37 -27.5 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.231 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.405 ' O ' HD23 ' A' ' 213' ' ' LEU . 4.0 tt -66.84 -39.8 87.72 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.921 0.391 . . . . 0.0 111.315 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.519 ' O ' HG12 ' A' ' 217' ' ' VAL . 4.5 tp -47.83 -57.34 10.33 Favored Pre-proline 0 CA--C 1.553 1.068 0 CA-C-O 118.895 -0.574 . . . . 0.0 111.581 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -64.0 -34.02 60.58 Favored 'Trans proline' 0 N--CA 1.503 2.083 0 C-N-CA 121.752 1.635 . . . . 0.0 113.113 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.6 tp -61.13 -45.32 95.14 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.011 0.434 . . . . 0.0 111.634 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.519 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.2 p -65.39 -36.6 78.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 O-C-N 122.204 -0.31 . . . . 0.0 110.631 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 42.2 mm -65.05 -42.41 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -60.96 -36.75 80.19 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.394 0.616 . . . . 0.0 110.287 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.88 -42.13 83.93 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.399 0.619 . . . . 0.0 109.897 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -65.47 -33.8 87.43 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 7.4 tp -58.75 -34.58 71.56 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.253 0.549 . . . . 0.0 111.077 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.63 -38.76 88.84 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.24 0.543 . . . . 0.0 110.974 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.9 mp -61.5 -38.87 88.9 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.357 0.599 . . . . 0.0 110.443 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.435 HD13 HD13 ' B' ' 225' ' ' LEU . 16.8 tp -59.07 -41.91 89.1 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.278 0.561 . . . . 0.0 110.447 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 46.9 t -59.9 -42.26 93.45 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.299 0.571 . . . . 0.0 110.742 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 1.6 tt -62.63 -46.71 86.97 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.365 0.602 . . . . 0.0 110.48 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.4 mp -66.0 -40.18 90.93 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.915 0.388 . . . . 0.0 111.376 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -70.06 -42.27 73.04 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.219 0.533 . . . . 0.0 110.95 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 93.4 mt -68.04 -42.16 85.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.484 0.659 . . . . 0.0 110.164 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -62.97 -34.3 89.56 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.449 ' O ' HD23 ' A' ' 232' ' ' LEU . 1.4 tt -68.24 -39.18 82.35 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.57 0.7 . . . . 0.0 110.929 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -70.32 -35.61 73.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.294 0.569 . . . . 0.0 112.279 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 34.6 t80 . . . . . 0 CA--C 1.538 0.482 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.276 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 41.5 t . . . . . 0 CA--C 1.543 0.685 0 CA-C-O 121.302 0.572 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 12.1 tp -64.14 -40.94 97.24 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 122.149 -0.344 . . . . 0.0 111.847 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.497 ' O ' HG12 ' B' ' 217' ' ' VAL . 1.5 tt -54.54 -57.07 20.54 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-O 119.103 -0.475 . . . . 0.0 111.332 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.86 -33.31 64.81 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 121.852 1.701 . . . . 0.0 112.942 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 216' ' ' LEU . . . . . 0.445 HD23 ' O ' ' B' ' 216' ' ' LEU . 3.6 tt -61.86 -45.53 93.4 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.091 0.472 . . . . 0.0 111.493 -178.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.497 HG12 ' O ' ' B' ' 214' ' ' LEU . 7.2 p -66.66 -36.53 77.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 O-C-N 122.128 -0.357 . . . . 0.0 110.302 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . 0.444 HD11 ' CD2' ' B' ' 214' ' ' LEU . 53.5 mt -67.46 -44.69 86.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -64.43 -36.74 85.13 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.515 0.674 . . . . 0.0 110.029 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -57.65 -43.74 85.17 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.295 0.569 . . . . 0.0 110.408 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -70.15 -35.68 70.91 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.21 -27.56 69.15 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.185 0.517 . . . . 0.0 110.71 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.72 -38.88 89.52 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.263 0.554 . . . . 0.0 110.323 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 51.1 mt -60.31 -38.49 83.85 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.331 0.586 . . . . 0.0 110.367 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . 0.435 HD13 HD13 ' A' ' 225' ' ' LEU . 17.4 tp -57.98 -35.41 71.15 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.193 0.52 . . . . 0.0 110.655 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 17.1 m -58.4 -40.43 82.38 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.202 0.525 . . . . 0.0 110.834 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 8.0 mp -63.33 -45.59 90.54 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.49 0.662 . . . . 0.0 110.796 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 8.0 mp -71.23 -34.98 71.28 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.267 0.556 . . . . 0.0 111.224 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -72.52 -42.12 65.12 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.111 0.481 . . . . 0.0 111.82 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 7.7 tp -66.12 -35.92 76.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 121.411 0.624 . . . . 0.0 111.326 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -73.11 -36.73 56.28 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 232' ' ' LEU . . . . . 0.409 ' O ' HD23 ' B' ' 232' ' ' LEU . 3.0 tt . . . . . 0 N--CA 1.466 0.336 0 CA-C-O 121.718 0.77 . . . . 0.0 111.126 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 15.0 tp . . . . . 0 C--O 1.235 0.317 0 CA-C-O 120.831 0.348 . . . . 0.0 111.775 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 214' ' ' LEU . . . . . 0.484 ' O ' HG12 ' C' ' 217' ' ' VAL . 11.0 tp -50.6 -57.11 14.34 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-O 119.011 -0.519 . . . . 0.0 111.634 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.87 -35.56 55.26 Favored 'Trans proline' 0 N--CA 1.504 2.116 0 C-N-CA 121.824 1.682 . . . . 0.0 112.961 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 5.3 tt -61.35 -45.43 94.45 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.987 0.423 . . . . 0.0 111.701 -178.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 217' ' ' VAL . . . . . 0.484 HG12 ' O ' ' C' ' 214' ' ' LEU . 10.0 p -66.99 -36.45 77.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 122.214 -0.303 . . . . 0.0 110.339 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 57.0 mt -67.59 -45.15 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -66.45 -37.32 84.88 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.41 0.624 . . . . 0.0 110.285 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -60.5 -45.79 92.5 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.462 0.649 . . . . 0.0 110.067 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.23 -33.64 87.77 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 222' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' B' ' 218' ' ' ILE . 6.0 tp -58.73 -39.64 81.47 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.522 0.677 . . . . 0.0 110.172 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.72 -38.46 87.99 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.577 0.704 . . . . 0.0 110.32 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 2.3 tp -58.71 -45.9 88.52 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.248 0.546 . . . . 0.0 110.257 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . 0.428 HD13 ' CD1' ' A' ' 225' ' ' LEU . 25.4 tp -62.5 -39.56 93.9 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.256 0.55 . . . . 0.0 109.997 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 16.6 t -57.35 -45.56 84.24 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.095 0.474 . . . . 0.0 110.296 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 11.4 mt -63.12 -42.14 99.46 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.206 0.527 . . . . 0.0 110.499 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 5.8 tp -65.88 -34.89 79.18 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.274 0.559 . . . . 0.0 110.442 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -65.34 -38.11 89.13 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.189 0.518 . . . . 0.0 110.936 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 36.3 mm -62.79 -43.39 98.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.526 0.679 . . . . 0.0 110.035 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.98 -37.05 56.76 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 232' ' ' LEU . . . . . 0.416 HD23 ' C ' ' C' ' 232' ' ' LEU . 8.3 tt -63.59 -44.08 95.09 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.387 0.613 . . . . 0.0 111.272 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -65.55 -35.55 81.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.347 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -59.73 -44.0 93.95 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.432 0.634 . . . . 0.0 110.296 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -69.64 -18.68 63.61 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.359 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 59.5 t80 . . . . . 0 CA--C 1.542 0.665 0 O-C-N 122.023 -0.423 . . . . 0.0 111.419 179.947 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 56.3 p . . . . . 0 C--O 1.238 0.486 0 CA-C-O 122.159 0.98 . . . . 0.0 111.736 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 12.9 p -69.9 -21.5 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.356 178.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.14 -33.0 72.74 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.073 0.463 . . . . 0.0 110.811 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.468 ' O ' HG12 ' A' ' 217' ' ' VAL . 3.3 tp -53.95 -57.07 19.43 Favored Pre-proline 0 CA--C 1.554 1.108 0 CA-C-O 119.063 -0.494 . . . . 0.0 111.534 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -63.32 -29.87 72.92 Favored 'Trans proline' 0 N--CA 1.504 2.128 0 C-N-CA 121.969 1.779 . . . . 0.0 113.612 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.5 tt -69.32 -45.31 69.79 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.813 -0.554 . . . . 0.0 111.44 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.9 p -64.93 -36.8 78.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 O-C-N 122.066 -0.396 . . . . 0.0 111.62 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 21.2 pt -70.68 -40.17 76.67 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 O-C-N 121.421 -0.8 . . . . 0.0 110.616 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -67.95 -42.14 81.4 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.668 0.747 . . . . 0.0 110.088 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -60.38 -44.14 95.92 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.535 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.62 -33.84 88.31 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.485 HD13 HG23 ' C' ' 218' ' ' ILE . 4.4 tp -59.57 -39.36 83.84 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.561 0.696 . . . . 0.0 110.323 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.52 88.28 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.292 0.568 . . . . 0.0 110.285 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.5 tp -58.89 -38.58 79.2 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.377 0.608 . . . . 0.0 110.007 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.424 HD13 HD13 ' B' ' 225' ' ' LEU . 17.5 tp -60.52 -32.35 71.38 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.197 0.522 . . . . 0.0 110.431 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 16.9 m -59.76 -43.67 94.21 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.212 0.529 . . . . 0.0 111.192 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.1 mp -65.04 -41.77 94.92 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.739 0.781 . . . . 0.0 110.58 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 25.8 mt -71.11 -34.8 71.44 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.397 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -69.24 -42.32 75.78 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.24 0.543 . . . . 0.0 111.677 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 6.1 tp -68.1 -36.06 73.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 121.588 0.708 . . . . 0.0 110.866 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -67.51 -31.69 77.18 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' LEU . . . . . 0.51 HD13 ' C ' ' A' ' 232' ' ' LEU . 3.2 tm? -56.89 -43.04 80.9 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.542 0.687 . . . . 0.0 110.485 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -59.66 -38.94 82.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.351 0.596 . . . . 0.0 110.686 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 53.0 t80 . . . . . 0 C--O 1.234 0.286 0 CA-C-O 121.603 0.716 . . . . 0.0 110.011 179.617 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 CA--C 1.539 0.534 0 CA-C-O 121.35 0.595 . . . . 0.0 110.785 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 10.0 tp -67.14 -36.56 82.14 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.487 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.503 ' O ' HG12 ' B' ' 217' ' ' VAL . 0.2 OUTLIER -54.07 -57.64 17.12 Favored Pre-proline 0 CA--C 1.552 1.023 0 O-C-N 122.052 -0.405 . . . . 0.0 110.8 -179.149 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.95 -34.87 58.02 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 121.9 1.733 . . . . 0.0 112.722 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 7.8 tp -61.33 -45.4 94.59 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.944 0.402 . . . . 0.0 111.694 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.503 HG12 ' O ' ' B' ' 214' ' ' LEU . 9.2 p -66.46 -36.48 77.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 O-C-N 122.228 -0.295 . . . . 0.0 110.257 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 55.6 mt -68.57 -42.72 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.433 0.635 . . . . 0.0 109.342 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -65.01 -40.55 95.07 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.572 0.701 . . . . 0.0 110.193 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -59.42 -41.65 90.03 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.558 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.66 -33.74 86.1 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 6.4 tp -58.92 -31.69 68.88 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.3 0.572 . . . . 0.0 111.317 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.68 -38.78 89.05 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.091 0.472 . . . . 0.0 110.805 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 6.4 mp -61.69 -39.25 90.78 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.368 0.604 . . . . 0.0 110.149 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . 0.424 HD13 HD13 ' A' ' 225' ' ' LEU . 24.7 tp -58.36 -37.96 76.28 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.228 0.537 . . . . 0.0 110.678 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 12.1 t -60.36 -41.65 94.11 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.238 0.542 . . . . 0.0 110.684 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 7.4 mp -62.36 -43.32 99.09 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.189 0.519 . . . . 0.0 110.588 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 1.3 mp -68.38 -42.63 78.83 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.454 0.645 . . . . 0.0 110.22 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -63.96 -42.24 97.33 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.066 0.46 . . . . 0.0 110.748 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.75 -36.13 76.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.336 0.589 . . . . 0.0 110.13 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.82 -32.87 62.48 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 4.1 tt . . . . . 0 C--O 1.234 0.253 0 CA-C-O 121.663 0.744 . . . . 0.0 110.595 179.942 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 213' ' ' LEU . . . . . 0.54 ' O ' HD23 ' C' ' 213' ' ' LEU . 1.4 tt . . . . . 0 C--O 1.235 0.319 0 CA-C-O 120.939 0.399 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 214' ' ' LEU . . . . . 0.581 ' O ' HG12 ' C' ' 217' ' ' VAL . 0.2 OUTLIER -50.64 -58.11 11.1 Favored Pre-proline 0 CA--C 1.553 1.084 0 O-C-N 122.03 -0.419 . . . . 0.0 110.895 -178.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -64.27 -34.79 54.58 Favored 'Trans proline' 0 N--CA 1.501 1.926 0 C-N-CA 121.882 1.721 . . . . 0.0 113.044 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.91 -45.11 95.94 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.417 -178.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 217' ' ' VAL . . . . . 0.581 HG12 ' O ' ' C' ' 214' ' ' LEU . 10.4 p -64.59 -36.18 76.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 122.084 -0.385 . . . . 0.0 110.873 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 218' ' ' ILE . . . . . 0.485 HG23 HD13 ' A' ' 222' ' ' LEU . 48.9 mt -62.68 -41.7 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -59.39 -42.97 92.94 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.64 0.734 . . . . 0.0 110.05 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.85 -36.96 73.06 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.364 0.602 . . . . 0.0 110.708 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.5 -33.76 88.1 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 4.9 tp -59.18 -39.77 83.59 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.38 0.61 . . . . 0.0 110.994 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.68 -40.03 93.52 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.215 0.531 . . . . 0.0 110.952 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 76.5 mt -62.04 -39.09 91.15 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.389 0.614 . . . . 0.0 110.775 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 44.7 tp -59.32 -39.14 82.17 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.498 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 9.9 p -60.81 -42.09 96.94 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.089 0.471 . . . . 0.0 110.644 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 7.1 mp -63.19 -45.48 91.58 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.342 0.592 . . . . 0.0 109.865 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.69 -37.42 87.54 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.098 0.475 . . . . 0.0 110.439 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -62.75 -42.3 99.61 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.327 0.584 . . . . 0.0 109.72 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.71 -38.93 82.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 121.462 0.648 . . . . 0.0 109.758 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.59 -31.85 60.74 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 5.7 tt -58.67 -40.33 83.21 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.472 0.653 . . . . 0.0 110.388 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -61.17 -44.26 97.59 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.386 0.612 . . . . 0.0 110.761 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -62.08 -46.22 90.05 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.358 0.599 . . . . 0.0 110.645 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -68.47 -36.01 78.37 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.233 0.54 . . . . 0.0 111.49 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 6.9 t80 . . . . . 0 CA--C 1.542 0.658 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.284 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.381 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 41.6 p 46.12 47.21 13.09 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.977 0.894 . . . . 0.0 111.203 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 25.5 p -93.14 33.97 1.16 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 122.209 1.004 . . . . 0.0 110.946 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 14.0 p -70.46 -27.95 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.887 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.5 HD13 ' O ' ' A' ' 213' ' ' LEU . 0.2 OUTLIER -69.02 -34.66 75.6 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.999 0.428 . . . . 0.0 111.571 -179.386 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.486 ' O ' HG12 ' A' ' 217' ' ' VAL . 3.2 tp -48.44 -57.19 11.4 Favored Pre-proline 0 CA--C 1.552 1.038 0 O-C-N 121.949 -0.469 . . . . 0.0 111.529 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -63.68 -37.84 44.08 Favored 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 121.802 1.668 . . . . 0.0 113.194 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 10.0 tp -60.99 -45.4 94.96 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.835 0.35 . . . . 0.0 111.667 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 214' ' ' LEU . 8.5 p -65.43 -36.39 77.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 O-C-N 122.271 -0.268 . . . . 0.0 110.697 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 68.6 mt -64.43 -43.96 97.02 Favored 'Isoleucine or valine' 0 C--N 1.345 0.374 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.475 ' CD1' HG21 ' C' ' 218' ' ' ILE . 8.3 m-30 -69.36 -37.06 77.44 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.494 0.664 . . . . 0.0 110.592 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -63.72 -36.7 84.73 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.335 0.588 . . . . 0.0 110.652 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.55 -33.71 82.92 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.537 HD13 HG23 ' C' ' 218' ' ' ILE . 0.2 OUTLIER -58.95 -25.53 63.59 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.157 0.503 . . . . 0.0 111.217 179.598 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.62 -38.69 88.55 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.139 0.495 . . . . 0.0 110.616 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.3 mp -59.5 -39.63 84.42 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.287 0.565 . . . . 0.0 110.407 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 14.7 tp -61.58 -40.97 96.67 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.384 0.611 . . . . 0.0 110.322 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 5.9 t -59.02 -46.31 88.52 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 121.333 0.587 . . . . 0.0 110.292 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.4 mt -64.47 -40.57 95.93 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.368 0.604 . . . . 0.0 110.179 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 18.2 mt -64.83 -36.58 84.8 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.062 0.458 . . . . 0.0 110.789 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -65.13 -42.21 94.1 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.249 0.547 . . . . 0.0 110.286 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 43.6 mm -63.91 -41.73 93.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 121.613 0.721 . . . . 0.0 109.967 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -62.26 -32.0 81.13 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 111.611 -0.596 . . . . 0.0 111.611 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.8 tt -58.46 -42.29 87.11 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.601 0.715 . . . . 0.0 110.819 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -66.77 -36.67 82.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.92 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -59.95 -44.54 94.34 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.44 0.638 . . . . 0.0 110.422 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 52.9 mmm-85 -61.12 -31.98 71.68 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.26 0.552 . . . . 0.0 111.021 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -85.79 -6.53 59.09 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.873 0.368 . . . . 0.0 111.536 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -130.03 46.57 2.63 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.978 0.894 . . . . 0.0 110.171 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.925 -179.878 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 6.1 m -152.17 -41.85 0.11 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.381 0.61 . . . . 0.0 110.585 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 69.8 p -131.1 50.26 2.25 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 122.42 1.105 . . . . 0.0 110.43 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 47.7 t -70.07 -36.16 67.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.099 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 6.6 tt -67.82 -34.74 77.33 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.664 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.512 ' O ' HG12 ' B' ' 217' ' ' VAL . 0.7 OUTLIER -49.84 -57.52 12.11 Favored Pre-proline 0 CA--C 1.552 1.049 0 O-C-N 121.881 -0.512 . . . . 0.0 111.088 -178.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 0.431 ' HA ' HD12 ' B' ' 218' ' ' ILE . 33.9 Cg_endo -63.96 -34.62 58.83 Favored 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 121.797 1.664 . . . . 0.0 112.846 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 8.2 tp -60.36 -45.37 93.75 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.987 0.422 . . . . 0.0 111.705 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.512 HG12 ' O ' ' B' ' 214' ' ' LEU . 7.2 p -66.34 -36.56 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 122.214 -0.304 . . . . 0.0 110.286 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . 0.474 ' HA ' HD22 ' C' ' 222' ' ' LEU . 53.5 mt -63.67 -42.24 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -65.14 -36.71 85.1 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.616 0.722 . . . . 0.0 109.942 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.65 -33.39 68.24 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.129 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . 0.41 ' HA3' HD11 ' C' ' 222' ' ' LEU . . . -70.92 -33.94 65.62 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.47 -32.26 73.12 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.152 0.501 . . . . 0.0 111.119 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -62.13 -38.95 90.91 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.276 0.56 . . . . 0.0 110.838 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 16.7 mt -63.77 -42.31 97.81 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.335 0.588 . . . . 0.0 110.418 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 22.0 tp -58.96 -30.82 68.19 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.189 0.518 . . . . 0.0 110.479 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 6.8 t -56.83 -45.93 82.01 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.984 0.421 . . . . 0.0 110.435 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 10.8 mt -64.52 -42.17 95.94 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.208 0.527 . . . . 0.0 110.249 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 6.7 mp -61.15 -37.42 82.79 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.483 0.659 . . . . 0.0 109.745 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -58.94 -35.48 73.19 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.347 0.594 . . . . 0.0 110.722 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 44.9 mm -62.17 -42.54 95.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.508 0.671 . . . . 0.0 110.205 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -62.77 -33.23 86.29 Favored Glycine 0 CA--C 1.535 1.306 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 232' ' ' LEU . . . . . 0.421 ' C ' HD23 ' B' ' 232' ' ' LEU . 9.3 tt -60.92 -44.47 97.14 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.43 0.633 . . . . 0.0 111.387 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -66.0 -39.27 90.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.291 0.567 . . . . 0.0 111.004 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -61.49 -45.9 92.29 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.472 0.653 . . . . 0.0 110.616 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -63.52 -35.63 81.11 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.23 0.538 . . . . 0.0 111.12 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -85.75 -6.66 59.09 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 120.891 0.377 . . . . 0.0 111.548 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -93.1 -31.78 14.69 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.806 -0.559 . . . . 0.0 111.11 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.545 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 210' ' ' THR . . . . . 0.447 ' O ' HG23 ' C' ' 210' ' ' THR . 7.3 t -154.27 119.67 5.12 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 122.219 -0.577 . . . . 0.0 110.714 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 9.7 t 40.25 44.89 1.67 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 122.359 1.076 . . . . 0.0 111.991 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 35.5 m -70.01 -28.83 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.042 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 213' ' ' LEU . . . . . 0.405 HD12 ' N ' ' C' ' 214' ' ' LEU . 3.2 pp -66.37 -35.2 79.72 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 122.646 0.378 . . . . 0.0 111.833 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 214' ' ' LEU . . . . . 0.493 ' O ' HG12 ' C' ' 217' ' ' VAL . 0.6 OUTLIER -53.36 -57.4 17.01 Favored Pre-proline 0 CA--C 1.552 1.028 0 O-C-N 121.931 -0.48 . . . . 0.0 111.062 -179.113 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.67 -32.1 68.98 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 121.869 1.713 . . . . 0.0 112.992 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.49 -45.31 93.61 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.084 0.469 . . . . 0.0 111.361 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 217' ' ' VAL . . . . . 0.493 HG12 ' O ' ' C' ' 214' ' ' LEU . 7.1 p -67.0 -36.39 77.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 O-C-N 122.132 -0.355 . . . . 0.0 110.244 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 218' ' ' ILE . . . . . 0.537 HG23 HD13 ' A' ' 222' ' ' LEU . 41.8 mm -62.79 -43.71 98.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -63.04 -36.9 85.11 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.381 0.61 . . . . 0.0 109.868 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -57.74 -41.91 82.81 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.518 0.675 . . . . 0.0 110.222 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.04 -33.91 81.3 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 222' ' ' LEU . . . . . 0.474 HD22 ' HA ' ' B' ' 218' ' ' ILE . 5.2 tp -58.91 -41.61 87.66 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.573 0.701 . . . . 0.0 110.279 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.81 -38.67 89.02 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.501 0.667 . . . . 0.0 110.151 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 1.9 tt -58.62 -38.37 77.87 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.366 0.603 . . . . 0.0 110.047 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 37.9 tp -57.91 -37.63 74.39 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.116 0.484 . . . . 0.0 110.183 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 6.5 t -59.18 -40.24 85.08 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.301 0.572 . . . . 0.0 110.401 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 11.4 mt -67.21 -42.81 83.5 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.465 0.65 . . . . 0.0 110.066 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 17.0 mt -65.69 -36.48 83.76 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.069 0.461 . . . . 0.0 111.11 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -74.98 -42.18 58.06 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.321 0.581 . . . . 0.0 110.893 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 91.1 mt -64.93 -40.56 89.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.29 0.567 . . . . 0.0 110.471 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -63.83 -34.99 91.41 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.49 -39.76 81.2 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.592 0.711 . . . . 0.0 111.248 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.31 -39.27 94.1 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.576 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -65.59 -48.13 73.39 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.503 0.668 . . . . 0.0 110.873 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 -66.43 -45.98 78.02 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.589 0.709 . . . . 0.0 110.861 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -86.39 5.24 35.88 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.772 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -174.81 97.68 0.08 Allowed 'General case' 0 C--N 1.343 0.307 0 O-C-N 121.675 -0.64 . . . . 0.0 110.131 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 . . . . . 0 N--CA 1.47 0.546 0 CA-C-O 117.929 -1.034 . . . . 0.0 111.763 -179.654 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.366 0 N-CA-C 109.712 -1.355 . . . . 859.95 109.712 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 29.3 p -143.54 146.94 33.75 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 122.195 -0.591 . . . . 999.99 110.608 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 39.0 p -115.03 50.68 0.96 Allowed 'General case' 0 C--O 1.237 0.423 0 CA-C-O 122.498 1.142 . . . . 342.29 110.463 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 40.2 t -70.03 -29.88 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 115.258 -0.883 . . . . 373.69 110.093 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.92 -31.03 69.63 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.906 0.384 . . . . 305.66 111.18 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.493 ' O ' HG12 ' A' ' 217' ' ' VAL . 1.3 tp -54.31 -57.67 17.37 Favored Pre-proline 0 CA--C 1.551 1.002 0 O-C-N 121.922 -0.486 . . . . 225.87 110.747 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -63.94 -32.48 65.59 Favored 'Trans proline' 0 N--CA 1.502 2.025 0 C-N-CA 121.887 1.725 . . . . 62.09 112.803 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 8.6 tp -62.06 -45.48 93.36 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.035 0.445 . . . . 248.22 111.471 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.493 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.9 p -67.91 -36.41 75.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.762 0.315 . . . . 35.87 110.505 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 43.6 mt -68.5 -43.88 83.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 121.857 -0.527 . . . . 147.8 109.743 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -67.04 -38.1 85.29 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.312 0.577 . . . . 807.13 110.246 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -57.95 -42.35 84.74 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.423 0.63 . . . . 227.36 110.27 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.8 -33.89 88.43 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 110.367 -1.093 . . . . 19.0 110.367 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.441 HD22 ' HA ' ' C' ' 218' ' ' ILE . 6.1 tp -60.75 -42.56 97.63 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.53 0.681 . . . . 75.47 110.653 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.73 89.31 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.402 0.62 . . . . 23.1 110.527 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.02 -37.43 76.93 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.293 0.568 . . . . 167.95 110.318 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 18.3 tp -57.67 -36.31 71.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.205 0.526 . . . . 68.45 110.337 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 5.9 t -59.7 -38.85 82.73 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.371 0.605 . . . . 138.3 110.426 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.8 mt -64.47 -42.68 95.78 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.242 0.544 . . . . 287.99 110.398 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.6 mp -71.33 -34.99 71.03 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.237 0.542 . . . . 177.82 110.718 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -70.77 -42.19 70.72 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 122.163 -0.335 . . . . 258.75 111.821 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 6.0 tp -63.84 -35.91 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.673 0.749 . . . . 271.85 110.813 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -69.14 -31.92 72.37 Favored Glycine 0 CA--C 1.533 1.206 0 N-CA-C 111.314 -0.714 . . . . 63.24 111.314 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.407 ' O ' HD23 ' A' ' 232' ' ' LEU . 5.2 tt -56.98 -46.09 82.48 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.72 0.771 . . . . 132.76 110.261 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.5 -36.49 73.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.661 -0.7 . . . . 86.51 110.567 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -62.99 -41.01 99.45 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.353 0.597 . . . . 462.81 110.368 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -70.29 -36.52 74.41 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.251 0.548 . . . . 999.99 111.027 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -85.69 -11.99 52.34 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.928 0.394 . . . . 832.95 111.093 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 10.5 tm0? -114.83 -3.95 12.7 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.501 0.556 . . . . 999.99 112.501 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.952 0 C-N-CA 124.123 0.969 . . . . 999.99 113.289 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.562 -1.415 . . . . 999.99 109.562 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 45.5 p -132.41 157.94 43.27 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.424 0.63 . . . . 999.99 110.635 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 17.8 p -103.06 54.5 0.76 Allowed 'General case' 0 C--O 1.237 0.438 0 CA-C-O 122.291 1.044 . . . . 355.66 110.394 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 29.0 m -69.97 -27.8 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 115.465 -0.789 . . . . 341.94 110.669 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 13.4 tp -68.38 -34.73 76.57 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.902 0.382 . . . . 191.08 111.276 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.494 ' O ' HG12 ' B' ' 217' ' ' VAL . 1.3 tp -53.53 -57.62 16.39 Favored Pre-proline 0 CA--C 1.553 1.062 0 O-C-N 121.993 -0.442 . . . . 265.74 110.942 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.05 -32.77 64.05 Favored 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 121.928 1.752 . . . . 66.31 112.78 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 11.0 tp -62.41 -45.51 92.81 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.086 0.47 . . . . 240.79 111.548 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.494 HG12 ' O ' ' B' ' 214' ' ' LEU . 8.8 p -67.79 -36.48 76.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.756 0.312 . . . . 30.7 110.412 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 43.6 mt -68.97 -42.98 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 109.423 -0.584 . . . . 112.32 109.423 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -67.75 -38.34 83.34 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.502 0.668 . . . . 176.28 110.532 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -58.73 -43.65 90.23 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.349 0.595 . . . . 284.73 110.623 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.95 -33.93 87.16 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 110.407 -1.077 . . . . 23.71 110.407 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 4.3 tp -61.32 -33.63 73.92 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.528 0.68 . . . . 108.06 111.29 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.59 -38.4 87.41 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.304 0.573 . . . . 37.97 110.956 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 2.0 mp -58.76 -38.19 77.9 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.151 0.5 . . . . 134.24 110.206 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 16.4 tp -61.83 -36.69 81.91 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.989 0.423 . . . . 103.12 110.854 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.3 -46.07 86.82 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 109.831 -0.433 . . . . 198.08 109.831 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 5.9 mp -62.03 -41.38 98.04 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.199 0.523 . . . . 283.7 110.223 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 6.8 mp -60.23 -38.62 83.97 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.234 0.54 . . . . 103.06 109.772 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -62.53 -42.31 99.43 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.343 0.592 . . . . 213.98 110.236 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 50.6 mm -62.94 -45.67 98.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.508 0.671 . . . . 160.19 110.378 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.12 -36.87 86.41 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 111.38 -0.688 . . . . 76.3 111.38 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 5.8 tt -63.13 -46.15 88.62 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.5 0.667 . . . . 167.04 111.299 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.24 -37.29 80.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.19 0.519 . . . . 155.61 110.982 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -59.85 -44.1 94.3 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.521 0.677 . . . . 450.22 109.859 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 51.5 mtt-85 -63.69 -40.73 97.53 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.433 0.635 . . . . 999.99 110.467 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -88.75 4.79 46.19 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.253 -0.431 . . . . 999.99 111.777 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -80.5 -91.42 0.05 Allowed 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.744 -0.598 . . . . 999.99 109.938 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.219 -0.529 0 CA-C-O 118.041 -0.98 . . . . 999.99 110.37 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.619 -1.392 . . . . 999.99 109.619 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 34.8 p -137.91 164.55 28.73 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.357 0.599 . . . . 999.99 110.733 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 20.1 p -103.8 52.33 0.77 Allowed 'General case' 0 C--O 1.238 0.463 0 CA-C-O 122.416 1.103 . . . . 428.22 110.451 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 28.6 m -70.01 -29.79 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 115.415 -0.811 . . . . 341.68 110.761 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 12.4 tp -68.88 -32.68 72.51 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.943 0.402 . . . . 417.6 111.316 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 214' ' ' LEU . . . . . 0.488 ' O ' HG12 ' C' ' 217' ' ' VAL . 1.4 tp -53.19 -57.54 16.18 Favored Pre-proline 0 CA--C 1.551 1.011 0 O-C-N 121.987 -0.445 . . . . 279.05 110.989 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.73 -33.58 65.34 Favored 'Trans proline' 0 N--CA 1.503 2.053 0 C-N-CA 121.853 1.702 . . . . 82.65 113.016 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 216' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' C' ' 216' ' ' LEU . 0.2 OUTLIER -62.09 -45.34 93.93 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.087 0.47 . . . . 291.53 111.362 -178.458 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 217' ' ' VAL . . . . . 0.488 HG12 ' O ' ' C' ' 214' ' ' LEU . 9.0 p -68.48 -36.46 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 O-C-N 122.136 -0.352 . . . . 51.53 110.447 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 218' ' ' ILE . . . . . 0.441 ' HA ' HD22 ' A' ' 222' ' ' LEU . 50.1 mt -66.05 -44.6 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 O-C-N 121.787 -0.57 . . . . 172.35 109.496 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -66.71 -40.07 88.28 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.472 0.653 . . . . 320.86 110.117 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -59.92 -44.04 94.56 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.356 0.598 . . . . 248.21 110.652 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.32 -33.82 85.92 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 110.409 -1.077 . . . . 14.55 110.409 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 4.4 tp -59.76 -36.85 77.49 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.452 0.644 . . . . 49.3 111.13 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.66 -38.64 88.49 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.271 0.558 . . . . 28.03 110.9 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 1.1 mp -58.93 -39.86 82.89 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.247 0.546 . . . . 136.06 110.044 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 17.0 tp -58.01 -39.52 78.48 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.303 0.573 . . . . 104.95 110.503 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 40.5 t -59.12 -44.23 91.98 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.281 0.562 . . . . 166.55 110.475 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 8.8 mt -61.03 -43.49 98.82 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.231 0.538 . . . . 300.73 110.282 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 7.5 mp -67.96 -36.45 80.09 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.122 0.487 . . . . 140.32 110.66 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -66.11 -42.22 89.5 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.338 0.59 . . . . 213.53 110.782 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 32.2 mm -63.34 -42.23 95.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.642 0.734 . . . . 237.51 109.797 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -67.12 -33.3 82.87 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 111.54 -0.624 . . . . 55.48 111.54 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 232' ' ' LEU . . . . . 0.419 HD23 ' O ' ' C' ' 232' ' ' LEU . 5.0 tt -61.0 -46.12 92.04 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.638 0.732 . . . . 135.05 110.779 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -62.35 -35.93 80.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.901 -0.591 . . . . 79.83 110.8 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -61.63 -39.06 89.95 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.294 0.569 . . . . 526.85 110.402 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 5.2 mtt85 -75.26 -34.37 61.36 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.127 0.489 . . . . 940.87 111.349 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -85.66 -13.3 48.99 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.098 0.475 . . . . 507.37 111.225 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -106.43 -29.98 9.38 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.217 0.532 . . . . 999.99 111.452 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 117.925 -1.036 . . . . 999.99 110.855 -179.84 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.6 m -163.73 153.04 14.38 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 122.306 -0.526 . . . . 0.0 110.056 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 8.9 t -126.91 26.66 6.11 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.578 0.704 . . . . 0.0 112.208 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 29.5 m -70.47 -33.63 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 121.626 0.727 . . . . 0.0 110.861 178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 51.9 mt -69.04 -29.35 67.48 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.2 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.519 ' O ' HG12 ' A' ' 217' ' ' VAL . 1.4 tp -54.22 -57.68 17.16 Favored Pre-proline 0 CA--C 1.551 1.004 0 O-C-N 121.862 -0.524 . . . . 0.0 110.408 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.458 ' HA ' HD12 ' A' ' 218' ' ' ILE . 34.8 Cg_endo -64.05 -33.38 62.4 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 121.958 1.772 . . . . 0.0 112.503 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.83 -45.27 94.56 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.669 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.519 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.1 p -66.09 -36.46 77.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 O-C-N 122.087 -0.383 . . . . 0.0 110.392 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.458 HD12 ' HA ' ' A' ' 215' ' ' PRO . 54.5 mt -63.0 -44.53 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -65.94 -36.78 84.31 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.414 0.626 . . . . 0.0 110.032 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -57.7 -44.44 85.88 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.372 0.606 . . . . 0.0 109.786 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -66.17 -33.87 86.52 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.494 HD22 ' HA ' ' C' ' 218' ' ' ILE . 5.5 tp -59.79 -41.76 91.88 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.662 0.744 . . . . 0.0 110.31 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.7 -38.54 88.22 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.702 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.98 -37.15 76.16 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.378 0.609 . . . . 0.0 109.819 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.417 HD13 HD13 ' B' ' 225' ' ' LEU . 15.9 tp -61.73 -41.33 97.49 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.748 -0.595 . . . . 0.0 110.486 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 4.4 m -56.73 -40.83 76.44 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.215 0.531 . . . . 0.0 110.309 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 12.3 mt -66.11 -41.52 90.46 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.087 0.47 . . . . 0.0 110.121 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 6.7 mp -62.48 -38.53 90.21 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.202 0.525 . . . . 0.0 109.991 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -58.84 -41.82 87.82 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.308 0.575 . . . . 0.0 110.098 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 48.6 mm -63.04 -42.09 95.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 121.593 0.711 . . . . 0.0 109.966 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -63.87 -31.99 82.68 Favored Glycine 0 CA--C 1.535 1.286 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.403 ' C ' HD23 ' A' ' 232' ' ' LEU . 6.8 tt -58.87 -45.76 89.4 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.636 0.731 . . . . 0.0 110.943 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -59.1 -35.91 74.24 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.957 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -59.73 -41.25 90.49 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.46 0.647 . . . . 0.0 110.31 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 55.6 mtt85 -64.32 -20.46 66.1 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.089 0.471 . . . . 0.0 111.391 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -85.76 -11.77 52.72 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.962 -0.461 . . . . 0.0 111.553 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -80.47 -48.54 12.66 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.799 0.809 . . . . 0.0 110.479 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.58 179.873 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 3.0 m 53.47 99.49 0.01 OUTLIER 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.287 0.565 . . . . 0.0 110.989 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 7.2 t -127.27 41.23 3.56 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 122.24 1.019 . . . . 0.0 110.819 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 34.7 m -70.33 -37.92 72.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.0 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 5.9 tt -69.42 -36.27 76.53 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.451 ' O ' HG12 ' B' ' 217' ' ' VAL . 0.4 OUTLIER -52.41 -57.5 15.28 Favored Pre-proline 0 CA--C 1.552 1.026 0 O-C-N 121.604 -0.685 . . . . 0.0 111.761 -177.408 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 0.449 ' HA ' HD12 ' B' ' 218' ' ' ILE . 19.8 Cg_exo -63.46 -31.83 71.59 Favored 'Trans proline' 0 N--CA 1.503 2.083 0 C-N-CA 121.599 1.533 . . . . 0.0 112.942 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 216' ' ' LEU . . . . . 0.51 ' O ' HD13 ' B' ' 216' ' ' LEU . 0.3 OUTLIER -62.86 -45.38 92.82 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.081 0.467 . . . . 0.0 111.458 -178.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.451 HG12 ' O ' ' B' ' 214' ' ' LEU . 8.0 p -69.29 -36.47 72.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 O-C-N 122.179 -0.326 . . . . 0.0 110.187 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . 0.449 HD12 ' HA ' ' B' ' 215' ' ' PRO . 68.9 mt -63.01 -42.99 98.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -60.55 -36.77 79.25 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.509 0.671 . . . . 0.0 110.183 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -57.78 -43.59 85.68 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.336 0.589 . . . . 0.0 110.774 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.23 -33.92 88.57 Favored Glycine 0 CA--C 1.532 1.137 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 6.6 tp -62.45 -37.11 84.62 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.515 0.674 . . . . 0.0 111.061 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.63 88.3 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.177 0.513 . . . . 0.0 110.877 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 7.2 mp -60.47 -45.27 94.34 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 121.127 0.489 . . . . 0.0 110.451 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . 0.417 HD13 HD13 ' A' ' 225' ' ' LEU . 21.6 tp -63.42 -38.56 91.62 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.337 0.589 . . . . 0.0 109.993 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.39 -45.42 84.52 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.324 0.583 . . . . 0.0 110.291 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . 0.427 ' O ' HD23 ' B' ' 227' ' ' LEU . 3.1 tt -60.63 -46.14 91.42 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.411 0.624 . . . . 0.0 110.153 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 7.3 mp -63.0 -37.63 87.93 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.196 0.522 . . . . 0.0 110.4 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -63.44 -42.2 98.67 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.154 0.502 . . . . 0.0 110.274 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 39.5 mm -67.41 -42.76 87.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 121.592 0.71 . . . . 0.0 109.761 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -67.2 -33.1 81.87 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 4.3 tt -58.69 -45.96 88.31 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.599 0.714 . . . . 0.0 111.002 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -61.06 -43.57 98.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.311 0.576 . . . . 0.0 110.942 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -60.0 -44.63 94.4 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.511 0.672 . . . . 0.0 110.142 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -68.09 -37.5 81.28 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.363 0.601 . . . . 0.0 110.941 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -86.69 5.02 38.14 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -119.1 39.53 3.53 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.931 0.872 . . . . 0.0 110.544 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.623 179.619 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 5.8 t -124.22 -36.25 2.7 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.282 0.563 . . . . 0.0 110.904 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 6.5 t -95.75 47.28 1.1 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 122.255 1.026 . . . . 0.0 110.208 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 13.9 p -70.28 -32.63 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.963 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 13.3 tp -67.11 -39.98 86.8 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 214' ' ' LEU . . . . . 0.567 ' CD2' HD11 ' C' ' 218' ' ' ILE . 1.3 tt -50.37 -57.02 14.31 Favored Pre-proline 0 CA--C 1.552 1.055 0 O-C-N 121.938 -0.476 . . . . 0.0 111.623 -178.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.8 -33.68 64.13 Favored 'Trans proline' 0 N--CA 1.503 2.065 0 C-N-CA 121.841 1.694 . . . . 0.0 113.186 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 216' ' ' LEU . . . . . 0.506 HD13 ' O ' ' C' ' 216' ' ' LEU . 0.3 OUTLIER -61.71 -45.41 94.09 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.065 0.46 . . . . 0.0 111.499 -178.442 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 217' ' ' VAL . . . . . 0.482 HG12 ' O ' ' C' ' 214' ' ' LEU . 7.4 p -67.32 -36.44 76.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 120.848 0.356 . . . . 0.0 110.377 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 218' ' ' ILE . . . . . 0.567 HD11 ' CD2' ' C' ' 214' ' ' LEU . 47.9 mt -68.22 -42.62 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 121.358 0.599 . . . . 0.0 109.512 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -64.06 -42.1 97.12 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.496 0.665 . . . . 0.0 110.399 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -60.15 -43.53 95.66 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.524 0.678 . . . . 0.0 110.357 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.45 -33.7 87.94 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 10.2 tp -58.96 -40.81 85.86 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.24 0.543 . . . . 0.0 110.657 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.77 -43.58 98.57 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.544 0.688 . . . . 0.0 109.686 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 1.5 tt -64.74 -39.06 92.99 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.832 0.825 . . . . 0.0 109.326 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 4.7 tt -57.94 -44.16 86.78 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.457 0.646 . . . . 0.0 110.155 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 8.2 t -59.37 -43.26 92.88 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.33 0.586 . . . . 0.0 110.824 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 10.1 mt -66.53 -42.69 86.83 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.296 0.57 . . . . 0.0 110.232 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 10.7 tp -66.63 -34.82 78.73 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.092 0.472 . . . . 0.0 110.681 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -66.48 -42.13 87.95 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.413 0.625 . . . . 0.0 110.02 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 88.3 mt -63.25 -36.3 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 121.307 0.575 . . . . 0.0 110.079 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.81 -32.19 61.73 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 232' ' ' LEU . . . . . 0.527 HD13 ' C ' ' C' ' 232' ' ' LEU . 3.1 tm? -58.46 -40.61 83.16 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.625 0.726 . . . . 0.0 110.273 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.99 -39.2 77.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.052 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -60.29 -48.07 83.31 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.364 0.602 . . . . 0.0 110.679 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 35.6 mmt-85 -72.27 -26.68 62.08 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.097 0.475 . . . . 0.0 111.597 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -85.82 -11.31 53.74 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.973 0.416 . . . . 0.0 111.447 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 57.01 88.13 0.05 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.826 0.822 . . . . 0.0 110.512 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.519 -179.942 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.466 HG22 ' N ' ' A' ' 211' ' ' THR . 17.8 m -133.73 162.98 30.48 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.315 0.578 . . . . 0.0 110.399 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.466 ' N ' HG22 ' A' ' 210' ' ' THR . 22.1 p -86.19 54.36 3.12 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 122.292 1.044 . . . . 0.0 110.926 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.13 -31.32 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.875 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 13.5 tp -69.08 -34.4 75.07 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.828 0.347 . . . . 0.0 111.419 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.54 ' O ' HG12 ' A' ' 217' ' ' VAL . 10.3 tp -51.24 -56.85 16.78 Favored Pre-proline 0 CA--C 1.551 1.012 0 CA-C-O 119.065 -0.493 . . . . 0.0 111.212 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.536 ' HA ' HD12 ' A' ' 218' ' ' ILE . 35.7 Cg_endo -64.03 -38.82 35.23 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 121.614 1.543 . . . . 0.0 112.79 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.4 tp -56.88 -45.44 82.53 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.4 p -63.95 -35.97 75.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 122.23 -0.294 . . . . 0.0 110.227 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 215' ' ' PRO . 58.2 mt -62.66 -45.13 99.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 O-C-N 121.755 -0.591 . . . . 0.0 109.443 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -60.16 -46.93 88.0 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.767 0.794 . . . . 0.0 110.04 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -59.08 -44.16 91.86 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.042 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.441 ' HA3' HD11 ' B' ' 222' ' ' LEU . . . -60.3 -33.98 82.85 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 4.6 tp -61.67 -42.5 99.0 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.44 0.638 . . . . 0.0 110.694 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.82 89.47 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.223 0.535 . . . . 0.0 110.447 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.6 tt -59.68 -48.64 80.87 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.312 0.577 . . . . 0.0 109.705 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.457 HD13 HD13 ' C' ' 225' ' ' LEU . 23.6 tp -61.12 -41.27 96.39 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.443 0.64 . . . . 0.0 109.743 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 47.8 t -58.81 -47.08 86.05 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.251 0.548 . . . . 0.0 109.732 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 21.0 tp -63.62 -42.2 98.2 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.235 0.54 . . . . 0.0 110.103 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 2.6 tp -61.98 -34.95 77.09 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.26 0.552 . . . . 0.0 109.924 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -58.93 -37.72 77.35 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.245 0.545 . . . . 0.0 110.216 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.6 mp -62.95 -42.32 96.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.536 0.684 . . . . 0.0 109.246 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -63.31 -31.88 82.26 Favored Glycine 0 CA--C 1.535 1.312 0 N-CA-C 111.419 -0.672 . . . . 0.0 111.419 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.407 ' O ' HD23 ' A' ' 232' ' ' LEU . 4.9 tt -58.32 -44.23 88.56 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.723 0.773 . . . . 0.0 110.511 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.79 -40.55 80.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.792 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -62.77 -45.72 91.34 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.524 0.678 . . . . 0.0 110.223 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -63.28 -32.76 74.26 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.277 0.561 . . . . 0.0 111.165 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -85.86 0.58 52.69 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 122.112 -0.368 . . . . 0.0 111.914 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -64.26 -27.54 69.11 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.763 -0.585 . . . . 0.0 111.116 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.451 179.986 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 7.6 t -71.01 172.65 8.7 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.424 0.631 . . . . 0.0 111.001 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 9.6 p -131.04 50.0 2.27 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 122.212 1.006 . . . . 0.0 110.398 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 12.5 p -70.13 -28.99 38.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.567 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 13.0 tp -67.22 -38.31 85.06 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.934 0.397 . . . . 0.0 111.544 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.499 ' O ' HG12 ' B' ' 217' ' ' VAL . 0.2 OUTLIER -50.56 -57.3 13.66 Favored Pre-proline 0 CA--C 1.552 1.046 0 O-C-N 121.961 -0.462 . . . . 0.0 111.437 -179.1 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.75 -33.93 63.75 Favored 'Trans proline' 0 N--CA 1.504 2.108 0 C-N-CA 121.783 1.655 . . . . 0.0 113.018 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 9.4 tp -62.43 -45.48 92.92 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.997 0.427 . . . . 0.0 111.699 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.499 HG12 ' O ' ' B' ' 214' ' ' LEU . 7.8 p -66.29 -36.47 77.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 120.669 0.271 . . . . 0.0 110.552 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . 0.467 ' HA ' HD22 ' C' ' 222' ' ' LEU . 53.4 mt -65.19 -43.96 95.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -68.87 -36.92 78.68 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.62 0.724 . . . . 0.0 109.93 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -58.46 -42.64 87.9 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.27 0.557 . . . . 0.0 110.828 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.11 -34.13 82.57 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . 0.441 HD11 ' HA3' ' A' ' 221' ' ' GLY . 0.3 OUTLIER -60.63 -23.82 65.05 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.307 0.575 . . . . 0.0 110.967 179.403 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.46 -38.55 87.64 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.189 0.518 . . . . 0.0 110.569 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . 0.475 HD23 ' CG ' ' C' ' 229' ' ' PHE . 4.8 mp -59.01 -39.34 81.58 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.137 0.494 . . . . 0.0 110.471 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . 0.443 HD13 HD13 ' A' ' 225' ' ' LEU . 47.2 tp -65.98 -33.92 76.92 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.029 0.442 . . . . 0.0 110.548 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 71.4 m -58.52 -43.8 89.28 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.999 0.428 . . . . 0.0 110.115 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -60.75 -43.1 98.41 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.452 0.644 . . . . 0.0 109.771 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 7.4 mp -64.52 -38.18 90.1 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.238 0.542 . . . . 0.0 110.318 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -61.6 -42.22 98.57 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.398 0.618 . . . . 0.0 110.164 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 43.4 mm -66.35 -42.98 91.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 121.605 0.717 . . . . 0.0 109.873 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -66.31 -31.99 80.67 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 9.2 tt -58.46 -39.28 79.46 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.537 0.684 . . . . 0.0 110.962 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.4 -36.75 79.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.383 0.611 . . . . 0.0 110.866 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -60.26 -46.98 87.92 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.43 0.633 . . . . 0.0 110.794 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -70.71 -32.22 69.35 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.395 0.617 . . . . 0.0 111.555 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -85.58 -10.37 55.98 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.431 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -99.83 -38.18 8.76 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 121.7 -0.625 . . . . 0.0 111.195 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.556 -179.867 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 10.6 m -62.64 -58.87 5.99 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 122.291 -0.534 . . . . 0.0 110.565 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 5.6 p -152.88 33.93 0.48 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.983 0.897 . . . . 0.0 111.211 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 11.7 p -70.37 -39.31 76.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 121.762 0.791 . . . . 0.0 110.424 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 9.1 tt -67.27 -38.72 85.54 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.824 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 214' ' ' LEU . . . . . 0.553 ' O ' HG12 ' C' ' 217' ' ' VAL . 0.8 OUTLIER -46.52 -57.5 8.57 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-O 118.986 -0.531 . . . . 0.0 111.713 -178.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.01 -40.04 29.29 Favored 'Trans proline' 0 N--CA 1.505 2.171 0 C-N-CA 121.883 1.722 . . . . 0.0 113.5 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 7.3 tp -57.14 -45.19 83.76 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.006 0.431 . . . . 0.0 111.919 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 217' ' ' VAL . . . . . 0.553 HG12 ' O ' ' C' ' 214' ' ' LEU . 8.3 p -63.72 -36.35 76.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 O-C-N 122.187 -0.32 . . . . 0.0 111.03 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 19.4 mm -62.96 -45.07 99.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -67.4 -36.98 82.37 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.568 0.699 . . . . 0.0 109.721 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -58.16 -44.37 87.89 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.287 0.565 . . . . 0.0 110.407 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.72 -33.89 88.46 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 222' ' ' LEU . . . . . 0.467 HD22 ' HA ' ' B' ' 218' ' ' ILE . 6.6 tp -60.7 -41.56 95.44 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.443 0.639 . . . . 0.0 110.694 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.89 -38.72 89.39 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.326 0.584 . . . . 0.0 110.571 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 1.2 tp -58.79 -40.75 84.96 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.353 0.597 . . . . 0.0 109.997 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . 0.457 HD13 HD13 ' A' ' 225' ' ' LEU . 20.4 tp -58.28 -39.53 79.5 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.233 0.539 . . . . 0.0 110.448 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 49.8 m -57.64 -45.96 84.78 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.269 0.557 . . . . 0.0 110.703 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 26.5 tp -63.63 -42.08 98.21 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.236 0.541 . . . . 0.0 110.359 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 7.4 mp -66.22 -36.99 84.46 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.043 0.449 . . . . 0.0 110.771 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 229' ' ' PHE . . . . . 0.475 ' CG ' HD23 ' B' ' 224' ' ' LEU . 30.1 t80 -70.51 -42.45 71.29 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.089 0.471 . . . . 0.0 111.355 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 37.9 mm -67.8 -41.16 84.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 121.575 0.702 . . . . 0.0 109.874 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -64.24 -33.0 86.06 Favored Glycine 0 CA--C 1.533 1.201 0 N-CA-C 111.634 -0.587 . . . . 0.0 111.634 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 232' ' ' LEU . . . . . 0.454 HD23 ' O ' ' C' ' 232' ' ' LEU . 4.1 tt -59.44 -46.02 89.94 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.704 0.764 . . . . 0.0 110.632 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -69.49 -35.79 75.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.158 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -59.85 -48.09 83.08 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.303 0.573 . . . . 0.0 110.868 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -72.03 -40.35 68.47 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.524 0.678 . . . . 0.0 111.299 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -85.91 5.14 34.34 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.132 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -172.91 93.07 0.11 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.625 0.726 . . . . 0.0 109.939 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 117.958 -1.02 . . . . 0.0 111.092 -179.451 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.497 HG23 HG13 ' A' ' 212' ' ' VAL . 6.5 t -145.93 171.89 14.16 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.356 0.598 . . . . 0.0 110.908 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 211' ' ' THR . 9.5 t -78.18 61.32 2.66 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.329 1.061 . . . . 0.0 110.834 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.497 HG13 HG23 ' A' ' 210' ' ' THR . 28.3 m -57.85 -25.23 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.455 179.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 12.8 tp -69.07 -32.29 71.64 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.883 0.373 . . . . 0.0 110.98 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.471 ' O ' HG12 ' A' ' 217' ' ' VAL . 0.2 OUTLIER -51.77 -57.68 13.84 Favored Pre-proline 0 CA--C 1.55 0.972 0 O-C-N 121.985 -0.447 . . . . 0.0 111.35 -179.272 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.64 -31.35 70.05 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 121.962 1.775 . . . . 0.0 113.433 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.471 ' O ' HD23 ' A' ' 216' ' ' LEU . 3.9 tt -64.03 -45.59 88.23 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.277 0.56 . . . . 0.0 111.151 -178.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.6 p -67.91 -36.65 76.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 120.784 0.326 . . . . 0.0 110.434 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.425 HD11 HD12 ' A' ' 214' ' ' LEU . 47.1 mt -69.46 -41.72 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -63.57 -36.86 85.19 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.325 0.583 . . . . 0.0 110.119 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -57.57 -44.61 85.43 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.259 0.552 . . . . 0.0 110.126 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.445 ' HA3' HD11 ' B' ' 222' ' ' LEU . . . -67.78 -33.95 81.58 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 7.7 tp -60.29 -35.02 74.61 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.33 0.586 . . . . 0.0 111.039 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.74 89.16 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.213 0.53 . . . . 0.0 110.891 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 48.8 mt -59.04 -39.56 82.36 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.274 0.559 . . . . 0.0 110.638 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 18.1 tp -58.95 -38.65 79.53 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.322 0.582 . . . . 0.0 110.5 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 7.5 t -59.89 -43.41 94.79 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.418 0.627 . . . . 0.0 110.646 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -63.04 -42.44 99.75 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.427 0.632 . . . . 0.0 110.693 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.6 mp -71.08 -35.25 71.79 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.07 0.462 . . . . 0.0 111.225 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -70.13 -42.43 72.61 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.253 0.549 . . . . 0.0 111.618 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 7.3 tp -69.15 -36.37 72.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.617 0.722 . . . . 0.0 111.166 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.82 -31.92 61.8 Favored Glycine 0 CA--C 1.533 1.185 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 5.1 tt -59.93 -46.04 90.64 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.725 0.774 . . . . 0.0 110.659 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -64.96 -39.5 93.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.74 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -61.91 -47.49 84.72 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.524 0.678 . . . . 0.0 110.339 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.16 -31.89 73.3 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.241 0.543 . . . . 0.0 111.148 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -85.85 -1.1 56.93 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 122.172 -0.33 . . . . 0.0 111.878 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -121.05 65.66 0.86 Allowed 'General case' 0 C--O 1.239 0.511 0 CA-C-O 122.24 1.019 . . . . 0.0 110.055 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.728 -179.892 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.401 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 39.9 p -65.1 -39.7 93.51 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.476 0.655 . . . . 0.0 110.669 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 41.9 p 46.57 54.32 8.89 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 122.384 1.088 . . . . 0.0 111.077 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 13.2 p -70.11 -33.08 53.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.626 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 12.7 tp -68.82 -31.6 70.7 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.674 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.477 ' O ' HG12 ' B' ' 217' ' ' VAL . 0.1 OUTLIER -53.29 -57.72 15.57 Favored Pre-proline 0 CA--C 1.552 1.054 0 O-C-N 122.007 -0.433 . . . . 0.0 110.913 -179.218 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.88 -32.9 65.8 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 121.85 1.7 . . . . 0.0 113.025 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 9.5 tp -62.56 -45.37 93.26 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.099 0.476 . . . . 0.0 111.491 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.477 HG12 ' O ' ' B' ' 214' ' ' LEU . 8.3 p -67.96 -36.58 76.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 122.248 -0.283 . . . . 0.0 110.285 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 53.5 mt -66.62 -44.14 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -65.13 -37.33 87.09 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.435 0.636 . . . . 0.0 110.299 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.96 -36.6 72.79 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.163 0.506 . . . . 0.0 110.447 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . 0.483 ' HA3' HD11 ' C' ' 222' ' ' LEU . . . -65.6 -33.85 87.38 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . 0.445 HD11 ' HA3' ' A' ' 221' ' ' GLY . 7.3 tp -58.96 -39.66 82.37 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.387 0.613 . . . . 0.0 110.855 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.84 89.52 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.288 0.566 . . . . 0.0 110.825 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 7.8 mp -62.01 -38.23 87.86 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.24 0.543 . . . . 0.0 110.627 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 16.3 tp -61.28 -40.59 94.68 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.296 0.57 . . . . 0.0 110.391 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 28.3 p -57.98 -45.89 86.04 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.263 0.554 . . . . 0.0 110.213 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 17.6 tp -64.48 -42.21 96.02 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.385 0.612 . . . . 0.0 110.066 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 49.6 mt -63.45 -34.85 78.66 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.246 0.546 . . . . 0.0 110.649 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -65.03 -42.06 94.71 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.476 0.655 . . . . 0.0 110.373 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 43.1 mm -63.33 -43.47 98.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 121.624 0.726 . . . . 0.0 110.033 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -67.0 -33.42 83.79 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 5.8 tt -60.58 -45.95 92.03 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.565 0.698 . . . . 0.0 111.091 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.95 -38.85 92.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.296 0.569 . . . . 0.0 110.877 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -61.6 -47.31 86.03 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.459 0.647 . . . . 0.0 110.28 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -65.56 -39.19 91.4 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.428 0.632 . . . . 0.0 110.796 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -86.83 5.03 38.7 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.846 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -163.94 87.21 0.5 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.786 0.803 . . . . 0.0 110.348 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 50.8 ptt85 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.787 -179.84 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 43.2 p -94.28 121.99 36.37 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.416 0.627 . . . . 0.0 110.505 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 211' ' ' THR . . . . . 0.401 HG22 ' HB2' ' C' ' 214' ' ' LEU . 0.2 OUTLIER -122.28 57.2 1.08 Allowed 'General case' 0 C--O 1.238 0.492 0 CA-C-O 122.356 1.074 . . . . 0.0 110.099 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 41.5 t -64.98 -26.47 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.139 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.32 -34.59 74.89 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.99 0.424 . . . . 0.0 110.953 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 214' ' ' LEU . . . . . 0.493 ' O ' HG12 ' C' ' 217' ' ' VAL . 13.6 tp -47.12 -57.01 10.24 Favored Pre-proline 0 CA--C 1.553 1.078 0 CA-C-O 118.892 -0.575 . . . . 0.0 111.975 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 215' ' ' PRO . . . . . 0.463 ' HA ' HD12 ' C' ' 218' ' ' ILE . 36.6 Cg_endo -63.38 -34.77 65.03 Favored 'Trans proline' 0 N--CA 1.505 2.172 0 C-N-CA 121.857 1.705 . . . . 0.0 113.401 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 216' ' ' LEU . . . . . 0.416 ' O ' HD23 ' C' ' 216' ' ' LEU . 3.3 tt -61.45 -45.6 93.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.072 0.463 . . . . 0.0 111.341 -178.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 217' ' ' VAL . . . . . 0.493 HG12 ' O ' ' C' ' 214' ' ' LEU . 7.1 p -66.34 -36.6 77.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 O-C-N 122.111 -0.368 . . . . 0.0 110.498 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 218' ' ' ILE . . . . . 0.463 HD12 ' HA ' ' C' ' 215' ' ' PRO . 62.1 mt -62.95 -39.65 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -59.41 -43.45 93.01 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.359 0.599 . . . . 0.0 110.509 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -58.38 -44.03 88.73 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.06 0.457 . . . . 0.0 110.599 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.81 -33.85 88.36 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 222' ' ' LEU . . . . . 0.483 HD11 ' HA3' ' B' ' 221' ' ' GLY . 6.0 tp -59.21 -40.09 84.71 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.47 0.653 . . . . 0.0 110.871 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.7 -38.91 89.59 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.237 0.541 . . . . 0.0 110.833 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 7.5 mp -61.74 -41.32 97.49 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.258 0.552 . . . . 0.0 110.436 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 15.2 tp -60.54 -41.06 93.71 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.363 0.601 . . . . 0.0 110.328 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 38.9 t -60.35 -40.35 90.4 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.282 0.563 . . . . 0.0 110.643 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 12.2 mt -66.54 -41.11 89.2 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.357 0.599 . . . . 0.0 110.706 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 7.1 mp -71.13 -35.06 71.59 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.223 0.535 . . . . 0.0 110.941 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -63.6 -42.89 98.21 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.098 0.475 . . . . 0.0 111.869 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 40.1 pt -69.28 -35.43 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-O 121.514 0.673 . . . . 0.0 110.738 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.83 -31.97 61.56 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 110.559 -1.017 . . . . 0.0 110.559 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 232' ' ' LEU . . . . . 0.454 HD23 ' O ' ' C' ' 232' ' ' LEU . 3.8 tt -56.93 -39.34 74.33 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-O 121.692 0.758 . . . . 0.0 110.165 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.89 -44.01 86.45 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.395 0.617 . . . . 0.0 110.594 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -65.39 -43.42 90.72 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.387 0.613 . . . . 0.0 110.49 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 6.5 mmt85 -65.36 -25.04 67.4 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.115 0.483 . . . . 0.0 111.54 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -85.94 5.11 34.57 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.968 -0.458 . . . . 0.0 111.975 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -52.29 -35.65 50.9 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.479 0.657 . . . . 0.0 111.152 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 14.7 ttt85 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 117.934 -1.031 . . . . 0.0 110.711 179.734 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 8.6 p -139.9 165.33 27.6 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.325 0.583 . . . . 0.0 110.587 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 39.6 p -109.09 45.52 1.04 Allowed 'General case' 0 C--O 1.236 0.381 0 CA-C-O 122.545 1.164 . . . . 0.0 110.185 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 13.1 p -70.14 -34.09 57.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.759 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.579 HD13 ' O ' ' A' ' 213' ' ' LEU . 0.3 OUTLIER -63.66 -40.11 96.03 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.978 -179.24 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.49 ' O ' HG12 ' A' ' 217' ' ' VAL . 3.1 tp -51.49 -57.36 14.62 Favored Pre-proline 0 CA--C 1.553 1.067 0 O-C-N 121.74 -0.6 . . . . 0.0 111.332 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.09 -32.68 63.76 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 121.816 1.678 . . . . 0.0 112.79 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.1 tt -62.3 -45.46 93.15 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.955 0.407 . . . . 0.0 111.317 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 214' ' ' LEU . 8.0 p -67.76 -36.53 76.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 O-C-N 122.243 -0.286 . . . . 0.0 110.385 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 43.7 mt -69.3 -43.41 81.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-O 121.404 0.621 . . . . 0.0 109.333 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -65.41 -37.02 85.7 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.397 0.618 . . . . 0.0 110.688 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.79 -38.44 75.48 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.653 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.484 ' HA3' HD11 ' B' ' 222' ' ' LEU . . . -65.31 -33.87 87.9 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.451 HD11 ' HA3' ' C' ' 221' ' ' GLY . 3.8 tp -59.28 -45.35 91.49 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.704 0.764 . . . . 0.0 109.677 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.87 -38.34 87.92 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.644 0.735 . . . . 0.0 110.072 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.473 HD21 ' CE2' ' B' ' 229' ' ' PHE . 4.6 tp -58.67 -40.39 83.39 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.25 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 22.8 tp -59.09 -37.42 77.08 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.955 0.407 . . . . 0.0 110.582 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 17.5 m -56.99 -41.88 79.24 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.413 0.625 . . . . 0.0 110.149 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.438 ' O ' HG22 ' A' ' 230' ' ' ILE . 7.0 mp -64.47 -39.9 94.68 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.397 0.618 . . . . 0.0 110.43 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 61.5 mt -71.37 -34.55 70.54 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.215 0.531 . . . . 0.0 111.439 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -59.93 -42.47 94.03 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 227' ' ' LEU . 7.5 tp -65.08 -35.93 76.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.608 0.718 . . . . 0.0 110.996 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -62.41 -31.9 81.11 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.413 ' C ' HD23 ' A' ' 232' ' ' LEU . 8.1 tt -57.12 -43.08 82.0 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.74 0.781 . . . . 0.0 110.479 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -69.35 -35.91 76.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.096 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -59.87 -48.18 82.72 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.045 0.45 . . . . 0.0 111.22 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.63 -36.87 85.64 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.327 0.584 . . . . 0.0 111.115 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -90.16 5.14 48.2 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 120.886 0.374 . . . . 0.0 111.768 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 56.96 24.0 8.93 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 121.575 -0.703 . . . . 0.0 111.408 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 50.9 ttt-85 . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 117.864 -1.065 . . . . 0.0 110.598 179.65 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . 0.587 HG22 HG22 ' B' ' 212' ' ' VAL . 7.3 m 54.57 98.63 0.01 OUTLIER 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.301 0.572 . . . . 0.0 110.647 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 10.1 p -105.14 36.24 2.55 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 122.21 1.005 . . . . 0.0 110.907 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . 0.587 HG22 HG22 ' B' ' 210' ' ' THR . 34.4 m -70.23 -32.68 51.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.918 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 13.4 tp -66.12 -32.59 74.14 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.059 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.526 ' O ' HG12 ' B' ' 217' ' ' VAL . 0.2 OUTLIER -54.99 -58.01 16.77 Favored Pre-proline 0 CA--C 1.55 0.945 0 O-C-N 121.817 -0.552 . . . . 0.0 110.401 -179.24 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 0.405 ' HA ' HD12 ' B' ' 218' ' ' ILE . 31.2 Cg_endo -64.5 -34.0 54.82 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 121.765 1.644 . . . . 0.0 112.178 178.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 216' ' ' LEU . . . . . 0.461 ' O ' HD13 ' B' ' 216' ' ' LEU . 0.2 OUTLIER -61.16 -45.26 95.35 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.631 -178.362 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.526 HG12 ' O ' ' B' ' 214' ' ' LEU . 9.6 p -66.39 -36.43 77.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 122.114 -0.366 . . . . 0.0 110.302 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' B' ' 215' ' ' PRO . 36.8 mt -66.48 -45.21 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -64.44 -36.7 85.04 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.506 0.669 . . . . 0.0 110.121 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -57.63 -44.58 85.65 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.259 0.552 . . . . 0.0 110.51 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.65 -35.11 91.61 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . 0.484 HD11 ' HA3' ' A' ' 221' ' ' GLY . 7.2 tp -58.85 -43.99 90.91 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.549 0.69 . . . . 0.0 110.284 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.57 88.37 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.403 0.621 . . . . 0.0 110.605 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 1.4 tp -58.94 -40.61 85.17 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.274 0.559 . . . . 0.0 109.989 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 18.8 tp -58.68 -37.22 75.57 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.173 0.511 . . . . 0.0 110.695 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 11.1 p -56.93 -38.92 73.57 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.294 0.569 . . . . 0.0 110.629 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . 0.68 ' O ' HG22 ' B' ' 230' ' ' ILE . 1.5 tt -58.02 -48.26 80.6 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.375 0.607 . . . . 0.0 110.453 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 8.4 mp -71.7 -36.74 70.65 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.286 0.565 . . . . 0.0 110.964 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 229' ' ' PHE . . . . . 0.473 ' CE2' HD21 ' A' ' 224' ' ' LEU . 38.5 t80 -66.4 -37.43 85.23 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.68 HG22 ' O ' ' B' ' 227' ' ' LEU . 7.9 tp -62.83 -35.51 71.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.32 0.581 . . . . 0.0 111.629 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.18 -31.9 63.43 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 232' ' ' LEU . . . . . 0.489 ' C ' HD23 ' B' ' 232' ' ' LEU . 9.4 tt -61.24 -42.03 97.9 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.485 0.659 . . . . 0.0 111.122 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -65.35 -35.9 82.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.144 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -59.83 -47.68 84.73 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.265 0.555 . . . . 0.0 110.43 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 62.8 mtp85 -64.05 -28.92 70.12 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.189 0.519 . . . . 0.0 111.078 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -85.81 -7.78 58.52 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 120.975 0.417 . . . . 0.0 111.602 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 56.55 86.55 0.07 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.82 0.819 . . . . 0.0 110.754 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.678 179.942 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.375 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 16.6 m -164.48 105.23 0.85 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.153 0.501 . . . . 0.0 110.698 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 2.7 m -124.54 33.58 5.21 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 122.225 1.012 . . . . 0.0 111.122 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 27.3 m -70.38 -26.91 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.831 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 16.5 tp -64.76 -39.98 94.52 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.549 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 214' ' ' LEU . . . . . 0.515 ' O ' HG12 ' C' ' 217' ' ' VAL . 1.9 tt -53.23 -57.49 16.45 Favored Pre-proline 0 CA--C 1.551 0.985 0 CA-C-O 119.083 -0.484 . . . . 0.0 111.039 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.14 -34.72 56.35 Favored 'Trans proline' 0 N--CA 1.501 1.957 0 C-N-CA 121.714 1.609 . . . . 0.0 112.748 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 216' ' ' LEU . . . . . 0.464 ' O ' HD23 ' C' ' 216' ' ' LEU . 2.8 tt -62.29 -45.36 93.61 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.55 -178.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 217' ' ' VAL . . . . . 0.515 HG12 ' O ' ' C' ' 214' ' ' LEU . 10.3 p -65.7 -36.37 77.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 O-C-N 122.163 -0.336 . . . . 0.0 110.775 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 53.8 mt -65.66 -44.05 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -67.56 -36.48 81.02 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.585 0.707 . . . . 0.0 110.072 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -57.71 -42.43 83.74 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.011 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 221' ' ' GLY . . . . . 0.451 ' HA3' HD11 ' A' ' 222' ' ' LEU . . . -59.89 -33.89 80.51 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.79 -29.45 66.83 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.206 0.527 . . . . 0.0 110.942 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.79 -38.79 89.39 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.324 0.583 . . . . 0.0 110.656 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 25.4 mt -61.89 -37.51 84.85 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.409 0.623 . . . . 0.0 110.647 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 11.6 tp -59.65 -36.51 76.54 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.078 0.466 . . . . 0.0 110.838 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 15.7 t -58.39 -39.12 78.79 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.329 0.585 . . . . 0.0 110.498 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 227' ' ' LEU . . . . . 0.421 ' O ' HG22 ' C' ' 230' ' ' ILE . 21.3 tp -62.78 -44.49 96.04 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.415 0.626 . . . . 0.0 110.385 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 8.3 mp -71.36 -34.86 70.86 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.477 0.656 . . . . 0.0 111.349 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -62.27 -42.33 99.25 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 230' ' ' ILE . . . . . 0.421 HG22 ' O ' ' C' ' 227' ' ' LEU . 5.5 tp -65.32 -38.53 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.494 0.664 . . . . 0.0 111.211 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.87 -32.79 74.08 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 4.4 tt -58.87 -43.06 90.78 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.551 0.691 . . . . 0.0 110.98 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -60.68 -40.96 94.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.368 0.604 . . . . 0.0 110.581 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -65.63 -43.06 90.68 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.619 0.723 . . . . 0.0 110.402 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.77 -18.06 64.73 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.207 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -85.88 5.09 34.4 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.898 -0.501 . . . . 0.0 111.962 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -111.38 61.39 0.61 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 122.28 1.038 . . . . 0.0 110.156 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 20.4 mtp-105 . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.872 -179.898 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 8.1 p -71.97 139.58 48.72 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.345 0.593 . . . . 0.0 110.423 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 80.0 p -114.38 57.74 0.7 Allowed 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.338 1.066 . . . . 0.0 110.335 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 26.9 m -66.2 -30.0 48.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.88 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.488 HD23 ' O ' ' A' ' 213' ' ' LEU . 1.2 tt -68.98 -35.64 76.96 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.955 0.407 . . . . 0.0 110.931 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.502 ' O ' HG12 ' A' ' 217' ' ' VAL . 0.9 OUTLIER -48.77 -57.32 11.45 Favored Pre-proline 0 CA--C 1.551 1.015 0 O-C-N 121.829 -0.544 . . . . 0.0 111.299 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.503 ' HA ' HD12 ' A' ' 218' ' ' ILE . 32.7 Cg_endo -63.86 -34.22 61.41 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 121.82 1.68 . . . . 0.0 112.931 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 5.4 tt -61.69 -45.49 93.78 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.959 0.409 . . . . 0.0 111.529 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.3 p -66.08 -36.65 77.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 O-C-N 122.174 -0.329 . . . . 0.0 110.534 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 215' ' ' PRO . 48.9 mt -63.11 -45.13 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -67.48 -36.98 82.2 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.615 0.722 . . . . 0.0 109.799 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -58.86 -42.54 89.65 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.34 0.59 . . . . 0.0 110.692 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -62.74 -33.89 88.12 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.432 HD11 ' HA3' ' C' ' 221' ' ' GLY . 0.3 OUTLIER -62.89 -29.2 70.58 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.194 0.521 . . . . 0.0 111.012 179.598 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -62.15 -38.84 90.53 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.251 0.548 . . . . 0.0 110.674 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.9 mp -63.14 -42.86 99.54 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.289 0.566 . . . . 0.0 110.218 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.623 HD11 HD12 ' C' ' 228' ' ' LEU . 31.8 tp -59.48 -41.17 89.18 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.256 0.55 . . . . 0.0 109.995 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 33.1 m -58.18 -47.18 84.2 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.17 0.509 . . . . 0.0 110.471 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -61.54 -42.11 98.35 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.189 0.519 . . . . 0.0 110.528 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 6.7 mp -66.52 -36.59 83.09 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.158 0.504 . . . . 0.0 110.588 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -66.93 -42.15 85.82 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.321 0.582 . . . . 0.0 110.909 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 27.6 mm -62.81 -41.95 94.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 121.494 0.664 . . . . 0.0 110.002 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -61.14 -32.77 81.67 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 111.706 -0.558 . . . . 0.0 111.706 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 9.5 tt -61.41 -38.31 86.64 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 122.037 -0.684 . . . . 0.0 111.369 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.87 -35.92 82.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.136 0.493 . . . . 0.0 111.255 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -59.87 -41.83 92.38 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.409 0.623 . . . . 0.0 110.389 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -59.94 -24.29 64.26 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.148 0.499 . . . . 0.0 111.243 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -85.74 -10.73 55.12 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.977 0.418 . . . . 0.0 111.442 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -70.71 -30.36 66.9 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.431 0.634 . . . . 0.0 111.169 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.733 -179.913 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 4.5 t -118.64 143.6 46.71 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.493 0.663 . . . . 0.0 110.807 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 41.0 p -138.67 49.19 1.89 Allowed 'General case' 0 C--O 1.238 0.462 0 CA-C-O 122.293 1.044 . . . . 0.0 110.299 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.07 -28.44 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.593 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 213' ' ' LEU . . . . . 0.443 HD23 ' O ' ' B' ' 213' ' ' LEU . 3.5 tt -66.96 -40.79 87.56 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.986 0.422 . . . . 0.0 111.161 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.469 ' O ' HG12 ' B' ' 217' ' ' VAL . 20.2 tp -48.98 -57.54 11.09 Favored Pre-proline 0 CA--C 1.559 1.323 0 O-C-N 121.828 -0.545 . . . . 0.0 111.415 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.23 -29.57 64.32 Favored 'Trans proline' 0 N--CA 1.504 2.09 0 C-N-CA 122.01 1.807 . . . . 0.0 113.05 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 9.5 tp -68.51 -45.08 73.24 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.085 0.469 . . . . 0.0 111.761 -178.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.469 HG12 ' O ' ' B' ' 214' ' ' LEU . 9.8 p -65.81 -36.96 78.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 O-C-N 122.272 -0.268 . . . . 0.0 111.344 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 24.8 pt -71.15 -39.24 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 O-C-N 121.518 -0.739 . . . . 0.0 110.589 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -67.21 -37.09 83.04 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.468 0.652 . . . . 0.0 110.3 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -57.69 -40.4 79.35 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.219 0.533 . . . . 0.0 110.74 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . 0.501 ' HA3' HD11 ' C' ' 222' ' ' LEU . . . -65.28 -34.0 88.29 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 7.6 tp -58.95 -39.67 82.39 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.688 0.756 . . . . 0.0 109.88 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.67 -38.19 86.85 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.586 0.708 . . . . 0.0 109.981 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.2 tp -58.46 -41.88 86.18 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.344 0.592 . . . . 0.0 109.914 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 19.3 tp -57.96 -32.36 67.77 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.15 0.5 . . . . 0.0 110.352 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 6.3 m -56.95 -43.2 81.33 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.15 0.5 . . . . 0.0 110.251 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 6.1 mp -59.08 -44.04 91.84 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.212 0.53 . . . . 0.0 110.28 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 7.3 mp -67.06 -39.37 86.88 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.181 0.515 . . . . 0.0 110.535 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -63.6 -42.16 98.26 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.205 0.526 . . . . 0.0 110.804 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 31.1 mm -62.9 -39.02 83.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.474 0.654 . . . . 0.0 109.862 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -58.23 -32.82 68.3 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.91 -33.65 70.8 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.458 0.647 . . . . 0.0 111.589 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.78 -35.97 71.53 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.325 0.584 . . . . 0.0 110.897 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -59.81 -39.67 85.81 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.376 0.608 . . . . 0.0 110.336 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -60.81 -16.08 36.96 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.994 0.425 . . . . 0.0 111.584 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -85.73 -12.5 50.95 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.994 -0.441 . . . . 0.0 111.624 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -107.55 58.76 0.62 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 122.242 1.02 . . . . 0.0 110.278 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.468 179.943 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 15.8 m -101.35 -56.44 2.3 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 122.226 -0.573 . . . . 0.0 111.305 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 14.7 p -108.89 26.36 10.68 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.828 0.823 . . . . 0.0 111.922 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.66 -29.95 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.196 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 9.9 tp -69.08 -33.05 72.92 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.929 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 214' ' ' LEU . . . . . 0.485 ' O ' HG12 ' C' ' 217' ' ' VAL . 3.5 tp -48.98 -57.22 11.96 Favored Pre-proline 0 CA--C 1.551 0.998 0 O-C-N 121.892 -0.505 . . . . 0.0 111.133 -179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -63.85 -35.5 55.86 Favored 'Trans proline' 0 N--CA 1.505 2.192 0 C-N-CA 121.736 1.624 . . . . 0.0 113.073 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 216' ' ' LEU . . . . . 0.453 ' O ' HD23 ' C' ' 216' ' ' LEU . 3.6 tt -62.02 -45.53 93.18 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.057 0.456 . . . . 0.0 111.487 -178.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 217' ' ' VAL . . . . . 0.485 HG12 ' O ' ' C' ' 214' ' ' LEU . 9.2 p -66.53 -36.63 77.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 O-C-N 122.087 -0.383 . . . . 0.0 110.63 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 43.3 mt -69.03 -42.35 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -66.55 -38.35 86.94 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.621 0.725 . . . . 0.0 110.276 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -57.93 -39.19 77.4 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.676 0.75 . . . . 0.0 110.378 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 221' ' ' GLY . . . . . 0.432 ' HA3' HD11 ' A' ' 222' ' ' LEU . . . -59.89 -33.41 78.41 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 222' ' ' LEU . . . . . 0.501 HD11 ' HA3' ' B' ' 221' ' ' GLY . 3.6 tp -58.49 -39.44 80.02 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.541 0.686 . . . . 0.0 110.441 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.94 -38.29 87.92 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.503 0.668 . . . . 0.0 110.032 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 3.2 tp -58.66 -40.32 83.15 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.419 0.628 . . . . 0.0 110.072 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 18.7 tp -59.84 -30.86 69.25 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.231 0.538 . . . . 0.0 110.415 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 2.1 t -58.55 -38.97 78.95 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.136 0.493 . . . . 0.0 110.695 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 8.2 mp -61.29 -47.82 84.23 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.398 0.618 . . . . 0.0 111.007 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 228' ' ' LEU . . . . . 0.623 HD12 HD11 ' A' ' 225' ' ' LEU . 14.6 mt -71.21 -35.08 71.38 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.167 0.508 . . . . 0.0 111.252 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -70.74 -42.22 70.81 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.015 0.436 . . . . 0.0 111.808 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 7.6 tp -67.9 -35.93 73.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 121.561 0.696 . . . . 0.0 111.293 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -69.6 -31.82 70.87 Favored Glycine 0 CA--C 1.535 1.312 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 232' ' ' LEU . . . . . 0.483 HD23 ' C ' ' C' ' 232' ' ' LEU . 10.3 tt -60.78 -43.7 97.75 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.442 0.639 . . . . 0.0 110.867 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -67.68 -38.78 84.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.456 0.646 . . . . 0.0 110.763 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -61.58 -47.57 84.91 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.503 0.668 . . . . 0.0 110.378 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 10.1 ttt-85 -66.96 -21.67 65.96 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.313 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -86.23 -8.32 57.87 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 122.097 -0.377 . . . . 0.0 111.731 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -165.91 88.14 0.39 Allowed 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.974 0.892 . . . . 0.0 111.002 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 . . . . . 0 N--CA 1.469 0.52 0 CA-C-O 117.896 -1.05 . . . . 0.0 111.07 179.79 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 18.4 p 45.69 32.56 1.23 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.47 0.652 . . . . 0.0 111.67 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 15.2 p -80.35 6.83 11.03 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.328 0.585 . . . . 0.0 112.401 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 47.3 t -70.67 -40.09 76.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.704 0.764 . . . . 0.0 109.905 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 10.6 tp -67.84 -29.9 69.16 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.145 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.535 ' O ' HG12 ' A' ' 217' ' ' VAL . 0.7 OUTLIER -54.15 -57.65 17.19 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 121.901 -0.499 . . . . 0.0 110.816 -178.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.16 -32.31 63.39 Favored 'Trans proline' 0 N--CA 1.504 2.135 0 C-N-CA 121.759 1.639 . . . . 0.0 112.849 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.9 tt -62.89 -45.44 92.52 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.981 0.419 . . . . 0.0 111.582 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.6 p -65.4 -36.77 78.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 O-C-N 122.25 -0.281 . . . . 0.0 110.68 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 38.4 mm -70.71 -43.51 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-O 121.636 0.732 . . . . 0.0 109.127 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -62.12 -36.5 81.94 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.402 0.62 . . . . 0.0 110.475 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -57.53 -43.8 84.6 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.366 0.603 . . . . 0.0 110.171 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -66.62 -34.34 87.24 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.401 HD11 ' HA3' ' C' ' 221' ' ' GLY . 6.5 tp -61.45 -39.99 92.85 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.55 0.691 . . . . 0.0 110.5 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.66 -38.42 87.67 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.409 0.624 . . . . 0.0 110.417 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.455 ' O ' HD23 ' A' ' 224' ' ' LEU . 1.6 tt -58.62 -37.43 75.88 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.17 0.509 . . . . 0.0 110.083 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 20.9 tp -59.11 -41.6 88.54 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.31 0.576 . . . . 0.0 110.021 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 43.1 t -60.51 -40.79 92.7 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.469 0.652 . . . . 0.0 110.208 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.471 ' O ' HG22 ' A' ' 230' ' ' ILE . 0.8 OUTLIER -61.83 -42.69 99.34 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.397 0.618 . . . . 0.0 110.162 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.416 HD21 ' CD1' ' B' ' 232' ' ' LEU . 1.6 mp -71.35 -34.79 70.81 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.368 0.604 . . . . 0.0 110.949 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -58.96 -42.28 89.53 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 227' ' ' LEU . 7.6 tp -64.55 -36.93 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.603 0.716 . . . . 0.0 111.227 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.42 -31.82 62.92 Favored Glycine 0 CA--C 1.534 1.225 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.497 ' O ' HD23 ' A' ' 232' ' ' LEU . 1.6 tt -57.67 -36.18 71.57 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.549 0.69 . . . . 0.0 110.849 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -61.21 -39.76 91.44 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.32 0.581 . . . . 0.0 111.006 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -61.22 -48.03 83.38 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.407 0.622 . . . . 0.0 111.066 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -72.1 -36.19 69.41 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.399 0.618 . . . . 0.0 111.632 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -85.77 5.44 32.41 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.074 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -151.14 81.76 1.32 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.913 0.863 . . . . 0.0 110.168 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.766 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 3.3 m -130.96 44.81 2.91 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 122.075 0.94 . . . . 0.0 110.319 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 211' ' ' THR . . . . . 0.532 HG22 ' HB2' ' B' ' 214' ' ' LEU . 4.0 m 55.86 35.97 26.42 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 122.205 1.002 . . . . 0.0 110.875 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 35.6 m -70.47 -33.97 55.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.221 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 11.1 tp -64.62 -36.4 84.12 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.537 ' O ' HG12 ' B' ' 217' ' ' VAL . 0.1 OUTLIER -54.41 -57.73 17.23 Favored Pre-proline 0 CA--C 1.55 0.958 0 O-C-N 121.882 -0.511 . . . . 0.0 110.905 -179.056 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -64.07 -32.84 63.77 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 121.872 1.715 . . . . 0.0 112.896 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 8.9 tp -60.72 -45.23 95.03 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.049 0.452 . . . . 0.0 111.754 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.537 HG12 ' O ' ' B' ' 214' ' ' LEU . 7.3 p -65.67 -36.65 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 O-C-N 122.098 -0.376 . . . . 0.0 110.524 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 39.3 mm -65.18 -43.84 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -64.95 -36.59 84.9 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.225 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -57.35 -44.94 84.77 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.345 0.593 . . . . 0.0 109.716 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -67.43 -33.77 82.81 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 178.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 6.0 tp -61.95 -35.38 78.27 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.513 0.673 . . . . 0.0 111.055 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.62 88.27 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.152 0.501 . . . . 0.0 110.971 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 7.9 mp -58.87 -39.17 80.57 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.134 0.492 . . . . 0.0 110.49 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . 0.461 HD13 HD13 ' C' ' 225' ' ' LEU . 15.1 tp -61.46 -42.85 99.4 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.296 0.57 . . . . 0.0 110.083 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 58.7 m -60.42 -47.08 87.63 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 121.116 0.484 . . . . 0.0 110.426 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.19 -41.63 97.0 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.314 0.578 . . . . 0.0 110.152 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 7.4 tp -61.73 -34.81 76.46 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.286 0.565 . . . . 0.0 109.806 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -62.31 -36.29 81.67 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.412 0.625 . . . . 0.0 110.321 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 46.2 mm -62.88 -44.91 99.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 121.581 0.705 . . . . 0.0 110.34 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -71.74 -33.36 63.36 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 232' ' ' LEU . . . . . 0.416 ' CD1' HD21 ' A' ' 228' ' ' LEU . 5.1 tt -60.5 -45.77 92.56 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.531 0.681 . . . . 0.0 111.176 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.41 95.48 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.287 0.565 . . . . 0.0 110.726 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -64.05 -45.95 86.52 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.564 0.697 . . . . 0.0 110.126 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -69.39 -30.58 68.6 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.709 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -85.81 -4.1 59.08 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 122.121 -0.362 . . . . 0.0 111.755 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 55.33 87.35 0.05 OUTLIER 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.752 0.787 . . . . 0.0 110.595 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 118.118 -0.944 . . . . 0.0 110.463 179.962 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 11.3 m -106.82 126.09 51.85 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.511 0.672 . . . . 0.0 110.853 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 9.8 t 40.32 43.01 1.36 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 122.309 1.052 . . . . 0.0 111.96 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 27.5 m -70.25 -35.68 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.019 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 213' ' ' LEU . . . . . 0.506 ' O ' HD23 ' C' ' 213' ' ' LEU . 3.2 tt -66.9 -40.61 87.77 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.114 0.483 . . . . 0.0 111.277 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 214' ' ' LEU . . . . . 0.488 ' O ' HG12 ' C' ' 217' ' ' VAL . 14.0 tp -45.62 -57.25 8.08 Favored Pre-proline 0 CA--C 1.556 1.187 0 CA-C-O 118.962 -0.542 . . . . 0.0 112.038 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 215' ' ' PRO . . . . . 0.424 ' HA ' HD12 ' C' ' 218' ' ' ILE . 37.6 Cg_endo -63.7 -36.85 49.75 Favored 'Trans proline' 0 N--CA 1.506 2.236 0 C-N-CA 121.801 1.667 . . . . 0.0 113.689 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.8 -45.22 94.8 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 122.075 -0.391 . . . . 0.0 111.465 -178.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 217' ' ' VAL . . . . . 0.488 HG12 ' O ' ' C' ' 214' ' ' LEU . 7.9 p -64.98 -36.66 78.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 O-C-N 122.084 -0.385 . . . . 0.0 110.566 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 218' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' C' ' 215' ' ' PRO . 50.8 mt -63.11 -45.16 99.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -65.6 -37.31 86.26 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.492 0.663 . . . . 0.0 109.729 178.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -58.12 -44.33 87.71 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.513 0.673 . . . . 0.0 110.393 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 221' ' ' GLY . . . . . 0.401 ' HA3' HD11 ' A' ' 222' ' ' LEU . . . -65.35 -33.99 88.15 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 4.9 tp -59.78 -43.19 94.49 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.421 0.629 . . . . 0.0 109.97 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.62 88.89 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.367 0.603 . . . . 0.0 110.413 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 1.2 tt -58.9 -40.9 85.88 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.124 0.487 . . . . 0.0 110.357 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . 0.461 HD13 HD13 ' B' ' 225' ' ' LEU . 22.7 tp -58.99 -40.48 84.99 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.057 0.456 . . . . 0.0 110.764 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 26.9 p -56.64 -41.04 76.49 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.195 0.521 . . . . 0.0 110.409 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.66 -39.79 91.74 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.267 0.556 . . . . 0.0 110.245 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 6.8 mp -67.22 -38.25 84.94 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.154 0.502 . . . . 0.0 110.484 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -64.92 -42.18 94.92 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.316 0.579 . . . . 0.0 110.619 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 35.4 mm -66.46 -42.16 89.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 121.54 0.686 . . . . 0.0 110.095 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -70.6 -35.94 67.69 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 232' ' ' LEU . . . . . 0.468 HD23 ' C ' ' C' ' 232' ' ' LEU . 8.1 tt -63.79 -46.37 85.48 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 122.043 -0.681 . . . . 0.0 111.13 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -70.26 -35.85 74.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.151 0.501 . . . . 0.0 111.221 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -59.98 -47.91 83.88 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.391 0.615 . . . . 0.0 110.497 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -69.77 -21.25 63.45 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.086 0.47 . . . . 0.0 111.499 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -86.17 -6.17 59.05 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 122.034 -0.416 . . . . 0.0 111.717 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 58.86 88.61 0.07 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.623 0.725 . . . . 0.0 110.408 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 118.119 -0.944 . . . . 0.0 111.135 -179.96 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 26.7 p 46.39 92.59 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.593 0.711 . . . . 0.0 111.242 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 9.0 t -84.23 50.81 1.93 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.374 1.083 . . . . 0.0 111.096 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 23.9 t -69.08 -22.59 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.081 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.564 HD13 ' O ' ' A' ' 213' ' ' LEU . 0.3 OUTLIER -67.26 -36.43 81.58 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.944 0.402 . . . . 0.0 111.09 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.504 ' O ' HG12 ' A' ' 217' ' ' VAL . 0.9 OUTLIER -51.29 -57.35 14.41 Favored Pre-proline 0 CA--C 1.552 1.032 0 O-C-N 121.894 -0.503 . . . . 0.0 111.194 -179.012 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.529 ' HA ' HD12 ' A' ' 218' ' ' ILE . 33.2 Cg_endo -63.76 -31.88 68.31 Favored 'Trans proline' 0 N--CA 1.502 1.993 0 C-N-CA 121.776 1.65 . . . . 0.0 113.039 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 8.9 tp -62.72 -45.38 93.0 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.155 0.502 . . . . 0.0 111.562 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.1 p -66.51 -36.43 77.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 O-C-N 122.226 -0.296 . . . . 0.0 110.371 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 215' ' ' PRO . 51.6 mt -62.8 -44.06 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -67.9 -36.79 80.82 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.345 0.593 . . . . 0.0 109.908 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -57.75 -44.35 86.05 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.288 0.566 . . . . 0.0 110.128 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -67.9 -34.0 81.17 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' C' ' 218' ' ' ILE . 6.2 tp -62.89 -36.07 82.11 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.391 0.615 . . . . 0.0 111.111 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.66 -38.61 88.37 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.226 0.536 . . . . 0.0 111.088 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 19.7 mt -58.95 -44.63 91.47 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.938 0.399 . . . . 0.0 110.74 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.563 ' HB2' HD11 ' B' ' 225' ' ' LEU . 26.0 tp -61.6 -31.76 71.84 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.997 0.427 . . . . 0.0 110.624 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 31.7 t -62.16 -46.41 89.08 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.181 0.515 . . . . 0.0 110.693 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.435 ' N ' HD12 ' A' ' 227' ' ' LEU . 7.7 mp -66.42 -39.6 89.06 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.572 0.701 . . . . 0.0 110.577 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 13.1 tp -71.13 -34.38 70.99 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.148 0.499 . . . . 0.0 111.345 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.434 ' CE1' HD23 ' C' ' 224' ' ' LEU . 27.8 t80 -63.84 -43.22 96.82 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.237 0.541 . . . . 0.0 111.793 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 32.1 pt -69.2 -35.7 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-O 121.417 0.627 . . . . 0.0 110.838 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -59.16 -31.95 70.38 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.8 -32.01 68.96 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.574 0.702 . . . . 0.0 110.581 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.85 -43.5 90.81 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.384 0.612 . . . . 0.0 110.868 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -63.24 -43.67 97.39 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.529 0.681 . . . . 0.0 110.577 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -65.68 -20.75 66.41 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.637 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -85.81 -12.45 50.85 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 122.013 -0.43 . . . . 0.0 111.386 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -118.32 46.82 1.72 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.998 0.904 . . . . 0.0 110.516 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 26.6 ttm105 . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.816 179.952 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 46.5 p -106.46 80.69 1.51 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.895 0.855 . . . . 0.0 110.461 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 25.2 p 46.6 48.05 14.37 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 122.362 1.077 . . . . 0.0 111.157 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 35.9 m -70.03 -34.2 58.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.059 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 14.1 tp -68.67 -29.82 68.37 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.636 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.504 ' O ' HG12 ' B' ' 217' ' ' VAL . 1.0 OUTLIER -55.25 -57.78 18.41 Favored Pre-proline 0 CA--C 1.552 1.035 0 O-C-N 121.976 -0.452 . . . . 0.0 110.812 -179.151 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.04 -32.95 63.93 Favored 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 122.042 1.828 . . . . 0.0 112.889 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.86 -45.22 94.74 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.03 0.443 . . . . 0.0 111.517 -178.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.504 HG12 ' O ' ' B' ' 214' ' ' LEU . 7.4 p -67.58 -36.4 76.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 122.194 -0.316 . . . . 0.0 110.33 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 46.4 mt -67.44 -43.14 87.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -65.87 -38.97 90.22 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.511 0.672 . . . . 0.0 109.847 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -57.88 -43.78 86.24 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.523 0.677 . . . . 0.0 110.199 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.23 -33.7 87.94 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 218' ' ' ILE . 9.8 tp -58.76 -39.73 81.82 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.293 0.568 . . . . 0.0 110.337 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.71 88.39 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.652 0.739 . . . . 0.0 109.252 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 3.0 tp -59.76 -38.95 83.22 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.77 0.795 . . . . 0.0 109.335 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . 0.563 HD11 ' HB2' ' A' ' 225' ' ' LEU . 3.7 tt -59.6 -45.1 92.92 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.617 0.722 . . . . 0.0 110.13 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 45.0 m -60.91 -43.8 98.06 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.389 0.614 . . . . 0.0 110.347 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 11.8 mt -64.36 -41.48 96.7 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.282 0.563 . . . . 0.0 110.23 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 21.6 mt -65.87 -37.97 87.58 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.989 0.423 . . . . 0.0 111.079 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -69.55 -42.36 74.67 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.201 0.524 . . . . 0.0 110.892 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 38.8 mm -67.45 -41.21 85.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.716 0.77 . . . . 0.0 109.655 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -58.45 -31.88 67.46 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.529 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 4.6 tt -58.7 -39.87 82.0 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.512 0.672 . . . . 0.0 110.979 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -68.09 -37.11 80.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.337 0.589 . . . . 0.0 110.789 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -61.44 -47.85 83.85 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.442 0.639 . . . . 0.0 110.658 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -68.61 -37.36 79.72 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.381 0.61 . . . . 0.0 111.192 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -85.83 -2.6 58.4 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.715 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 50.58 50.75 18.25 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 122.191 0.996 . . . . 0.0 110.732 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 118.141 -0.933 . . . . 0.0 110.926 -179.992 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 24.1 p -57.14 116.8 3.47 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.409 0.623 . . . . 0.0 110.672 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 40.2 p -143.96 52.13 1.31 Allowed 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.374 1.083 . . . . 0.0 110.48 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 41.3 t -70.06 -36.0 66.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.14 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 11.2 tp -66.73 -35.7 80.73 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.779 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 214' ' ' LEU . . . . . 0.547 ' O ' HG12 ' C' ' 217' ' ' VAL . 1.0 OUTLIER -50.82 -57.35 13.82 Favored Pre-proline 0 CA--C 1.551 0.988 0 CA-C-O 118.919 -0.562 . . . . 0.0 111.367 -178.692 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.97 -36.68 47.88 Favored 'Trans proline' 0 N--CA 1.505 2.184 0 C-N-CA 121.979 1.786 . . . . 0.0 113.297 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.93 -45.23 93.29 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.893 0.378 . . . . 0.0 111.793 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 217' ' ' VAL . . . . . 0.547 HG12 ' O ' ' C' ' 214' ' ' LEU . 7.6 p -63.84 -36.19 75.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 O-C-N 122.126 -0.359 . . . . 0.0 110.905 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 218' ' ' ILE . . . . . 0.44 ' HA ' HD22 ' A' ' 222' ' ' LEU . 33.1 mm -62.75 -44.97 99.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 O-C-N 121.615 -0.678 . . . . 0.0 109.198 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -68.9 -37.56 79.07 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.636 0.731 . . . . 0.0 110.205 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -59.37 -44.48 92.72 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.392 0.615 . . . . 0.0 110.529 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.29 -33.8 88.21 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 110.454 -1.059 . . . . 0.0 110.454 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 2.4 tp -62.91 -42.57 99.83 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.561 0.696 . . . . 0.0 110.72 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.86 -38.95 90.18 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.347 0.594 . . . . 0.0 110.798 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . 0.434 HD23 ' CE1' ' A' ' 229' ' ' PHE . 0.6 OUTLIER -61.8 -42.04 98.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.319 0.581 . . . . 0.0 109.949 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . 0.478 HD13 HD13 ' A' ' 225' ' ' LEU . 22.4 tp -61.37 -38.7 87.94 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.31 0.576 . . . . 0.0 110.246 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 37.4 m -58.43 -46.96 85.46 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.205 0.526 . . . . 0.0 110.3 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -62.88 -41.79 99.54 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.216 0.532 . . . . 0.0 110.478 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 228' ' ' LEU . . . . . 0.41 HD13 ' O ' ' C' ' 224' ' ' LEU . 6.6 mp -63.79 -38.31 90.64 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.196 0.522 . . . . 0.0 110.372 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -62.23 -42.22 99.12 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.36 0.6 . . . . 0.0 110.129 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 48.0 mm -68.0 -42.22 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-O 121.621 0.724 . . . . 0.0 109.869 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -65.51 -31.88 81.58 Favored Glycine 0 CA--C 1.533 1.178 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 232' ' ' LEU . . . . . 0.411 HD23 ' O ' ' C' ' 232' ' ' LEU . 4.5 tt -57.26 -45.98 83.48 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.711 0.767 . . . . 0.0 110.733 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -61.64 -38.77 88.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.904 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -63.28 -47.18 83.41 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.47 0.652 . . . . 0.0 110.678 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -68.4 -41.2 80.81 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.283 0.563 . . . . 0.0 111.1 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -88.42 4.96 44.53 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.912 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -175.68 92.2 0.05 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.587 0.708 . . . . 0.0 110.471 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.46 179.754 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.98 160.13 40.5 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 122.288 -0.536 . . . . 0.0 110.148 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 8.1 t -117.1 45.17 1.93 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 122.346 1.069 . . . . 0.0 110.93 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 41.3 t -70.18 -35.69 64.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.439 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 31.7 mt -64.05 -40.58 96.59 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.521 ' O ' HG12 ' A' ' 217' ' ' VAL . 0.8 OUTLIER -49.39 -57.26 12.36 Favored Pre-proline 0 CA--C 1.552 1.035 0 O-C-N 121.924 -0.485 . . . . 0.0 111.638 -178.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.56 -36.44 53.7 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 121.805 1.67 . . . . 0.0 113.358 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.441 ' O ' HD13 ' A' ' 216' ' ' LEU . 0.2 OUTLIER -61.34 -45.17 95.55 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.949 0.404 . . . . 0.0 111.74 -178.602 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 214' ' ' LEU . 8.7 p -65.36 -36.48 77.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 O-C-N 122.14 -0.35 . . . . 0.0 110.507 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 59.8 mt -63.46 -44.84 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 O-C-N 121.6 -0.688 . . . . 0.0 109.461 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -63.96 -42.97 97.11 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.642 0.734 . . . . 0.0 109.749 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -58.1 -42.72 86.29 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.67 0.748 . . . . 0.0 110.567 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.1 -33.61 84.79 Favored Glycine 0 CA--C 1.531 1.031 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.437 HD22 ' HA ' ' C' ' 218' ' ' ILE . 8.8 tp -58.51 -41.37 85.28 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.235 0.54 . . . . 0.0 110.094 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.93 -39.01 90.59 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.508 0.671 . . . . 0.0 109.467 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.6 tp -62.42 -43.47 98.73 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.938 0.875 . . . . 0.0 109.55 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.533 HD11 ' HB2' ' C' ' 225' ' ' LEU . 0.9 OUTLIER -59.69 -38.21 80.91 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.357 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 48.0 m -58.95 -43.53 91.26 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 121.406 0.622 . . . . 0.0 110.428 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.73 -43.98 97.81 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.246 0.546 . . . . 0.0 110.265 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.6 mp -65.95 -38.62 89.07 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.195 0.522 . . . . 0.0 110.48 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -67.38 -42.18 83.78 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.16 0.505 . . . . 0.0 110.595 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 96.0 mt -66.67 -35.48 74.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.444 0.64 . . . . 0.0 109.991 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.5 -31.81 60.43 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.425 ' C ' HD23 ' A' ' 232' ' ' LEU . 8.7 tt -59.85 -42.78 94.38 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.698 0.761 . . . . 0.0 110.376 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -62.48 -44.08 97.25 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.432 0.634 . . . . 0.0 110.881 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -65.45 -46.81 78.4 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.605 0.717 . . . . 0.0 110.737 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -61.31 -38.34 86.51 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.418 0.628 . . . . 0.0 111.229 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -85.88 -1.51 57.34 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.807 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -152.19 79.28 1.24 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.839 0.828 . . . . 0.0 110.423 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 90.9 mtm-85 . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 117.872 -1.061 . . . . 0.0 110.561 -179.949 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 34.5 p -62.98 134.39 56.11 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.346 0.593 . . . . 0.0 110.706 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 7.4 t -148.57 47.37 1.03 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 122.305 1.05 . . . . 0.0 110.513 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 33.5 m -69.6 -32.71 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.058 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 11.2 tp -65.97 -37.49 86.11 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.716 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.545 ' O ' HG12 ' B' ' 217' ' ' VAL . 7.1 tp -51.94 -57.19 15.85 Favored Pre-proline 0 CA--C 1.552 1.021 0 CA-C-O 118.867 -0.587 . . . . 0.0 111.231 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.13 -34.54 57.17 Favored 'Trans proline' 0 N--CA 1.504 2.126 0 C-N-CA 121.823 1.682 . . . . 0.0 113.205 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.75 -45.16 95.38 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.901 0.381 . . . . 0.0 111.724 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.545 HG12 ' O ' ' B' ' 214' ' ' LEU . 7.1 p -63.3 -36.33 75.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 O-C-N 122.06 -0.4 . . . . 0.0 110.756 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 21.5 mm -62.93 -44.75 99.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -64.59 -36.86 85.6 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.451 0.644 . . . . 0.0 110.044 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -57.68 -44.72 86.0 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.201 0.524 . . . . 0.0 110.585 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -67.6 -34.78 84.83 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 5.2 tp -61.85 -40.97 97.19 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.667 0.746 . . . . 0.0 110.235 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.79 -38.44 88.1 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.32 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 2.5 tp -58.69 -38.13 77.57 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.209 0.528 . . . . 0.0 110.2 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . 0.478 HD13 ' HG ' ' A' ' 225' ' ' LEU . 19.3 tp -59.08 -32.34 69.71 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.119 0.485 . . . . 0.0 110.718 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 33.1 t -58.97 -47.03 86.58 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.057 0.456 . . . . 0.0 110.289 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . 0.421 ' N ' HD12 ' B' ' 227' ' ' LEU . 7.8 mp -62.41 -43.98 97.52 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.197 0.522 . . . . 0.0 110.394 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 7.2 mp -61.56 -36.84 81.76 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.237 0.542 . . . . 0.0 109.974 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -59.46 -42.07 91.14 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.651 0.738 . . . . 0.0 109.956 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 50.4 mm -64.67 -41.04 91.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 121.767 0.794 . . . . 0.0 110.083 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -63.92 -32.01 82.73 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.554 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 232' ' ' LEU . . . . . 0.413 ' C ' HD23 ' B' ' 232' ' ' LEU . 6.6 tt -60.5 -46.21 90.96 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.598 0.713 . . . . 0.0 110.794 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -70.07 -39.17 75.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.477 0.656 . . . . 0.0 110.781 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -64.09 -40.65 96.69 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.326 0.584 . . . . 0.0 110.867 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -62.83 -17.42 61.32 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.9 0.381 . . . . 0.0 111.887 -179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -85.8 -21.16 28.28 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.115 0.483 . . . . 0.0 110.68 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 40.86 31.03 0.11 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.509 0.671 . . . . 0.0 112.178 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.633 -179.796 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 19.7 m -63.79 -47.58 80.31 Favored 'General case' 0 CA--C 1.533 0.327 0 O-C-N 122.31 -0.523 . . . . 0.0 110.561 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 23.0 p -150.54 48.73 0.88 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 122.325 1.06 . . . . 0.0 110.326 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 34.8 m -70.0 -32.48 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.087 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 21.9 mt -69.06 -30.95 69.39 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.893 0.378 . . . . 0.0 111.497 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 214' ' ' LEU . . . . . 0.536 ' O ' HG12 ' C' ' 217' ' ' VAL . 0.2 OUTLIER -54.38 -57.49 18.31 Favored Pre-proline 0 CA--C 1.549 0.918 0 CA-C-O 118.929 -0.558 . . . . 0.0 111.118 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -63.7 -34.67 61.65 Favored 'Trans proline' 0 N--CA 1.505 2.165 0 C-N-CA 121.777 1.651 . . . . 0.0 113.406 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 tt -59.69 -45.57 91.69 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.103 0.478 . . . . 0.0 111.6 -178.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 217' ' ' VAL . . . . . 0.536 HG12 ' O ' ' C' ' 214' ' ' LEU . 7.1 p -64.54 -36.34 77.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 O-C-N 122.156 -0.34 . . . . 0.0 110.794 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 218' ' ' ILE . . . . . 0.437 ' HA ' HD22 ' A' ' 222' ' ' LEU . 36.0 mm -63.17 -44.93 99.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -61.73 -36.93 82.38 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.356 0.598 . . . . 0.0 110.186 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -57.79 -44.71 86.44 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.325 0.583 . . . . 0.0 110.101 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -65.6 -33.72 87.0 Favored Glycine 0 CA--C 1.534 1.219 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 4.7 tp -61.9 -38.62 89.03 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.575 0.702 . . . . 0.0 110.842 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.68 -38.49 87.98 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.95 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 7.4 mp -58.91 -42.11 88.88 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.217 0.532 . . . . 0.0 110.164 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . 0.533 ' HB2' HD11 ' A' ' 225' ' ' LEU . 18.6 tp -58.56 -30.88 67.48 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.108 0.48 . . . . 0.0 110.648 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 8.0 t -57.06 -44.45 83.02 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.45 0.643 . . . . 0.0 109.939 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 7.9 mp -66.72 -40.81 88.55 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.36 0.6 . . . . 0.0 110.065 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 30.0 mt -63.61 -35.98 82.32 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.045 0.45 . . . . 0.0 110.547 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -66.79 -42.13 86.48 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.33 0.586 . . . . 0.0 109.971 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.29 -35.73 74.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 121.462 0.648 . . . . 0.0 109.844 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.74 -31.92 61.25 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 5.2 tt -59.49 -42.13 91.42 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.703 0.763 . . . . 0.0 110.172 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -62.45 -44.13 97.15 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.528 0.68 . . . . 0.0 110.554 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -62.44 -45.61 92.29 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.445 0.64 . . . . 0.0 110.586 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -59.64 -19.24 47.87 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.427 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -85.86 -5.62 59.21 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.938 -0.476 . . . . 0.0 111.958 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -129.15 55.57 1.74 Allowed 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 122.302 1.049 . . . . 0.0 110.299 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 79.8 mtm-85 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.788 -179.909 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.481 ' O ' HG23 ' A' ' 211' ' ' THR . . . . . . . . 0 N--CA 1.49 2.264 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 74.9 p -56.94 115.55 2.67 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 122.316 -0.52 . . . . 0.0 110.056 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 209' ' ' GLY . 66.6 p -109.45 50.82 0.77 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 122.289 1.042 . . . . 0.0 110.673 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 34.7 m -70.16 -41.32 78.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.428 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 14.0 tp -69.27 -35.54 76.18 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.405 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.553 ' O ' HG12 ' A' ' 217' ' ' VAL . 2.3 tt -44.94 -57.1 7.56 Favored Pre-proline 0 CA--C 1.554 1.102 0 CA-C-O 118.887 -0.578 . . . . 0.0 111.744 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -63.79 -38.25 40.65 Favored 'Trans proline' 0 N--CA 1.507 2.27 0 C-N-CA 122.037 1.825 . . . . 0.0 113.925 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.2 tt -59.47 -45.36 91.86 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.205 0.526 . . . . 0.0 111.947 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 214' ' ' LEU . 9.1 p -61.94 -35.95 71.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.963 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 25.2 mm -62.56 -44.84 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 121.656 -0.653 . . . . 0.0 109.533 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -65.13 -36.66 84.98 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.709 0.766 . . . . 0.0 110.07 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -57.68 -42.38 83.49 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.243 0.544 . . . . 0.0 111.345 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.518 ' HA3' HD11 ' B' ' 222' ' ' LEU . . . -59.77 -33.63 78.77 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.95 -31.75 71.7 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.124 0.488 . . . . 0.0 111.444 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.64 -38.71 88.69 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.317 0.579 . . . . 0.0 110.619 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.86 -37.54 76.73 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.111 0.481 . . . . 0.0 110.456 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 16.8 tp -57.83 -35.37 70.8 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.079 0.466 . . . . 0.0 110.867 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 35.5 t -58.65 -41.72 86.68 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.228 0.537 . . . . 0.0 110.742 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.443 ' N ' HD12 ' A' ' 227' ' ' LEU . 7.8 mp -62.22 -42.78 99.61 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.587 0.708 . . . . 0.0 110.426 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.8 mp -71.25 -36.67 71.85 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.14 0.495 . . . . 0.0 111.029 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -70.36 -42.47 71.76 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.097 0.475 . . . . 0.0 111.568 -179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 7.9 tp -69.09 -38.37 78.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 121.813 0.816 . . . . 0.0 110.913 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -71.77 -31.8 64.59 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.448 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.402 ' C ' HD23 ' A' ' 232' ' ' LEU . 10.4 tt -60.87 -37.18 81.25 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 122.084 -0.657 . . . . 0.0 111.174 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.26 -37.48 87.4 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.17 0.509 . . . . 0.0 111.256 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -60.04 -46.33 89.88 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.525 0.679 . . . . 0.0 110.217 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -76.99 -10.87 59.66 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.992 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -85.83 -18.04 33.98 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.882 -0.511 . . . . 0.0 111.178 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -155.73 39.0 0.37 Allowed 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.932 0.873 . . . . 0.0 110.545 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 29.8 ttp180 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.747 -179.734 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 2.0 m -144.04 145.7 32.37 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 122.28 -0.541 . . . . 0.0 110.292 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 40.8 p -98.88 49.26 0.96 Allowed 'General case' 0 C--O 1.238 0.473 0 CA-C-O 122.41 1.1 . . . . 0.0 110.811 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 29.7 m -70.06 -31.94 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.627 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 10.9 tp -63.69 -40.68 97.4 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.795 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.511 ' O ' HG12 ' B' ' 217' ' ' VAL . 2.9 tp -49.6 -57.55 11.75 Favored Pre-proline 0 CA--C 1.553 1.09 0 O-C-N 121.79 -0.569 . . . . 0.0 111.512 -178.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.42 -39.55 28.42 Favored 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 121.786 1.657 . . . . 0.0 112.754 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.34 -43.66 92.74 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.939 -177.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.511 HG12 ' O ' ' B' ' 214' ' ' LEU . 10.6 p -66.17 -36.58 77.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 O-C-N 121.971 -0.456 . . . . 0.0 110.714 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 33.6 mt -65.92 -44.45 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -66.58 -36.62 83.08 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.355 0.598 . . . . 0.0 110.139 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -57.55 -43.49 84.5 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.319 0.581 . . . . 0.0 110.116 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . 0.493 ' HA3' HD11 ' C' ' 222' ' ' LEU . . . -63.42 -33.64 87.79 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 178.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . 0.518 HD11 ' HA3' ' A' ' 221' ' ' GLY . 5.4 tp -58.79 -42.32 88.77 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.543 0.687 . . . . 0.0 110.103 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.8 -38.85 89.65 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.697 0.76 . . . . 0.0 109.567 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 2.9 tp -60.84 -40.1 91.56 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.757 0.789 . . . . 0.0 109.783 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.99 -42.86 89.23 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.061 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . 0.402 ' O ' HD13 ' B' ' 230' ' ' ILE . 19.4 t -63.24 -44.02 96.4 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 121.51 0.671 . . . . 0.0 109.948 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 11.2 mt -66.85 -39.79 87.71 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.284 0.564 . . . . 0.0 110.23 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.42 HD11 HD13 ' C' ' 232' ' ' LEU . 7.6 tp -64.1 -34.76 78.77 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.202 0.525 . . . . 0.0 110.422 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -68.54 -41.17 80.24 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.314 0.578 . . . . 0.0 110.474 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.402 HD13 ' O ' ' B' ' 226' ' ' SER . 1.4 mp -66.01 -41.5 89.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 121.585 0.707 . . . . 0.0 109.114 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -60.58 -32.04 76.88 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 232' ' ' LEU . . . . . 0.458 ' C ' HD23 ' B' ' 232' ' ' LEU . 6.4 tt -58.98 -46.41 88.2 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.638 0.732 . . . . 0.0 110.762 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -62.8 -38.55 91.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.782 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -60.26 -46.19 90.67 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.562 0.696 . . . . 0.0 109.891 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 72.2 mtt85 -70.74 -32.2 69.29 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.102 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -85.24 -8.96 58.29 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 120.991 0.424 . . . . 0.0 111.329 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 47.8 22.09 0.33 Allowed 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.709 -0.619 . . . . 0.0 111.789 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.401 -179.472 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 5.1 t -115.96 24.46 11.45 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 122.151 -0.617 . . . . 0.0 111.6 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 50.2 p -113.85 29.24 8.15 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 122.016 0.912 . . . . 0.0 111.286 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 38.2 t -70.47 -28.09 33.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.637 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 11.9 tp -68.7 -34.05 74.99 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.852 0.358 . . . . 0.0 111.873 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 214' ' ' LEU . . . . . 0.579 ' O ' HG12 ' C' ' 217' ' ' VAL . 20.8 tp -46.87 -57.37 9.19 Favored Pre-proline 0 CA--C 1.556 1.202 0 CA-C-O 118.913 -0.565 . . . . 0.0 111.59 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.5 -42.74 15.6 Favored 'Trans proline' 0 N--CA 1.504 2.117 0 C-N-CA 121.882 1.721 . . . . 0.0 113.316 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.96 -45.16 83.04 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.89 -177.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 217' ' ' VAL . . . . . 0.579 HG12 ' O ' ' C' ' 214' ' ' LEU . 11.6 p -60.26 -35.78 64.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 122.055 -0.403 . . . . 0.0 110.757 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 44.7 mm -62.15 -45.16 99.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -60.34 -41.83 94.43 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.511 0.672 . . . . 0.0 109.462 177.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -57.72 -37.7 73.99 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.697 0.76 . . . . 0.0 110.447 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -59.97 -33.52 79.25 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 222' ' ' LEU . . . . . 0.493 HD11 ' HA3' ' B' ' 221' ' ' GLY . 4.9 tp -58.65 -38.38 78.01 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.534 0.683 . . . . 0.0 110.776 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.71 89.2 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.214 0.53 . . . . 0.0 110.751 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 11.8 mt -61.47 -47.77 84.14 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.2 0.524 . . . . 0.0 110.44 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 18.0 tp -58.19 -38.49 76.81 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.196 0.522 . . . . 0.0 110.381 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 36.1 t -59.85 -40.56 88.99 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.272 0.558 . . . . 0.0 110.746 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 10.5 mt -64.78 -42.72 94.87 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.671 0.748 . . . . 0.0 110.2 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 7.7 mp -70.52 -34.88 72.8 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.204 0.526 . . . . 0.0 111.046 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 229' ' ' PHE . . . . . 0.414 ' CD2' HD13 ' B' ' 228' ' ' LEU . 31.7 t80 -70.1 -42.41 72.76 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.022 0.439 . . . . 0.0 111.653 -178.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 6.2 tp -68.84 -35.93 71.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 121.417 0.627 . . . . 0.0 110.931 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -66.72 -32.15 80.5 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 111.559 -0.617 . . . . 0.0 111.559 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 232' ' ' LEU . . . . . 0.461 HD23 ' O ' ' C' ' 232' ' ' LEU . 1.9 tt -56.9 -40.8 76.95 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.58 0.705 . . . . 0.0 110.611 -179.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -57.52 -37.48 73.09 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.837 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -60.32 -44.22 95.65 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.535 0.683 . . . . 0.0 109.954 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 78.8 mtt85 -65.73 -25.99 67.54 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.477 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -85.24 -1.54 57.05 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 122.038 -0.414 . . . . 0.0 111.777 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -126.58 22.91 6.9 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.827 -0.546 . . . . 0.0 111.315 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.81 -1.091 . . . . 0.0 110.639 179.976 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 210' ' ' THR . 6.4 t -121.1 94.56 4.38 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 122.048 0.927 . . . . 0.0 111.085 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 3.2 m 46.36 31.14 1.18 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 122.006 0.908 . . . . 0.0 111.794 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 26.1 m -70.68 -28.91 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.247 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 21.1 tp -66.1 -41.06 91.14 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 122.11 -0.369 . . . . 0.0 111.891 -178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.418 ' O ' HG12 ' A' ' 217' ' ' VAL . 8.0 tp -52.19 -57.29 15.82 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-O 119.03 -0.51 . . . . 0.0 111.396 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.12 -32.06 64.19 Favored 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 121.924 1.75 . . . . 0.0 113.355 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 7.5 tp -69.4 -45.11 70.04 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 122.001 -0.437 . . . . 0.0 111.813 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 214' ' ' LEU . 13.1 p -65.83 -36.68 78.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 O-C-N 122.245 -0.284 . . . . 0.0 111.456 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 26.4 pt -69.09 -38.39 78.13 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 O-C-N 121.488 -0.757 . . . . 0.0 110.744 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -68.98 -40.56 78.73 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.538 0.685 . . . . 0.0 110.319 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.84 -37.04 75.55 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.568 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.473 ' HA3' HD11 ' B' ' 222' ' ' LEU . . . -66.65 -33.78 85.46 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.469 HD11 ' HA3' ' C' ' 221' ' ' GLY . 8.2 tp -58.78 -37.44 76.31 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.229 0.538 . . . . 0.0 111.195 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.94 -39.23 91.38 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.105 0.479 . . . . 0.0 110.725 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.2 mp -65.69 -39.32 91.16 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.301 0.572 . . . . 0.0 110.493 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 19.4 tp -59.72 -39.79 85.84 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.191 0.52 . . . . 0.0 110.428 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 50.6 m -58.33 -41.54 84.79 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.308 0.575 . . . . 0.0 110.303 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.3 mt -64.16 -43.47 95.06 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.216 0.531 . . . . 0.0 110.546 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.0 mp -66.49 -38.07 86.45 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.101 0.476 . . . . 0.0 110.607 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -59.77 -42.18 92.7 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.049 0.452 . . . . 0.0 110.572 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 1.4 mp -64.21 -39.82 86.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.594 0.712 . . . . 0.0 109.367 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -59.67 -32.01 72.79 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.461 ' C ' HD23 ' A' ' 232' ' ' LEU . 9.1 tt -58.13 -45.27 87.62 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.475 0.655 . . . . 0.0 110.936 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -65.09 -37.51 87.74 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.354 0.597 . . . . 0.0 110.997 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -64.04 -37.52 87.75 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.338 0.589 . . . . 0.0 110.738 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -61.29 -37.79 84.45 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.224 0.535 . . . . 0.0 110.934 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -86.24 5.2 35.44 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.868 0.366 . . . . 0.0 111.956 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -52.18 -32.49 36.36 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.45 0.643 . . . . 0.0 111.056 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 . . . . . 0 N--CA 1.469 0.505 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.794 179.879 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 17.5 p -99.9 115.17 29.01 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.391 0.615 . . . . 0.0 110.565 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 3.2 m 53.0 34.28 16.63 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 122.306 1.051 . . . . 0.0 110.924 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 14.8 p -70.59 -23.23 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.833 179.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 9.3 tt -69.19 -40.18 78.21 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.497 ' O ' HG12 ' B' ' 217' ' ' VAL . 2.0 tp -54.42 -56.86 22.1 Favored Pre-proline 0 CA--C 1.548 0.892 0 O-C-N 121.691 -0.631 . . . . 0.0 110.924 -178.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 0.406 ' HD3' ' HB3' ' B' ' 214' ' ' LEU . 16.2 Cg_exo -64.24 -37.45 40.87 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 121.544 1.496 . . . . 0.0 112.476 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 4.4 tt -60.06 -45.38 93.06 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.102 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.497 HG12 ' O ' ' B' ' 214' ' ' LEU . 11.0 p -65.1 -36.57 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 O-C-N 122.219 -0.301 . . . . 0.0 110.682 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 46.2 mt -65.38 -44.95 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -67.93 -36.72 80.63 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.695 0.759 . . . . 0.0 109.987 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -57.78 -45.18 86.36 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.344 0.592 . . . . 0.0 110.678 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.66 -33.91 86.71 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . 0.473 HD11 ' HA3' ' A' ' 221' ' ' GLY . 6.5 tp -59.86 -41.25 91.04 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.455 0.645 . . . . 0.0 110.959 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.33 91.57 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.266 0.555 . . . . 0.0 110.614 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 1.1 tt -61.78 -41.54 97.85 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.532 0.682 . . . . 0.0 109.811 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . 0.401 HD13 HD13 ' C' ' 225' ' ' LEU . 20.7 tp -58.81 -42.97 90.39 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.263 0.554 . . . . 0.0 110.49 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 6.7 m -62.68 -43.51 98.61 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.474 0.654 . . . . 0.0 110.222 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 5.7 mp -65.5 -40.76 93.43 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.326 0.584 . . . . 0.0 110.686 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 16.8 tp -71.13 -34.66 71.26 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.505 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -71.03 -42.64 69.25 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 121.867 -0.521 . . . . 0.0 111.274 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 7.5 tp -69.34 -37.19 75.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 121.838 0.828 . . . . 0.0 111.081 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.69 -31.83 62.23 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.614 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 4.3 tt -61.14 -41.02 95.98 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.526 0.679 . . . . 0.0 111.007 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -63.97 -41.92 97.4 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.365 0.602 . . . . 0.0 110.907 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -63.34 -46.95 84.22 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.614 0.721 . . . . 0.0 110.493 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -59.01 -38.06 78.35 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.418 0.628 . . . . 0.0 110.897 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -86.02 4.52 37.54 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.79 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -141.55 40.41 1.72 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.994 0.902 . . . . 0.0 110.298 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 47.5 ttt85 . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.771 179.989 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 2.5 t 41.26 99.07 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.991 0.9 . . . . 0.0 112.509 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 7.0 p -70.24 73.09 0.47 Allowed 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.321 1.058 . . . . 0.0 110.964 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 27.7 m -64.81 -25.83 38.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.125 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 4.4 tt -68.98 -35.37 76.64 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.886 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 214' ' ' LEU . . . . . 0.499 ' O ' HG12 ' C' ' 217' ' ' VAL . 4.0 tp -46.36 -57.17 9.05 Favored Pre-proline 0 CA--C 1.553 1.093 0 CA-C-O 119.112 -0.471 . . . . 0.0 111.642 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 215' ' ' PRO . . . . . 0.429 ' HA ' HD12 ' C' ' 218' ' ' ILE . 37.0 Cg_endo -63.84 -38.97 35.92 Favored 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 121.841 1.694 . . . . 0.0 113.032 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -45.35 90.91 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.839 0.352 . . . . 0.0 111.723 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 217' ' ' VAL . . . . . 0.499 HG12 ' O ' ' C' ' 214' ' ' LEU . 7.1 p -64.46 -36.57 77.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 122.088 -0.382 . . . . 0.0 110.514 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 218' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' C' ' 215' ' ' PRO . 50.9 mt -63.0 -45.15 99.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.455 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -64.39 -37.32 87.09 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.618 0.723 . . . . 0.0 110.092 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -57.96 -45.29 86.92 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.419 0.628 . . . . 0.0 110.578 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 221' ' ' GLY . . . . . 0.469 ' HA3' HD11 ' A' ' 222' ' ' LEU . . . -60.13 -33.79 81.22 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 4.8 tp -59.06 -40.33 84.79 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.585 0.707 . . . . 0.0 110.629 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.83 -39.05 90.45 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.864 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 36.2 mt -61.6 -40.01 93.28 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.416 0.627 . . . . 0.0 110.581 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . 0.401 HD13 HD13 ' B' ' 225' ' ' LEU . 32.3 tp -60.93 -35.28 76.3 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.062 0.458 . . . . 0.0 110.314 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 42.8 t -57.6 -46.7 83.71 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.371 0.605 . . . . 0.0 109.669 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 8.1 mp -60.89 -42.24 97.63 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.395 0.617 . . . . 0.0 110.244 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.63 -37.25 86.93 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.201 0.524 . . . . 0.0 110.585 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -69.79 -42.08 74.24 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.173 0.511 . . . . 0.0 111.183 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 34.0 mm -63.01 -41.04 91.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.506 0.669 . . . . 0.0 110.072 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -62.78 -33.28 86.44 Favored Glycine 0 CA--C 1.535 1.289 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 7.8 tt -61.89 -34.66 76.44 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 122.178 -0.601 . . . . 0.0 111.764 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -61.43 -35.81 78.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.138 0.494 . . . . 0.0 111.354 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -59.87 -44.49 94.14 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.365 0.602 . . . . 0.0 110.575 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 66.5 mtp85 -63.96 -32.12 73.54 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.429 0.633 . . . . 0.0 110.832 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -85.79 -8.76 57.91 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 120.959 0.409 . . . . 0.0 111.146 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -164.86 88.79 0.48 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.737 0.779 . . . . 0.0 110.231 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.883 -1.056 . . . . 0.0 111.03 -179.693 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 48.4 p -73.14 168.81 18.34 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.385 0.612 . . . . 0.0 110.624 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 43.7 p -97.96 59.51 1.43 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 122.133 0.968 . . . . 0.0 111.039 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 26.2 t -70.31 -34.83 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-O 121.471 0.653 . . . . 0.0 110.207 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 54.2 mt -66.56 -33.26 75.28 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.499 ' O ' HG12 ' A' ' 217' ' ' VAL . 0.1 OUTLIER -53.77 -57.54 17.1 Favored Pre-proline 0 CA--C 1.55 0.955 0 O-C-N 121.96 -0.463 . . . . 0.0 111.085 -179.213 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.73 -32.94 67.52 Favored 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 121.868 1.712 . . . . 0.0 112.814 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.94 -45.32 95.19 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.041 0.448 . . . . 0.0 111.468 -178.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.499 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.3 p -67.92 -36.51 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 O-C-N 122.125 -0.359 . . . . 0.0 110.203 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 52.6 mt -67.84 -42.83 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 121.507 0.67 . . . . 0.0 109.212 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -62.93 -36.72 84.34 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.482 0.658 . . . . 0.0 110.524 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -57.74 -43.44 85.39 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.367 0.603 . . . . 0.0 110.207 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.415 ' HA3' HD11 ' B' ' 222' ' ' LEU . . . -64.12 -33.91 88.49 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 178.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 6.8 tp -60.58 -38.82 85.87 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.587 0.708 . . . . 0.0 110.643 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.81 -38.77 89.38 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.239 0.542 . . . . 0.0 110.711 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 6.1 mp -59.8 -35.95 75.72 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.207 0.527 . . . . 0.0 110.471 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 13.4 tp -58.44 -36.58 73.86 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.089 0.471 . . . . 0.0 110.913 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 23.5 t -58.46 -44.36 89.21 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.27 0.557 . . . . 0.0 110.533 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.9 mt -61.66 -43.14 99.42 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.461 0.648 . . . . 0.0 110.013 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 6.8 mt -66.51 -37.31 84.77 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.149 0.5 . . . . 0.0 110.414 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -65.85 -41.98 91.01 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.319 0.58 . . . . 0.0 110.117 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 92.6 mt -63.01 -35.96 73.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 121.409 0.623 . . . . 0.0 110.003 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.56 -32.2 61.0 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 10.0 tt -59.21 -37.33 77.19 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.593 0.711 . . . . 0.0 110.568 179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -58.82 -36.01 73.82 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.254 0.549 . . . . 0.0 111.157 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -60.49 -46.94 88.29 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.486 0.66 . . . . 0.0 110.568 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -64.46 -37.67 88.33 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.274 0.559 . . . . 0.0 110.955 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -85.91 4.18 38.59 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 120.88 0.371 . . . . 0.0 111.948 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -156.67 82.81 0.96 Allowed 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.772 0.796 . . . . 0.0 109.749 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 34.4 ptt-85 . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 117.914 -1.041 . . . . 0.0 111.166 -179.086 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 20.2 m -101.07 83.24 2.47 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.882 0.848 . . . . 0.0 110.139 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 17.1 p 47.3 50.76 14.15 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 122.405 1.098 . . . . 0.0 111.018 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 34.7 t -70.04 -36.74 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.014 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 9.1 tp -69.16 -33.39 73.33 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.592 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.445 ' O ' HG12 ' B' ' 217' ' ' VAL . 1.0 OUTLIER -49.13 -57.26 12.04 Favored Pre-proline 0 CA--C 1.553 1.058 0 O-C-N 121.908 -0.495 . . . . 0.0 111.319 -178.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 0.419 ' HA ' HG12 ' B' ' 218' ' ' ILE . 37.3 Cg_endo -63.7 -29.31 69.08 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 121.905 1.736 . . . . 0.0 113.484 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.16 -45.14 67.36 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.106 0.479 . . . . 0.0 111.51 -178.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.445 HG12 ' O ' ' B' ' 214' ' ' LEU . 8.5 p -65.23 -36.78 78.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 122.098 -0.376 . . . . 0.0 111.409 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . 0.419 HG12 ' HA ' ' B' ' 215' ' ' PRO . 28.7 pt -69.07 -38.2 77.92 Favored 'Isoleucine or valine' 0 C--N 1.348 0.526 0 O-C-N 121.355 -0.841 . . . . 0.0 110.661 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -64.42 -44.03 92.49 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.555 0.693 . . . . 0.0 110.083 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -59.22 -44.63 92.3 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.688 0.756 . . . . 0.0 109.956 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -59.97 -33.37 78.63 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . 0.415 HD11 ' HA3' ' A' ' 221' ' ' GLY . 3.7 tp -59.02 -40.79 86.06 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.417 0.627 . . . . 0.0 110.393 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.89 -38.76 89.53 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.141 0.496 . . . . 0.0 110.873 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 15.3 mt -59.35 -39.08 82.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.227 0.537 . . . . 0.0 110.434 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 18.0 tp -60.82 -38.43 85.4 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.316 0.579 . . . . 0.0 110.317 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 5.6 t -58.29 -47.03 84.95 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.286 0.565 . . . . 0.0 110.425 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 7.7 mp -59.09 -43.8 91.86 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.224 0.535 . . . . 0.0 110.54 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 6.9 mp -67.01 -38.74 86.51 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.127 0.489 . . . . 0.0 110.777 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -67.3 -42.27 84.0 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.208 0.528 . . . . 0.0 111.126 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 34.2 mm -64.99 -42.42 94.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-O 121.648 0.737 . . . . 0.0 109.615 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -58.54 -31.84 67.71 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 232' ' ' LEU . . . . . 0.489 HD13 ' C ' ' B' ' 232' ' ' LEU . 3.2 tm? -57.78 -43.36 85.48 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.718 0.771 . . . . 0.0 110.608 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -64.53 -37.96 89.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.733 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -60.29 -43.22 96.45 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.516 0.674 . . . . 0.0 110.294 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -59.38 -43.09 92.97 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.428 0.632 . . . . 0.0 110.621 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -86.18 4.96 36.31 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.919 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -102.5 55.89 0.78 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 122.217 1.008 . . . . 0.0 110.397 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 36.9 mtm105 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.772 179.965 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 210' ' ' THR . . . . . 0.412 ' O ' HG23 ' C' ' 210' ' ' THR . 7.6 t -66.92 123.55 20.51 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.329 0.585 . . . . 0.0 110.882 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 11.7 p -124.93 55.6 1.35 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 122.322 1.058 . . . . 0.0 110.314 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 44.7 t -70.05 -33.01 53.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.076 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 213' ' ' LEU . . . . . 0.498 ' O ' HD13 ' C' ' 213' ' ' LEU . 0.2 OUTLIER -66.24 -38.49 88.0 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.943 0.402 . . . . 0.0 111.257 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 214' ' ' LEU . . . . . 0.492 ' O ' HG12 ' C' ' 217' ' ' VAL . 3.1 tp -49.26 -57.41 11.77 Favored Pre-proline 0 CA--C 1.554 1.1 0 O-C-N 121.889 -0.507 . . . . 0.0 111.534 -178.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.09 -34.52 57.65 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 121.852 1.701 . . . . 0.0 112.97 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 216' ' ' LEU . . . . . 0.445 HD13 ' O ' ' C' ' 216' ' ' LEU . 0.2 OUTLIER -61.61 -45.26 94.85 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.073 0.463 . . . . 0.0 111.615 -178.34 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 217' ' ' VAL . . . . . 0.492 HG12 ' O ' ' C' ' 214' ' ' LEU . 8.4 p -67.3 -36.56 76.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 122.059 -0.4 . . . . 0.0 110.29 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 41.5 mt -68.66 -41.23 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.498 0.666 . . . . 0.0 109.318 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -62.52 -36.97 84.26 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.379 0.609 . . . . 0.0 110.544 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -57.87 -43.55 86.09 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.503 0.668 . . . . 0.0 110.324 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -60.43 -33.78 82.63 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 179.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 7.4 tp -59.39 -36.47 75.86 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.314 0.578 . . . . 0.0 111.293 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.68 -38.72 88.83 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.132 0.491 . . . . 0.0 111.012 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 7.2 mp -59.3 -39.27 82.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.214 0.53 . . . . 0.0 110.416 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 24.2 tp -61.75 -38.51 88.25 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.258 0.551 . . . . 0.0 110.458 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 74.9 m -58.32 -42.65 87.25 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.24 0.543 . . . . 0.0 110.916 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.97 -42.3 97.3 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.386 0.612 . . . . 0.0 110.647 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 6.5 mp -71.16 -34.68 71.19 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.199 0.523 . . . . 0.0 111.103 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -64.94 -42.28 94.77 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.921 0.391 . . . . 0.0 111.816 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 6.6 tp -69.26 -35.77 69.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 121.543 0.687 . . . . 0.0 110.983 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.69 -31.96 62.08 Favored Glycine 0 CA--C 1.535 1.285 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 232' ' ' LEU . . . . . 0.448 HD23 ' C ' ' C' ' 232' ' ' LEU . 9.1 tt -57.2 -44.7 83.9 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.513 0.673 . . . . 0.0 111.016 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -62.93 -39.61 95.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.388 0.613 . . . . 0.0 110.797 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -61.0 -45.25 95.59 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.418 0.627 . . . . 0.0 110.539 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -61.52 -38.33 86.97 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.254 0.549 . . . . 0.0 111.029 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -85.83 -1.81 57.62 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.902 0.382 . . . . 0.0 111.677 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -95.79 -31.93 12.94 Favored 'General case' 0 C--N 1.344 0.343 0 O-C-N 121.741 -0.599 . . . . 0.0 111.295 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.541 -179.938 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 5.9 m -140.17 130.76 25.61 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 122.339 -0.507 . . . . 0.0 110.299 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 41.0 p -126.44 36.04 4.55 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 122.099 0.952 . . . . 0.0 111.474 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 57.3 t -70.37 -27.5 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.231 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.405 ' O ' HD23 ' A' ' 213' ' ' LEU . 4.0 tt -66.84 -39.8 87.72 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.921 0.391 . . . . 0.0 111.315 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.519 ' O ' HG12 ' A' ' 217' ' ' VAL . 4.5 tp -47.83 -57.34 10.33 Favored Pre-proline 0 CA--C 1.553 1.068 0 CA-C-O 118.895 -0.574 . . . . 0.0 111.581 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -64.0 -34.02 60.58 Favored 'Trans proline' 0 N--CA 1.503 2.083 0 C-N-CA 121.752 1.635 . . . . 0.0 113.113 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.6 tp -61.13 -45.32 95.14 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.011 0.434 . . . . 0.0 111.634 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.519 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.2 p -65.39 -36.6 78.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 O-C-N 122.204 -0.31 . . . . 0.0 110.631 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 42.2 mm -65.05 -42.41 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -60.96 -36.75 80.19 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.394 0.616 . . . . 0.0 110.287 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.88 -42.13 83.93 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.399 0.619 . . . . 0.0 109.897 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -65.47 -33.8 87.43 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 7.4 tp -58.75 -34.58 71.56 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.253 0.549 . . . . 0.0 111.077 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.63 -38.76 88.84 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.24 0.543 . . . . 0.0 110.974 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.9 mp -61.5 -38.87 88.9 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.357 0.599 . . . . 0.0 110.443 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.435 HD13 HD13 ' B' ' 225' ' ' LEU . 16.8 tp -59.07 -41.91 89.1 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.278 0.561 . . . . 0.0 110.447 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 46.9 t -59.9 -42.26 93.45 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.299 0.571 . . . . 0.0 110.742 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 1.6 tt -62.63 -46.71 86.97 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.365 0.602 . . . . 0.0 110.48 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 7.4 mp -66.0 -40.18 90.93 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.915 0.388 . . . . 0.0 111.376 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -70.06 -42.27 73.04 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.219 0.533 . . . . 0.0 110.95 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 93.4 mt -68.04 -42.16 85.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.484 0.659 . . . . 0.0 110.164 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -62.97 -34.3 89.56 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.449 ' O ' HD23 ' A' ' 232' ' ' LEU . 1.4 tt -68.24 -39.18 82.35 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.57 0.7 . . . . 0.0 110.929 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . 0.42 ' HA ' ' CZ ' ' A' ' 236' ' ' TYR . . . -70.32 -35.61 73.75 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.294 0.569 . . . . 0.0 112.279 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -59.76 -31.9 70.08 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.34 -48.3 70.67 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.59 -0.694 . . . . 0.0 112.516 -178.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.42 ' CZ ' ' HA ' ' A' ' 233' ' ' ALA . 19.1 p90 -96.5 5.54 50.6 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 121.631 -0.668 . . . . 0.0 111.96 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -52.75 -38.95 61.72 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.556 0.693 . . . . 0.0 110.852 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 56.5 ttt-85 . . . . . 0 C--O 1.218 -0.59 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.623 -179.848 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.354 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 3.8 m -111.39 -60.37 1.85 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.369 0.604 . . . . 0.0 110.574 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 1.4 m -139.0 37.78 2.14 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 122.164 0.983 . . . . 0.0 110.675 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 41.5 t -70.34 -26.61 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.422 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 12.1 tp -64.14 -40.94 97.24 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 122.149 -0.344 . . . . 0.0 111.847 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.497 ' O ' HG12 ' B' ' 217' ' ' VAL . 1.5 tt -54.54 -57.07 20.54 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-O 119.103 -0.475 . . . . 0.0 111.332 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.86 -33.31 64.81 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 121.852 1.701 . . . . 0.0 112.942 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 216' ' ' LEU . . . . . 0.445 HD23 ' O ' ' B' ' 216' ' ' LEU . 3.6 tt -61.86 -45.53 93.4 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.091 0.472 . . . . 0.0 111.493 -178.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.497 HG12 ' O ' ' B' ' 214' ' ' LEU . 7.2 p -66.66 -36.53 77.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 O-C-N 122.128 -0.357 . . . . 0.0 110.302 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . 0.444 HD11 ' CD2' ' B' ' 214' ' ' LEU . 53.5 mt -67.46 -44.69 86.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -64.43 -36.74 85.13 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.515 0.674 . . . . 0.0 110.029 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -57.65 -43.74 85.17 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.295 0.569 . . . . 0.0 110.408 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -70.15 -35.68 70.91 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.21 -27.56 69.15 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.185 0.517 . . . . 0.0 110.71 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.72 -38.88 89.52 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.263 0.554 . . . . 0.0 110.323 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 51.1 mt -60.31 -38.49 83.85 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.331 0.586 . . . . 0.0 110.367 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . 0.435 HD13 HD13 ' A' ' 225' ' ' LEU . 17.4 tp -57.98 -35.41 71.15 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.193 0.52 . . . . 0.0 110.655 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 17.1 m -58.4 -40.43 82.38 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.202 0.525 . . . . 0.0 110.834 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 8.0 mp -63.33 -45.59 90.54 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.49 0.662 . . . . 0.0 110.796 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 8.0 mp -71.23 -34.98 71.28 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.267 0.556 . . . . 0.0 111.224 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -72.52 -42.12 65.12 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.111 0.481 . . . . 0.0 111.82 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 7.7 tp -66.12 -35.92 76.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 121.411 0.624 . . . . 0.0 111.326 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -73.11 -36.73 56.28 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 232' ' ' LEU . . . . . 0.409 ' O ' HD23 ' B' ' 232' ' ' LEU . 3.0 tt -62.85 -46.08 89.56 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.718 0.77 . . . . 0.0 111.126 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -70.35 -35.35 73.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.539 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -59.37 -45.45 91.41 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -177.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -60.74 -34.43 74.4 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.452 0.644 . . . . 0.0 110.977 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -85.97 -5.57 59.2 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.824 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -90.14 44.66 1.21 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.987 0.899 . . . . 0.0 110.622 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.717 179.677 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . 0.436 ' O ' HG23 ' C' ' 210' ' ' THR . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 210' ' ' THR . . . . . 0.436 HG23 ' O ' ' C' ' 209' ' ' GLY . 6.9 p -155.5 150.26 26.38 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.293 0.568 . . . . 0.0 110.53 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 211' ' ' THR . . . . . 0.447 HG22 ' HB2' ' C' ' 214' ' ' LEU . 0.2 OUTLIER -118.82 42.15 2.86 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 122.437 1.113 . . . . 0.0 110.244 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 13.4 p -70.24 -29.14 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.779 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 213' ' ' LEU . . . . . . . . . . . . . 15.0 tp -65.6 -40.43 92.66 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.831 0.348 . . . . 0.0 111.775 -179.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 214' ' ' LEU . . . . . 0.484 ' O ' HG12 ' C' ' 217' ' ' VAL . 11.0 tp -50.6 -57.11 14.34 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-O 119.011 -0.519 . . . . 0.0 111.634 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.87 -35.56 55.26 Favored 'Trans proline' 0 N--CA 1.504 2.116 0 C-N-CA 121.824 1.682 . . . . 0.0 112.961 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 5.3 tt -61.35 -45.43 94.45 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.987 0.423 . . . . 0.0 111.701 -178.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 217' ' ' VAL . . . . . 0.484 HG12 ' O ' ' C' ' 214' ' ' LEU . 10.0 p -66.99 -36.45 77.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 122.214 -0.303 . . . . 0.0 110.339 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 218' ' ' ILE . . . . . . . . . . . . . 57.0 mt -67.59 -45.15 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -66.45 -37.32 84.88 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.41 0.624 . . . . 0.0 110.285 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -60.5 -45.79 92.5 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.462 0.649 . . . . 0.0 110.067 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.23 -33.64 87.77 Favored Glycine 0 CA--C 1.531 1.038 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 222' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' B' ' 218' ' ' ILE . 6.0 tp -58.73 -39.64 81.47 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.522 0.677 . . . . 0.0 110.172 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.72 -38.46 87.99 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.577 0.704 . . . . 0.0 110.32 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 2.3 tp -58.71 -45.9 88.52 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.248 0.546 . . . . 0.0 110.257 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . 0.428 HD13 ' CD1' ' A' ' 225' ' ' LEU . 25.4 tp -62.5 -39.56 93.9 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.256 0.55 . . . . 0.0 109.997 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 16.6 t -57.35 -45.56 84.24 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.095 0.474 . . . . 0.0 110.296 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 11.4 mt -63.12 -42.14 99.46 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.206 0.527 . . . . 0.0 110.499 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 5.8 tp -65.88 -34.89 79.18 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.274 0.559 . . . . 0.0 110.442 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -65.34 -38.11 89.13 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.189 0.518 . . . . 0.0 110.936 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 36.3 mm -62.79 -43.39 98.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.526 0.679 . . . . 0.0 110.035 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -72.98 -37.05 56.76 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 232' ' ' LEU . . . . . 0.416 HD23 ' C ' ' C' ' 232' ' ' LEU . 8.3 tt -63.59 -44.08 95.09 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.387 0.613 . . . . 0.0 111.272 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -65.55 -35.55 81.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.347 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -59.73 -44.0 93.95 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 121.432 0.634 . . . . 0.0 110.296 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 63.0 mtt-85 -69.64 -18.68 63.61 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.359 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -85.76 -13.68 47.52 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 122.023 -0.423 . . . . 0.0 111.419 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 53.1 49.61 19.65 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 122.123 0.963 . . . . 0.0 110.428 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.737 -179.973 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.369 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.426 HG23 ' O ' ' A' ' 210' ' ' THR . 3.6 t -127.77 109.44 11.65 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.747 0.784 . . . . 0.0 111.01 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 56.3 p 45.26 47.32 10.29 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-O 122.159 0.98 . . . . 0.0 111.736 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 12.9 p -69.9 -21.5 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.356 178.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.14 -33.0 72.74 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.073 0.463 . . . . 0.0 110.811 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.468 ' O ' HG12 ' A' ' 217' ' ' VAL . 3.3 tp -53.95 -57.07 19.43 Favored Pre-proline 0 CA--C 1.554 1.108 0 CA-C-O 119.063 -0.494 . . . . 0.0 111.534 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -63.32 -29.87 72.92 Favored 'Trans proline' 0 N--CA 1.504 2.128 0 C-N-CA 121.969 1.779 . . . . 0.0 113.612 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.5 tt -69.32 -45.31 69.79 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.813 -0.554 . . . . 0.0 111.44 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 214' ' ' LEU . 7.9 p -64.93 -36.8 78.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 O-C-N 122.066 -0.396 . . . . 0.0 111.62 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 21.2 pt -70.68 -40.17 76.67 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 O-C-N 121.421 -0.8 . . . . 0.0 110.616 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -67.95 -42.14 81.4 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.668 0.747 . . . . 0.0 110.088 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -60.38 -44.14 95.92 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.535 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -64.62 -33.84 88.31 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.485 HD13 HG23 ' C' ' 218' ' ' ILE . 4.4 tp -59.57 -39.36 83.84 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.561 0.696 . . . . 0.0 110.323 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.52 88.28 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.292 0.568 . . . . 0.0 110.285 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.5 tp -58.89 -38.58 79.2 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.377 0.608 . . . . 0.0 110.007 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.424 HD13 HD13 ' B' ' 225' ' ' LEU . 17.5 tp -60.52 -32.35 71.38 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.197 0.522 . . . . 0.0 110.431 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 16.9 m -59.76 -43.67 94.21 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.212 0.529 . . . . 0.0 111.192 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 7.1 mp -65.04 -41.77 94.92 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.739 0.781 . . . . 0.0 110.58 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 25.8 mt -71.11 -34.8 71.44 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.397 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -69.24 -42.32 75.78 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.24 0.543 . . . . 0.0 111.677 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 6.1 tp -68.1 -36.06 73.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 121.588 0.708 . . . . 0.0 110.866 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -67.51 -31.69 77.18 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.51 HD13 ' C ' ' A' ' 232' ' ' LEU . 3.2 tm? -56.89 -43.04 80.9 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.542 0.687 . . . . 0.0 110.485 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -59.66 -38.94 82.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.351 0.596 . . . . 0.0 110.686 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -60.91 -44.16 97.54 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.603 0.716 . . . . 0.0 110.011 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 76.1 mtp85 -66.53 -34.62 78.32 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.464 0.65 . . . . 0.0 110.736 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -85.93 0.22 53.75 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.602 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -127.97 36.96 4.25 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.912 0.863 . . . . 0.0 110.625 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.747 179.802 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 210' ' ' THR . . . . . . . . . . . . . 25.2 m -149.59 108.3 3.84 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.375 0.607 . . . . 0.0 110.796 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 7.4 t -131.49 40.93 3.36 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.302 1.049 . . . . 0.0 110.592 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 212' ' ' VAL . . . . . . . . . . . . . 34.2 m -70.26 -25.25 26.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.785 179.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 10.0 tp -67.14 -36.56 82.14 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.487 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.503 ' O ' HG12 ' B' ' 217' ' ' VAL . 0.2 OUTLIER -54.07 -57.64 17.12 Favored Pre-proline 0 CA--C 1.552 1.023 0 O-C-N 122.052 -0.405 . . . . 0.0 110.8 -179.149 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.95 -34.87 58.02 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 121.9 1.733 . . . . 0.0 112.722 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 7.8 tp -61.33 -45.4 94.59 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.944 0.402 . . . . 0.0 111.694 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.503 HG12 ' O ' ' B' ' 214' ' ' LEU . 9.2 p -66.46 -36.48 77.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 O-C-N 122.228 -0.295 . . . . 0.0 110.257 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 218' ' ' ILE . . . . . . . . . . . . . 55.6 mt -68.57 -42.72 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.433 0.635 . . . . 0.0 109.342 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 219' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -65.01 -40.55 95.07 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.572 0.701 . . . . 0.0 110.193 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 220' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -59.42 -41.65 90.03 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.558 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -61.66 -33.74 86.1 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 6.4 tp -58.92 -31.69 68.88 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.3 0.572 . . . . 0.0 111.317 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.68 -38.78 89.05 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.091 0.472 . . . . 0.0 110.805 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 6.4 mp -61.69 -39.25 90.78 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.368 0.604 . . . . 0.0 110.149 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . 0.424 HD13 HD13 ' A' ' 225' ' ' LEU . 24.7 tp -58.36 -37.96 76.28 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.228 0.537 . . . . 0.0 110.678 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 12.1 t -60.36 -41.65 94.11 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.238 0.542 . . . . 0.0 110.684 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 7.4 mp -62.36 -43.32 99.09 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.189 0.519 . . . . 0.0 110.588 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . . . . . . . . . 1.3 mp -68.38 -42.63 78.83 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.454 0.645 . . . . 0.0 110.22 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -63.96 -42.24 97.33 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.066 0.46 . . . . 0.0 110.748 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.75 -36.13 76.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.336 0.589 . . . . 0.0 110.13 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.82 -32.87 62.48 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 232' ' ' LEU . . . . . . . . . . . . . 4.1 tt -62.85 -44.88 94.96 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.663 0.744 . . . . 0.0 110.595 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -66.88 -36.63 82.73 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.476 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 234' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -59.88 -48.02 83.4 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.337 0.589 . . . . 0.0 110.844 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 235' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -66.47 -22.54 66.2 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.979 0.418 . . . . 0.0 111.647 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 236' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -86.18 -7.16 58.76 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.812 0.339 . . . . 0.0 111.882 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 237' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -61.4 -36.23 79.71 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-O 121.415 0.626 . . . . 0.0 111.332 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 33.8 mtp180 . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.603 -179.59 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 210' ' ' THR . . . . . . . . . . . . . 4.3 m -97.68 -67.23 0.86 Allowed 'General case' 0 CA--C 1.536 0.433 0 O-C-N 122.308 -0.525 . . . . 0.0 111.403 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 211' ' ' THR . . . . . . . . . . . . . 8.1 t -112.55 39.23 2.53 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.056 0.931 . . . . 0.0 111.583 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 212' ' ' VAL . . . . . . . . . . . . . 27.1 m -70.26 -22.34 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.72 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 213' ' ' LEU . . . . . 0.54 ' O ' HD23 ' C' ' 213' ' ' LEU . 1.4 tt -66.81 -35.02 79.09 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.939 0.399 . . . . 0.0 110.962 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 214' ' ' LEU . . . . . 0.581 ' O ' HG12 ' C' ' 217' ' ' VAL . 0.2 OUTLIER -50.64 -58.11 11.1 Favored Pre-proline 0 CA--C 1.553 1.084 0 O-C-N 122.03 -0.419 . . . . 0.0 110.895 -178.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 215' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -64.27 -34.79 54.58 Favored 'Trans proline' 0 N--CA 1.501 1.926 0 C-N-CA 121.882 1.721 . . . . 0.0 113.044 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.91 -45.11 95.94 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.417 -178.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 217' ' ' VAL . . . . . 0.581 HG12 ' O ' ' C' ' 214' ' ' LEU . 10.4 p -64.59 -36.18 76.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 122.084 -0.385 . . . . 0.0 110.873 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 218' ' ' ILE . . . . . 0.485 HG23 HD13 ' A' ' 222' ' ' LEU . 48.9 mt -62.68 -41.7 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -59.39 -42.97 92.94 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.64 0.734 . . . . 0.0 110.05 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.85 -36.96 73.06 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.364 0.602 . . . . 0.0 110.708 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 221' ' ' GLY . . . . . . . . . . . . . . . -63.5 -33.76 88.1 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 4.9 tp -59.18 -39.77 83.59 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.38 0.61 . . . . 0.0 110.994 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -61.68 -40.03 93.52 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.215 0.531 . . . . 0.0 110.952 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 76.5 mt -62.04 -39.09 91.15 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.389 0.614 . . . . 0.0 110.775 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 44.7 tp -59.32 -39.14 82.17 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.498 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 226' ' ' SER . . . . . . . . . . . . . 9.9 p -60.81 -42.09 96.94 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.089 0.471 . . . . 0.0 110.644 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 227' ' ' LEU . . . . . . . . . . . . . 7.1 mp -63.19 -45.48 91.58 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.342 0.592 . . . . 0.0 109.865 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.69 -37.42 87.54 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.098 0.475 . . . . 0.0 110.439 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -62.75 -42.3 99.61 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.327 0.584 . . . . 0.0 109.72 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 230' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.71 -38.93 82.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 121.462 0.648 . . . . 0.0 109.758 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -56.59 -31.85 60.74 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 232' ' ' LEU . . . . . . . . . . . . . 5.7 tt -58.67 -40.33 83.21 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.472 0.653 . . . . 0.0 110.388 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -61.17 -44.26 97.59 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.386 0.612 . . . . 0.0 110.761 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 234' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -62.08 -46.22 90.05 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.358 0.599 . . . . 0.0 110.645 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 235' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -68.47 -36.01 78.37 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.233 0.54 . . . . 0.0 111.49 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 236' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -89.58 4.98 47.62 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 237' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -135.36 55.12 1.89 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 122.081 0.943 . . . . 0.0 110.319 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 63.5 ttt-85 . . . . . 0 C--O 1.221 -0.411 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.548 -179.994 . . . . . . . . 0 0 . 1 stop_ save_